{"meta":{"query_hash":"c2894d613fe8","filters":{"venue":"OncoImmunology"},"cohort_total":218,"direct_labels_cover":1,"predictions_cover":218,"exported":218,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/c2894d613fe8","api":"https://metacan.xera.ac/api/v1/cohort?venue=OncoImmunology"},"results":[{"id":"W1495108757","doi":"10.1080/2162402x.2015.1016709","title":"The antitumor immune response generated by fractionated radiation therapy may be limited by tumor cell adaptive resistance and can be circumvented by PD-L1 blockade","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Blockade; Immune system; Cancer research; CD8; PD-L1; Tumor microenvironment; Immunotherapy; T cell; Medicine; Cell; Radiation therapy; Acquired immune system; Immunology; Biology; Receptor; Internal medicine","score_opus":0.02045912337141762,"score_gpt":0.26386041447586994,"score_spread":0.24340129110445233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1495108757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98042417,0.0045765396,0.013068549,0.00010751535,0.00003220054,0.00005332354,0.000069317764,0.0001719587,0.0014963573],"genre_scores_gemma":[0.997113,0.00057830685,0.0018331755,0.00003854524,0.000015490705,0.000030401,0.000040688057,0.000011498691,0.00033891795],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998915,0.000031572745,0.000007077155,0.00002339062,0.000021606416,0.00002488613],"domain_scores_gemma":[0.9998487,0.00006378583,0.00003745129,0.000026714179,0.00000733217,0.000015896396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032603738,0.0004215092,0.0003938415,0.00025412222,0.0001095628,0.00031184097,0.00017764635,0.00023202488,0.0011404189],"category_scores_gemma":[0.0002368987,0.00009391751,0.0002585097,0.00012519036,0.0003147937,0.00023372407,0.00015774957,0.00075543334,0.00017759827],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026615534,0.00009072431,0.00049462536,0.000080974,0.000019763947,0.000034762314,0.000022078659,0.0004546714,0.9845403,0.00027267757,0.000054527143,0.0136688035],"study_design_scores_gemma":[0.00009173824,0.003515221,0.0050660423,0.000018941948,0.00007817515,0.00060639007,0.000020969703,0.0020106635,0.98576343,0.00023328867,0.0025872407,0.000007941823],"about_ca_topic_score_codex":0.00018837578,"about_ca_topic_score_gemma":0.00026628206,"teacher_disagreement_score":0.0011404189,"about_ca_system_score_codex":0.00024312132,"about_ca_system_score_gemma":0.00020295967,"threshold_uncertainty_score":0.003815055},"labels":[],"label_agreement":null},{"id":"W1556179571","doi":"10.1080/2162402x.2015.1008354","title":"T cell receptor-therapy in HBV-related hepatocellularcarcinoma","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Wellcome Trust","keywords":"T-cell receptor; Chimeric antigen receptor; Adoptive cell transfer; Medicine; Antigen; Immunology; Hepatitis B virus; T cell; Receptor; Cell therapy; Hepatitis B; Cancer research; Virology; Cell; Virus; Immune system; Biology; Internal medicine","score_opus":0.05337410790290423,"score_gpt":0.30603250749086675,"score_spread":0.25265839958796255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1556179571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97544765,0.014649249,0.003369552,0.00039404727,0.0000801167,0.00011144454,0.000049508097,0.00013740399,0.005760961],"genre_scores_gemma":[0.9938257,0.0040975646,0.00061070966,0.000063869906,0.000019295532,0.00003215362,0.000051223902,0.000007875595,0.0012917669],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999422,0.000020784715,0.0000035083576,0.000005514276,0.00001042182,0.000017734266],"domain_scores_gemma":[0.9999709,0.000008468607,0.0000059203235,0.0000043460573,0.0000034152827,0.0000068213767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016313008,0.00017100759,0.00021044578,0.0002130108,0.000113484835,0.00015474788,0.00013758443,0.00027488178,0.001216833],"category_scores_gemma":[0.00011269524,0.000055898254,0.00013347193,0.00015583592,0.00020249885,0.00015698027,0.00013534258,0.0004358204,0.00027481577],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002536457,0.0015830458,0.001965156,0.0008446382,0.000051829746,0.00235758,0.00015516742,0.0018820857,0.8747978,0.002388505,0.00107725,0.110360354],"study_design_scores_gemma":[0.001538947,0.012541973,0.0069096438,0.00006260786,0.0001632259,0.0067326226,0.000095615556,0.0053547993,0.9412655,0.00082930987,0.024484009,0.000021686317],"about_ca_topic_score_codex":0.00038984927,"about_ca_topic_score_gemma":0.0005083486,"teacher_disagreement_score":0.001216833,"about_ca_system_score_codex":0.00017731669,"about_ca_system_score_gemma":0.00020508314,"threshold_uncertainty_score":0.004070699},"labels":[],"label_agreement":null},{"id":"W1574165260","doi":"10.1080/2162402x.2014.999536","title":"CD20<sup>+</sup>T cells have a predominantly Tc1 effector memory phenotype and are expanded in the ascites of patients with ovarian cancer","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","keywords":"CD20; CD8; Immunology; Cytotoxic T cell; Medicine; Biology; Cancer research; Antigen; In vitro","score_opus":0.010496928941660568,"score_gpt":0.22431096020262825,"score_spread":0.21381403126096768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1574165260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99751306,0.0008128797,0.00029172303,0.000049726485,0.000010728988,0.000012569683,0.00021724692,0.000035272024,0.0010568849],"genre_scores_gemma":[0.9983979,0.00022881443,0.00015908177,0.00005803366,0.000032276144,0.000009943492,0.00035676593,0.000010740012,0.00074650167],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999287,0.000009418714,0.0000071535137,0.000016352318,0.00001602697,0.000022363185],"domain_scores_gemma":[0.9997713,0.000034964578,0.00009947675,0.000014366056,0.000026756754,0.00005303236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000931621,0.00023830893,0.00025067385,0.00052256143,0.0001943482,0.00029632103,0.00007874509,0.0001763376,0.002934561],"category_scores_gemma":[0.0003819828,0.0000962486,0.000098503035,0.00032392188,0.00012547252,0.00017704774,0.00016037798,0.00026644435,0.0005000691],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024903289,0.00015510847,0.59734,0.00018827718,0.0000549863,0.0036991686,0.00039982234,0.00019693568,0.33511496,0.000092279006,0.0011692095,0.05909887],"study_design_scores_gemma":[0.000048698632,0.0009955685,0.95199037,0.000018540695,0.00006047375,0.013457831,0.00030161883,0.00050492573,0.026313884,0.0001391514,0.0061594085,0.000009465001],"about_ca_topic_score_codex":0.00043741197,"about_ca_topic_score_gemma":0.00042284856,"teacher_disagreement_score":0.002934561,"about_ca_system_score_codex":0.000096907264,"about_ca_system_score_gemma":0.000063144835,"threshold_uncertainty_score":0.009817123},"labels":[],"label_agreement":null},{"id":"W1601735325","doi":"10.1080/2162402x.2015.1016707","title":"Deficient regulatory B cells in human chronic graft-versus-host disease","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institut National Du Cancer; Institute of Cancer Research; Société Française de Dermatologie et de Pathologie Sexuellement Transmissible","keywords":"Regulatory B cells; Graft-versus-host disease; Immunology; Hematopoietic stem cell transplantation; Disease; Immune system; Medicine; Stem cell; Haematopoiesis; Transplantation; Innate immune system; Downregulation and upregulation; Cancer research; Biology; Interleukin 10; Gene; Internal medicine; Cell biology; Genetics","score_opus":0.03451271174651163,"score_gpt":0.2981925151773277,"score_spread":0.2636798034308161,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1601735325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884724,0.007778626,0.0010843915,0.0001386268,0.000033581524,0.000028073455,0.00021771094,0.00005346217,0.0021931333],"genre_scores_gemma":[0.9963636,0.002081748,0.00048735217,0.000067977846,0.000017037593,0.00001713894,0.00026772538,0.000009667769,0.00068779173],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99987924,0.00004707948,0.000017373302,0.000020243555,0.000017495777,0.000018503135],"domain_scores_gemma":[0.9998392,0.00004522816,0.00003408002,0.000019471396,0.000018602059,0.00004334969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040966293,0.0003305338,0.00024533976,0.0008628544,0.00018264468,0.00020543327,0.00013567478,0.0003414807,0.0016778831],"category_scores_gemma":[0.00029389298,0.00011830517,0.00010548458,0.0002564469,0.00039131942,0.0001922297,0.00026699717,0.00027985135,0.00038012743],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005192949,0.0004276413,0.019039594,0.0003531256,0.000054569235,0.005928674,0.00029921858,0.00035039472,0.93602896,0.0021647722,0.000973684,0.02918643],"study_design_scores_gemma":[0.0024728677,0.009360633,0.2766063,0.00032120853,0.00066949433,0.11571542,0.0008289921,0.0035518925,0.5063067,0.006677597,0.07740279,0.00008611547],"about_ca_topic_score_codex":0.00031617304,"about_ca_topic_score_gemma":0.00021542872,"teacher_disagreement_score":0.0016778831,"about_ca_system_score_codex":0.0000985549,"about_ca_system_score_gemma":0.0001589842,"threshold_uncertainty_score":0.005613029},"labels":[],"label_agreement":null},{"id":"W1602732985","doi":"10.1080/2162402x.2015.1026529","title":"Survivin-targeted immunotherapy drives robust polyfunctional T cell generation and differentiation in advanced ovarian cancer patients","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Health Authority; Princess Margaret Cancer Centre; University Health Network; Immunovaccine (Canada); Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Immune system; CD8; Survivin; Immunotherapy; Antigen; Immunology; Medicine; Cancer research; Cytotoxic T cell; Ovarian cancer; Cancer immunotherapy; T cell; Tumor antigen; Cancer; Biology; Internal medicine","score_opus":0.01658068134635127,"score_gpt":0.23476289167382006,"score_spread":0.2181822103274688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1602732985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99626607,0.0008820814,0.0010261703,0.00011083389,0.000016872073,0.000040852992,0.0000774762,0.000046604622,0.0015329767],"genre_scores_gemma":[0.9991923,0.00014877359,0.00018631153,0.000041695603,0.0000050227563,0.000012640027,0.00008159945,0.000003723657,0.0003280026],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99990106,0.000024623116,0.000009675685,0.000020350399,0.000016134487,0.000028183926],"domain_scores_gemma":[0.99994326,0.000012462134,0.000009866335,0.000010239621,0.000006989224,0.000017065848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018297204,0.00010402251,0.00020347624,0.00012929097,0.000098956734,0.0002706432,0.000065630156,0.00014723593,0.0009774663],"category_scores_gemma":[0.00024772531,0.00007068421,0.00008595785,0.00012914608,0.0001717516,0.00010842143,0.00013166592,0.00046717838,0.00017261879],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022010393,0.0006360782,0.021910172,0.00012433235,0.000039876624,0.0005796343,0.00024718422,0.0011181404,0.89509785,0.0006674289,0.0014965826,0.07588168],"study_design_scores_gemma":[0.0011216047,0.024427721,0.24535412,0.000056991954,0.00028254837,0.008281169,0.0005754254,0.011416259,0.6652578,0.0014997011,0.04169454,0.000032009062],"about_ca_topic_score_codex":0.0004250582,"about_ca_topic_score_gemma":0.0006306004,"teacher_disagreement_score":0.0009774663,"about_ca_system_score_codex":0.00018580718,"about_ca_system_score_gemma":0.00016554318,"threshold_uncertainty_score":0.0032699108},"labels":[],"label_agreement":null},{"id":"W1626602876","doi":"10.1080/2162402x.2015.1074375","title":"Autoantibodies specific to estrogen receptor alpha act as estrogen agonists and their levels correlate with breast cancer cell proliferation","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Lethbridge","keywords":"Breast cancer; Estrogen receptor; Cancer; Autoantibody; Medicine; Cancer research; Estrogen; Receptor; Cell growth; Estrogen receptor alpha; Internal medicine; Endocrinology; Cancer cell; Immunology; Antibody; Biology","score_opus":0.010404165211724417,"score_gpt":0.24315693716277084,"score_spread":0.23275277195104643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1626602876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952095,0.0026265148,0.000561049,0.000031835687,0.000014968234,0.000008182649,0.00006501625,0.000025324007,0.001457606],"genre_scores_gemma":[0.99843115,0.000535278,0.00033386415,0.000024137824,0.000023631866,0.000006454065,0.00007931329,0.0000026943987,0.0005634783],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997819,0.000084693536,0.00001796648,0.00003728433,0.000038452272,0.000039579467],"domain_scores_gemma":[0.9995964,0.00016045,0.000109798304,0.000023764938,0.00006275988,0.000046883964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022662313,0.0002524612,0.00017513148,0.0005792036,0.000113110276,0.00022879182,0.00007787081,0.00021457879,0.0019907241],"category_scores_gemma":[0.0006112561,0.00009182063,0.00009457672,0.00031149987,0.00012996662,0.0001385349,0.00010659646,0.00020538607,0.0003981846],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012316707,0.000249334,0.48680487,0.00018875794,0.00009032347,0.0018222497,0.00022361029,0.00011435097,0.4686049,0.00014229078,0.0004153693,0.040112223],"study_design_scores_gemma":[0.000054911754,0.0014946335,0.83350736,0.000036659716,0.00015154423,0.015490706,0.00028479003,0.00084775983,0.14289723,0.00023588113,0.004988023,0.000010532293],"about_ca_topic_score_codex":0.00014681857,"about_ca_topic_score_gemma":0.00012877237,"teacher_disagreement_score":0.0019907241,"about_ca_system_score_codex":0.00008245516,"about_ca_system_score_gemma":0.000044866727,"threshold_uncertainty_score":0.0066596866},"labels":[],"label_agreement":null},{"id":"W1658471897","doi":"10.1080/2162402x.2015.1030561","title":"Characterization of T cell repertoire of blood, tumor, and ascites in ovarian cancer patients using next generation sequencing","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Saskatchewan","keywords":"Ascites; Ovarian cancer; T-cell receptor; Immune system; CD8; Biology; Tumor microenvironment; T cell; Cancer research; Cancer; Cytotoxic T cell; Cell; Immunology; Medicine; Internal medicine; Genetics; In vitro","score_opus":0.044810602246881416,"score_gpt":0.24254404966384677,"score_spread":0.19773344741696536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1658471897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987925,0.00020393443,0.000543322,0.000015800146,0.0000023731984,0.000008750752,0.0001317526,0.0000091536185,0.00029228587],"genre_scores_gemma":[0.998623,0.00010548112,0.0008456104,0.0000347436,0.000006333317,0.000013328347,0.00024453073,0.0000045940283,0.00012248177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998685,0.000026829548,0.000013174174,0.000036135138,0.00002463554,0.000030543826],"domain_scores_gemma":[0.9998307,0.00005581073,0.000030314091,0.000015056967,0.00003107467,0.000036997717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015283856,0.00013885032,0.00021952264,0.00086931774,0.0002330134,0.00027702708,0.00009412228,0.00020541331,0.000569005],"category_scores_gemma":[0.00068904663,0.00010333461,0.00012130905,0.0004157832,0.00012101304,0.00013335234,0.00017500945,0.0001868392,0.00009880587],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007411218,0.000056354722,0.8036249,0.000046234894,0.000037181544,0.00090305245,0.0005886421,0.0004253271,0.16691393,0.00009102875,0.00026608983,0.026306042],"study_design_scores_gemma":[0.000028955024,0.00037321565,0.9616313,0.000015609727,0.00007709471,0.0044640787,0.0005582358,0.0050111474,0.025223164,0.000264009,0.0023396648,0.000013416702],"about_ca_topic_score_codex":0.0008290827,"about_ca_topic_score_gemma":0.00082692987,"teacher_disagreement_score":0.00086931774,"about_ca_system_score_codex":0.00010938001,"about_ca_system_score_gemma":0.00008664916,"threshold_uncertainty_score":0.0019035339},"labels":[],"label_agreement":null},{"id":"W1781387617","doi":"10.1080/2162402x.2015.1050575","title":"B7-H4 is a positive regulator of antitumor immunity","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Regulator; Negative regulator; Cancer research; Immunity; Medicine; Immune system; T cell; Immunology; Biology; Signal transduction; Cell biology; Genetics; Gene","score_opus":0.030064290279245134,"score_gpt":0.3041757713370558,"score_spread":0.2741114810578107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1781387617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.71597785,0.16129139,0.013359085,0.0041786954,0.0030860761,0.0002712263,0.0037264058,0.0012590282,0.09685026],"genre_scores_gemma":[0.90575695,0.027474746,0.003630081,0.0008786074,0.00071600947,0.00013817109,0.0049334904,0.00009173394,0.05638031],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997769,0.000036112262,0.000010452793,0.00003634576,0.000084619234,0.000055580556],"domain_scores_gemma":[0.99987495,0.00000905996,0.000021946451,0.0000056565295,0.000048828762,0.000039469684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016274821,0.00044352678,0.00029990243,0.00067803054,0.00051017234,0.0005133073,0.00034421994,0.0004674218,0.008808877],"category_scores_gemma":[0.00017823052,0.00013602505,0.0003556454,0.0003707436,0.00028475592,0.00025949746,0.00044015708,0.0005744439,0.0026625316],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010553657,0.00019046295,0.01047375,0.001124788,0.00015661049,0.0013264711,0.00008886226,0.00035062883,0.8521802,0.006084825,0.02100849,0.105959386],"study_design_scores_gemma":[0.0002044197,0.0010573904,0.043882024,0.00015814071,0.000216321,0.0034241711,0.00026987828,0.0013528388,0.6511205,0.0030856242,0.29516625,0.00006246584],"about_ca_topic_score_codex":0.0006349803,"about_ca_topic_score_gemma":0.0004257847,"teacher_disagreement_score":0.008808877,"about_ca_system_score_codex":0.00048091527,"about_ca_system_score_gemma":0.0003907614,"threshold_uncertainty_score":0.029468656},"labels":[],"label_agreement":null},{"id":"W1860654126","doi":"10.1080/2162402x.2015.1008342","title":"Accumulation of tolerogenic human 6-sulfo LacNAc dendritic cells in renal cell carcinoma is associated with poor prognosis","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Technische Universität Dresden","keywords":"Clear cell renal cell carcinoma; Cancer research; Acquired immune system; Immune system; Medicine; Dendritic cell; Immunotherapy; T cell; Tumor progression; Primary tumor; Cell; Immunology; Renal cell carcinoma; Metastasis; Biology; Cancer; Pathology; Internal medicine","score_opus":0.04511338071340423,"score_gpt":0.28320222357011393,"score_spread":0.2380888428567097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1860654126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99939525,0.00031278864,0.000126133,0.000009253939,0.0000014229444,0.0000024045519,0.000039061328,0.0000051390043,0.000108578424],"genre_scores_gemma":[0.9997377,0.000061465995,0.000049285234,0.0000040349364,0.000002426397,0.0000017959544,0.000055575623,9.1726804e-7,0.00008686135],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998435,0.000027315666,0.000017317814,0.00003160075,0.00004424068,0.00003610967],"domain_scores_gemma":[0.99946624,0.000081011895,0.00021680321,0.000044272605,0.00005973893,0.00013195719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021448081,0.00014306916,0.00025091847,0.00051310624,0.00020998057,0.00027039848,0.000094047464,0.00024271625,0.0006713166],"category_scores_gemma":[0.00045544005,0.000109486245,0.00012266393,0.0003060665,0.00020894525,0.00012745633,0.000156281,0.0002288263,0.00013686188],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016708887,0.00006510644,0.7894186,0.0000595623,0.00005132906,0.000999978,0.00015640967,0.00020728663,0.2026309,0.00005992906,0.000088478824,0.004591609],"study_design_scores_gemma":[0.000010753042,0.00025472825,0.9826984,0.0000042177203,0.000043567892,0.0021636614,0.000102708305,0.0004168632,0.013766664,0.000048420658,0.00048299477,0.00000708288],"about_ca_topic_score_codex":0.0009221411,"about_ca_topic_score_gemma":0.0009362431,"teacher_disagreement_score":0.0009221411,"about_ca_system_score_codex":0.00019100921,"about_ca_system_score_gemma":0.0002359895,"threshold_uncertainty_score":0.0022457838},"labels":[],"label_agreement":null},{"id":"W1890562348","doi":"10.1080/2162402x.2014.1001232","title":"Mast cell/MDSC a liaison immunosuppressive for tumor microenvironment","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Nautical Research Society","funders":"","keywords":"Tumor microenvironment; Myeloid-derived Suppressor Cell; Crosstalk; Cancer research; Immunosuppression; Suppressor; Medicine; Immunology; Cancer; Tumor cells","score_opus":0.019150018419893697,"score_gpt":0.24441366908194395,"score_spread":0.22526365066205026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1890562348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8615615,0.10765584,0.009372061,0.004081567,0.0009816568,0.00015213473,0.00048732795,0.0003045981,0.015403327],"genre_scores_gemma":[0.9786588,0.013088777,0.0018883776,0.0004897929,0.000681348,0.000043307853,0.00014545025,0.000010982401,0.004993125],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999887,0.000023667542,0.0000072382386,0.000018420105,0.000032167267,0.000031483545],"domain_scores_gemma":[0.9999387,0.0000080530535,0.000014559783,0.0000051777,0.000008333214,0.000025178002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017464788,0.00023141531,0.00017380546,0.00028805665,0.00021867051,0.0003058722,0.000113454545,0.00022404543,0.0021952896],"category_scores_gemma":[0.00012309008,0.000053564017,0.0001450873,0.00011128435,0.00025275722,0.0002610967,0.00035773666,0.00048793945,0.0002187212],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006167015,0.00015005152,0.008831225,0.0006436232,0.000043434564,0.004685369,0.00017807353,0.0002097741,0.9072628,0.0074094925,0.0039337315,0.06603577],"study_design_scores_gemma":[0.0002658671,0.002070274,0.05968681,0.00028897825,0.00030300146,0.020625848,0.00072058546,0.0026988566,0.6179336,0.008830195,0.2865418,0.0000343242],"about_ca_topic_score_codex":0.00008063508,"about_ca_topic_score_gemma":0.00020322496,"teacher_disagreement_score":0.0021952896,"about_ca_system_score_codex":0.00017379054,"about_ca_system_score_gemma":0.00018210303,"threshold_uncertainty_score":0.0073440075},"labels":[],"label_agreement":null},{"id":"W1899263436","doi":"10.1080/2162402x.2015.1021537","title":"Identification of characteristic TRB V usage in HBV-associated HCC by using differential expression profiling analysis","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Hepatocellular carcinoma; Liver cancer; T-cell receptor; Antigen; Cancer; clone (Java method); Biology; Immune system; Cancer research; Immunology; T cell; Medicine; Gene; Genetics","score_opus":0.03060118265010576,"score_gpt":0.312870143548007,"score_spread":0.28226896089790127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1899263436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99705434,0.0006262225,0.0014225566,0.000021317368,0.0000041183216,0.000008168957,0.00028362314,0.000022112923,0.0005574585],"genre_scores_gemma":[0.9974353,0.00033133125,0.001318743,0.000028820907,0.0000073053116,0.000013833621,0.00050116726,0.000006168173,0.0003574406],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998592,0.000019469428,0.000011494326,0.000037606154,0.000032017877,0.000040222654],"domain_scores_gemma":[0.9998704,0.000030770967,0.000039555947,0.000010855139,0.00002918114,0.000019183542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012070407,0.00009317303,0.00017894314,0.00067021506,0.00011655767,0.00032171307,0.000078178025,0.00015170373,0.00056279893],"category_scores_gemma":[0.00030106638,0.00007137585,0.000113084934,0.00061058364,0.000102754275,0.00009878853,0.00014813028,0.0001916945,0.00020764141],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049311336,0.0000378708,0.09492235,0.00007978592,0.000031991756,0.00017945637,0.0001471173,0.00014862168,0.88142323,0.000074506024,0.00011541402,0.022346511],"study_design_scores_gemma":[0.000014923901,0.00042459197,0.80788505,0.00002349277,0.00010711395,0.0023477944,0.00045938924,0.007092068,0.1785665,0.00023876283,0.0028222397,0.000018114495],"about_ca_topic_score_codex":0.0005279963,"about_ca_topic_score_gemma":0.00059836416,"teacher_disagreement_score":0.00067021506,"about_ca_system_score_codex":0.00012229022,"about_ca_system_score_gemma":0.00006811643,"threshold_uncertainty_score":0.0018827319},"labels":[],"label_agreement":null},{"id":"W1962016368","doi":"10.1080/2162402x.2015.1085146","title":"PD-1 expression on dendritic cells suppresses CD8<sup>+</sup>T cell function and antitumor immunity","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":181,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Lethbridge","keywords":"Granzyme B; Cytotoxic T cell; Adoptive cell transfer; CD8; Perforin; Cancer research; Granzyme; Dendritic cell; CD11c; Immune system; T cell; Immunology; Biology; In vitro; Phenotype","score_opus":0.022566461775047106,"score_gpt":0.26425986540270396,"score_spread":0.24169340362765684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1962016368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99369746,0.00078584644,0.0014672644,0.00028379622,0.00008956851,0.000028435143,0.00014761268,0.00007325995,0.0034268387],"genre_scores_gemma":[0.9963709,0.00025369436,0.00065415667,0.00010033544,0.000025774392,0.000019441066,0.00016727463,0.000014365392,0.002394062],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999803,0.000036733647,0.000016870483,0.000025436864,0.000045280995,0.00007259576],"domain_scores_gemma":[0.9998603,0.000035036788,0.000025084095,0.000025458246,0.000020848343,0.00003332557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016893522,0.00022041608,0.00026260686,0.00014855464,0.0001557214,0.0004358694,0.00015781425,0.0002751293,0.0014344],"category_scores_gemma":[0.0002267617,0.00011601312,0.00015816513,0.00008366637,0.0002637043,0.0001698988,0.00016235499,0.001108143,0.0004781751],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004289308,0.00019039826,0.0003649909,0.00003305894,0.0000047316353,0.00006425711,0.00001442746,0.00026689927,0.9933981,0.00031461465,0.00026391106,0.0046556382],"study_design_scores_gemma":[0.00008931901,0.00072685716,0.0020491148,0.0000057172206,0.000013668531,0.00031670323,0.000034683988,0.0028982724,0.98873657,0.0002327839,0.0048927967,0.0000034886427],"about_ca_topic_score_codex":0.00016787942,"about_ca_topic_score_gemma":0.00025699052,"teacher_disagreement_score":0.0014344,"about_ca_system_score_codex":0.00027474712,"about_ca_system_score_gemma":0.00029315168,"threshold_uncertainty_score":0.004798472},"labels":[],"label_agreement":null},{"id":"W1968645192","doi":"10.4161/21624011.2014.946361","title":"The potential impact of mouse model selection in preclinical evaluation of cancer immunotherapy","year":2014,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine; Immunotherapy; Cancer; Cancer research; Cancer immunotherapy; Human disease; Disease; Immunology; Pathology; Internal medicine","score_opus":0.030266896491353553,"score_gpt":0.41854889522530525,"score_spread":0.3882819987339517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968645192","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22485861,0.11042243,0.45643348,0.0995809,0.042539082,0.0032195288,0.0057705357,0.0042773476,0.052898172],"genre_scores_gemma":[0.61777574,0.082775004,0.1895348,0.06034232,0.007834017,0.006282314,0.004852166,0.0034408371,0.027162785],"study_design_codex":"bench_or_experimental","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.98457724,0.0104255015,0.00085343164,0.0010135655,0.002621188,0.00050904916],"domain_scores_gemma":[0.98972404,0.0060757967,0.0013072937,0.0012015007,0.001346256,0.00034518936],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.029341307,0.0014277889,0.001661265,0.0012333128,0.0005705033,0.0024776808,0.0016108664,0.0020509905,0.0037354715],"category_scores_gemma":[0.013678923,0.0006375721,0.000911332,0.0007606612,0.0011554147,0.0018911212,0.001339475,0.003958087,0.0011863082],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007219465,0.0012207723,0.0144815855,0.0032021564,0.00085258356,0.0015038307,0.00075476646,0.0047644856,0.5610747,0.05151335,0.105835944,0.2475764],"study_design_scores_gemma":[0.0010912666,0.011261262,0.009171067,0.0014097715,0.0020003472,0.007830948,0.00053043466,0.01428814,0.41193262,0.020614369,0.5195602,0.00030959785],"about_ca_topic_score_codex":0.00137133,"about_ca_topic_score_gemma":0.004588934,"teacher_disagreement_score":0.9706587,"about_ca_system_score_codex":0.0011885449,"about_ca_system_score_gemma":0.0015739173,"threshold_uncertainty_score":0.15517354},"labels":[],"label_agreement":null},{"id":"W1968823017","doi":"10.4161/onci.28441","title":"Macrophages in the liver prevent metastasis by efficiently eliminating circulating tumor cells after monoclonal antibody immunotherapy","year":2014,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Monoclonal antibody; Immunotherapy; Metastasis; Antibody; Monoclonal antibody therapy; Immune system; Medicine; Cancer research; Immunology; Effector; Monoclonal; Cancer; Phagocytosis; Cancer immunotherapy; Internal medicine","score_opus":0.01103759606715744,"score_gpt":0.2993532819969469,"score_spread":0.28831568592978946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968823017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97088516,0.009614971,0.014546341,0.000940295,0.00023560027,0.000097136464,0.00006299403,0.00025769515,0.0033597683],"genre_scores_gemma":[0.9902602,0.001950332,0.0040468853,0.00021410882,0.0000778436,0.00005239187,0.000061922685,0.000024860838,0.003311494],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99972147,0.000090652975,0.000015343421,0.000023710883,0.000054725377,0.00009404732],"domain_scores_gemma":[0.99985266,0.000035925794,0.00002905311,0.000020235297,0.000030052352,0.000031984277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004295052,0.00024065228,0.00043163027,0.00029344865,0.0001861221,0.00028124434,0.00022585758,0.00043674972,0.0010742847],"category_scores_gemma":[0.0003534844,0.00014901343,0.00024401542,0.00009935746,0.00031229708,0.00028397026,0.00028644578,0.00085800904,0.0003296561],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006695336,0.00016954966,0.00047838298,0.000109723995,0.000012590329,0.0001283157,0.00003969349,0.00022569667,0.98336464,0.00094266416,0.00034349627,0.013515809],"study_design_scores_gemma":[0.00019634124,0.0025882453,0.0023394234,0.000022250955,0.000039207403,0.00039568517,0.000036241698,0.0014877621,0.98544484,0.0005166915,0.0069256313,0.000007717967],"about_ca_topic_score_codex":0.0005497131,"about_ca_topic_score_gemma":0.0010024474,"teacher_disagreement_score":0.0010742847,"about_ca_system_score_codex":0.00020596183,"about_ca_system_score_gemma":0.0004105412,"threshold_uncertainty_score":0.003593862},"labels":[],"label_agreement":null},{"id":"W1971136482","doi":"10.4161/onci.21205","title":"Targeting the MHC Class II antigen presentation pathway in cancer immunotherapy","year":2012,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":161,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Institute for Research in Immunology and Cancer; Hôpital Notre-Dame; Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Immunotherapy; Immune system; Cancer immunotherapy; MHC class I; Immunology; Antigen presentation; Major histocompatibility complex; Cancer; Medicine; Antigen processing; Antigen; Cancer research; T cell; Internal medicine","score_opus":0.018448110644944202,"score_gpt":0.2858585649095042,"score_spread":0.26741045426455995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971136482","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007359068,0.9791247,0.0051543913,0.0018375778,0.0008004459,0.000017655237,0.000012156424,0.000036184825,0.0056579253],"genre_scores_gemma":[0.05655557,0.9311668,0.0051476555,0.0009843258,0.0011305278,0.00003445258,0.000034241202,0.000010970501,0.0049355887],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999877,0.000033292006,0.000009045775,0.000014609373,0.000042750107,0.000023307846],"domain_scores_gemma":[0.9999405,0.000020550175,0.0000095845835,0.0000030388035,0.0000122772735,0.000014089608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046245896,0.00034786394,0.00047112454,0.00053133664,0.0003187034,0.000680482,0.00031472408,0.00082459685,0.0011488912],"category_scores_gemma":[0.00016594952,0.00015389631,0.00018715908,0.00045525492,0.0005415301,0.0009517337,0.00038688647,0.0013591426,0.000827818],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034597245,0.00024781143,0.0009733563,0.0043737106,0.000038786413,0.001007906,0.000183182,0.0018858992,0.2813842,0.034971446,0.014726547,0.6598611],"study_design_scores_gemma":[0.000054610508,0.00079917983,0.0028679403,0.00078318955,0.000078274155,0.003886691,0.00016038236,0.0015162289,0.08008652,0.023536947,0.88618803,0.00004199646],"about_ca_topic_score_codex":0.0002458758,"about_ca_topic_score_gemma":0.00042592763,"teacher_disagreement_score":0.0011488912,"about_ca_system_score_codex":0.0005802269,"about_ca_system_score_gemma":0.00046522435,"threshold_uncertainty_score":0.0042098165},"labels":[],"label_agreement":null},{"id":"W1971374789","doi":"10.4161/onci.20735","title":"Stromal CEACAM1 expression regulates colorectal cancer metastasis","year":2012,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Occupational Cancer Research Centre; McGill University Health Centre","funders":"","keywords":"Stromal cell; Colorectal cancer; Metastasis; Medicine; Cancer research; Chemokine; Infiltration (HVAC); Adoptive cell transfer; Immune system; Bone marrow; Pathology; Cancer; T cell; Immunology; Internal medicine","score_opus":0.019980594437794104,"score_gpt":0.3082504443025227,"score_spread":0.2882698498647286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971374789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99671173,0.0011670778,0.0005893722,0.0000941195,0.000009548553,0.000008291742,0.00016722655,0.000055985573,0.0011965672],"genre_scores_gemma":[0.9979528,0.0004395898,0.00025757658,0.000015970958,0.0000050877743,0.0000065247127,0.00013149077,0.000007960952,0.0011829622],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999062,0.000014032992,0.0000056214385,0.000015572783,0.00002244783,0.00003615956],"domain_scores_gemma":[0.9998964,0.000008804312,0.000030503314,0.0000059271756,0.000011258395,0.000047185786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000808826,0.00023685038,0.00016996346,0.0003547259,0.00014896272,0.0003524324,0.00011216488,0.00015724199,0.0012554486],"category_scores_gemma":[0.00010270932,0.00014262933,0.00011440197,0.00012586737,0.00023192688,0.00012706315,0.00012755237,0.00036301237,0.00030252544],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015876521,0.000015747222,0.00052206434,0.000014591563,0.0000021568644,0.000047608584,0.0000065259565,0.000052485586,0.99792033,0.00011790971,0.000052933367,0.0010888545],"study_design_scores_gemma":[0.000041409618,0.00037036405,0.037099432,0.000009048666,0.000025758058,0.00053278694,0.00006011267,0.0024561756,0.95685107,0.00014439477,0.002402012,0.000007434128],"about_ca_topic_score_codex":0.00102864,"about_ca_topic_score_gemma":0.0017399166,"teacher_disagreement_score":0.0012554486,"about_ca_system_score_codex":0.00038236481,"about_ca_system_score_gemma":0.00023392163,"threshold_uncertainty_score":0.004199922},"labels":[],"label_agreement":null},{"id":"W1972406166","doi":"10.4161/onci.27156","title":"An allogeneic NK cell line engineered to express chimeric antigen receptors","year":2013,"lang":"en","type":"article","venue":"OncoImmunology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Labex Immuno-Oncology; Institut National Du Cancer; Ligue Contre le Cancer; Agence Nationale de la Recherche","keywords":"Cytotoxic T cell; Chimeric antigen receptor; Antigen; Interleukin 21; NK-92; Biology; Antibody; Antibody-dependent cell-mediated cytotoxicity; Adoptive cell transfer; Immunology; Natural killer T cell; Immunotherapy; Cancer research; T cell; Monoclonal antibody; Immune system; CD8; In vitro","score_opus":0.019229888736515183,"score_gpt":0.29912613956505857,"score_spread":0.2798962508285434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972406166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9597417,0.0025695101,0.023395907,0.00037431513,0.00048160445,0.00023801679,0.0021838213,0.0005785959,0.010436626],"genre_scores_gemma":[0.98415965,0.0007757146,0.0076487274,0.00010404534,0.000029691631,0.00012942393,0.0016872636,0.00006480427,0.0054007494],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99967504,0.000037469938,0.000048324706,0.00008230083,0.00010496864,0.000051893665],"domain_scores_gemma":[0.99989223,0.000019941315,0.000018523539,0.000029269266,0.000017094964,0.000023012193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015695796,0.0004201911,0.0005487415,0.00023658495,0.00014144507,0.00047137047,0.00038686563,0.00047785704,0.0018997832],"category_scores_gemma":[0.00016158633,0.00015376724,0.0002608133,0.00021800913,0.00019398791,0.00028058336,0.000262678,0.0013763241,0.0014416291],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021101326,0.00014301052,0.00027435625,0.000047493177,0.0000105259805,0.00021280115,0.00003073434,0.00045311527,0.99491864,0.0005890488,0.00019620695,0.0029129873],"study_design_scores_gemma":[0.00016099209,0.0006953564,0.0010471699,0.000013715198,0.000056270826,0.0017705313,0.00002887117,0.0064544673,0.97301775,0.00015795817,0.016583344,0.000013518527],"about_ca_topic_score_codex":0.0003568398,"about_ca_topic_score_gemma":0.0002847424,"teacher_disagreement_score":0.0018997832,"about_ca_system_score_codex":0.00029824578,"about_ca_system_score_gemma":0.0002190075,"threshold_uncertainty_score":0.006355405},"labels":[],"label_agreement":null},{"id":"W1972729597","doi":"10.4161/onci.19534","title":"Combined vaccination and immunostimulatory antibodies provides durable cure of murine melanoma and induces transcriptional changes associated with positive outcome in human melanoma patients","year":2012,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Canadian Institutes of Health Research; Terry Fox Foundation; McMaster University","keywords":"Melanoma; Immune system; Vaccination; Medicine; Immunotherapy; Tumor microenvironment; Immunology; Antibody; Cancer research; Cytokine; Immunity","score_opus":0.014010005627188704,"score_gpt":0.24953616600434272,"score_spread":0.23552616037715401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972729597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99802375,0.0006014345,0.0005965026,0.000034010875,0.000010760403,0.000040467567,0.00006206722,0.000035648158,0.00059551385],"genre_scores_gemma":[0.99863845,0.00021180906,0.0003513707,0.000027475626,0.000007950073,0.000026250398,0.00016380157,0.0000045554316,0.0005683125],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999008,0.000019270454,0.0000063996777,0.000022886281,0.000018081246,0.0000324124],"domain_scores_gemma":[0.9999455,0.000008906492,0.000012419948,0.000010135822,0.000004260515,0.000018731345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019790398,0.00026935484,0.00036224304,0.00017845549,0.000109475804,0.00024870175,0.000096032876,0.00019159382,0.00072850083],"category_scores_gemma":[0.00010001211,0.000085484484,0.00017544437,0.000088347646,0.00014249135,0.00009122123,0.00012934141,0.00043235155,0.00019638926],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010936817,0.0007009049,0.0038123475,0.000041907195,0.000030537863,0.00016257957,0.000039806855,0.0002560022,0.97961545,0.000075396776,0.0001696295,0.014001776],"study_design_scores_gemma":[0.00062470976,0.035586458,0.08405014,0.000024987436,0.00023671903,0.0033901534,0.00009808592,0.0042628995,0.86285096,0.00016199944,0.008692816,0.00002013659],"about_ca_topic_score_codex":0.00025497458,"about_ca_topic_score_gemma":0.00037291882,"teacher_disagreement_score":0.00072850083,"about_ca_system_score_codex":0.00016208738,"about_ca_system_score_gemma":0.00011497075,"threshold_uncertainty_score":0.002437055},"labels":[],"label_agreement":null},{"id":"W1973832362","doi":"10.4161/onci.27384","title":"Immunopathogenesis of paraneoplastic neurological syndromes associated with anti-Hu antibodies","year":2013,"lang":"en","type":"review","venue":"OncoImmunology","topic":"Autoimmune Neurological Disorders and Treatments","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Nautical Research Society","funders":"Conseil Régional Midi-Pyrénées; Institut National de la Santé et de la Recherche Médicale","keywords":"Medicine; Immune system; Cancer; Antibody; Immunology; Central nervous system; Immunotherapy; Antigen; Nervous system; Paraneoplastic cerebellar degeneration; Neuroscience; Cancer research; Autoantibody; Biology; Internal medicine","score_opus":0.05387051741663455,"score_gpt":0.31133909519088276,"score_spread":0.2574685777742482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973832362","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033166385,0.9986241,0.00010499117,0.00012061521,0.000060482784,0.0000028838133,0.000008795994,0.0000052347004,0.00074126374],"genre_scores_gemma":[0.001852134,0.99741924,0.00013325142,0.000105574334,0.00010939784,0.000004119373,0.000018983284,9.142589e-7,0.0003562373],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999062,0.000016404008,0.00001773275,0.000016748843,0.000030975996,0.000011903787],"domain_scores_gemma":[0.99985635,0.00006344051,0.000032510765,0.0000036836693,0.000031148098,0.0000128183365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025352425,0.00068861555,0.0010216876,0.0023245045,0.00021235297,0.0005555745,0.00054161315,0.0007791077,0.001780838],"category_scores_gemma":[0.00035204456,0.00019199413,0.00032182995,0.001539707,0.00037179724,0.0006830286,0.00038878038,0.0008565684,0.0008299177],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008216121,0.00008114935,0.00076435576,0.014186779,0.00011647855,0.0018596826,0.000066570006,0.00038591863,0.0029704764,0.0022578677,0.017461248,0.9597673],"study_design_scores_gemma":[0.00004337984,0.00014284207,0.006249051,0.0074800975,0.00033686435,0.035272136,0.0001769623,0.0003026445,0.002439872,0.0031798345,0.9443313,0.000045126228],"about_ca_topic_score_codex":0.0009007753,"about_ca_topic_score_gemma":0.0015946272,"teacher_disagreement_score":0.0023245045,"about_ca_system_score_codex":0.00042106264,"about_ca_system_score_gemma":0.00057075126,"threshold_uncertainty_score":0.0059574842},"labels":[],"label_agreement":null},{"id":"W1973901905","doi":"10.4161/onci.26013","title":"Oncolytic vesicular stomatitis virus quantitatively and qualitatively improves primary CD8<sup>+</sup>T-cell responses to anticancer vaccines","year":2013,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre; University of Guelph","funders":"Canadian Institutes of Health Research","keywords":"Vesicular stomatitis virus; Cytotoxic T cell; Adoptive cell transfer; CD8; Immunology; Biology; Priming (agriculture); Virology; Granzyme; Granzyme B; T cell; Vaccination; Viral vector; Immune system; Virus; Perforin; Recombinant DNA; In vitro","score_opus":0.017907814448584348,"score_gpt":0.31237317765651385,"score_spread":0.2944653632079295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973901905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99118644,0.0011696646,0.003973853,0.00014688441,0.00006949461,0.000038265054,0.00032622463,0.00032218578,0.002767053],"genre_scores_gemma":[0.9922699,0.00057376915,0.0022991977,0.00007308016,0.000020802256,0.000031428448,0.00032887657,0.00007143943,0.0043314407],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998723,0.000024233786,0.000010605743,0.000020869025,0.00003071626,0.000041137406],"domain_scores_gemma":[0.99991167,0.000020792606,0.000018679619,0.000014424913,0.000014743561,0.00001964042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013665324,0.00042021053,0.0002346118,0.00015427539,0.00008587052,0.00031022134,0.00017958636,0.00020984127,0.0015470483],"category_scores_gemma":[0.00013846069,0.00014042025,0.00016229709,0.00007625961,0.00023310029,0.00021516904,0.00013737348,0.00066279725,0.00046990212],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012450559,0.00004022535,0.000058294358,0.00001812611,0.0000027020797,0.0000056107215,0.0000049713117,0.00007326479,0.99781334,0.000051814066,0.000050074243,0.001756905],"study_design_scores_gemma":[0.000017840868,0.0002537715,0.0005861123,0.000002342468,0.000010370257,0.000036533987,0.0000041627272,0.00022191349,0.9980702,0.000023053608,0.000772502,0.0000012820177],"about_ca_topic_score_codex":0.00036648297,"about_ca_topic_score_gemma":0.0008740425,"teacher_disagreement_score":0.0015470483,"about_ca_system_score_codex":0.00027614026,"about_ca_system_score_gemma":0.000225669,"threshold_uncertainty_score":0.005175352},"labels":[],"label_agreement":null},{"id":"W1976716096","doi":"10.4161/onci.26618","title":"Preventing surgery-induced NK cell dysfunction and cancer metastases with influenza vaccination","year":2013,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Vaccination; Cancer; Immunology; Immunotherapy; Cancer research; Cell; Natural killer cell; Immune system; Internal medicine; Cytotoxic T cell; Biology; In vitro","score_opus":0.020681078058053238,"score_gpt":0.2711012058860209,"score_spread":0.25042012782796763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976716096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953603,0.0025116235,0.0010444176,0.00017611012,0.00006037625,0.000050073053,0.00003133378,0.00004041577,0.0007252962],"genre_scores_gemma":[0.9980305,0.00081604865,0.0005638035,0.00007099246,0.000028079843,0.000028921007,0.000044840406,0.0000040490904,0.0004127161],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999064,0.000030393478,0.000008367043,0.000011409963,0.000011321343,0.000032119213],"domain_scores_gemma":[0.9999099,0.000018408762,0.00002823949,0.000011755299,0.00000699963,0.000024695366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016056465,0.00024087518,0.0002795151,0.00009469531,0.000095183634,0.00013273186,0.00013396499,0.00022137922,0.00094609085],"category_scores_gemma":[0.00024929407,0.0000833054,0.0001835499,0.000051211962,0.00028238088,0.00015166916,0.00017380214,0.0005799013,0.00016483456],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004158198,0.0010782854,0.003274277,0.00019494462,0.000030626667,0.000109881104,0.00004659017,0.00030689308,0.9587869,0.00023882606,0.0002858802,0.03148868],"study_design_scores_gemma":[0.0009876393,0.047017988,0.09678299,0.00011564068,0.00015892636,0.0015529436,0.00016674284,0.003220399,0.84222,0.00048093914,0.007268332,0.000027416876],"about_ca_topic_score_codex":0.00027112928,"about_ca_topic_score_gemma":0.00050426216,"teacher_disagreement_score":0.00094609085,"about_ca_system_score_codex":0.0000945384,"about_ca_system_score_gemma":0.00024295055,"threshold_uncertainty_score":0.0031650066},"labels":[],"label_agreement":null},{"id":"W1977957999","doi":"10.4161/onci.20696","title":"Trial Watch","year":2012,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":192,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer; American Society of Clinical Oncology","keywords":"Innate immune system; Immune system; TLR2; Toll-like receptor; Pattern recognition receptor; TLR4; Immunology; Biology; Acquired immune system; TLR7; TLR3; Medicine; Cancer research","score_opus":0.016659581501656043,"score_gpt":0.25980436783370914,"score_spread":0.2431447863320531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977957999","genre_codex":"other","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015557067,0.057156313,0.007940989,0.059342317,0.051544957,0.011556086,0.052495126,0.0046694106,0.73973775],"genre_scores_gemma":[0.05535868,0.026693452,0.006462035,0.099219345,0.022272076,0.011243686,0.04219841,0.0012084609,0.73534393],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994393,0.00017971333,0.000047852012,0.00011115162,0.00013322596,0.00008870277],"domain_scores_gemma":[0.9988298,0.00016073494,0.00016004388,0.00011782498,0.00018064144,0.00055102643],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010714618,0.000616834,0.0008726195,0.0004125487,0.00040829933,0.0018070894,0.00074792036,0.0025517922,0.30010194],"category_scores_gemma":[0.0025714124,0.0001583536,0.0009227321,0.00031628038,0.0002755664,0.0014098214,0.0008171261,0.0026517904,0.09003637],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0087095015,0.0003930323,0.00037346114,0.0022172087,0.00019626004,0.00011070972,0.000019480209,0.0001514594,0.0009936168,0.0037950044,0.6924459,0.29059443],"study_design_scores_gemma":[0.007821832,0.001220842,0.0009510072,0.0012103402,0.000089828776,0.00021777525,0.0000226573,0.00022320448,0.00040895873,0.004189747,0.9836255,0.000018445517],"about_ca_topic_score_codex":0.00044800565,"about_ca_topic_score_gemma":0.001201687,"teacher_disagreement_score":0.30010194,"about_ca_system_score_codex":0.0007613886,"about_ca_system_score_gemma":0.00089995307,"threshold_uncertainty_score":0.9983196},"labels":[],"label_agreement":null},{"id":"W1978074643","doi":"10.4161/onci.28541","title":"Smac mimetics combined with innate immune stimuli create the perfect cytokine storm to kill tumor cells","year":2014,"lang":"en","type":"article","venue":"OncoImmunology","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Children's Hospital of Eastern Ontario","funders":"","keywords":"Innate immune system; Immunotherapy; Immune system; Cytokine storm; Cytokine; Medicine; Immunology; Cancer research; Neuroscience; Biology; Disease; Internal medicine","score_opus":0.00722489540134074,"score_gpt":0.22468664850088546,"score_spread":0.2174617530995447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978074643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9582939,0.0058969245,0.029046426,0.0005384907,0.0002173812,0.00016527901,0.00034766813,0.0003343876,0.005159419],"genre_scores_gemma":[0.98385507,0.0014410397,0.012295766,0.00015037891,0.000055756478,0.00010341238,0.0001987271,0.000027042594,0.0018728707],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99980587,0.00003731322,0.000015836462,0.000032198048,0.00006310749,0.000045769113],"domain_scores_gemma":[0.9999095,0.000020543031,0.000023259752,0.000012752418,0.000009956391,0.000023919269],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025096966,0.00036011304,0.00042543336,0.0003438021,0.00016558108,0.0003562399,0.00015480588,0.00035195544,0.0008242123],"category_scores_gemma":[0.00015259102,0.00013787638,0.00022672905,0.0001931476,0.00023751748,0.00029246215,0.00024083682,0.00070816727,0.00037348593],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001177247,0.000032336313,0.00015035365,0.000030531985,0.000007558508,0.0000474031,0.0000067949127,0.00013500062,0.99634224,0.0003851532,0.000094081646,0.002650752],"study_design_scores_gemma":[0.000029585352,0.0003338565,0.0004621226,0.0000024919198,0.000010310542,0.00020113855,0.0000058851383,0.0009204945,0.994985,0.00010708102,0.0029389602,0.0000030955503],"about_ca_topic_score_codex":0.00011775537,"about_ca_topic_score_gemma":0.00030430735,"teacher_disagreement_score":0.0008242123,"about_ca_system_score_codex":0.00022860082,"about_ca_system_score_gemma":0.0002603306,"threshold_uncertainty_score":0.0027572513},"labels":[],"label_agreement":null},{"id":"W1978261324","doi":"10.4161/21624011.2014.958952","title":"Co-blockade of immune checkpoints and adenosine A<sub>2A</sub>receptor suppresses metastasis","year":2014,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Evidence-based Healthcare Collaborating Agency","keywords":"Blockade; Immune checkpoint; Immune system; Tumor microenvironment; Cancer research; CD8; Adenosine; Immunotherapy; Metastasis; Medicine; T cell; Receptor; CTLA-4; Immunology; Cancer; Internal medicine","score_opus":0.006129508302185307,"score_gpt":0.23196646970393464,"score_spread":0.22583696140174933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978261324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98494256,0.004849691,0.0031793783,0.0005739655,0.00025911492,0.00009424782,0.00025045135,0.00020298752,0.005647572],"genre_scores_gemma":[0.99422246,0.0011129607,0.0013046035,0.0000878319,0.00007252067,0.000081002094,0.00017245937,0.00001604249,0.0029300288],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997968,0.000034271063,0.000016525279,0.000025099875,0.000056714685,0.00007051884],"domain_scores_gemma":[0.9998914,0.000018024399,0.000024087083,0.000015486046,0.00000854871,0.000042380554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018464755,0.00036715667,0.00053437724,0.00021042791,0.00014793336,0.00039169606,0.00023931648,0.00026676513,0.0015030153],"category_scores_gemma":[0.00013241128,0.00010970612,0.00022405933,0.00013942627,0.00024504802,0.00028422027,0.00019603437,0.0009896886,0.0005746015],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007102469,0.0005196671,0.0003970986,0.00008432662,0.000025379395,0.00008859698,0.000013279773,0.0002869683,0.98631454,0.00045080835,0.0004973188,0.010611774],"study_design_scores_gemma":[0.00020287777,0.006145159,0.006945649,0.000016583332,0.00007827582,0.0006669266,0.000063277344,0.0019332222,0.9752322,0.00032712304,0.008378212,0.000010521522],"about_ca_topic_score_codex":0.00028957304,"about_ca_topic_score_gemma":0.0015640773,"teacher_disagreement_score":0.0015030153,"about_ca_system_score_codex":0.0002202352,"about_ca_system_score_gemma":0.0003609868,"threshold_uncertainty_score":0.0050281286},"labels":[],"label_agreement":null},{"id":"W1984152314","doi":"10.4161/onci.21424","title":"Surviving host innate immunity","year":2012,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Autocrine signalling; Crosstalk; Tumor necrosis factor alpha; Innate immune system; Cancer research; Apoptosis; Immunology; Biology; Medicine; Immune system; Receptor; Internal medicine","score_opus":0.033818690060529004,"score_gpt":0.3090216571003404,"score_spread":0.2752029670398114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984152314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86995727,0.05796043,0.016483333,0.0022394536,0.0008632269,0.00020046228,0.0009937917,0.00054526806,0.050756797],"genre_scores_gemma":[0.9714366,0.007109113,0.002850675,0.00064871256,0.00015707199,0.00009807694,0.00042644772,0.000019621113,0.017253641],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99967945,0.00006193774,0.000017996586,0.00005793993,0.0000750952,0.00010758296],"domain_scores_gemma":[0.9998191,0.000014987268,0.00003628578,0.000035035613,0.000029291388,0.00006532761],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002577033,0.00038268644,0.00036136693,0.0001735448,0.00024746353,0.0007744122,0.0001851018,0.00042239812,0.006759547],"category_scores_gemma":[0.00023601629,0.000100350866,0.00022185869,0.00007790401,0.0002579705,0.0003817611,0.00065873517,0.0008588286,0.0017213344],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005158977,0.00015005907,0.006067224,0.00064270734,0.0000577467,0.0013246867,0.00035187876,0.00028211254,0.8976638,0.008242158,0.0028417178,0.08185991],"study_design_scores_gemma":[0.00021577076,0.0051619704,0.044571903,0.0005626282,0.0001795616,0.016467586,0.0015271676,0.0032000276,0.46565685,0.009803918,0.4525895,0.00006311208],"about_ca_topic_score_codex":0.00011681838,"about_ca_topic_score_gemma":0.00018472537,"teacher_disagreement_score":0.006759547,"about_ca_system_score_codex":0.0003127184,"about_ca_system_score_gemma":0.0003683183,"threshold_uncertainty_score":0.022612989},"labels":[],"label_agreement":null},{"id":"W1984454936","doi":"10.4161/onci.1.2.18231","title":"Anti-leukemia activity of human gamma delta T cells","year":2012,"lang":"en","type":"article","venue":"OncoImmunology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; University of Toronto; Western University","funders":"","keywords":"Leukemia; Chronic lymphocytic leukemia; Cancer research; Adoptive cell transfer; Medicine; Immunology; T cell; Immune system","score_opus":0.040782841344297514,"score_gpt":0.3459616183447385,"score_spread":0.305178777000441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984454936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9570371,0.021477751,0.005052497,0.0010931358,0.00065622776,0.00011735336,0.00040876842,0.0002481037,0.013909117],"genre_scores_gemma":[0.97312474,0.012567032,0.0031418267,0.0007840052,0.00027040727,0.00006846192,0.00081460306,0.00003691719,0.009191891],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998956,0.000026691137,0.000008700868,0.000018735178,0.000027490489,0.00002278294],"domain_scores_gemma":[0.99992216,0.000030349987,0.000008230786,0.000014576074,0.000012811261,0.000011898007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022178868,0.00027154552,0.00017048432,0.0001858031,0.000078831865,0.00041649307,0.00013624158,0.00025646106,0.0015759725],"category_scores_gemma":[0.00016187083,0.000057497262,0.00015619623,0.00011912249,0.00012566638,0.00014647779,0.00013520842,0.0005542059,0.00048390485],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064767175,0.00018975555,0.0006347459,0.00018110625,0.000022882396,0.00019159653,0.00006262841,0.00037278968,0.92658436,0.00091756164,0.0014597247,0.068735175],"study_design_scores_gemma":[0.00015846621,0.0011661211,0.00140706,0.000021282787,0.000050038103,0.00069078105,0.000030071873,0.00038372076,0.9517886,0.00013804344,0.04415948,0.0000062777967],"about_ca_topic_score_codex":0.00027133437,"about_ca_topic_score_gemma":0.00048032886,"teacher_disagreement_score":0.0015759725,"about_ca_system_score_codex":0.00018377652,"about_ca_system_score_gemma":0.0002160289,"threshold_uncertainty_score":0.00527215},"labels":[],"label_agreement":null},{"id":"W1986380014","doi":"10.4161/onci.20499","title":"Hunting for clues","year":2012,"lang":"en","type":"article","venue":"OncoImmunology","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Biology","score_opus":0.020343398721294103,"score_gpt":0.2591857794699303,"score_spread":0.23884238074863623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986380014","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029545345,0.0784969,0.0068774493,0.62833637,0.15044494,0.0001197012,0.0018406209,0.00096209,0.12996744],"genre_scores_gemma":[0.045201845,0.060083605,0.011021177,0.46443376,0.07724883,0.00021578766,0.002295273,0.0010233652,0.33847645],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99866784,0.0004399652,0.00008959805,0.00026010233,0.00039082606,0.00015166051],"domain_scores_gemma":[0.9949196,0.0021094708,0.00030602654,0.0005488557,0.00096608506,0.0011500893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020288967,0.0008407263,0.0007398817,0.001507178,0.0022002922,0.0050406004,0.0012394565,0.0046381066,0.079307795],"category_scores_gemma":[0.013305127,0.0002599608,0.0006048555,0.0008353442,0.0039085383,0.0077275885,0.0032063732,0.0078534065,0.03324708],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009055292,0.000030566498,0.00070538325,0.0002596527,0.000032002692,0.00081508746,0.00047522644,0.00005884215,0.00046844227,0.032899812,0.8857473,0.07841714],"study_design_scores_gemma":[0.000014014822,0.0000147843475,0.00029181794,0.00022201374,0.000009175205,0.00057646097,0.0007011513,0.00003363386,0.00009497235,0.029760724,0.96826786,0.000013420897],"about_ca_topic_score_codex":0.0016373534,"about_ca_topic_score_gemma":0.002366284,"teacher_disagreement_score":0.079307795,"about_ca_system_score_codex":0.001401068,"about_ca_system_score_gemma":0.0015187314,"threshold_uncertainty_score":0.265311},"labels":[],"label_agreement":null},{"id":"W1987682745","doi":"10.4161/onci.26384","title":"Crucial role of inflammatory monocytes in antitumor immunity","year":2013,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Nautical Research Society","funders":"","keywords":"Myeloid cells; Inflammation; Cancer research; Immunity; Immunology; Myeloid; Carcinogenesis; Monocyte; Immune system; Myeloid-derived Suppressor Cell; Macrophage; Medicine; Biology; Cancer; In vitro; Suppressor","score_opus":0.005448230770923328,"score_gpt":0.21340089871955212,"score_spread":0.2079526679486288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987682745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78548527,0.18666662,0.010693361,0.002771772,0.00066066714,0.0000847941,0.00030908227,0.0001435922,0.01318475],"genre_scores_gemma":[0.976039,0.01852224,0.0020851996,0.00025572765,0.0003353027,0.000036482168,0.00009899618,0.000006052239,0.002620956],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99976236,0.00009050386,0.000016152324,0.000021026257,0.000030936942,0.000078975616],"domain_scores_gemma":[0.99984777,0.00003615935,0.000025117679,0.00001548685,0.000026594504,0.000048798156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036749846,0.0003068211,0.0002484496,0.0003348457,0.00027104863,0.00052651623,0.00012186288,0.00029733358,0.0014031569],"category_scores_gemma":[0.00026019488,0.000088454195,0.00013895257,0.00016551289,0.00042738774,0.00022920143,0.00036688292,0.0004689233,0.0003099343],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036650598,0.00022770735,0.011645916,0.0012707899,0.00003665105,0.0022882652,0.00037391274,0.00057910255,0.79045206,0.025971523,0.0028592201,0.16062969],"study_design_scores_gemma":[0.00038057467,0.003900905,0.06574791,0.0006045551,0.0002653155,0.008018347,0.0012437063,0.003265621,0.71616316,0.02357024,0.1767834,0.000056215817],"about_ca_topic_score_codex":0.00020241873,"about_ca_topic_score_gemma":0.00021750979,"teacher_disagreement_score":0.0014031569,"about_ca_system_score_codex":0.00025188635,"about_ca_system_score_gemma":0.00056978187,"threshold_uncertainty_score":0.004693985},"labels":[],"label_agreement":null},{"id":"W1988726471","doi":"10.4161/onci.1.2.18458","title":"FIST, a sword and shield fusokine for cancer immunotherapy","year":2012,"lang":"en","type":"article","venue":"OncoImmunology","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Occupational Cancer Research Centre","funders":"","keywords":"Fist; Ectodomain; Cancer research; Immunotherapy; Cancer immunotherapy; Angiogenesis; Immune system; Medicine; Receptor; Fusion protein; Immunology; Biology; Internal medicine; Recombinant DNA; Gene","score_opus":0.014381532727476675,"score_gpt":0.2964366606507601,"score_spread":0.2820551279232834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988726471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8500872,0.062338877,0.057424106,0.0027074195,0.0010149686,0.000374422,0.001097403,0.0009055556,0.024049947],"genre_scores_gemma":[0.9555818,0.01331796,0.018941108,0.00045392805,0.00017799098,0.00013476104,0.00089973945,0.000033372722,0.010459301],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999337,0.000015212212,0.000004579965,0.000011275147,0.000020983764,0.000014270503],"domain_scores_gemma":[0.99993134,0.000013763898,0.000013880014,0.000008381107,0.00000664489,0.000025974146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001842694,0.0004414172,0.00021723974,0.00041335967,0.00016248584,0.0002782712,0.00017750278,0.00040192215,0.0014878305],"category_scores_gemma":[0.000098208904,0.00008384463,0.00030216225,0.00017496075,0.00024001984,0.000249884,0.0002858047,0.0007083123,0.00051436597],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003163224,0.00008376436,0.0002730078,0.00010806863,0.000015167193,0.0002980162,0.000022464217,0.00048837636,0.9682833,0.00297477,0.0009396457,0.026197288],"study_design_scores_gemma":[0.000225784,0.0017481319,0.0013474658,0.00003457316,0.00007069712,0.0028904444,0.000023279823,0.0014481111,0.9136779,0.0010294006,0.07748599,0.000018256796],"about_ca_topic_score_codex":0.00019271825,"about_ca_topic_score_gemma":0.00036124224,"teacher_disagreement_score":0.0014878305,"about_ca_system_score_codex":0.00026263917,"about_ca_system_score_gemma":0.00033443383,"threshold_uncertainty_score":0.004977286},"labels":[],"label_agreement":null},{"id":"W1990584931","doi":"10.4161/onci.20238","title":"Turning the tumor microenvironment into a self vaccine site","year":2012,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bentley (Canada)","funders":"","keywords":"Tumor microenvironment; Infiltration (HVAC); Effector; Innate immune system; Medicine; Cancer research; Tumor cells; Immunology; Immune system","score_opus":0.005435569502497045,"score_gpt":0.21868467715843848,"score_spread":0.21324910765594143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990584931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898419,0.001246245,0.0059666005,0.00026017346,0.00016376731,0.000060033264,0.000044401724,0.000088152265,0.0023287763],"genre_scores_gemma":[0.99493295,0.0005320438,0.0023809646,0.00014003985,0.00003600436,0.00002776826,0.000031078132,0.000013808604,0.0019052848],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986947,0.000023668934,0.000003977681,0.000028337354,0.000024148289,0.00005033358],"domain_scores_gemma":[0.9999224,0.000016112597,0.000017033053,0.000010399226,0.000009883504,0.000024166615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012649038,0.00021316156,0.0002441946,0.00011430829,0.0001651588,0.00046857054,0.00013346302,0.0003101344,0.0018376663],"category_scores_gemma":[0.00012609406,0.00009370291,0.00022040938,0.000041121435,0.00031005725,0.00042786894,0.00024816312,0.000781531,0.00028387146],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013864138,0.000108240114,0.00051027717,0.00005434185,0.000004810242,0.00019800646,0.000051275743,0.00021774106,0.9937211,0.0014298784,0.00010342497,0.0034622585],"study_design_scores_gemma":[0.00003938917,0.0018919853,0.0026261602,0.000014077442,0.000023520372,0.00063849206,0.00013407558,0.001442373,0.9853754,0.00064549624,0.007160616,0.0000085070105],"about_ca_topic_score_codex":0.00009574722,"about_ca_topic_score_gemma":0.00023378494,"teacher_disagreement_score":0.0018376663,"about_ca_system_score_codex":0.000121166726,"about_ca_system_score_gemma":0.00019243106,"threshold_uncertainty_score":0.006147623},"labels":[],"label_agreement":null},{"id":"W1996126071","doi":"10.4161/onci.21175","title":"A new dynamic model of three cell interactions for CTL responses","year":2012,"lang":"en","type":"article","venue":"OncoImmunology","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatoon Medical Imaging; Saskatchewan Cancer Agency","funders":"","keywords":"Cytotoxic T cell; Priming (agriculture); CTL*; CD8; T cell; Cell biology; Dendritic cell; Immunology; Cd4 t cell; Antigen-presenting cell; Biology; Chemistry; Immune system; In vitro; Genetics","score_opus":0.028656930243499478,"score_gpt":0.2756263314810068,"score_spread":0.24696940123750732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996126071","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05558516,0.00385525,0.6533856,0.013146261,0.0014603116,0.00018939882,0.00053563324,0.0007457261,0.2710967],"genre_scores_gemma":[0.72512007,0.003633206,0.07227078,0.0020582678,0.0009818618,0.0008388451,0.00038320178,0.00030837045,0.19440536],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9996649,0.000077939694,0.000011286207,0.00007590224,0.00009686744,0.00007306439],"domain_scores_gemma":[0.99977547,0.00006435175,0.00002551583,0.000029054525,0.000045022334,0.00006056147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045211345,0.00067135144,0.0008289705,0.0006468842,0.0015163999,0.0023304592,0.0026119966,0.0028957992,0.024713974],"category_scores_gemma":[0.0007253627,0.0003896867,0.0010413969,0.0005314347,0.0013759409,0.0048510367,0.0013522743,0.0016828824,0.0047986046],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036914178,0.000032371845,0.00016183901,0.00006362336,0.00001191223,0.00022752676,0.00014002099,0.04643913,0.00427405,0.9383226,0.0040184385,0.006271632],"study_design_scores_gemma":[0.000047399695,0.00006534486,0.00013807991,0.000028108843,0.000014036333,0.00024818096,0.0000947809,0.35954234,0.00058749836,0.6165689,0.022632262,0.000032998898],"about_ca_topic_score_codex":0.002472983,"about_ca_topic_score_gemma":0.0011474676,"teacher_disagreement_score":0.024713974,"about_ca_system_score_codex":0.0013753742,"about_ca_system_score_gemma":0.0011957046,"threshold_uncertainty_score":0.08267647},"labels":[],"label_agreement":null},{"id":"W1996316168","doi":"10.4161/onci.24889","title":"IgG4 antibodies and cancer-associated inflammation","year":2013,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"Medical Research Council; Cancer Research UK","keywords":"Antibody; Inflammation; Cancer; Immunology; Immune system; Medicine; Cytotoxic T cell; Melanoma; Immunotherapy; Subclass; Cancer immunotherapy; Cancer research; Biology; Internal medicine","score_opus":0.020335001030632422,"score_gpt":0.3109879214035046,"score_spread":0.2906529203728722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996316168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.54894817,0.43160647,0.0017132262,0.0045832004,0.0002775748,0.000032741507,0.00010307335,0.000051160852,0.012684476],"genre_scores_gemma":[0.9165397,0.07691721,0.0006051853,0.0007570767,0.00044160988,0.000025158897,0.00009108218,0.0000036525164,0.0046191625],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9999052,0.00004145659,0.0000056476993,0.000008440428,0.000019026025,0.000020230533],"domain_scores_gemma":[0.9999045,0.00002212476,0.00004004424,0.0000036287752,0.000012122513,0.000017564127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002953936,0.00022249378,0.00014642431,0.00040576636,0.0001256847,0.00031129413,0.00013811862,0.0004404362,0.0012432721],"category_scores_gemma":[0.00027988924,0.00006153659,0.00012143451,0.00026110045,0.00030539406,0.00016477736,0.00020758738,0.00039110295,0.00013113266],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0077228304,0.0014763216,0.11487559,0.0031891041,0.0006213516,0.012517029,0.0005319337,0.00237049,0.35847774,0.04817507,0.011176684,0.43886587],"study_design_scores_gemma":[0.0010921103,0.005870139,0.49982035,0.0010054987,0.0009348506,0.028182004,0.0008882503,0.0059828954,0.1162481,0.061101153,0.27880147,0.00007311933],"about_ca_topic_score_codex":0.0012495362,"about_ca_topic_score_gemma":0.00085464603,"teacher_disagreement_score":0.0012495362,"about_ca_system_score_codex":0.00053053454,"about_ca_system_score_gemma":0.00038502656,"threshold_uncertainty_score":0.0041591525},"labels":[],"label_agreement":null},{"id":"W1998048839","doi":"10.4161/21624011.2014.958951","title":"Unleashing antitumor T-cell activation without ensuing autoimmunity: the case for A20-deletion in adoptive CD8<sup>+</sup>T-cell therapy","year":2014,"lang":"en","type":"article","venue":"OncoImmunology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Nautical Research Society","funders":"","keywords":"Autoimmunity; Cytotoxic T cell; Adoptive cell transfer; Immune system; CD8; Immunology; T cell; Inflammation; Cancer research; Immunotherapy; Immunity; Immune checkpoint; Biology; Medicine; In vitro; Biochemistry","score_opus":0.03481339900123783,"score_gpt":0.3126402239680923,"score_spread":0.2778268249668545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998048839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9252034,0.028923318,0.028323762,0.0063795107,0.00057594816,0.00024594326,0.00017784827,0.00068993005,0.009480344],"genre_scores_gemma":[0.98447686,0.0050512995,0.0074371863,0.0009163813,0.00018562315,0.000097826975,0.000057670102,0.000048469443,0.0017286444],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997738,0.00006080437,0.000022344671,0.000026684576,0.000056299676,0.000060227252],"domain_scores_gemma":[0.9996631,0.00012559979,0.000060658702,0.00007294187,0.000023998202,0.00005374335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011521253,0.0004242789,0.00048480148,0.0002089837,0.00020953816,0.00064710155,0.00037447613,0.0008731917,0.0008460205],"category_scores_gemma":[0.0006104309,0.00017450773,0.00025392894,0.00011719929,0.00074589887,0.00070545904,0.00031033906,0.0020771252,0.00040703223],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003122837,0.0014404312,0.0042070565,0.00063844485,0.00009156692,0.0018729001,0.00012598655,0.0021387618,0.83690184,0.008236357,0.002826908,0.13839692],"study_design_scores_gemma":[0.0015534743,0.014306733,0.008216958,0.00024957178,0.000319548,0.0136540225,0.0001683662,0.005900157,0.8638439,0.011542289,0.08018191,0.000063040636],"about_ca_topic_score_codex":0.00011089739,"about_ca_topic_score_gemma":0.0002107954,"teacher_disagreement_score":0.0011521253,"about_ca_system_score_codex":0.00024929765,"about_ca_system_score_gemma":0.0002901481,"threshold_uncertainty_score":0.006093085},"labels":[],"label_agreement":null},{"id":"W1999014052","doi":"10.4161/onci.28047","title":"The battle for the brain","year":2014,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Neuroinflammation and Neurodegeneration Mechanisms","field":"Neuroscience","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Glioma; Microglia; In vivo; Cancer research; In vitro; Medicine; Brain tumor; Immunology; Inflammation; Chemistry; Biology; Pathology; Biotechnology","score_opus":0.030764460746479833,"score_gpt":0.2762381161020951,"score_spread":0.24547365535561524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999014052","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013877794,0.35270742,0.0048750406,0.5547266,0.012234491,0.00003218389,0.0004912693,0.0004602859,0.060595024],"genre_scores_gemma":[0.28146574,0.37045667,0.008613655,0.2121176,0.019891666,0.0001872987,0.00059338694,0.00041567668,0.10625836],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99938786,0.0001586302,0.000029660237,0.00011702559,0.00015438336,0.00015244205],"domain_scores_gemma":[0.99904245,0.00017205955,0.000075645825,0.0001154978,0.00017661451,0.00041775696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001512121,0.00061623286,0.00077369047,0.0005952715,0.0018691398,0.004397037,0.00079606776,0.0031598464,0.014494845],"category_scores_gemma":[0.0021735076,0.00016611225,0.00032327586,0.0003373126,0.0066990103,0.005882948,0.0042951363,0.0086231185,0.007978271],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038625396,0.0001179825,0.0012481565,0.0007808157,0.00011014034,0.0008017616,0.001146528,0.00032085436,0.0141392015,0.2466391,0.44752082,0.28678837],"study_design_scores_gemma":[0.000027212222,0.000091805785,0.00066504936,0.0004812711,0.000017679622,0.0009122467,0.0008189489,0.00009506263,0.001478672,0.098692454,0.89669377,0.000025800991],"about_ca_topic_score_codex":0.0025242982,"about_ca_topic_score_gemma":0.0033498264,"teacher_disagreement_score":0.014494845,"about_ca_system_score_codex":0.0017416136,"about_ca_system_score_gemma":0.0037445915,"threshold_uncertainty_score":0.048490047},"labels":[],"label_agreement":null},{"id":"W2005988914","doi":"10.4161/2162402x.2014.994370","title":"CD4<sup>+</sup>T cell plasticity engenders robust immunity in response to cytokine therapy","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Effector; Immune system; Cytokine; Population; Immunology; Immunity; Acquired immune system; Immunotherapy; Biology; Medicine","score_opus":0.03580790354298228,"score_gpt":0.2485230319113967,"score_spread":0.21271512836841444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005988914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927065,0.0007464485,0.0016488407,0.000237209,0.00006080689,0.000043930333,0.000104701394,0.0001082564,0.0043433644],"genre_scores_gemma":[0.99771154,0.00021002437,0.0006727805,0.00008997888,0.000037943464,0.000028721728,0.00006271231,0.000014184901,0.001172108],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99976176,0.00006413918,0.00001854675,0.000021919872,0.000040506355,0.00009311109],"domain_scores_gemma":[0.9998363,0.000036795525,0.00003244111,0.00002749206,0.000015207917,0.000051733823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022912737,0.00018869685,0.0002785959,0.00019716453,0.00014876045,0.0004627584,0.00013533211,0.00022124102,0.002072404],"category_scores_gemma":[0.00032515984,0.00010003748,0.0001561931,0.00009337209,0.00025413337,0.00023578641,0.00025801332,0.0008532266,0.0006013873],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010403243,0.00017591381,0.0018459079,0.000052672924,0.000009612296,0.00027937282,0.00004416022,0.0004600179,0.978212,0.0004497485,0.00038494664,0.017045403],"study_design_scores_gemma":[0.00020499526,0.0052871592,0.025693,0.000032627027,0.00006849254,0.0019463456,0.00025250943,0.004086873,0.94837284,0.0014513644,0.012584996,0.000018921814],"about_ca_topic_score_codex":0.00008132622,"about_ca_topic_score_gemma":0.00017040696,"teacher_disagreement_score":0.002072404,"about_ca_system_score_codex":0.000144491,"about_ca_system_score_gemma":0.00015147461,"threshold_uncertainty_score":0.0069328547},"labels":[],"label_agreement":null},{"id":"W2010813474","doi":"10.4161/21624011.2014.948705","title":"IFNα signaling through PKC-θ is essential for antitumor NK cell function","year":2014,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Nautical Research Society","funders":"","keywords":"Degranulation; Protein kinase C; Cell biology; CXCL10; Signal transduction; Biology; Cancer research; Chemokine; Chemistry; Immunology; Immune system; Receptor; Biochemistry","score_opus":0.01164085981488639,"score_gpt":0.24208964567579766,"score_spread":0.23044878586091128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010813474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896331,0.0049588885,0.0033611646,0.000116877345,0.000072675924,0.00003237696,0.00035178324,0.00007234656,0.0014008633],"genre_scores_gemma":[0.9948315,0.0018686284,0.0013418073,0.000032057844,0.000015617205,0.000024567553,0.00031046482,0.000011886915,0.001563523],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998172,0.0000257423,0.00002641365,0.00004331506,0.000039884828,0.00004741326],"domain_scores_gemma":[0.99982053,0.000010870241,0.000088546905,0.000024229226,0.000016939974,0.000038940078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014822622,0.00049153325,0.00025432874,0.00014044462,0.00012676338,0.00037340383,0.0001660961,0.00019338883,0.0014785617],"category_scores_gemma":[0.00012873468,0.000125629,0.00022823951,0.00011068483,0.00023451472,0.00027297423,0.00019272209,0.0006431904,0.0005869427],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023679885,0.000023192692,0.0006093428,0.00005924569,0.000003721168,0.000051766605,0.0000058678293,0.00006538878,0.9971636,0.00007797828,0.000015167683,0.0016879048],"study_design_scores_gemma":[0.000037492016,0.00034863685,0.012675098,0.000021431504,0.000024204775,0.00050850544,0.00003664518,0.000547103,0.98184204,0.00012842161,0.003825147,0.0000053413055],"about_ca_topic_score_codex":0.00025992683,"about_ca_topic_score_gemma":0.00027525786,"teacher_disagreement_score":0.0014785617,"about_ca_system_score_codex":0.00034619222,"about_ca_system_score_gemma":0.00026248046,"threshold_uncertainty_score":0.004946232},"labels":[],"label_agreement":null},{"id":"W2011945701","doi":"10.4161/2162402x.2014.991613","title":"Human NK cells activated by EBV<sup>+</sup>lymphoblastoid cells overcome anti-apoptotic mechanisms of drug resistance in haematological cancer cells","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"K562 cells; Cancer research; Cytotoxic T cell; Biology; Cancer cell; Interleukin 12; Lymphoblast; Interleukin 21; NK-92; Leukemia; Apoptosis; Cancer; Immunology; Cell culture; In vitro; Immune system; T cell","score_opus":0.013473782813572874,"score_gpt":0.24417292361582346,"score_spread":0.2306991408022506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011945701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99512535,0.0017070994,0.0015005593,0.000036996855,0.000024142506,0.00003871998,0.000100745085,0.00003265509,0.0014336084],"genre_scores_gemma":[0.9966935,0.00046568512,0.0010179629,0.000025328387,0.000008303643,0.000020888718,0.00027439155,0.00000685717,0.0014871358],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999113,0.000025251593,0.000012655035,0.00001561038,0.000016414766,0.000018791501],"domain_scores_gemma":[0.999943,0.00001294372,0.000010691271,0.000015845098,0.0000068146387,0.000010697391],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008307511,0.00018073508,0.00020039469,0.00007847529,0.00006221587,0.0002679609,0.00009269306,0.00011167768,0.0014078477],"category_scores_gemma":[0.00012573518,0.000054013304,0.00013394609,0.000058716385,0.000105152365,0.00010462536,0.0001896035,0.00026647077,0.00038761634],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003315911,0.000039181632,0.00058673637,0.00004364179,0.000005485517,0.00007516416,0.0000365627,0.00007862425,0.99436474,0.00009242686,0.0000453404,0.0043006144],"study_design_scores_gemma":[0.00006942482,0.0009228918,0.005268905,0.000012000231,0.000030412064,0.0011314193,0.0000507491,0.00048306034,0.9861201,0.00006032458,0.0058467058,0.0000039372258],"about_ca_topic_score_codex":0.00022710225,"about_ca_topic_score_gemma":0.00032815224,"teacher_disagreement_score":0.0014078477,"about_ca_system_score_codex":0.00008792355,"about_ca_system_score_gemma":0.000103411396,"threshold_uncertainty_score":0.00470978},"labels":[],"label_agreement":null},{"id":"W2012028285","doi":"10.4161/onci.23793","title":"Enhanced immunity in slowly aging mutant mice with high mitochondrial oxidative stress","year":2013,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Oxidative stress; Reactive oxygen species; Immune system; Mitochondrion; Mutant; Carcinogenesis; Lipopolysaccharide; Immunity; Cell biology; Biology; Cancer research; Immunology; Cancer; Biochemistry; Genetics","score_opus":0.006693063568824412,"score_gpt":0.22614816449124095,"score_spread":0.21945510092241655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012028285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957377,0.00040980463,0.0028678102,0.00009059387,0.00002411034,0.000015459975,0.00023596465,0.0001537224,0.00046488526],"genre_scores_gemma":[0.99529076,0.00036930188,0.0019946746,0.000074129166,0.000018969167,0.000031872496,0.00026770987,0.000060442773,0.001892183],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998386,0.000030345049,0.000022353579,0.000049086437,0.000025141677,0.000034428856],"domain_scores_gemma":[0.99948454,0.00004121163,0.00022760386,0.00004778431,0.000031860338,0.00016705091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027398302,0.00059013,0.00029838172,0.000772522,0.0001378865,0.00031573235,0.0002370042,0.0004711656,0.0015854004],"category_scores_gemma":[0.00022434749,0.00024613005,0.00024957923,0.00015353634,0.00041187537,0.00034308867,0.00028985145,0.0006562759,0.00030831542],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003140277,0.00005135203,0.00069499644,0.000022868551,0.000008523695,0.00015584493,0.000021834709,0.00007953391,0.997246,0.0003066,0.000044728058,0.0010535452],"study_design_scores_gemma":[0.00023861439,0.0021714994,0.03670542,0.000037685175,0.0001152033,0.004066617,0.00010997598,0.002526068,0.9490439,0.001218698,0.003731366,0.000034989433],"about_ca_topic_score_codex":0.00017441307,"about_ca_topic_score_gemma":0.0002029049,"teacher_disagreement_score":0.0015854004,"about_ca_system_score_codex":0.00018125107,"about_ca_system_score_gemma":0.00013140141,"threshold_uncertainty_score":0.005303681},"labels":[],"label_agreement":null},{"id":"W2014111919","doi":"10.4161/onci.27616","title":"Immunosurveillance of senescent cancer cells by natural killer cells","year":2014,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Immunosurveillance; Senescence; Chemokine; Cancer cell; Cell biology; Natural killer cell; CCL2; Biology; NKG2D; Cell; Cancer research; Cancer; Immunology; Chemistry; Cytotoxicity; Tumor cells; Inflammation; In vitro; Biochemistry","score_opus":0.004553497089941164,"score_gpt":0.2188645361097816,"score_spread":0.21431103901984044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014111919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902766,0.004904304,0.0032641822,0.00016175324,0.000042928783,0.000013024878,0.000027188667,0.000029099054,0.0012809208],"genre_scores_gemma":[0.9967836,0.001287249,0.0008922898,0.000056496858,0.000031526793,0.000006002327,0.000034705445,0.000002992137,0.00090521923],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998795,0.00003196879,0.000007995026,0.000016779426,0.000026888041,0.000036841146],"domain_scores_gemma":[0.99989855,0.0000137477955,0.00002198497,0.000013749487,0.000023415067,0.000028621407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027390104,0.00022401423,0.00013971812,0.00016677247,0.000118031356,0.00029619815,0.00009343514,0.00013768286,0.0005459845],"category_scores_gemma":[0.00022100931,0.000058646772,0.00014596038,0.000049054706,0.00022075091,0.00029145757,0.00028802286,0.0003512187,0.00014073726],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022978525,0.000030334908,0.0018365446,0.00005785387,0.000006395506,0.00023009445,0.00010816827,0.00016667088,0.98447037,0.0019046814,0.000114713235,0.01084453],"study_design_scores_gemma":[0.00006908552,0.0010013775,0.013802191,0.000033640386,0.00003366038,0.0014920937,0.0002829431,0.0042239055,0.96040803,0.0022864372,0.016347693,0.000019006618],"about_ca_topic_score_codex":0.00015423038,"about_ca_topic_score_gemma":0.0002731307,"teacher_disagreement_score":0.0005459845,"about_ca_system_score_codex":0.00015879422,"about_ca_system_score_gemma":0.00017398753,"threshold_uncertainty_score":0.0018264651},"labels":[],"label_agreement":null},{"id":"W2020518300","doi":"10.4161/onci.27138","title":"Rewiring cancer cell death to enhance oncolytic viro-immunotherapy","year":2013,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"","keywords":"Oncolytic virus; Virotherapy; Immunotherapy; Cancer immunotherapy; Cancer; Immune system; Medicine; Cancer research; Immunogenic cell death; Cancer therapy; Immunology; Internal medicine","score_opus":0.014043599230312384,"score_gpt":0.3248581717362995,"score_spread":0.3108145725059871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020518300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9668392,0.005644047,0.020238265,0.0003844102,0.00016011999,0.0001600861,0.00016108766,0.00036232907,0.0060506216],"genre_scores_gemma":[0.9920441,0.0017218092,0.0035597559,0.00007641112,0.00002387843,0.000043082455,0.00007539762,0.000026312431,0.0024293025],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998654,0.000018469911,0.0000087884355,0.000021842345,0.000044926102,0.000040547195],"domain_scores_gemma":[0.99991906,0.000023015224,0.000016206319,0.000015050156,0.00000991645,0.000016790767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022165253,0.00034127667,0.00032943368,0.0003078942,0.00014750742,0.00053474534,0.00022692108,0.0003726649,0.0014415166],"category_scores_gemma":[0.00019581486,0.00014132899,0.00019776176,0.00014112644,0.00031134635,0.00038380202,0.00033728257,0.00085283077,0.0004637073],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000097416865,0.0001312442,0.000094959854,0.00005370274,0.0000073096103,0.000034403958,0.000032180356,0.00083454413,0.9886778,0.0013677083,0.0001136616,0.008554957],"study_design_scores_gemma":[0.000044643384,0.0006698152,0.00047747872,0.0000067753626,0.00001677707,0.00014841571,0.000013667671,0.002343289,0.98985356,0.00041445968,0.006006118,0.0000050358094],"about_ca_topic_score_codex":0.0002212771,"about_ca_topic_score_gemma":0.00056049245,"teacher_disagreement_score":0.0014415166,"about_ca_system_score_codex":0.0002944615,"about_ca_system_score_gemma":0.000248629,"threshold_uncertainty_score":0.004822314},"labels":[],"label_agreement":null},{"id":"W2020650741","doi":"10.4161/onci.21650","title":"Tumor-infiltrating B cells and T cells","year":2012,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Immunity; CD8; Cancer research; Antigen-presenting cell; Cytotoxic T cell; Immunology; Ovarian cancer; Antigen; Medicine; Immune system; Biology; Cancer; T cell; In vitro; Internal medicine","score_opus":0.010793764532306668,"score_gpt":0.2256077316471736,"score_spread":0.21481396711486694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020650741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8568547,0.099950686,0.019849889,0.0017680372,0.00035066946,0.00012466445,0.00012334257,0.00020740558,0.02077065],"genre_scores_gemma":[0.97513366,0.012045564,0.005072095,0.00040407944,0.00044194752,0.00006879804,0.0000896784,0.000013660969,0.006730443],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99981564,0.00006666307,0.000010757397,0.000035714686,0.000021722064,0.00004959074],"domain_scores_gemma":[0.99988496,0.000029084322,0.00002442223,0.000010076687,0.000012742391,0.000038656195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029210572,0.00029191253,0.00020672481,0.00040609724,0.00021801182,0.00036715667,0.00020309034,0.00048756448,0.002783955],"category_scores_gemma":[0.0002421892,0.00011704695,0.00016911235,0.0001906075,0.00030744748,0.00041968588,0.00035588568,0.00049417274,0.00063266215],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009841477,0.00019830321,0.010607141,0.0007514831,0.000047022775,0.0025744082,0.00042341856,0.0002857233,0.87254053,0.009473387,0.0010795326,0.10103493],"study_design_scores_gemma":[0.0004824281,0.0054813977,0.0666548,0.00030759012,0.0002755677,0.028786547,0.0013585498,0.0039946646,0.710439,0.01251186,0.16965756,0.000050058316],"about_ca_topic_score_codex":0.00020513125,"about_ca_topic_score_gemma":0.00019363237,"teacher_disagreement_score":0.002783955,"about_ca_system_score_codex":0.00014452683,"about_ca_system_score_gemma":0.00016786838,"threshold_uncertainty_score":0.009313226},"labels":[],"label_agreement":null},{"id":"W2022364340","doi":"10.4161/2162402x.2014.990803","title":"miR-23a blockade enhances adoptive T cell transfer therapy by preserving immune-competence in the tumor microenvironment","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Immunosuppression; Tumor microenvironment; Adoptive cell transfer; Blockade; Medicine; CD8; Cytotoxic T cell; Immune system; T cell; Immunology; Cancer research; Tumor-infiltrating lymphocytes; Biology; Internal medicine; Receptor","score_opus":0.028752533743026068,"score_gpt":0.28106612261061253,"score_spread":0.2523135888675865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022364340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9783539,0.004584752,0.009427643,0.00032767325,0.00017110471,0.0000933492,0.00029220394,0.00048877764,0.0062606432],"genre_scores_gemma":[0.99359894,0.0011976308,0.0028823968,0.00006440817,0.000028967977,0.000048771733,0.00011893657,0.00003228891,0.002027623],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997689,0.00004855154,0.000021012705,0.000032718923,0.00007027573,0.00005858618],"domain_scores_gemma":[0.99989724,0.0000210232,0.000025851507,0.00001273883,0.000012984049,0.00003017149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021683931,0.00044914073,0.0003616454,0.00028454425,0.0002289293,0.00060682365,0.00018214,0.00030846687,0.0017803498],"category_scores_gemma":[0.00016832341,0.00010324202,0.00028356822,0.00016392954,0.00028219598,0.00026454186,0.00019466718,0.0011164551,0.00058832724],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018038356,0.00013294714,0.00013407193,0.000045823086,0.0000100351235,0.00006603882,0.000019836183,0.00019035157,0.992912,0.00018892103,0.00011572788,0.006003904],"study_design_scores_gemma":[0.0000147039655,0.00052776857,0.00071234896,0.0000043656682,0.000027312684,0.00016772216,0.0000120558125,0.00061292766,0.99411076,0.00006409089,0.0037417419,0.0000042219062],"about_ca_topic_score_codex":0.0003362829,"about_ca_topic_score_gemma":0.0006899232,"teacher_disagreement_score":0.0017803498,"about_ca_system_score_codex":0.0002444061,"about_ca_system_score_gemma":0.00032370642,"threshold_uncertainty_score":0.005955875},"labels":[],"label_agreement":null},{"id":"W2025291611","doi":"10.4161/onci.1.1.17962","title":"Targeting platelet function to improve drug delivery","year":2012,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; Kom op tegen Kanker; Terry Fox Foundation","keywords":"Drug; Medicine; Drug delivery; Platelet; Cancer; Pharmacology; Cancer drugs; Intensive care medicine; Internal medicine; Nanotechnology","score_opus":0.008943299060013734,"score_gpt":0.24522583524272215,"score_spread":0.23628253618270842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025291611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84008825,0.08541106,0.05398414,0.004758713,0.00063756184,0.0003368142,0.00040580193,0.00073876977,0.013638902],"genre_scores_gemma":[0.96776843,0.018021945,0.009842076,0.00076774985,0.0001382488,0.00012867368,0.00022627796,0.00004188289,0.0030648375],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998516,0.0000408551,0.00001145396,0.00001911572,0.000040037117,0.000036906724],"domain_scores_gemma":[0.9999075,0.00003389034,0.000022630675,0.000009448067,0.0000130884155,0.00001334105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035828698,0.00037844825,0.00040379225,0.00040670237,0.00017520497,0.0006190166,0.00025099813,0.00047564277,0.0018566013],"category_scores_gemma":[0.00034767925,0.00016160542,0.00024487145,0.00023504527,0.0001655443,0.00038069335,0.00024532105,0.0010123695,0.00049598585],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039573672,0.0004099275,0.00043017595,0.0002935437,0.000053575357,0.00015872037,0.00004504915,0.00077466306,0.9385855,0.0020681948,0.0019255151,0.054859336],"study_design_scores_gemma":[0.00025100686,0.0026000044,0.0026992126,0.000043283926,0.00012721623,0.0007667414,0.000029525296,0.005700846,0.96378064,0.0011146136,0.022867318,0.000019571857],"about_ca_topic_score_codex":0.0003181445,"about_ca_topic_score_gemma":0.00043595585,"teacher_disagreement_score":0.0018566013,"about_ca_system_score_codex":0.0002985351,"about_ca_system_score_gemma":0.00022393033,"threshold_uncertainty_score":0.006210923},"labels":[],"label_agreement":null},{"id":"W2031719011","doi":"10.4161/onci.27668","title":"Location, location, location","year":2014,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Victoria; BC Cancer Agency","funders":"","keywords":"Phenotype; Tumor-infiltrating lymphocytes; Serous fluid; Pathology; Ovarian cancer; Disease; Biology; Cancer research; Medicine; Cancer; Immunology; Antigen; Gene; Internal medicine; CD8; Genetics","score_opus":0.00854983309411879,"score_gpt":0.22865939567008706,"score_spread":0.22010956257596825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031719011","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7864067,0.060796343,0.022692513,0.004348437,0.0021308379,0.00046257247,0.013752418,0.0010190731,0.108391084],"genre_scores_gemma":[0.94838524,0.009577582,0.007900632,0.00069650117,0.00056085375,0.00015657309,0.0019633295,0.00017418902,0.0305851],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99963665,0.000040551837,0.000043349137,0.00010118318,0.00009952133,0.00007872117],"domain_scores_gemma":[0.9995826,0.00006557584,0.00012151449,0.000053275075,0.00009512882,0.000081934406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034034645,0.00047315267,0.0005007703,0.0010513625,0.00040346288,0.0012154568,0.0003545639,0.0007593481,0.016689954],"category_scores_gemma":[0.0016132102,0.00014265884,0.0005209024,0.00089400896,0.0004030187,0.0008478804,0.00047824258,0.00056162704,0.009856057],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029486252,0.0001453966,0.41855487,0.002193283,0.00027108897,0.017617872,0.0009149729,0.0012805068,0.083393544,0.003712699,0.027218295,0.4417488],"study_design_scores_gemma":[0.00017246338,0.001253509,0.59097964,0.00083741505,0.000436365,0.15587695,0.0019235617,0.001766397,0.013895115,0.004892053,0.22779295,0.00017351906],"about_ca_topic_score_codex":0.0013794525,"about_ca_topic_score_gemma":0.0019273867,"teacher_disagreement_score":0.016689954,"about_ca_system_score_codex":0.00031578986,"about_ca_system_score_gemma":0.00044434564,"threshold_uncertainty_score":0.05583346},"labels":[],"label_agreement":null},{"id":"W2042681245","doi":"10.4161/onci.1.1.18312","title":"NK cells sense tumors, course of disease and treatments","year":2012,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Nautical Research Society","funders":"Ligue Contre le Cancer; Société Française de Dermatologie et de Pathologie Sexuellement Transmissible; Institut National de la Santé et de la Recherche Médicale","keywords":"Disease; Cancer research; Medicine; Immunology; Interleukin 12; Cell; Lymphokine-activated killer cell; Janus kinase 3; NK-92; Interleukin 21; Biology; Pathology; T cell; Immune system; Cytotoxic T cell; In vitro","score_opus":0.009935568665127206,"score_gpt":0.24097433833419996,"score_spread":0.23103876966907275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042681245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6202892,0.21148904,0.051908366,0.00874461,0.0041299616,0.00030057816,0.0013605006,0.0013476312,0.10043007],"genre_scores_gemma":[0.9137904,0.0365297,0.011083473,0.0015468167,0.0009119337,0.00013960559,0.00047124078,0.00008987451,0.03543691],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999683,0.000089763234,0.000030509429,0.000058415953,0.00010115449,0.000037123224],"domain_scores_gemma":[0.9998338,0.00003112851,0.000052242773,0.000014422662,0.000035755,0.000032653774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003232275,0.00025147962,0.00035032065,0.00043282576,0.00015814234,0.0008923511,0.0001823553,0.00048453396,0.0022106364],"category_scores_gemma":[0.00053953385,0.00012622122,0.00011372696,0.00023879338,0.0003891436,0.00072069,0.00045044848,0.00074783195,0.0012227264],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010115001,0.00013567801,0.01785584,0.0007976981,0.00007192553,0.0005500585,0.0007348003,0.00083419925,0.69017845,0.007749856,0.0053853146,0.27469468],"study_design_scores_gemma":[0.00018031856,0.002639253,0.11403896,0.0005880596,0.0002316021,0.009681118,0.0031720216,0.002805954,0.3440033,0.019704022,0.5027867,0.00016866437],"about_ca_topic_score_codex":0.00029187524,"about_ca_topic_score_gemma":0.0004927992,"teacher_disagreement_score":0.0022106364,"about_ca_system_score_codex":0.00038267055,"about_ca_system_score_gemma":0.00020070274,"threshold_uncertainty_score":0.007395327},"labels":[],"label_agreement":null},{"id":"W2047167261","doi":"10.4161/onci.24272","title":"High endothelial venules","year":2013,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"High endothelial venules; Immune system; Medicine; Endothelium; Pathology; Cancer research; Biology; Immunology; Internal medicine","score_opus":0.007380598495121902,"score_gpt":0.23030742454405434,"score_spread":0.22292682604893244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047167261","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80790097,0.08098675,0.06006179,0.0011230507,0.0006305219,0.00017077084,0.0019356825,0.00060127105,0.046589147],"genre_scores_gemma":[0.97441906,0.007781354,0.0080642225,0.0002154984,0.00016367165,0.000055988086,0.00072377035,0.00001953145,0.008556936],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997396,0.00006519558,0.0000091943175,0.00005926763,0.000059394657,0.000067387424],"domain_scores_gemma":[0.9996045,0.00010956394,0.00007962938,0.000038647857,0.00006831267,0.00009944432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002752046,0.00014337875,0.00016897099,0.00071437476,0.00031122143,0.00054522,0.00020860923,0.00036789736,0.0031362711],"category_scores_gemma":[0.00038371186,0.00008741793,0.00013175308,0.000396441,0.00024837215,0.00045692857,0.00031998026,0.00048409885,0.00049804524],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089168746,0.00018625942,0.012850988,0.0011334042,0.00014066225,0.0020740856,0.00034281326,0.0008940154,0.8013992,0.05935695,0.00716748,0.11356248],"study_design_scores_gemma":[0.00013680567,0.0012668286,0.10260471,0.0004400351,0.00020059792,0.019248456,0.0004422569,0.005271503,0.5254654,0.019376341,0.3254512,0.00009592217],"about_ca_topic_score_codex":0.00046922918,"about_ca_topic_score_gemma":0.0005233448,"teacher_disagreement_score":0.0031362711,"about_ca_system_score_codex":0.00027845328,"about_ca_system_score_gemma":0.0001571997,"threshold_uncertainty_score":0.010491908},"labels":[],"label_agreement":null},{"id":"W2047682874","doi":"10.4161/21624011.2014.945378","title":"Anti-melanoma vaccines engineered to simultaneously modulate cytokine priming and silence PD-L1 characterized using<i>ex vivo</i>myeloid-derived suppressor cells as a readout of therapeutic efficacy","year":2014,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Ex vivo; Cancer research; Interleukin 12; Priming (agriculture); Gene silencing; Cytokine; Interleukin 10; Small hairpin RNA; Melanoma; T cell; Immunology; Immunotherapy; Cancer immunotherapy; FOXP3; Immune system; Biology; In vivo; Medicine; Cytotoxic T cell; Cell culture; In vitro; Gene knockdown","score_opus":0.011704032580891824,"score_gpt":0.2438292344512137,"score_spread":0.23212520187032187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047682874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98752415,0.00080303004,0.008897571,0.000113863694,0.00008504079,0.00010021094,0.00028420828,0.00015013404,0.0020418423],"genre_scores_gemma":[0.9932822,0.0003381872,0.0047039753,0.00005978269,0.000023100742,0.000053584106,0.00032636806,0.000029471106,0.0011833279],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998627,0.000028341108,0.000011223217,0.000025613826,0.00003165263,0.000040449057],"domain_scores_gemma":[0.99990165,0.000015157738,0.000038880265,0.000012491267,0.000011925731,0.000019860161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017295324,0.00044823802,0.00022102217,0.00015217936,0.000089354275,0.00036827635,0.00016222236,0.000250397,0.0009588393],"category_scores_gemma":[0.00011468038,0.00009145535,0.00014561605,0.000102916376,0.00020752108,0.00023059334,0.00012474766,0.0009289586,0.0003253285],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010154944,0.000073094576,0.00010091218,0.000014831481,0.000003341693,0.000007010995,0.0000055928895,0.000112038215,0.9977192,0.00014199906,0.00004455123,0.001675828],"study_design_scores_gemma":[0.000026260532,0.0005117236,0.00027874555,0.000001903713,0.000009555602,0.000043502787,0.0000064578417,0.000534057,0.9976044,0.000039484446,0.0009424923,0.0000014358282],"about_ca_topic_score_codex":0.00010840044,"about_ca_topic_score_gemma":0.00024037596,"teacher_disagreement_score":0.0009588393,"about_ca_system_score_codex":0.00020061816,"about_ca_system_score_gemma":0.00015718186,"threshold_uncertainty_score":0.003207624},"labels":[],"label_agreement":null},{"id":"W2047928035","doi":"10.4161/onci.27589","title":"Dasatinib promotes the expansion of a therapeutically superior T-cell repertoire in response to dendritic cell vaccination against melanoma","year":2014,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Institutes of Health; Cancer Institute, University of Pittsburgh; Atomic Energy of Canada Limited; University of Pittsburgh","keywords":"Tumor microenvironment; Cancer research; Dasatinib; Immunotherapy; Melanoma; Medicine; Dendritic cell; CD8; T cell; Immunology; Antigen; Immune system; Imatinib; Myeloid leukemia","score_opus":0.00939459129431934,"score_gpt":0.24049565005159484,"score_spread":0.2311010587572755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047928035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949822,0.00082069583,0.00079033285,0.0002156178,0.00008343274,0.00003838881,0.00021045416,0.00008047334,0.0027784745],"genre_scores_gemma":[0.9987822,0.00016824939,0.0002950822,0.000038066068,0.000015557489,0.000013820065,0.00011980813,0.000008350409,0.0005588169],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997166,0.000070424074,0.00002183297,0.00004322108,0.000053486063,0.000094447096],"domain_scores_gemma":[0.9998715,0.000031489362,0.000017876513,0.000026134168,0.000011852523,0.000041221057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022804808,0.00016329395,0.00032756492,0.0001406199,0.00017669964,0.00037371437,0.0001492458,0.00022056534,0.002821051],"category_scores_gemma":[0.00034214044,0.00010134493,0.00017085795,0.00013047486,0.0002214301,0.00025810482,0.00018798983,0.00086861436,0.00070975797],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023415063,0.00046151906,0.0010800299,0.00011702652,0.000023474646,0.000099966346,0.000036986352,0.00046882135,0.9745044,0.00027644372,0.0006885922,0.019901188],"study_design_scores_gemma":[0.0013852289,0.013694497,0.028493483,0.000022025646,0.00010165052,0.0030104143,0.00018673422,0.0038695384,0.9313223,0.00097448495,0.016911214,0.0000283692],"about_ca_topic_score_codex":0.00016494776,"about_ca_topic_score_gemma":0.00036203084,"teacher_disagreement_score":0.002821051,"about_ca_system_score_codex":0.00018669174,"about_ca_system_score_gemma":0.00025943763,"threshold_uncertainty_score":0.009437382},"labels":[],"label_agreement":null},{"id":"W2048856583","doi":"10.4161/onci.29243","title":"Tumor-associated autoantibodies correlate with poor outcome in prostate cancer patients treated with androgen deprivation and external beam radiation therapy","year":2014,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; University of Victoria","funders":"BC Cancer Agency; Canadian Institutes of Health Research","keywords":"Medicine; Prostate cancer; Autoantibody; Androgen deprivation therapy; Cancer; Oncology; Radiation therapy; Prostate-specific antigen; Internal medicine; Androgen; Immune system; Androgen suppression; Immunology; Antibody; Hormone","score_opus":0.012896353262131238,"score_gpt":0.2829936209693502,"score_spread":0.270097267707219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048856583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99907,0.00043132182,0.00005602371,0.000027463599,0.000005428428,0.000004715467,0.000036116064,0.0000042938136,0.00036453208],"genre_scores_gemma":[0.9998258,0.00004102505,0.000016349091,0.000011859818,0.0000060277757,0.0000019770096,0.000039602535,6.53895e-7,0.000056676854],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999741,0.000092564835,0.000021964155,0.00003218644,0.000054716846,0.000057567468],"domain_scores_gemma":[0.9984854,0.0002449841,0.0007364331,0.00004835935,0.00009606056,0.00038883372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036659653,0.00022178044,0.00028618702,0.0005660812,0.00033485494,0.00041428333,0.00018779241,0.00034359845,0.001045611],"category_scores_gemma":[0.0014147331,0.00013962676,0.0002835482,0.00056656107,0.00023957218,0.00027695444,0.0002870869,0.00056053494,0.00014105812],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034454354,0.000065740634,0.9968425,0.0000072864877,0.00005046536,0.0001153201,0.000026556956,0.00007211119,0.00063461455,0.000007431774,0.000046187924,0.0017873131],"study_design_scores_gemma":[0.000007991024,0.00036307928,0.99868923,0.000002796019,0.00003373259,0.0005237817,0.000039732684,0.00012223667,0.000103767634,0.000017812124,0.00009316825,0.000002636095],"about_ca_topic_score_codex":0.0010203322,"about_ca_topic_score_gemma":0.0013943319,"teacher_disagreement_score":0.001045611,"about_ca_system_score_codex":0.00020850782,"about_ca_system_score_gemma":0.00021203047,"threshold_uncertainty_score":0.0034979582},"labels":[],"label_agreement":null},{"id":"W2049898667","doi":"10.4161/21624011.2014.953407","title":"Metronomic cyclophosphamide enhances HPV16E7 peptide vaccine induced antigen-specific and cytotoxic T-cell mediated antitumor immune response","year":2014,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Public Health; Queen Elizabeth II Health Sciences Centre; Ontario Institute for Cancer Research; Immunovaccine (Canada); Dalhousie University","funders":"Dalhousie University","keywords":"Cytotoxic T cell; Medicine; Immune system; Immunology; Peptide vaccine; Vaccination; Antigen; CD8; Vaccine therapy; Immunization; Cancer vaccine; Context (archaeology); Immunotherapy; Cancer research; Epitope; Biology; In vitro","score_opus":0.008748838181144787,"score_gpt":0.22656435147671586,"score_spread":0.21781551329557108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049898667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99761045,0.00041311543,0.000603293,0.000037216094,0.000027387254,0.000030478945,0.00012161746,0.000044238215,0.0011122224],"genre_scores_gemma":[0.99832195,0.00016482854,0.00040899895,0.000020586134,0.000012586909,0.0000270785,0.00013364946,0.0000063416564,0.0009038653],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998598,0.00002489994,0.000010326945,0.000019087714,0.00002878231,0.00005707921],"domain_scores_gemma":[0.99993837,0.000013957791,0.00001088833,0.000008146222,0.0000067023057,0.00002194981],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009188702,0.0003067568,0.00028017786,0.00020775449,0.0000866661,0.00017687614,0.00009844257,0.00019482986,0.0015697426],"category_scores_gemma":[0.00011910748,0.000085711974,0.00010992435,0.00012780902,0.00013002648,0.00014616986,0.00013150607,0.00059187587,0.00023636421],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000685941,0.00020841043,0.0002709323,0.000038482813,0.0000066988378,0.00003947683,0.000011674104,0.0001711203,0.9935963,0.000069923495,0.00009796341,0.004802981],"study_design_scores_gemma":[0.00012224904,0.005700688,0.0061696996,0.0000083874465,0.00003035871,0.00029187714,0.000021097001,0.0014002783,0.98447555,0.00005194063,0.0017216038,0.0000060855273],"about_ca_topic_score_codex":0.00021684819,"about_ca_topic_score_gemma":0.0005272208,"teacher_disagreement_score":0.0015697426,"about_ca_system_score_codex":0.00017167711,"about_ca_system_score_gemma":0.00019939081,"threshold_uncertainty_score":0.005251348},"labels":[],"label_agreement":null},{"id":"W2052590920","doi":"10.4161/onci.1.1.17824","title":"PD-L1 co-stimulation, ligand-induced TCR down-modulation and anti-tumor immunotherapy","year":2012,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Versus Arthritis; Rosetrees Trust","keywords":"Cytotoxic T cell; Immunotherapy; T-cell receptor; Effector; Ligand (biochemistry); Downregulation and upregulation; Stimulation; Cancer research; Co-stimulation; Function (biology); Antigen presentation; Cell biology; Chemistry; Receptor; T cell; Immunology; Medicine; Immune system; Biology; Neuroscience; Biochemistry; CD28; In vitro","score_opus":0.022328723385317426,"score_gpt":0.30892876758755883,"score_spread":0.2866000442022414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052590920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.969466,0.01945909,0.0045417002,0.00063947716,0.00021649135,0.00006340068,0.00013870609,0.00012842515,0.0053467425],"genre_scores_gemma":[0.9937611,0.0024294204,0.00088665826,0.00019729794,0.00007279821,0.00004420541,0.00016260688,0.0000140495695,0.0024317233],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994925,0.0001315459,0.000042368254,0.00007578023,0.000117593445,0.00014005647],"domain_scores_gemma":[0.99986255,0.000042050655,0.000040834002,0.000020960331,0.000008724461,0.000024779361],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033967724,0.00034901628,0.000393152,0.000276604,0.00018228107,0.00082544,0.0004045779,0.00065588165,0.0016002167],"category_scores_gemma":[0.00030665737,0.00020390973,0.00023084544,0.00024152253,0.00035510145,0.0005124049,0.00036943814,0.0012716533,0.0005346325],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088085054,0.00038814257,0.0007179981,0.0003565902,0.000030503059,0.00031833365,0.0000404622,0.00045154715,0.9765189,0.001546864,0.00052957615,0.018220127],"study_design_scores_gemma":[0.00010507979,0.00084152666,0.0039897505,0.000021739124,0.000035877187,0.001163313,0.000037580754,0.002239828,0.9823627,0.0005763922,0.008616908,0.000009358623],"about_ca_topic_score_codex":0.00009527117,"about_ca_topic_score_gemma":0.00017704115,"teacher_disagreement_score":0.0016002167,"about_ca_system_score_codex":0.00031445597,"about_ca_system_score_gemma":0.00022865881,"threshold_uncertainty_score":0.0053532124},"labels":[],"label_agreement":null},{"id":"W2055332350","doi":"10.4161/onci.23081","title":"Targeting SIRPα in cancer","year":2013,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; SickKids Foundation; Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Cancer; Adoptive cell transfer; Blockade; Immune system; Cancer research; Cancer immunotherapy; Leukemia; Cancer cell; Medicine; Immune checkpoint; Immunotherapy; Immunology; T cell; Receptor; Internal medicine","score_opus":0.01407830196796735,"score_gpt":0.2593188735469524,"score_spread":0.24524057157898502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055332350","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39559773,0.562245,0.017312413,0.006324824,0.0008293022,0.000089775385,0.00013979436,0.0004272892,0.017033955],"genre_scores_gemma":[0.80993986,0.1787604,0.0043301964,0.0009346812,0.00039828647,0.000044551252,0.00014961154,0.000017448001,0.0054249386],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999418,0.000016015261,0.0000035103042,0.000006640101,0.000018390294,0.000013659638],"domain_scores_gemma":[0.9999552,0.0000095419055,0.000010816871,0.000004137096,0.000008157936,0.000012222395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024722295,0.00020177879,0.0001760243,0.0002733511,0.00011105295,0.00024677577,0.00015185743,0.0003984578,0.00045955073],"category_scores_gemma":[0.00010669245,0.00008864199,0.00012787875,0.0001697864,0.00023062629,0.0001707583,0.00019579114,0.0006892501,0.00032948016],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011558894,0.00020056582,0.0012172045,0.0010316896,0.0000475554,0.0010534414,0.0001050817,0.0016564918,0.7382009,0.006882458,0.005943722,0.24250507],"study_design_scores_gemma":[0.00030086655,0.002605871,0.006109742,0.00017588984,0.00012673702,0.0086646965,0.0000780025,0.005307968,0.6891179,0.0048536705,0.28263417,0.000024476274],"about_ca_topic_score_codex":0.00022433678,"about_ca_topic_score_gemma":0.00033979336,"teacher_disagreement_score":0.00045955073,"about_ca_system_score_codex":0.00027453815,"about_ca_system_score_gemma":0.00024057819,"threshold_uncertainty_score":0.0019919276},"labels":[],"label_agreement":null},{"id":"W2056373410","doi":"10.4161/onci.1.2.18100","title":"Tumor immune escape in acute myeloid leukemia","year":2012,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer","funders":"","keywords":"Myeloid leukemia; Medicine; Leukemia; Immune system; Cancer research; Myeloid; Human leukocyte antigen; Immunology; Myeloid cells; Immune escape; Antigen","score_opus":0.009594060998956773,"score_gpt":0.2445719505498521,"score_spread":0.23497788955089532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056373410","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06406099,0.91695523,0.003530625,0.0022739323,0.00051810435,0.000034949302,0.000053658045,0.0000870716,0.01248544],"genre_scores_gemma":[0.30666843,0.67769796,0.003026127,0.0017414665,0.0024089122,0.00006800376,0.00022083601,0.000017284201,0.008150993],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999336,0.000015982449,0.000006268637,0.000006681405,0.000018195768,0.000019197567],"domain_scores_gemma":[0.9999752,0.00000634749,0.000006937846,0.0000010361576,0.000003547512,0.0000069112466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014098777,0.00024978918,0.00024859744,0.000279929,0.00013176967,0.00037335185,0.0001402257,0.0003242086,0.0008243686],"category_scores_gemma":[0.00009869635,0.000042962027,0.00011308881,0.00019681554,0.00015702337,0.00025262736,0.0003226213,0.000470627,0.00041861009],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047207973,0.00016029524,0.005125826,0.0026785545,0.000037476282,0.0046748132,0.00028949528,0.0011117636,0.11269322,0.018764623,0.015443271,0.83854854],"study_design_scores_gemma":[0.0000930929,0.0013774586,0.018137494,0.0006368377,0.00010838906,0.03844075,0.00031795911,0.0010930853,0.038408343,0.0139071485,0.8874581,0.000021330374],"about_ca_topic_score_codex":0.00010917068,"about_ca_topic_score_gemma":0.00017465855,"teacher_disagreement_score":0.0008243686,"about_ca_system_score_codex":0.00025030557,"about_ca_system_score_gemma":0.0001598482,"threshold_uncertainty_score":0.0027577877},"labels":[],"label_agreement":null},{"id":"W2057270791","doi":"10.4161/onci.23687","title":"Victories and deceptions in tumor immunology","year":2013,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tumor immunology; Medicine; Immunology; Immune system; Immunotherapy","score_opus":0.00815938468256729,"score_gpt":0.252433483791686,"score_spread":0.2442740991091187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057270791","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011220304,0.14912936,0.0010744893,0.66899365,0.16949825,0.000010874739,0.00011994421,0.0001133976,0.0099379895],"genre_scores_gemma":[0.0341571,0.15720369,0.0018481645,0.46164325,0.29636583,0.000065267726,0.00035064825,0.0002520557,0.04811404],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99599,0.0011296358,0.0002774753,0.0006025905,0.0014626335,0.0005377327],"domain_scores_gemma":[0.98244023,0.0076075085,0.00083125173,0.0013057718,0.0031122812,0.0047029727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01209676,0.0010522999,0.0013928323,0.0013826605,0.0028520839,0.0073677744,0.0011509336,0.0072012264,0.011308367],"category_scores_gemma":[0.020021776,0.0003480316,0.0007038165,0.000969516,0.009029879,0.012733013,0.00467379,0.023304269,0.0052462695],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024911808,0.00007821657,0.00046302364,0.00038868835,0.000031982312,0.00020998462,0.00043524036,0.000097476244,0.00070244336,0.054245714,0.8346704,0.10842776],"study_design_scores_gemma":[0.000021737513,0.00007713662,0.00023969244,0.00023866555,0.0000074087766,0.00018750284,0.0002968018,0.00006425183,0.00017714311,0.019606525,0.97906417,0.000019016945],"about_ca_topic_score_codex":0.00059395155,"about_ca_topic_score_gemma":0.0009793489,"teacher_disagreement_score":0.01209676,"about_ca_system_score_codex":0.0024008616,"about_ca_system_score_gemma":0.0025736073,"threshold_uncertainty_score":0.06397456},"labels":[],"label_agreement":null},{"id":"W2058840851","doi":"10.4161/21624011.2014.963409","title":"Immunotherapy of metastatic and autochthonous liver cancer with IL-15/IL-15Rα fusion protein","year":2014,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Allergy and Infectious Diseases","keywords":"Immunotherapy; Medicine; Cancer research; Liver cancer; CD8; Cancer immunotherapy; Interleukin 15; Fusion protein; Cancer; Chimeric antigen receptor; Immunology; Immune system; Interleukin; Cytokine; Biology; Internal medicine; Recombinant DNA; Hepatocellular carcinoma; Gene","score_opus":0.010247891093694499,"score_gpt":0.233088115341293,"score_spread":0.2228402242475985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058840851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99108946,0.0049292473,0.0022151954,0.00021775797,0.00008088726,0.000051122784,0.00008270159,0.000093656716,0.0012399164],"genre_scores_gemma":[0.9960795,0.0014309842,0.00091529987,0.000063243555,0.000035667348,0.0000249227,0.00016393622,0.000005797451,0.0012806646],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999175,0.000016055918,0.0000044729413,0.000014176434,0.000020432411,0.00002730891],"domain_scores_gemma":[0.99995124,0.000007083911,0.000011515003,0.000009279713,0.000003919666,0.00001695056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001527628,0.000320356,0.00026575883,0.00010602086,0.000101072954,0.00014258773,0.000107952554,0.00019499786,0.0006887814],"category_scores_gemma":[0.000054746248,0.00004865052,0.0002581607,0.00009775343,0.00019990631,0.00013024501,0.00014769517,0.0005747407,0.00019989257],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006473623,0.00041970905,0.0015815428,0.00016121047,0.000044412896,0.00024925347,0.000040408875,0.0004173836,0.9700579,0.00026561628,0.0004626302,0.025652613],"study_design_scores_gemma":[0.00029320322,0.007681998,0.0118602505,0.000023800443,0.00013008494,0.0023849611,0.000057674828,0.0026070913,0.9610149,0.00026974207,0.0136653995,0.000011014595],"about_ca_topic_score_codex":0.00015281394,"about_ca_topic_score_gemma":0.0002941663,"teacher_disagreement_score":0.0006887814,"about_ca_system_score_codex":0.00013337117,"about_ca_system_score_gemma":0.00014535537,"threshold_uncertainty_score":0.002304256},"labels":[],"label_agreement":null},{"id":"W2059388136","doi":"10.4161/onci.28782","title":"Transplantation-induced cancers: Emerging evidence that clonal CMV-specific NK cells are causal immunogenic factors","year":2014,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Nautical Research Society","funders":"","keywords":"Cytomegalovirus; Immunology; Transplantation; Repertoire; Biology; Liver transplantation; Cancer research; Medicine; Virus; Herpesviridae; Viral disease; Internal medicine","score_opus":0.04018371493190794,"score_gpt":0.2628070945618559,"score_spread":0.22262337962994797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059388136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6603276,0.31804818,0.009199979,0.002263594,0.0004286848,0.00003076615,0.00033052874,0.00013501623,0.0092356345],"genre_scores_gemma":[0.9221202,0.074147746,0.0012899488,0.00045878536,0.0005286402,0.000013538609,0.00017133946,0.000015665033,0.0012541232],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997954,0.000039921517,0.000018182618,0.000049639795,0.00006150666,0.00003533152],"domain_scores_gemma":[0.99919504,0.00030335019,0.00023535885,0.00007994427,0.0000834564,0.00010283538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005098087,0.0002561683,0.00030560757,0.00054278114,0.000119167235,0.00050543656,0.00023219374,0.0004230282,0.0020038616],"category_scores_gemma":[0.0006787789,0.00007648239,0.00017093927,0.0004464679,0.000646057,0.0004946619,0.00041642698,0.0006732893,0.00027733998],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028294509,0.0003868561,0.15501751,0.0035213807,0.0003205052,0.0033034522,0.00029444974,0.0005192202,0.5009536,0.01386291,0.0017710896,0.31721953],"study_design_scores_gemma":[0.00019480044,0.0028572353,0.6218803,0.00088063657,0.0012121387,0.026321527,0.0008765543,0.0022433852,0.22191323,0.017958544,0.10356988,0.00009175712],"about_ca_topic_score_codex":0.0001433327,"about_ca_topic_score_gemma":0.00017922437,"teacher_disagreement_score":0.0020038616,"about_ca_system_score_codex":0.00021388612,"about_ca_system_score_gemma":0.00025818803,"threshold_uncertainty_score":0.0067035556},"labels":[],"label_agreement":null},{"id":"W2063193285","doi":"10.4161/onci.28329","title":"Natural killer T cell strategies to combat Epstein–Barr virus infection","year":2014,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; University of British Columbia","funders":"","keywords":"Natural killer T cell; Virus; Immune system; Epstein–Barr virus; CD1D; Immunology; Biology; Effector; Virology; Cell; Natural killer cell; T cell; Cytotoxic T cell; In vitro","score_opus":0.007527886998474594,"score_gpt":0.23421357835513607,"score_spread":0.22668569135666147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063193285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7641042,0.15361542,0.043957748,0.006539229,0.0025336246,0.0008254302,0.00037774126,0.00091776997,0.027128788],"genre_scores_gemma":[0.9231421,0.051913396,0.014316821,0.0012060904,0.00048205993,0.0003069484,0.000277554,0.000023638866,0.008331458],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998926,0.000022485792,0.000008097734,0.000016756123,0.000023154058,0.00003690422],"domain_scores_gemma":[0.9999577,0.0000070345827,0.000008692881,0.0000045883994,0.000009751157,0.00001222612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002945064,0.00041701613,0.00037515166,0.0003070857,0.00015478359,0.0004976203,0.00047469023,0.00048607582,0.0017034765],"category_scores_gemma":[0.00016438894,0.000103992956,0.00023994844,0.00014061655,0.00036937074,0.00045402694,0.00035817636,0.0012373439,0.0004630476],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075408,0.00087966287,0.00068851956,0.0012583669,0.00008004393,0.00050182425,0.0001739967,0.0018966772,0.7839955,0.009829459,0.0036782287,0.19626358],"study_design_scores_gemma":[0.0017754884,0.011731938,0.0035165402,0.00040610568,0.0003283849,0.0035101855,0.00039548796,0.010326145,0.68557024,0.0131089855,0.2692722,0.000058267426],"about_ca_topic_score_codex":0.00018493844,"about_ca_topic_score_gemma":0.00041489038,"teacher_disagreement_score":0.0017034765,"about_ca_system_score_codex":0.00029381257,"about_ca_system_score_gemma":0.00028754518,"threshold_uncertainty_score":0.005698681},"labels":[],"label_agreement":null},{"id":"W2064415726","doi":"10.4161/2162402x.2014.974374","title":"High endothelial venules are rare in colorectal cancers but accumulate in extra-tumoral areas with disease progression","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Medical Research Council; Wellcome Trust","keywords":"Medicine; Colorectal cancer; Disease; High endothelial venules; Cancer research; Pathology; Cancer; Endothelium; Internal medicine","score_opus":0.018742191533093807,"score_gpt":0.2794869923474949,"score_spread":0.2607448008144011,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064415726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99330634,0.0042619384,0.0008405567,0.000038655468,0.0000103972825,0.000013551175,0.00015252795,0.000032132742,0.0013438638],"genre_scores_gemma":[0.9988206,0.00051345484,0.00024384893,0.000008387357,0.000010250271,0.000005749031,0.000115506744,0.0000026739124,0.00027955472],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99977213,0.00005191529,0.000020655558,0.000047738384,0.000054346132,0.000053279993],"domain_scores_gemma":[0.99898607,0.00019381588,0.0005387914,0.00006260109,0.00008481946,0.00013397544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020084764,0.000128238,0.00017087311,0.00071615557,0.00019611999,0.000375563,0.00013417951,0.00025404253,0.0014265866],"category_scores_gemma":[0.0008510505,0.00011781883,0.00012874426,0.00061334827,0.00020087944,0.00024162389,0.00026622292,0.00024704108,0.00020488338],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011362552,0.000048506558,0.88188165,0.00029814494,0.00015262736,0.005527296,0.00019742182,0.00020663206,0.070783064,0.0006606565,0.00047092966,0.03863669],"study_design_scores_gemma":[0.000013469962,0.000185305,0.96479046,0.00002626951,0.000055075045,0.022809325,0.00027120396,0.00027860428,0.007571238,0.00029485073,0.0036948358,0.000009289412],"about_ca_topic_score_codex":0.00052541454,"about_ca_topic_score_gemma":0.0008702351,"teacher_disagreement_score":0.0014265866,"about_ca_system_score_codex":0.00016486237,"about_ca_system_score_gemma":0.00012737977,"threshold_uncertainty_score":0.004772365},"labels":[],"label_agreement":null},{"id":"W2071355800","doi":"10.4161/21624011.2014.944056","title":"Transcriptional profiling of whole blood: a rich source of immune biomarkers in cancer","year":2014,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Medicine; Tremelimumab; Immunotherapy; Cancer immunotherapy; Peripheral blood; Immune system; Cancer; Immunology; Whole blood; Gene expression profiling; Immune Dysfunction; Oncology; Internal medicine; Gene expression; Gene; Biology; Ipilimumab","score_opus":0.015273027825085274,"score_gpt":0.2774577912047784,"score_spread":0.26218476337969315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071355800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7420729,0.08247567,0.13232553,0.003744809,0.0010899189,0.0002148418,0.027146323,0.0017166932,0.009213292],"genre_scores_gemma":[0.90126705,0.023354506,0.05068818,0.0025575475,0.0010141294,0.00033983885,0.014801787,0.00031066986,0.0056662043],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9994066,0.00013249091,0.000033040604,0.00017489585,0.00019650419,0.00005658824],"domain_scores_gemma":[0.9995067,0.000182325,0.00010005145,0.00006652145,0.00010487312,0.0000394917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005842714,0.0003678304,0.0005557315,0.0010229864,0.00022538497,0.0008393492,0.00020158206,0.0004910743,0.000977072],"category_scores_gemma":[0.00094781717,0.00017807611,0.00021787405,0.0012078466,0.00035342848,0.00040397976,0.00036738618,0.0007578236,0.00071152765],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004577479,0.000054267384,0.010915723,0.00033169272,0.00006475837,0.000112017464,0.000080872196,0.00024015747,0.9426092,0.00039111552,0.0016840714,0.043058347],"study_design_scores_gemma":[0.00007038492,0.0008676243,0.16465135,0.000205673,0.00040876545,0.0020430116,0.0003506721,0.004990629,0.76349026,0.004775421,0.058067337,0.00007895911],"about_ca_topic_score_codex":0.00022918024,"about_ca_topic_score_gemma":0.000432325,"teacher_disagreement_score":0.0010229864,"about_ca_system_score_codex":0.000174742,"about_ca_system_score_gemma":0.00028848046,"threshold_uncertainty_score":0.0032685995},"labels":[],"label_agreement":null},{"id":"W2071754795","doi":"10.4161/onci.26770","title":"TCR/CD3 activation and co-stimulation combined in one T cell retargeting system improve anti-tumor immunity","year":2013,"lang":"en","type":"article","venue":"OncoImmunology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Retargeting; T cell; T-cell receptor; Cancer research; Antigen; CD3; Bispecific antibody; Immunity; Co-stimulation; Cell; Chimeric antigen receptor; Medicine; Stimulation; Antibody; Immunology; Immune system; CD28; CD8; Biology; Computer science; Monoclonal antibody; Internal medicine","score_opus":0.023860766809999833,"score_gpt":0.2860688319584116,"score_spread":0.2622080651484118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071754795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835835,0.0015694887,0.012010706,0.00014143513,0.00008085968,0.00007803084,0.00007739267,0.00040093146,0.002057574],"genre_scores_gemma":[0.9932661,0.00039876855,0.0044653234,0.00006367482,0.000024084535,0.0000254512,0.000071668175,0.000026448204,0.0016584906],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996886,0.00004130406,0.000017914113,0.00006572706,0.00006771698,0.000118783435],"domain_scores_gemma":[0.9999249,0.000013769677,0.000016035929,0.000011306133,0.000008666523,0.00002525049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015919097,0.00052654033,0.00040547963,0.00027179264,0.00012554001,0.00040408745,0.00025662422,0.00048499004,0.0017088848],"category_scores_gemma":[0.00011188148,0.00015013502,0.00028596335,0.00020619802,0.00018703152,0.00033102132,0.00032373265,0.0007725456,0.00047877073],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010670596,0.00008101304,0.00006521281,0.000024516099,0.000004951663,0.00004157717,0.0000070384367,0.00023125217,0.9952069,0.000114343486,0.000070029746,0.0040465384],"study_design_scores_gemma":[0.00003931352,0.00044579507,0.00052378926,0.0000022082822,0.000024702253,0.00014201547,0.0000051412358,0.0017131473,0.99532545,0.000046618195,0.0017266964,0.0000052353876],"about_ca_topic_score_codex":0.00029264763,"about_ca_topic_score_gemma":0.000720791,"teacher_disagreement_score":0.0017088848,"about_ca_system_score_codex":0.000216988,"about_ca_system_score_gemma":0.0002732734,"threshold_uncertainty_score":0.0057168007},"labels":[],"label_agreement":null},{"id":"W2071932221","doi":"10.4161/2162402x.2014.994441","title":"Tregs activated by bispecific antibodies","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Bispecific antibody; Tumor microenvironment; Cancer research; Antibody; CD3; Medicine; Immunology; Chemistry; Tumor cells; Immune system; Monoclonal antibody; CD8","score_opus":0.05954470185408708,"score_gpt":0.33956369655357954,"score_spread":0.2800189946994925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071932221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9426776,0.015970515,0.017524555,0.00045569843,0.0007540006,0.00032268278,0.000343972,0.0005851635,0.021365725],"genre_scores_gemma":[0.9818511,0.004357494,0.0048661684,0.0005071341,0.00019715501,0.00020498101,0.00031337864,0.000045499823,0.0076571126],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996289,0.000092453716,0.000017970038,0.000051886273,0.00007226002,0.00013650917],"domain_scores_gemma":[0.99993396,0.00001892476,0.000009927167,0.00000615442,0.000012103717,0.000018857669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026796627,0.0005342988,0.00034197595,0.00035055386,0.0001381002,0.00027889913,0.00019674744,0.0004243131,0.002883548],"category_scores_gemma":[0.00017443702,0.00012231972,0.00033267276,0.0001371986,0.00013942826,0.00018872149,0.00029772872,0.0010467815,0.00076002866],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055368576,0.00022613422,0.00026907166,0.0002587716,0.00002230292,0.00013013504,0.000052573392,0.00024241718,0.977228,0.0015870673,0.00072101114,0.018708903],"study_design_scores_gemma":[0.00016808754,0.0011240161,0.0015243584,0.000046911315,0.00006103359,0.0004113343,0.000038470942,0.0019167772,0.9662819,0.0009901294,0.02742525,0.000011733288],"about_ca_topic_score_codex":0.0002489582,"about_ca_topic_score_gemma":0.00038263533,"teacher_disagreement_score":0.002883548,"about_ca_system_score_codex":0.0002473161,"about_ca_system_score_gemma":0.00020249769,"threshold_uncertainty_score":0.009646475},"labels":[],"label_agreement":null},{"id":"W2075737968","doi":"10.4161/21624011.2014.970025","title":"Ectopic expression of embryonic stem cell and other developmental genes in cutaneous T-cell lymphoma","year":2014,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; University of British Columbia; Université Laval; Quest University Canada; McGill University Health Centre","funders":"National Cancer Institute; Novo Nordisk Fonden","keywords":"SOX2; Homeobox protein NANOG; Biology; Cancer research; Stem cell; Carcinogenesis; Ectopic expression; Embryonic stem cell; KLF4; Phenotype; Gene; Cutaneous T-cell lymphoma; Cancer stem cell; Stem cell marker; Cancer; Lymphoma; Genetics; Immunology; Induced pluripotent stem cell; Mycosis fungoides","score_opus":0.015121044678659688,"score_gpt":0.2631689459095448,"score_spread":0.24804790123088513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075737968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99454814,0.0005336447,0.0030835688,0.00003469849,0.000009982915,0.00001210442,0.000181251,0.00005121252,0.0015454493],"genre_scores_gemma":[0.9968354,0.0001626396,0.0014207427,0.00001740895,0.0000025346965,0.000008489632,0.00027207748,0.000013021674,0.0012678662],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998677,0.000020207155,0.000016046775,0.00002954678,0.00003836301,0.00002811067],"domain_scores_gemma":[0.9998437,0.000037378242,0.000031836244,0.000030048015,0.000021140975,0.00003593318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010036819,0.00011971199,0.00010823507,0.00032332458,0.00013218206,0.0002854145,0.000057309553,0.00014672942,0.0017699685],"category_scores_gemma":[0.00018409062,0.00008034993,0.00009071638,0.00022989762,0.0001856363,0.00010023916,0.000112564645,0.00019842944,0.00027253138],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041631185,0.0000069588555,0.0018892838,0.000014492618,0.0000035842133,0.00019299512,0.000013682344,0.0000230214,0.9964581,0.000052557487,0.000018926883,0.0012848054],"study_design_scores_gemma":[0.000010276662,0.00014232297,0.04772603,0.000008505591,0.000032665084,0.004005704,0.000117664014,0.0012082929,0.9444298,0.000083469,0.0022320137,0.000003275828],"about_ca_topic_score_codex":0.00043277172,"about_ca_topic_score_gemma":0.00095896685,"teacher_disagreement_score":0.0017699685,"about_ca_system_score_codex":0.00014163024,"about_ca_system_score_gemma":0.00011516629,"threshold_uncertainty_score":0.0059211254},"labels":[],"label_agreement":null},{"id":"W2077023409","doi":"10.4161/onci.24754","title":"Myeloid-derived suppressor cells, age and cancer","year":2013,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"","keywords":"Suppressor; Myeloid-derived Suppressor Cell; Cancer; Cancer research; Myeloid; Myeloid cells; Immunology; Medicine; Biology; Internal medicine","score_opus":0.010878609211907208,"score_gpt":0.2350063358891916,"score_spread":0.2241277266772844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077023409","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22283994,0.76527363,0.0008210664,0.003789992,0.00035469237,0.000014940428,0.00006475662,0.000024493456,0.006816497],"genre_scores_gemma":[0.76248795,0.229855,0.00078623055,0.00092939555,0.0009288108,0.000015843934,0.0000710401,0.0000040092914,0.004921806],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9999423,0.000017097223,0.000004249164,0.000006867866,0.0000140923885,0.000015356707],"domain_scores_gemma":[0.9999063,0.000022993472,0.000030018504,0.0000029282476,0.00000870806,0.000029001076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002506894,0.00013062685,0.00017678963,0.00038319753,0.00014478946,0.00031734628,0.00014308539,0.00034105548,0.00096592656],"category_scores_gemma":[0.00015981468,0.00003324208,0.000062351406,0.0002570361,0.00034351362,0.00024712284,0.00024204538,0.00035518847,0.00014010233],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035478473,0.0006826453,0.06275728,0.00204284,0.00012231781,0.004452035,0.0008194228,0.0012435316,0.20088366,0.065720685,0.011407348,0.64632034],"study_design_scores_gemma":[0.0002149136,0.004388661,0.3070773,0.0006998966,0.00018236176,0.015546236,0.0016527297,0.0013520148,0.051562224,0.066266745,0.5509878,0.00006913129],"about_ca_topic_score_codex":0.0002356736,"about_ca_topic_score_gemma":0.0005151633,"teacher_disagreement_score":0.00096592656,"about_ca_system_score_codex":0.00018722333,"about_ca_system_score_gemma":0.00016724369,"threshold_uncertainty_score":0.0032313466},"labels":[],"label_agreement":null},{"id":"W2080254064","doi":"10.4161/onci.26705","title":"A<sub>2A</sub>blockade enhances anti-metastatic immune responses","year":2013,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Health and Medical Research Council; Medical Research Council; National Evidence-based Healthcare Collaborating Agency","keywords":"Blockade; Immunosuppression; Medicine; Adenosine; Immune system; Metastatic melanoma; Adenosine receptor; Metastatic breast cancer; Cancer research; Immunotherapy; Receptor; Cancer; Immune checkpoint; Immunology; Melanoma; Breast cancer; Internal medicine; Agonist","score_opus":0.009144183630438738,"score_gpt":0.24564945300201316,"score_spread":0.23650526937157443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080254064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875892,0.0037310857,0.0017661281,0.0002778988,0.00013051499,0.000047426045,0.0002664307,0.00015230995,0.0060389796],"genre_scores_gemma":[0.9948672,0.0013074094,0.00081551506,0.0001083419,0.000053177602,0.000039484785,0.00017204718,0.00001543671,0.0026213292],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988437,0.000023810788,0.000006154244,0.000011231536,0.000027358888,0.000046920864],"domain_scores_gemma":[0.99993527,0.000013440623,0.000011629017,0.00000731872,0.000007290423,0.000025047895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012055247,0.0003167484,0.00032788643,0.0002143097,0.00013061104,0.00028007154,0.000108949265,0.00019771197,0.00209766],"category_scores_gemma":[0.00009828939,0.000081137296,0.00015125092,0.00012022253,0.00015199867,0.00016603974,0.0000934781,0.0007847557,0.0005746763],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027190638,0.00022320572,0.000117986834,0.00004744336,0.000010605396,0.00006707682,0.000008993723,0.00016013005,0.9931994,0.00023011473,0.00028758968,0.005375463],"study_design_scores_gemma":[0.000083350926,0.002807246,0.0068691075,0.00000895192,0.00003404326,0.00042433207,0.000039750033,0.0018455645,0.9808636,0.00018299949,0.006833485,0.000007651537],"about_ca_topic_score_codex":0.000315963,"about_ca_topic_score_gemma":0.0010469866,"teacher_disagreement_score":0.00209766,"about_ca_system_score_codex":0.0001777931,"about_ca_system_score_gemma":0.00021563873,"threshold_uncertainty_score":0.007017374},"labels":[],"label_agreement":null},{"id":"W2080830471","doi":"10.4161/onci.1.2.18101","title":"The double-edge sword effect of anti-CD73 cancer therapy","year":2012,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"SWORD; Medicine; Cancer; Immune system; Cancer research; Blockade; Targeted therapy; Cancer cell; Immunology; Internal medicine; Receptor; Computer science","score_opus":0.013532766654919433,"score_gpt":0.29495619015776603,"score_spread":0.2814234235028466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080830471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5578732,0.17545725,0.09967627,0.026198268,0.007735,0.00038653446,0.00071688736,0.0017087,0.13024798],"genre_scores_gemma":[0.92890495,0.026323078,0.013489885,0.004883833,0.0010945982,0.000104092935,0.000115861876,0.00007766605,0.025005959],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984574,0.000030450381,0.0000067791107,0.000022481907,0.00004949944,0.000045097437],"domain_scores_gemma":[0.9999145,0.000023951847,0.00001469673,0.000010063232,0.000010747324,0.000026084572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026286163,0.00032098946,0.00036510674,0.00026050193,0.00034045274,0.0005734969,0.00028020964,0.0005706341,0.002659511],"category_scores_gemma":[0.00020934767,0.00010037135,0.00024204307,0.00013484443,0.00042015663,0.0005387168,0.00041182435,0.0011462545,0.0006123961],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009662469,0.0002926918,0.00069525436,0.00048413558,0.00007292359,0.00087948795,0.00009546288,0.00096044707,0.6895398,0.038159013,0.014072027,0.25378248],"study_design_scores_gemma":[0.00025628312,0.0030463838,0.0034235897,0.000081643084,0.0001280168,0.0045175487,0.0001145804,0.0028344255,0.72290474,0.01210858,0.25053087,0.00005331554],"about_ca_topic_score_codex":0.00013891415,"about_ca_topic_score_gemma":0.0003548096,"teacher_disagreement_score":0.002659511,"about_ca_system_score_codex":0.00025981313,"about_ca_system_score_gemma":0.00024352103,"threshold_uncertainty_score":0.008896887},"labels":[],"label_agreement":null},{"id":"W2087198431","doi":"10.4161/onci.27988","title":"NKp44L","year":2014,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Nautical Research Society","funders":"","keywords":"Cytotoxicity; Ligand (biochemistry); Cancer research; Cancer; Immunotherapy; Receptor; Computational biology; Biology; Immunology; Medicine; Immune system; In vitro; Biochemistry; Genetics","score_opus":0.00795300873703434,"score_gpt":0.22066106657538942,"score_spread":0.21270805783835509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087198431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89819235,0.010749619,0.0165775,0.0033633034,0.0013142523,0.00032408343,0.0054299324,0.0009534195,0.06309558],"genre_scores_gemma":[0.91878295,0.0025393933,0.005484645,0.0012821078,0.00022425319,0.0002473395,0.0058660586,0.00011651413,0.06545683],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997235,0.00002711569,0.00001815603,0.00006605928,0.00009296157,0.00007228589],"domain_scores_gemma":[0.9999298,0.0000062314493,0.000012256014,0.000012490261,0.00001639986,0.000022778506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011609445,0.00024743425,0.0002175048,0.00022948941,0.00030542345,0.0004794245,0.00028240512,0.0004208632,0.018091917],"category_scores_gemma":[0.00023105042,0.000108385975,0.00021537593,0.00015365555,0.00017605654,0.0003112122,0.0004862417,0.00080173556,0.0054337755],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033521376,0.00013041291,0.0024690032,0.00013587775,0.00003355499,0.0010855857,0.000058806596,0.00026635357,0.94126076,0.0026478283,0.0074551827,0.0441215],"study_design_scores_gemma":[0.00019868146,0.00070117286,0.0191431,0.000034877048,0.000065817476,0.011988918,0.00013492962,0.004536547,0.63822746,0.0020901486,0.3228282,0.000050164217],"about_ca_topic_score_codex":0.0010289418,"about_ca_topic_score_gemma":0.0009431842,"teacher_disagreement_score":0.018091917,"about_ca_system_score_codex":0.0004478481,"about_ca_system_score_gemma":0.00030609072,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W2092063434","doi":"10.4161/onci.23472","title":"Analysis of NKp30/NCR3 isoforms in untreated HIV-1-infected patients from the ANRS SEROCO cohort","year":2013,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer; Ligue Contre le Cancer; Agence Nationale de la Recherche","keywords":"CD16; Cohort; Immunology; Medicine; Downregulation and upregulation; Disease; Immune system; Innate immune system; CD8; Cancer research; Biology; Internal medicine; CD3; Gene","score_opus":0.0048941428281209015,"score_gpt":0.20144396618921967,"score_spread":0.19654982336109877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092063434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992526,0.00008402969,0.000027211381,0.000009882123,0.00000281507,0.0000033833394,0.00024387322,0.0000017839865,0.00037424234],"genre_scores_gemma":[0.99900633,0.00006764431,0.000028888473,0.000015625401,0.0000072919697,0.000004710722,0.0005871365,0.0000020817836,0.0002803073],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99984884,0.000030282625,0.000018880122,0.00004204687,0.000024970721,0.00003493049],"domain_scores_gemma":[0.99974805,0.000047504844,0.00007864785,0.000036788,0.000025117519,0.00006382845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023770893,0.0002042343,0.00022004484,0.0004933218,0.0002783288,0.00038389553,0.00017164355,0.0002271384,0.002103683],"category_scores_gemma":[0.0006406933,0.00012933377,0.00024639114,0.00029428944,0.00015704434,0.00020301793,0.00019527825,0.00029014095,0.00036515863],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017463748,0.000085996515,0.98517966,0.000016371592,0.00009424337,0.00063603086,0.00019547244,0.0001334007,0.0071117193,0.0000754126,0.00030384294,0.004421595],"study_design_scores_gemma":[0.000027248843,0.00033657782,0.9970866,0.0000062644312,0.000038759452,0.0010592734,0.0002424412,0.00024681562,0.00037762302,0.000032484426,0.00054111396,0.00000488584],"about_ca_topic_score_codex":0.002133321,"about_ca_topic_score_gemma":0.002151336,"teacher_disagreement_score":0.002133321,"about_ca_system_score_codex":0.00013437861,"about_ca_system_score_gemma":0.000119416465,"threshold_uncertainty_score":0.0070375204},"labels":[],"label_agreement":null},{"id":"W2106492804","doi":"10.4161/onci.27622","title":"Two is better than one: Complementing oncolytic virotherapy with gemcitabine to potentiate antitumor immune responses","year":2014,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Oncolytic virus; Virotherapy; Immune system; Immunosuppression; Gemcitabine; Cancer research; Cancer; Immunology; Biology; Medicine; Internal medicine","score_opus":0.018314062069322037,"score_gpt":0.3078933072238697,"score_spread":0.2895792451545477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106492804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9152121,0.026461335,0.023829475,0.011113406,0.0019037889,0.00031892714,0.0005065903,0.0008102272,0.019844173],"genre_scores_gemma":[0.9776504,0.004607592,0.007344635,0.0022602743,0.00019106336,0.0001112755,0.00022379191,0.00011822711,0.007492774],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995389,0.00011285113,0.00003224771,0.000087969056,0.00011659053,0.000111451634],"domain_scores_gemma":[0.9994499,0.00014789909,0.000087036824,0.00008091869,0.000056851855,0.00017737689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006577759,0.00046142418,0.00095200987,0.0005466231,0.0003077463,0.001465364,0.00034508586,0.00096014293,0.0039433986],"category_scores_gemma":[0.00096653454,0.00017068307,0.00051209313,0.00023871395,0.000613733,0.0013684272,0.00067749986,0.001614146,0.0007496618],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005850905,0.0014138223,0.0034204223,0.0010187936,0.00024114703,0.00043366084,0.00021450475,0.0018143194,0.77920514,0.012792082,0.0041312035,0.18946397],"study_design_scores_gemma":[0.0011060842,0.017285433,0.011410171,0.00034006152,0.0007407529,0.004192765,0.00043062092,0.0050979154,0.8394404,0.013304301,0.10644274,0.00020877381],"about_ca_topic_score_codex":0.00035970475,"about_ca_topic_score_gemma":0.0006871681,"teacher_disagreement_score":0.0039433986,"about_ca_system_score_codex":0.00070780824,"about_ca_system_score_gemma":0.00090518687,"threshold_uncertainty_score":0.013192058},"labels":[],"label_agreement":null},{"id":"W2123262599","doi":"10.1080/2162402x.2015.1008791","title":"Understanding high endothelial venules: Lessons for cancer immunology","year":2015,"lang":"en","type":"review","venue":"OncoImmunology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Heart, Lung, and Blood Institute; Medical Research Council; Wellcome Trust","keywords":"High endothelial venules; Lymphotoxin; Immunology; Lymphotoxin beta receptor; Biology; Lymphatic system; Lymphangiogenesis; CD11c; Inflammation; Immune system; Tumor microenvironment; Cancer research; Medicine; Cancer; Metastasis","score_opus":0.20970323727528145,"score_gpt":0.3848510287832197,"score_spread":0.17514779150793824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123262599","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013572666,0.9971637,0.0003877955,0.0012841455,0.00038768645,0.0000024727742,0.000009322073,0.000008735532,0.0006203604],"genre_scores_gemma":[0.0013215191,0.99679345,0.0002487596,0.00045726856,0.0005301902,0.0000046675805,0.000016017832,0.0000016136141,0.00062654604],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998971,0.000018771567,0.00001019256,0.000018839753,0.000036091056,0.000018844965],"domain_scores_gemma":[0.9997011,0.000119100485,0.00003200396,0.000014320812,0.0000864971,0.00004683252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006500116,0.0006295794,0.0010115877,0.0011229374,0.00026756033,0.0012217392,0.00085499586,0.0018011059,0.0023676439],"category_scores_gemma":[0.0005119255,0.00022534565,0.00036611842,0.0008249548,0.0011024063,0.0030152374,0.0006822285,0.003259943,0.0012739107],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007870648,0.000060790997,0.0003253894,0.008051361,0.00006423529,0.0003408234,0.00009892058,0.0006475981,0.004475596,0.026247505,0.049176726,0.91043234],"study_design_scores_gemma":[0.000010964892,0.000073115414,0.0006145681,0.0013529619,0.00003441963,0.0011566703,0.00009602815,0.00017822294,0.0009887437,0.0115922075,0.9838832,0.00001880232],"about_ca_topic_score_codex":0.0008598497,"about_ca_topic_score_gemma":0.0011113345,"teacher_disagreement_score":0.0023676439,"about_ca_system_score_codex":0.00091265066,"about_ca_system_score_gemma":0.00094057055,"threshold_uncertainty_score":0.007920563},"labels":[],"label_agreement":null},{"id":"W2130024935","doi":"10.4161/onci.23621","title":"Lessons learned from a highly-active CD22-specific chimeric antigen receptor","year":2013,"lang":"en","type":"article","venue":"OncoImmunology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"CD22; Chimeric antigen receptor; Epitope; Antigen; Bispecific antibody; Receptor; Antibody; Immunology; Computational biology; Cancer research; Medicine; Immunotherapy; Biology; Monoclonal antibody; Internal medicine; Immune system","score_opus":0.07570445915132859,"score_gpt":0.34021376943611,"score_spread":0.2645093102847814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130024935","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07985567,0.5460273,0.05086187,0.27610922,0.008582378,0.00010455859,0.00045118874,0.00042905236,0.037578773],"genre_scores_gemma":[0.4028776,0.48327392,0.025350323,0.055174634,0.009562154,0.00013053048,0.00037365436,0.0001706297,0.023086503],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99949026,0.0001686251,0.000036632475,0.00007328077,0.00014820766,0.00008300965],"domain_scores_gemma":[0.9989856,0.0004378756,0.00004206084,0.00009798174,0.00020964979,0.00022694288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029563804,0.00055846927,0.00079002255,0.00031897056,0.0004258032,0.0017804914,0.000937621,0.0017217433,0.0027286187],"category_scores_gemma":[0.0023870491,0.00025109557,0.0004327387,0.00023795926,0.0028449409,0.0036458448,0.0010038485,0.0074072266,0.0013260134],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014755572,0.000864894,0.0022593373,0.003290638,0.00021141664,0.004901283,0.0012840076,0.005720936,0.0755814,0.19577055,0.11414434,0.5944957],"study_design_scores_gemma":[0.0003719386,0.0020999105,0.0016668463,0.000832104,0.00014493556,0.006300937,0.00097108,0.0034243276,0.038738426,0.12190708,0.823414,0.00012842845],"about_ca_topic_score_codex":0.00081433053,"about_ca_topic_score_gemma":0.0010609445,"teacher_disagreement_score":0.0029563804,"about_ca_system_score_codex":0.0009908275,"about_ca_system_score_gemma":0.0009858565,"threshold_uncertainty_score":0.015635014},"labels":[],"label_agreement":null},{"id":"W2159829076","doi":"10.4161/onci.27897","title":"Role of the complement system in NK cell-mediated antitumor T-cell responses","year":2014,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Armand Frappier Museum; Institut National de la Recherche Scientifique; Université du Québec à Montréal","funders":"","keywords":"Complement system; Complement (music); Immunology; Complement receptor; Cancer research; Carcinogenesis; CD8; Cell; Biology; Immune system; Cancer; Phenotype; Gene","score_opus":0.009471826718366015,"score_gpt":0.2281227994439035,"score_spread":0.2186509727255375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159829076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89637214,0.073516905,0.012280706,0.0012770608,0.00022438327,0.00016549909,0.00027381702,0.0001972672,0.015692215],"genre_scores_gemma":[0.99130696,0.0049883937,0.0017421537,0.000064466876,0.00003633171,0.000026928463,0.00006664197,0.00000805138,0.0017602168],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999723,0.00009921766,0.00001889338,0.00002741109,0.000052897714,0.00007851435],"domain_scores_gemma":[0.999851,0.000045851262,0.000022159938,0.0000123801765,0.00003314763,0.000035474826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043474592,0.00041457688,0.00029484692,0.00040364236,0.0003300992,0.0004921422,0.00022691331,0.0004480127,0.0025989027],"category_scores_gemma":[0.00043943812,0.00008704619,0.0001728901,0.00016772485,0.00038732655,0.00042547917,0.00035893588,0.0005304936,0.00029918275],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001052233,0.00007570076,0.0011810125,0.00036779305,0.000021048441,0.00029411382,0.00005797302,0.00088292436,0.96206164,0.0041019176,0.0003673554,0.029536197],"study_design_scores_gemma":[0.00023809321,0.002719482,0.019374587,0.00018041665,0.000119772856,0.00166935,0.00018403541,0.008489937,0.9398249,0.008481593,0.01866591,0.00005205393],"about_ca_topic_score_codex":0.0014579827,"about_ca_topic_score_gemma":0.0011645816,"teacher_disagreement_score":0.0025989027,"about_ca_system_score_codex":0.0008056332,"about_ca_system_score_gemma":0.0007535237,"threshold_uncertainty_score":0.0086942315},"labels":[],"label_agreement":null},{"id":"W2163252162","doi":"10.4161/21624011.2014.955691","title":"Consensus guidelines for the detection of immunogenic cell death","year":2014,"lang":"en","type":"review","venue":"OncoImmunology","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":824,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal; McMaster University; BC Cancer Agency; Institute of Cancer Research; McMaster University Medical Centre; Pancreas Centre (Canada)","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute; Cancer Research UK","keywords":"Immunogenic cell death; Calreticulin; Immune system; Programmed cell death; Autophagy; Acquired immune system; Immunology; Endoplasmic reticulum; Antigen; Medicine; Cancer research; Biology; Apoptosis; Immunotherapy; Cell biology","score_opus":0.10494768991068182,"score_gpt":0.3646024099074481,"score_spread":0.25965471999676626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163252162","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010972213,0.89290416,0.033559565,0.012530679,0.005872753,0.0011550304,0.0021922202,0.00069234014,0.049996037],"genre_scores_gemma":[0.007956048,0.88026935,0.06189621,0.009540116,0.0015100401,0.002733597,0.006208912,0.00018852789,0.029697156],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99697506,0.00083055976,0.0005725718,0.00026068196,0.0011278146,0.00023320538],"domain_scores_gemma":[0.9959663,0.001113782,0.0005358897,0.0003268018,0.0018002355,0.00025692786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055501275,0.001979794,0.0018161356,0.0050380016,0.00068879017,0.0018673349,0.0043483833,0.00441708,0.0092261145],"category_scores_gemma":[0.0040657716,0.0007674562,0.0018530268,0.0029163712,0.0017251044,0.0020251125,0.0018118039,0.0044973935,0.011568728],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023640401,0.000297429,0.0004744302,0.019171521,0.00011177503,0.0008379188,0.00024239728,0.00072416104,0.026065653,0.028809411,0.16179177,0.7612372],"study_design_scores_gemma":[0.000023920535,0.00009534438,0.0006419236,0.0030867038,0.00005278056,0.0010023392,0.00008597194,0.0000854154,0.0052990452,0.003413805,0.98618096,0.000031905834],"about_ca_topic_score_codex":0.002572441,"about_ca_topic_score_gemma":0.0024059126,"teacher_disagreement_score":0.0092261145,"about_ca_system_score_codex":0.0018527614,"about_ca_system_score_gemma":0.005624742,"threshold_uncertainty_score":0.030864418},"labels":[],"label_agreement":null},{"id":"W2165582666","doi":"10.1080/2162402x.2015.1046675","title":"CD73: A potential biomarker for anti-PD-1 therapy","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Biomarker; Blockade; Concomitant; Disease; Clinical trial; Oncology; Pharmacology; Internal medicine; Receptor; Biology","score_opus":0.04289721207157496,"score_gpt":0.29771285353848065,"score_spread":0.2548156414669057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165582666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7232361,0.2091186,0.03306399,0.009245024,0.001555152,0.00029228412,0.0011952044,0.0006688693,0.021624759],"genre_scores_gemma":[0.9650047,0.021246938,0.0075866035,0.0009661615,0.00040787336,0.00007832938,0.00037789595,0.000023555647,0.00430794],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997476,0.000070132955,0.000014073099,0.00003910324,0.000074256735,0.000054887794],"domain_scores_gemma":[0.9998111,0.000051082683,0.000044119173,0.0000114109,0.000045585522,0.000036801164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046637235,0.00045132008,0.00043365447,0.0010888957,0.00037419156,0.0010090581,0.00034430687,0.0007132966,0.00183052],"category_scores_gemma":[0.0004848558,0.00010515086,0.00020414978,0.00070661027,0.00045787642,0.00065448694,0.0002753017,0.0010864794,0.00045649952],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002006255,0.0005231526,0.014338688,0.00070627214,0.00016807446,0.0017709926,0.000097707016,0.0008993041,0.71808684,0.006128386,0.009746598,0.24552774],"study_design_scores_gemma":[0.00016427488,0.0026850908,0.049788106,0.00018919756,0.0004993194,0.0065722214,0.00033118427,0.010477024,0.80297786,0.005423034,0.12078785,0.00010484985],"about_ca_topic_score_codex":0.0007957712,"about_ca_topic_score_gemma":0.000950408,"teacher_disagreement_score":0.00183052,"about_ca_system_score_codex":0.00072693947,"about_ca_system_score_gemma":0.00034630627,"threshold_uncertainty_score":0.0061237216},"labels":[],"label_agreement":null},{"id":"W2165986055","doi":"10.4161/onci.24501","title":"Synchronous apoptosis in established tumors leads to the induction of adaptive immunity","year":2013,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; Health Sciences Centre","funders":"Cancer Research UK","keywords":"Immune system; Apoptosis; Immunogenic cell death; Acquired immune system; Programmed cell death; Cancer research; Immunity; Immunology; Caspase; Medicine; Biology; Immunotherapy","score_opus":0.01443459588058328,"score_gpt":0.23468555433767838,"score_spread":0.2202509584570951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165986055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99274534,0.0012709296,0.004147234,0.000070975635,0.00003777506,0.000040809995,0.00008568304,0.0001301531,0.0014710345],"genre_scores_gemma":[0.99791735,0.00037399362,0.0006296111,0.000022482243,0.000008637023,0.000016243588,0.000068345624,0.0000068867707,0.00095648965],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998281,0.0000258788,0.0000098139735,0.000025254452,0.00005212428,0.000058848982],"domain_scores_gemma":[0.99980956,0.000050461673,0.000043824137,0.00003424484,0.000015515112,0.000046453435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016838055,0.00024524832,0.00023696331,0.00023177567,0.000101854144,0.00026305616,0.00015953514,0.0002475539,0.0014204397],"category_scores_gemma":[0.00017181286,0.000103611266,0.00023053506,0.00011364673,0.00022831677,0.0002138329,0.0002548047,0.00096948317,0.00027540434],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002745509,0.00011566914,0.0006215633,0.000038399383,0.000007017873,0.00016776416,0.000023407058,0.00023477963,0.99487466,0.00040185006,0.00007124749,0.0031691503],"study_design_scores_gemma":[0.000054453438,0.0012694645,0.004393642,0.000005001617,0.0000101846135,0.00034071036,0.000029204839,0.0015622335,0.9906317,0.00028238827,0.0014173952,0.0000035711246],"about_ca_topic_score_codex":0.00017681728,"about_ca_topic_score_gemma":0.000310929,"teacher_disagreement_score":0.0014204397,"about_ca_system_score_codex":0.0003319055,"about_ca_system_score_gemma":0.00017992675,"threshold_uncertainty_score":0.004751861},"labels":[],"label_agreement":null},{"id":"W2180740294","doi":"10.1080/2162402x.2015.1048955","title":"Carving out its niche: A role for carbonic anhydrase IX in pre-metastatic niche development","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Canadian Centre for Applied Research in Cancer Control; BC Cancer Agency","funders":"","keywords":"Niche; Cancer research; Metastasis; Hypoxia (environmental); Bone marrow; Medicine; Carbonic anhydrase; Biology; Immunology; Enzyme; Chemistry; Cancer; Internal medicine; Biochemistry","score_opus":0.0379765576497468,"score_gpt":0.29800849841749366,"score_spread":0.2600319407677469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2180740294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97059155,0.015985902,0.0068167765,0.0015373104,0.00009938603,0.000055790668,0.00018129816,0.0001537713,0.00457823],"genre_scores_gemma":[0.99039286,0.0033279725,0.0021203465,0.00011407679,0.00005585807,0.000022098817,0.00008740134,0.000013390424,0.0038658339],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999362,0.000007566648,0.000002574987,0.00001040306,0.000016988919,0.00002616529],"domain_scores_gemma":[0.9999181,0.000005919096,0.000010798908,0.0000045467846,0.00001122822,0.000049427636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011341256,0.00020591354,0.00016320244,0.00018890208,0.00021353606,0.0003872571,0.00014146719,0.00025672652,0.0012145835],"category_scores_gemma":[0.00011029027,0.00006562321,0.00013580524,0.00008919636,0.00026686356,0.00033886894,0.00027779274,0.0005626002,0.00021780904],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019874073,0.000028828892,0.0017399027,0.00008185158,0.0000065318936,0.00062982837,0.00007044576,0.00007832239,0.9844679,0.0019074833,0.00035707513,0.0104330005],"study_design_scores_gemma":[0.00007559725,0.0008709047,0.07222132,0.000063583546,0.000047852052,0.0038523267,0.0005135931,0.0026370098,0.87748075,0.001932562,0.04028334,0.000021165299],"about_ca_topic_score_codex":0.00056831364,"about_ca_topic_score_gemma":0.0010667797,"teacher_disagreement_score":0.0012145835,"about_ca_system_score_codex":0.0003151306,"about_ca_system_score_gemma":0.00030995853,"threshold_uncertainty_score":0.0040632486},"labels":[],"label_agreement":null},{"id":"W2233686346","doi":"10.1080/2162402x.2015.1061176","title":"Biological network-driven gene selection identifies a stromal immune module as a key determinant of triple-negative breast carcinoma prognosis","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Bioinformatics and Genomic Networks","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Response Biomedical (Canada)","funders":"Agence Nationale de la Recherche","keywords":"Triple-negative breast cancer; Gene signature; Breast cancer; Stromal cell; Gene; Computational biology; Cancer research; Gene expression; Medicine; Biology; Cancer; Genetics","score_opus":0.015666360082826656,"score_gpt":0.23930737659338697,"score_spread":0.22364101651056031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2233686346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952732,0.00041893127,0.0020469194,0.00010126696,0.000004839735,0.00000905399,0.0017446582,0.0000599531,0.00034121258],"genre_scores_gemma":[0.9957073,0.00013335193,0.0015371237,0.000038682883,0.000008505398,0.000014348023,0.0023735391,0.00000898949,0.0001781214],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99973804,0.00005523436,0.000014594239,0.000109295535,0.000041593557,0.000041232146],"domain_scores_gemma":[0.9996551,0.00014067096,0.00010499518,0.00002766955,0.00003123016,0.00004035887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035268714,0.00023185679,0.00033980014,0.0007620974,0.00019101269,0.0004194993,0.00018033347,0.00019492015,0.00077008107],"category_scores_gemma":[0.0008186299,0.00010203769,0.00039489567,0.00094334106,0.00018834975,0.0001756263,0.00032875285,0.00019696348,0.0001753375],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009220877,0.000093026276,0.7946178,0.00018598913,0.00042603348,0.00028077283,0.00014292153,0.0054714303,0.17146662,0.0004036294,0.0010072535,0.024982482],"study_design_scores_gemma":[0.000011531476,0.000092763716,0.97097707,0.000009538901,0.0001447897,0.00031527109,0.00008134865,0.021534624,0.0054898714,0.00061216526,0.0007201869,0.000010877614],"about_ca_topic_score_codex":0.0014115013,"about_ca_topic_score_gemma":0.0022902556,"teacher_disagreement_score":0.0014115013,"about_ca_system_score_codex":0.00026728908,"about_ca_system_score_gemma":0.0002842845,"threshold_uncertainty_score":0.0028065443},"labels":[],"label_agreement":null},{"id":"W2240026571","doi":"10.1080/2162402x.2015.1057674","title":"All that glitters is not gold: the need to consider desirable and undesirable immune aspects of oncolytic virus therapy","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Oncolytic virus; Immunosuppression; Medicine; Immune system; Immunology; Cancer; Virus; Cancer therapy; Internal medicine","score_opus":0.08400600607620658,"score_gpt":0.333954609591915,"score_spread":0.2499486035157084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2240026571","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030353602,0.21646023,0.02868054,0.68221456,0.016952425,0.00010547497,0.00009012051,0.00049659546,0.024646416],"genre_scores_gemma":[0.44116864,0.20106445,0.03666851,0.2795046,0.015025392,0.00025955855,0.00012242264,0.00064840436,0.025538035],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.996278,0.0015381397,0.0002559645,0.00033167357,0.0012575882,0.00033866742],"domain_scores_gemma":[0.99180424,0.004506715,0.00056362397,0.0010579076,0.0013221985,0.00074527535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010401112,0.0005291752,0.0018175902,0.00059094356,0.0019990725,0.0049840165,0.001045462,0.003637784,0.0023012224],"category_scores_gemma":[0.01055021,0.0002899305,0.0005795333,0.00029428132,0.0129021015,0.008291394,0.0024711075,0.013238752,0.0009949441],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010171885,0.00059288926,0.0047111227,0.0034021016,0.00040570585,0.0026706534,0.004188082,0.0019366242,0.064852335,0.26372984,0.14107224,0.51142126],"study_design_scores_gemma":[0.00012556411,0.00095589075,0.0020953226,0.001516514,0.00017366062,0.005014022,0.004410451,0.0008549208,0.020035466,0.33722842,0.6274086,0.00018113127],"about_ca_topic_score_codex":0.0007640561,"about_ca_topic_score_gemma":0.0017594333,"teacher_disagreement_score":0.010401112,"about_ca_system_score_codex":0.0019811955,"about_ca_system_score_gemma":0.003977597,"threshold_uncertainty_score":0.05500698},"labels":[],"label_agreement":null},{"id":"W2265669938","doi":"10.1080/2162402x.2014.995562","title":"Natural killer T cell activation overcomes immunosuppression to enhance clearance of postsurgical breast cancer metastasis in mice","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Beatrice Hunter Cancer Research Institute; Dalhousie University","funders":"","keywords":"Natural killer T cell; Immunotherapy; Cancer research; Medicine; Cytotoxic T cell; Metastasis; Immunology; CD8; Cancer; Metastatic breast cancer; T cell; Dendritic cell; Myeloid-derived Suppressor Cell; Breast cancer; Immune system; Biology; Internal medicine; In vitro; Suppressor","score_opus":0.010811134840289772,"score_gpt":0.281672839730135,"score_spread":0.27086170488984523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2265669938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99419737,0.001052154,0.0017774592,0.00029823283,0.00012538332,0.000086602195,0.00013187536,0.00019352506,0.0021373779],"genre_scores_gemma":[0.9942526,0.00056496303,0.0013873033,0.00010055972,0.00004987581,0.000081462545,0.0001840269,0.000024308063,0.0033549159],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99964404,0.00005942955,0.00002452493,0.000050017545,0.000071472125,0.00015042066],"domain_scores_gemma":[0.9998061,0.000021692065,0.000054363893,0.000022414224,0.000016494161,0.000078988945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027438402,0.0005359008,0.00036927476,0.000456055,0.00018918452,0.00040693855,0.00033849198,0.00041036846,0.0014216237],"category_scores_gemma":[0.00021378662,0.00020118403,0.00027293494,0.00012395663,0.00042915874,0.0003321328,0.00020199304,0.0017173608,0.00037497893],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056501967,0.00047787264,0.00018582787,0.000051127477,0.000008706816,0.00007112361,0.000035558263,0.000133695,0.9939957,0.0002672779,0.00021206692,0.003996105],"study_design_scores_gemma":[0.0002764049,0.005659552,0.0025183326,0.000017218,0.000033157754,0.0004612023,0.000049892547,0.0013818261,0.9862329,0.00019554708,0.003162392,0.000011541168],"about_ca_topic_score_codex":0.00042764263,"about_ca_topic_score_gemma":0.0013589588,"teacher_disagreement_score":0.0014216237,"about_ca_system_score_codex":0.00032135381,"about_ca_system_score_gemma":0.00037148173,"threshold_uncertainty_score":0.0047558546},"labels":[],"label_agreement":null},{"id":"W2270967011","doi":"10.1080/2162402x.2015.1090077","title":"Pharmacological DNA demethylation: Implications for cancer immunotherapy","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"DNA demethylation; Stimulator of interferon genes; IRF7; Interferon; MDA5; Viral infection; TLR7; Demethylation; Downregulation and upregulation; Cancer immunotherapy; Cancer research; Biology; DNA; Immunotherapy; Cancer; Interferon regulatory factors; DNA methylation; Virology; Innate immune system; Gene; Immunology; RNA; Immune system; Virus; Genetics; Gene expression; Toll-like receptor; RNA interference","score_opus":0.07756765969573012,"score_gpt":0.37292225307251653,"score_spread":0.2953545933767864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2270967011","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15625562,0.7552081,0.029705472,0.02366429,0.0015292481,0.00031099684,0.0004627939,0.00036171798,0.032501884],"genre_scores_gemma":[0.7034737,0.27019203,0.011981552,0.0032686493,0.0011373472,0.00027167477,0.00034819383,0.000040307194,0.0092865545],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.999913,0.00002536009,0.0000055162973,0.00001840975,0.000016866514,0.000020984351],"domain_scores_gemma":[0.9998784,0.000049356335,0.000025002795,0.000012506114,0.0000149567995,0.000019815543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052809116,0.00034255575,0.0003778693,0.00036772678,0.0002258634,0.0006112794,0.00040408608,0.0007119603,0.0028565258],"category_scores_gemma":[0.00031250794,0.00011952629,0.00026990083,0.0002290199,0.00051311136,0.00063873286,0.00027520434,0.0014046081,0.00043706957],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011229928,0.0008471618,0.001560393,0.0017898696,0.000095669195,0.00047784534,0.00015546542,0.0024177325,0.5656398,0.023987489,0.0057835174,0.39612204],"study_design_scores_gemma":[0.00068280514,0.008671233,0.008308161,0.0007027411,0.0002637577,0.0041816137,0.0004887165,0.0055861985,0.5839048,0.038707662,0.34841225,0.00009006674],"about_ca_topic_score_codex":0.0002332459,"about_ca_topic_score_gemma":0.0005587778,"teacher_disagreement_score":0.0028565258,"about_ca_system_score_codex":0.00046590515,"about_ca_system_score_gemma":0.0003492376,"threshold_uncertainty_score":0.009555995},"labels":[],"label_agreement":null},{"id":"W2300857522","doi":"10.1080/2162402x.2015.1025194","title":"Effective combination treatment of GD2-expressing neuroblastoma and Ewing's sarcoma using anti-GD2 ch14.18/CHO antibody with Vγ9Vδ2+ γδT cells","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Cancer Research UK","keywords":"Antibody-dependent cell-mediated cytotoxicity; Neuroblastoma; Cancer research; Antibody; Immunotherapy; Cytotoxicity; Cancer; Medicine; Cell culture; In vitro; Biology; Immunology; Monoclonal antibody; Internal medicine; Biochemistry","score_opus":0.03790087040618048,"score_gpt":0.3386236049533383,"score_spread":0.3007227345471578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2300857522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935161,0.002777502,0.0015845648,0.000053468528,0.00008940163,0.00012933271,0.00022202813,0.00007221568,0.0015552887],"genre_scores_gemma":[0.99390996,0.0015750087,0.001973146,0.0000374993,0.000026350559,0.00008913318,0.00039356668,0.000014254727,0.001981118],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982446,0.000022005763,0.000017659831,0.000031500676,0.00005001103,0.00005438273],"domain_scores_gemma":[0.99995625,0.000006373841,0.000008172958,0.0000074222417,0.000005167708,0.000016561364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014768376,0.0004920184,0.0007441123,0.00028194967,0.00012199741,0.00024596913,0.00032737607,0.00026641384,0.0006947562],"category_scores_gemma":[0.00006422331,0.0001666968,0.00042170874,0.00023481881,0.00016298985,0.00020134138,0.0002607191,0.0004315949,0.00018335154],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070504035,0.00040369638,0.0002737742,0.000090912275,0.000047422614,0.00008813824,0.000027382051,0.000388746,0.9916202,0.00010176218,0.00012809479,0.006124924],"study_design_scores_gemma":[0.0002556549,0.005414953,0.0027379603,0.000008154355,0.0001388999,0.0003750122,0.000021630178,0.0010642579,0.9858764,0.00003493713,0.0040620863,0.000010120212],"about_ca_topic_score_codex":0.0011644446,"about_ca_topic_score_gemma":0.0025222867,"teacher_disagreement_score":0.0011644446,"about_ca_system_score_codex":0.00024364483,"about_ca_system_score_gemma":0.0003640802,"threshold_uncertainty_score":0.002324164},"labels":[],"label_agreement":null},{"id":"W2305268165","doi":"10.1080/2162402x.2015.1093276","title":"NKG2D- and T-cell receptor-dependent lysis of malignant glioma cell lines by human γδ T cells: Modulation by temozolomide and A disintegrin and metalloproteases 10 and 17 inhibitors","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cytotoxic T cell; NKG2D; Temozolomide; Cancer research; Glioma; T cell; Cell culture; Biology; Chemistry; Immunology; Immune system; In vitro","score_opus":0.011495009953035758,"score_gpt":0.22518120723283402,"score_spread":0.21368619727979826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2305268165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971916,0.0011918781,0.00063628174,0.000049041908,0.000023505958,0.000036770714,0.00017641984,0.000021223332,0.00067317],"genre_scores_gemma":[0.9963468,0.0010232162,0.00068567164,0.000053933614,0.000012574399,0.00008105309,0.0006230576,0.000006645608,0.0011670905],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999826,0.000044997912,0.000025774314,0.000019256246,0.000030802017,0.00005321238],"domain_scores_gemma":[0.99995697,0.00000775207,0.000010543548,0.000007486263,0.0000061263595,0.000011236711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016462879,0.00037132436,0.00030231668,0.00013927212,0.000093394614,0.00025003604,0.00017241712,0.00018100635,0.0007466065],"category_scores_gemma":[0.00010638534,0.00012399399,0.00028837073,0.00016967102,0.00015011182,0.000116896044,0.00013561192,0.00041424463,0.00032987053],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076789747,0.00017826316,0.00043974875,0.00008238879,0.000018024606,0.00011497346,0.00007158069,0.00017410445,0.9952318,0.000083982915,0.00009759104,0.0027397808],"study_design_scores_gemma":[0.00021362977,0.0019286142,0.01145094,0.000009969221,0.000050776416,0.00050009735,0.00007036684,0.0019476679,0.98079693,0.000049770242,0.0029729404,0.000008360697],"about_ca_topic_score_codex":0.0008924799,"about_ca_topic_score_gemma":0.00077691977,"teacher_disagreement_score":0.0008924799,"about_ca_system_score_codex":0.00019788172,"about_ca_system_score_gemma":0.00021564223,"threshold_uncertainty_score":0.002497673},"labels":[],"label_agreement":null},{"id":"W2307546987","doi":"10.1080/2162402x.2015.1084463","title":"The presence of CXCR4<sup>+</sup>CD1a<sup>+</sup>cells at onset of Langerhans cell histiocytosis is associated with a less favorable outcome","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Leids Universitair Medisch Centrum; Stichting Kinderen Kankervrij; Universiteit Leiden; Deutsches Krebsforschungszentrum","keywords":"Langerhans cell histiocytosis; Histiocyte; CXCR4; Histiocytosis; Pathology; Medicine; Cancer research; Bone marrow; Chemokine; Biology; Molecular biology; Immunology; Inflammation","score_opus":0.03356550537872877,"score_gpt":0.2673946211698069,"score_spread":0.23382911579107812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2307546987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995347,0.000100050536,0.00007459614,0.000013982767,0.000002251311,0.0000028551528,0.00004128947,0.000004133921,0.0002260862],"genre_scores_gemma":[0.99969864,0.000019391315,0.0000572004,0.000008664529,0.000007648491,0.0000026226555,0.000061987026,9.448963e-7,0.00014298226],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999082,0.000022636865,0.000008994075,0.00002209136,0.000015550686,0.000022631037],"domain_scores_gemma":[0.9995468,0.00008788532,0.00020668074,0.000025760237,0.000026257092,0.00010650067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020136576,0.00017805758,0.00017438979,0.0003542477,0.00020505478,0.00024772956,0.000115774084,0.0002272216,0.0045099338],"category_scores_gemma":[0.00050572935,0.000059930146,0.00008959326,0.0001353165,0.00029582452,0.00013742525,0.00014657601,0.00028650695,0.0002719274],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016394316,0.00007691133,0.9584341,0.000036677877,0.00003545553,0.00053786684,0.000044320386,0.00008444584,0.032010075,0.00004749286,0.000114124,0.0069390167],"study_design_scores_gemma":[0.00002809328,0.0005431942,0.9899254,0.000008223044,0.000049157396,0.0037522009,0.00007789524,0.00030820392,0.004902806,0.00007255347,0.00032821248,0.0000040827617],"about_ca_topic_score_codex":0.00026075167,"about_ca_topic_score_gemma":0.00027679183,"teacher_disagreement_score":0.0045099338,"about_ca_system_score_codex":0.00016443754,"about_ca_system_score_gemma":0.00012970947,"threshold_uncertainty_score":0.015087187},"labels":[],"label_agreement":null},{"id":"W2313718437","doi":"10.1080/2162402x.2016.1164364","title":"Tertiary lymphoid structures are confined to patients presenting with unifocal Langerhans Cell Histiocytosis","year":2016,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Leids Universitair Medisch Centrum; Universiteit Leiden","keywords":"High endothelial venules; Follicular dendritic cells; Pathology; Histiocyte; CXCL13; Lymphatic system; Immune system; Langerhans cell histiocytosis; Medicine; Myeloid; Lymph node; Chemokine; Lymph; Dendritic cell; Immunophenotyping; Lymphocyte; T cell; Immunology; Antigen-presenting cell; Antigen; Chemokine receptor","score_opus":0.007150763855680321,"score_gpt":0.22313640149611075,"score_spread":0.21598563764043044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313718437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99866617,0.0004103149,0.000095178395,0.00001936848,0.000004200529,0.000010956423,0.000051227606,0.000011369215,0.0007312249],"genre_scores_gemma":[0.99971014,0.00007489481,0.00003884124,0.000011703,0.0000088078605,0.0000028913166,0.00005273288,0.0000014877163,0.0000985055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997619,0.000035898353,0.000022859305,0.00006964016,0.00003766383,0.000072085575],"domain_scores_gemma":[0.9991153,0.00016309615,0.00038182616,0.00006876877,0.000050785362,0.00022025217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021627065,0.0002739744,0.00038501777,0.0006067534,0.00044096657,0.0005240548,0.00020918464,0.00035253054,0.004001502],"category_scores_gemma":[0.0011907779,0.00019823144,0.00020892631,0.00042116095,0.00042085597,0.00043881856,0.00042878115,0.00040427642,0.00059831137],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049226993,0.0000728151,0.983014,0.00003724224,0.00003427263,0.0026165957,0.00013255503,0.000036781687,0.0070494977,0.000044017004,0.0001753127,0.006294568],"study_design_scores_gemma":[0.000014802833,0.00035142567,0.97964257,0.00001240266,0.00004794536,0.018185355,0.000323424,0.0001427194,0.0008183681,0.00010020021,0.00035370412,0.000007103114],"about_ca_topic_score_codex":0.00064279785,"about_ca_topic_score_gemma":0.0009191954,"teacher_disagreement_score":0.004001502,"about_ca_system_score_codex":0.00017000624,"about_ca_system_score_gemma":0.00027729978,"threshold_uncertainty_score":0.013386369},"labels":[],"label_agreement":null},{"id":"W2317889432","doi":"10.1080/2162402x.2016.1151593","title":"NLRC5 elicits antitumor immunity by enhancing processing and presentation of tumor antigens to CD8<sup>+</sup> T lymphocytes","year":2016,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"CD80; Antigen; Cytotoxic T cell; CD8; Biology; Antigen presentation; MHC class I; Cancer research; Antigen-presenting cell; Major histocompatibility complex; Immunology; T cell; Immune system; CD40; In vitro","score_opus":0.009731550120782162,"score_gpt":0.25617748532565743,"score_spread":0.24644593520487526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317889432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915413,0.0019277638,0.003093799,0.00022683835,0.00004971794,0.000055927805,0.0003700828,0.00015939018,0.002575093],"genre_scores_gemma":[0.9934144,0.00047799025,0.002984859,0.00010234268,0.000020856063,0.000031641757,0.00060701155,0.000019884774,0.002340902],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997876,0.000044035914,0.000035294877,0.000031756317,0.00004835804,0.000052874304],"domain_scores_gemma":[0.99990225,0.000013477697,0.00003339257,0.00001466804,0.000008988928,0.000027292976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001789348,0.00038848288,0.0002380446,0.0001664092,0.00007742388,0.00027350933,0.0001755595,0.0003160974,0.0013573058],"category_scores_gemma":[0.00009584095,0.000111439615,0.00025229808,0.00009925244,0.00016387546,0.00019160863,0.00015378644,0.0006292906,0.00049544784],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017307233,0.000074231255,0.00019682264,0.000056488967,0.000005223561,0.000046753845,0.000008339452,0.00011377876,0.99744403,0.000071748975,0.00006105409,0.0017483453],"study_design_scores_gemma":[0.00007212213,0.00088338164,0.002794165,0.000009386618,0.000020094956,0.0003588781,0.000016670903,0.001302047,0.9913401,0.00003382634,0.0031661324,0.0000032268595],"about_ca_topic_score_codex":0.00023303252,"about_ca_topic_score_gemma":0.00033371785,"teacher_disagreement_score":0.0013573058,"about_ca_system_score_codex":0.00028574342,"about_ca_system_score_gemma":0.00013839033,"threshold_uncertainty_score":0.004540682},"labels":[],"label_agreement":null},{"id":"W2323614958","doi":"10.4161/onci.28272","title":"Tumor vascularity in ovarian cancer","year":2014,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; BC Cancer Agency","funders":"","keywords":"Ovarian cancer; Medicine; Vascularity; Tumor-infiltrating lymphocytes; Cancer research; Immune system; Cancer immunology; Immunotherapy; Cancer; Oncology; Immunology; Pathology; Internal medicine","score_opus":0.00989348837308657,"score_gpt":0.24238396542768137,"score_spread":0.2324904770545948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323614958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9670543,0.025131995,0.0011023465,0.00041413656,0.00003856744,0.000012755032,0.00013710807,0.00005537174,0.006053367],"genre_scores_gemma":[0.99620515,0.0028470808,0.00018426137,0.000039815168,0.000027550373,0.000009175785,0.000055044944,0.0000032129992,0.00062874064],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999454,0.000022049791,0.0000029324174,0.0000073932106,0.000009490989,0.000012671613],"domain_scores_gemma":[0.9999019,0.000021299695,0.000037892423,0.0000047787694,0.00001201198,0.000022133694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016606126,0.00006950056,0.00009155631,0.00049297913,0.00015005759,0.00034400454,0.00006631969,0.0001613352,0.00096005504],"category_scores_gemma":[0.00028349712,0.00008225694,0.000055267763,0.00033660716,0.00015805989,0.00020481404,0.00016318826,0.00024652155,0.00013015872],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036498406,0.00025325082,0.3004389,0.00090197974,0.00007702088,0.0036858132,0.0006075429,0.0018034606,0.45702142,0.0073378426,0.0038681473,0.2203548],"study_design_scores_gemma":[0.00011394018,0.0013524403,0.8156416,0.00013820475,0.00015344072,0.018101133,0.0011562201,0.0069869775,0.08066952,0.0066195116,0.06903928,0.000027769704],"about_ca_topic_score_codex":0.00060529145,"about_ca_topic_score_gemma":0.00059945934,"teacher_disagreement_score":0.00096005504,"about_ca_system_score_codex":0.00043368977,"about_ca_system_score_gemma":0.00017230422,"threshold_uncertainty_score":0.003211677},"labels":[],"label_agreement":null},{"id":"W2328903599","doi":"10.1080/2162402x.2016.1151591","title":"Ranitidine modifies myeloid cell populations and inhibits breast tumor development and spread in mice","year":2016,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Ranitidine; Medicine; Myeloid; Cancer research; Histamine H2 receptor; Breast cancer; Population; Cancer; Internal medicine; Immunology; Pharmacology; Receptor; Antagonist","score_opus":0.015340402216365132,"score_gpt":0.2255058756578487,"score_spread":0.21016547344148356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328903599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99249387,0.0018384184,0.0016447533,0.00023372735,0.0000459313,0.00007305644,0.000890081,0.00026676696,0.0025133593],"genre_scores_gemma":[0.9853136,0.0021915291,0.0029948684,0.00016199712,0.000027872758,0.00015191335,0.0015052509,0.0000637394,0.007589366],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998066,0.000039779414,0.000018487222,0.00003778341,0.0000369401,0.000060423168],"domain_scores_gemma":[0.9998412,0.000019840729,0.000053414075,0.000018822862,0.000013403546,0.000053321033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002277161,0.00048642972,0.00037208962,0.0007494714,0.00015653872,0.00024213862,0.00034273425,0.00037789613,0.0013089086],"category_scores_gemma":[0.00011473955,0.0002559796,0.00036618265,0.00020545736,0.00024074773,0.00023991229,0.0001404623,0.00096817786,0.00044411357],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089070434,0.00030284637,0.00019755946,0.000038484937,0.000009269599,0.000049984024,0.000025716718,0.00008481884,0.99592626,0.0001156335,0.000095995914,0.0022628014],"study_design_scores_gemma":[0.00014577452,0.004051678,0.0054959776,0.00001543596,0.000047357033,0.00022060999,0.000042978747,0.0014633915,0.9852958,0.00007892534,0.0031323633,0.000009812329],"about_ca_topic_score_codex":0.0008827998,"about_ca_topic_score_gemma":0.0018665928,"teacher_disagreement_score":0.0013089086,"about_ca_system_score_codex":0.0003437156,"about_ca_system_score_gemma":0.0002479803,"threshold_uncertainty_score":0.0043787956},"labels":[],"label_agreement":null},{"id":"W2336703042","doi":"10.1080/2162402x.2015.1129484","title":"Linking cancer-induced Nlrp3 inflammasome activation to efficient NK cell-mediated immunosurveillance","year":2016,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Inflammasome and immune disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Inflammasome; Immunosurveillance; Colorectal cancer; Cancer research; NKG2D; Apoptosis; Immunology; Cancer; Medicine; Biology; Inflammation; Immune system; Cytotoxicity; In vitro; Internal medicine","score_opus":0.00773803632410453,"score_gpt":0.2384469418959819,"score_spread":0.23070890557187737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2336703042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9637783,0.018066138,0.011876004,0.0014955936,0.00027636695,0.00013123278,0.00037677182,0.00020635106,0.003793253],"genre_scores_gemma":[0.99522346,0.0020620532,0.0017134112,0.00017345864,0.00003471023,0.000034741686,0.000103769984,0.000007992813,0.0006463106],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99972636,0.000083193794,0.00003091035,0.000039366838,0.000054660286,0.000065463544],"domain_scores_gemma":[0.999874,0.000018355544,0.000040858315,0.000020838908,0.00002154803,0.000024362062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031448592,0.00028107333,0.00021847044,0.00021408871,0.00014592908,0.0004034077,0.00012259015,0.00037010302,0.0015096277],"category_scores_gemma":[0.0003458498,0.00010064545,0.0002523053,0.00012987321,0.0003047632,0.00038752749,0.00047882117,0.00081795116,0.00030721366],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006145219,0.00010265761,0.0009776688,0.0003192712,0.000027692227,0.00040179543,0.00008162518,0.0003001009,0.9875557,0.0011912199,0.00051568437,0.007912116],"study_design_scores_gemma":[0.00017090898,0.0010879576,0.010462334,0.00005136407,0.000046553832,0.0022315388,0.00011097158,0.0029334254,0.96929616,0.0018101736,0.011783721,0.00001486947],"about_ca_topic_score_codex":0.00014497389,"about_ca_topic_score_gemma":0.00020529974,"teacher_disagreement_score":0.0015096277,"about_ca_system_score_codex":0.00027378404,"about_ca_system_score_gemma":0.0001956327,"threshold_uncertainty_score":0.005050242},"labels":[],"label_agreement":null},{"id":"W2339252122","doi":"10.1080/2162402x.2016.1160979","title":"CXCL16-positive dendritic cells enhance invariant natural killer T cell-dependent IFNγ production and tumor control","year":2016,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Beatrice Hunter Cancer Research Institute; Dalhousie University","funders":"","keywords":"CXCL16; Natural killer T cell; Interleukin 12; Dendritic cell; Immune system; Immunology; Medicine; Cancer research; Biology; Cell biology; Cytotoxic T cell; Chemokine; T cell; In vitro; Chemokine receptor; Genetics","score_opus":0.00416152982155571,"score_gpt":0.2064445161738855,"score_spread":0.2022829863523298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339252122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943825,0.0013189083,0.0017342361,0.00008928099,0.000054752003,0.00006614684,0.00029691018,0.0001163012,0.0019408589],"genre_scores_gemma":[0.9927884,0.0007986202,0.0022189482,0.00005025667,0.00002313109,0.00004646559,0.00037125338,0.000025032386,0.0036779647],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997943,0.000030775496,0.000023471199,0.000033309836,0.000046506186,0.00007170054],"domain_scores_gemma":[0.99986386,0.000015389045,0.000044712575,0.000019115007,0.000016229907,0.000040702645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001284692,0.0004115643,0.00031326295,0.00020147656,0.00007984612,0.00032180175,0.00011511084,0.00021369327,0.0016600057],"category_scores_gemma":[0.000087123495,0.00010261132,0.00026041624,0.00013744464,0.0001807642,0.00022388058,0.00022978522,0.0007907362,0.0005615047],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015075113,0.000047180765,0.00018524325,0.000041409774,0.00000256349,0.00003301362,0.000011313431,0.00007379212,0.9980477,0.000051464132,0.000026263207,0.0013291838],"study_design_scores_gemma":[0.00003996941,0.00030719215,0.0015226721,0.0000064767855,0.000011948553,0.00015982459,0.000017916214,0.0005229393,0.995346,0.00003764822,0.0020249342,0.0000023474595],"about_ca_topic_score_codex":0.00020039562,"about_ca_topic_score_gemma":0.00022782748,"teacher_disagreement_score":0.0016600057,"about_ca_system_score_codex":0.00026518403,"about_ca_system_score_gemma":0.00023316119,"threshold_uncertainty_score":0.005553305},"labels":[],"label_agreement":null},{"id":"W2339862396","doi":"10.1080/2162402x.2015.1127493","title":"Identification of CD245 as myosin 18A, a receptor for surfactant A: A novel pathway for activating human NK lymphocytes","year":2016,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer","keywords":"CD137; Myosin; Monoclonal antibody; Receptor; Cell biology; Biology; Cancer immunotherapy; Cytotoxicity; Antibody; Immunology; Immunotherapy; Immune system; Biochemistry","score_opus":0.020812556988940092,"score_gpt":0.27163881353149205,"score_spread":0.250826256542552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339862396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929878,0.0020611926,0.003351423,0.000104406565,0.0000270782,0.000037124842,0.00014886024,0.0000238488,0.0012581843],"genre_scores_gemma":[0.99275315,0.0010548916,0.0041240864,0.00006665981,0.000028002256,0.000020170075,0.00038859324,0.0000079112215,0.0015566293],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999423,0.000008587821,0.0000040297014,0.0000163839,0.000013184749,0.000015385776],"domain_scores_gemma":[0.9999609,0.0000035384026,0.000007386715,0.000002511823,0.000005857343,0.000019862777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006122344,0.00029464345,0.00014562826,0.00027396082,0.00012842497,0.00034386243,0.00013339698,0.00023974833,0.001241332],"category_scores_gemma":[0.00008871107,0.00008007503,0.00024000909,0.000093624665,0.00008802842,0.00020269975,0.0002548251,0.00024443804,0.00047577813],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008437969,0.000012387792,0.0011056961,0.000024724397,0.0000045408497,0.0003144647,0.0000163952,0.000029317804,0.9953896,0.00015504,0.000034133176,0.0028293699],"study_design_scores_gemma":[0.000043019987,0.0004674026,0.025893478,0.000027878386,0.00006585187,0.0046322974,0.00016184064,0.0032515598,0.9517317,0.00036273667,0.013347659,0.000014554217],"about_ca_topic_score_codex":0.00016312386,"about_ca_topic_score_gemma":0.00019814924,"teacher_disagreement_score":0.001241332,"about_ca_system_score_codex":0.00017668246,"about_ca_system_score_gemma":0.00013938066,"threshold_uncertainty_score":0.0041526556},"labels":[],"label_agreement":null},{"id":"W2342335890","doi":"10.1080/2162402x.2016.1170264","title":"Extracellular HSP110 skews macrophage polarization in colorectal cancer","year":2016,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer; Agence Nationale de la Recherche","keywords":"Extracellular; Cytotoxic T cell; Cancer research; Colorectal cancer; Macrophage polarization; Macrophage; Biology; Immunology; In vitro; Cancer; Cell biology; Genetics","score_opus":0.010368544051871327,"score_gpt":0.28553872900251714,"score_spread":0.2751701849506458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342335890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985423,0.00060272566,0.000175378,0.000047024332,0.000009978524,0.0000061006685,0.00004876959,0.000015015409,0.0005526746],"genre_scores_gemma":[0.99859494,0.000372223,0.000137848,0.00004852886,0.0000051799566,0.000009269671,0.00009124553,0.0000029529144,0.00073784153],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999521,0.000012031156,0.0000034840457,0.0000076202405,0.000008380794,0.00001649794],"domain_scores_gemma":[0.99996257,0.0000043835503,0.000009184063,0.0000027341712,0.000004907939,0.000016270998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000057824705,0.00010251234,0.00011084432,0.00014043605,0.000088428984,0.00014579958,0.000036786798,0.00013247783,0.0009955316],"category_scores_gemma":[0.00006659689,0.00006183241,0.000088970395,0.000099345416,0.000096138894,0.000064489854,0.00013827492,0.00031171227,0.00018965537],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005217717,0.00009029979,0.0029246688,0.00007615131,0.000005668512,0.00012972305,0.000028955754,0.000055547003,0.99204177,0.000046883255,0.00012760582,0.0039508473],"study_design_scores_gemma":[0.00012999057,0.0033614892,0.19507529,0.00002406878,0.00006121213,0.0023358073,0.0004112236,0.0019260886,0.78892624,0.00020586974,0.0075286967,0.000013975742],"about_ca_topic_score_codex":0.00021744487,"about_ca_topic_score_gemma":0.000409876,"teacher_disagreement_score":0.0009955316,"about_ca_system_score_codex":0.00011031845,"about_ca_system_score_gemma":0.0000763331,"threshold_uncertainty_score":0.00333035},"labels":[],"label_agreement":null},{"id":"W2345395916","doi":"10.1080/2162402x.2016.1178438","title":"No evidence for TSLP pathway activity in human breast cancer","year":2016,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto","funders":"Agence Nationale de la Recherche","keywords":"Thymic stromal lymphopoietin; Breast cancer; Stromal cell; Tumor microenvironment; Cancer research; Cytokine; Medicine; Immunology; Cancer; Biology; Internal medicine; Tumor cells","score_opus":0.043099836321001735,"score_gpt":0.35643586287957113,"score_spread":0.3133360265585694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345395916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986273,0.005147158,0.0012661427,0.00015990615,0.00003402206,0.000047834015,0.00253987,0.000088205285,0.004443757],"genre_scores_gemma":[0.99061805,0.002261912,0.0007140384,0.00010624657,0.00002029804,0.000055829438,0.0040436117,0.000019184341,0.0021607773],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99970967,0.000036657468,0.00002106525,0.00007726114,0.00009785547,0.00005744655],"domain_scores_gemma":[0.99968994,0.00009951685,0.000045974302,0.000060289953,0.00006632844,0.00003795929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017890356,0.00013601195,0.00018817188,0.0006201749,0.00020295598,0.0004895878,0.00011766457,0.00020523278,0.004732884],"category_scores_gemma":[0.00045090512,0.00010192963,0.0001806534,0.0005749508,0.00019932886,0.00010089192,0.000176185,0.00024050914,0.0010127684],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010373691,0.00009902785,0.041582063,0.00037861144,0.00005657044,0.0010206756,0.00020637563,0.00006993383,0.9354898,0.00019637439,0.00049562205,0.019367686],"study_design_scores_gemma":[0.00007792764,0.0015212741,0.4197869,0.00009310241,0.00028199778,0.0147850225,0.000946917,0.00076491217,0.5091978,0.0005398353,0.051981818,0.000022579074],"about_ca_topic_score_codex":0.0010446039,"about_ca_topic_score_gemma":0.00085514743,"teacher_disagreement_score":0.004732884,"about_ca_system_score_codex":0.00022668473,"about_ca_system_score_gemma":0.00026676717,"threshold_uncertainty_score":0.01583308},"labels":[],"label_agreement":null},{"id":"W2403976714","doi":"10.1080/2162402x.2016.1150398","title":"Maraviroc decreases CCL8-mediated migration of CCR5<sup>+</sup>regulatory T cells and reduces metastatic tumor growth in the lungs","year":2016,"lang":"en","type":"article","venue":"OncoImmunology","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Maraviroc; CCR5 receptor antagonist; Cancer research; Immune system; Chemokine; Primary tumor; Metastasis; Chemokine receptor CCR5; Immunology; Medicine; Biology; Chemokine receptor; Cancer; Internal medicine","score_opus":0.008929636011554665,"score_gpt":0.21276753879163793,"score_spread":0.20383790278008326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403976714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99522936,0.0020992358,0.0012085774,0.00012392111,0.000060227994,0.000028983268,0.0001735017,0.00019247425,0.0008837501],"genre_scores_gemma":[0.9963814,0.00061478943,0.0011876347,0.00008360546,0.000027806907,0.000034904093,0.000246519,0.00002122614,0.001402157],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99978083,0.000042278745,0.000017434744,0.000028174625,0.000042771568,0.00008849941],"domain_scores_gemma":[0.99985075,0.000018848943,0.000042012678,0.000010795482,0.000012972282,0.00006464873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012053097,0.0003889611,0.00035880893,0.00019921978,0.00011549687,0.00026716272,0.00017537529,0.0002615963,0.0010536135],"category_scores_gemma":[0.00014731428,0.00010927367,0.00024119437,0.00006338127,0.0001722367,0.00015845767,0.00010608377,0.0006975214,0.00027990792],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070916786,0.00020195512,0.00029145257,0.000043567903,0.000006848002,0.000039424525,0.000008714021,0.0001779308,0.9932105,0.000034081615,0.00014231681,0.0051340093],"study_design_scores_gemma":[0.0001265455,0.0057420037,0.008578135,0.000011641726,0.000036845642,0.00039348728,0.000044764252,0.0028960025,0.9795455,0.000045818684,0.0025687679,0.000010396528],"about_ca_topic_score_codex":0.0006884913,"about_ca_topic_score_gemma":0.0012934278,"teacher_disagreement_score":0.0010536135,"about_ca_system_score_codex":0.0002434628,"about_ca_system_score_gemma":0.00025583684,"threshold_uncertainty_score":0.003524661},"labels":[],"label_agreement":null},{"id":"W2415943726","doi":"10.1080/2162402x.2015.1062210","title":"Ovarian cancer chemokines may not be a significant barrier during whole tumor antigen dendritic-cell vaccine and adoptive T-cell immunotherapy","year":2015,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"McMaster University; National Cancer Institute; Ovarian Cancer Research Fund","keywords":"Homing (biology); Immunotherapy; Dendritic cell; Medicine; T cell; Immunology; Cancer immunotherapy; Chemokine receptor; Adoptive cell transfer; Antigen; Ovarian cancer; Chimeric antigen receptor; Chemokine; Cancer research; Cancer; Biology; Immune system; Internal medicine","score_opus":0.01680430745610839,"score_gpt":0.25149677571340245,"score_spread":0.23469246825729406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2415943726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913339,0.0036477984,0.0030544854,0.00029570705,0.0000598676,0.00004584866,0.000044449065,0.000053908363,0.0014639525],"genre_scores_gemma":[0.9979444,0.00052226987,0.0008120955,0.0000777876,0.000016073272,0.000025210862,0.000042119384,0.000009131291,0.0005508919],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998822,0.0000244135,0.0000057515695,0.000010990477,0.00002594089,0.000050685958],"domain_scores_gemma":[0.9999329,0.0000160391,0.000020338806,0.000007989622,0.000008102348,0.000014637802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013477194,0.00018064995,0.00020550712,0.00007630966,0.00012930307,0.0002815368,0.00009832033,0.00024745738,0.00082983234],"category_scores_gemma":[0.00016512636,0.00006414314,0.00011836452,0.00006580525,0.0001875249,0.00039327235,0.00017425366,0.0005963464,0.000113993934],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023074137,0.00006456424,0.0010077495,0.00011022682,0.000010612725,0.00008763986,0.000028960954,0.00019017483,0.98633575,0.0012391546,0.0002197554,0.010474745],"study_design_scores_gemma":[0.00011274301,0.0017291474,0.014198141,0.00003553298,0.000053557957,0.0012488139,0.00016788681,0.0021546027,0.9562739,0.0012318904,0.022783058,0.000010672252],"about_ca_topic_score_codex":0.0002745167,"about_ca_topic_score_gemma":0.00048825395,"teacher_disagreement_score":0.00082983234,"about_ca_system_score_codex":0.00020373269,"about_ca_system_score_gemma":0.0003344622,"threshold_uncertainty_score":0.0027760863},"labels":[],"label_agreement":null},{"id":"W2416441449","doi":"10.1080/2162402x.2015.1127496","title":"CD73-adenosine reduces immune responses and survival in ovarian cancer patients","year":2016,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Immunosurveillance; Immune system; Adenosine; Ovarian cancer; Tumor microenvironment; Medicine; Cancer research; Immunity; CD8; Cancer; Mechanism (biology); Immunology; Biology; Internal medicine","score_opus":0.010326311061765877,"score_gpt":0.26100682693125865,"score_spread":0.25068051586949275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2416441449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966828,0.002099186,0.00005068395,0.0000963112,0.000012051047,0.000007864039,0.000064771186,0.000007263038,0.0009790587],"genre_scores_gemma":[0.9993767,0.00024537966,0.000030337365,0.000046823625,0.000010443031,0.000004842364,0.000060267153,7.6421605e-7,0.00022435677],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993825,0.000015364027,0.000004269505,0.0000073949914,0.000014570361,0.000020175477],"domain_scores_gemma":[0.9998685,0.000023444798,0.00004532941,0.000005929775,0.0000129749615,0.000043797976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000085886575,0.00007189049,0.0002021281,0.00014056278,0.00013852671,0.00018913709,0.000052035914,0.0001448755,0.00088526483],"category_scores_gemma":[0.00035516915,0.000039729795,0.000101994,0.00018608998,0.000067088025,0.00009180679,0.0001021549,0.00022913152,0.000092944436],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013092388,0.00082492846,0.74065185,0.00014317148,0.00025264363,0.0011764623,0.00015106873,0.00041947552,0.07415324,0.0001741698,0.0018542004,0.16710633],"study_design_scores_gemma":[0.00020933543,0.0043960977,0.97680455,0.00002654575,0.00026583511,0.001744338,0.00019384139,0.0006975093,0.010151654,0.00017266099,0.005328486,0.000009076377],"about_ca_topic_score_codex":0.00061149587,"about_ca_topic_score_gemma":0.0011043657,"teacher_disagreement_score":0.00088526483,"about_ca_system_score_codex":0.0001754278,"about_ca_system_score_gemma":0.00015476854,"threshold_uncertainty_score":0.002961576},"labels":[],"label_agreement":null},{"id":"W2419661260","doi":"10.1080/2162402x.2016.1175799","title":"Investigating potential exogenous tumor initiating and promoting factors for Cutaneous T-Cell Lymphomas (CTCL), a rare skin malignancy","year":2016,"lang":"en","type":"review","venue":"OncoImmunology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Ottawa Hospital; University of Ottawa","funders":"Novo Nordisk Fonden","keywords":"Medicine; Malignancy; Immunology; Cancer; Cancer research; Internal medicine","score_opus":0.044574261023835444,"score_gpt":0.3364697416374679,"score_spread":0.29189548061363246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2419661260","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42126176,0.54942477,0.012209542,0.0016763874,0.00091910065,0.0002898957,0.0006135626,0.00016859325,0.013436402],"genre_scores_gemma":[0.7115208,0.27353692,0.0069118864,0.0011206497,0.000737656,0.0001973062,0.001045537,0.000025911097,0.0049032555],"study_design_codex":"bench_or_experimental","study_design_gemma":"systematic_review","domain_scores_codex":[0.99982893,0.000044285036,0.000016991244,0.000028949784,0.00004662192,0.0000341899],"domain_scores_gemma":[0.9998497,0.00006131088,0.000040052626,0.00000780024,0.000023208464,0.000017917802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000273592,0.00027446594,0.00027296747,0.0004691104,0.00015958885,0.00054026075,0.00017216134,0.00042709595,0.0013174402],"category_scores_gemma":[0.0004310076,0.00010383877,0.00036348123,0.00028853244,0.00019285537,0.00033812496,0.00017983172,0.00039728847,0.0003805462],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012345596,0.00051551074,0.05071659,0.009484647,0.0001867934,0.008273192,0.0003070755,0.0005721037,0.60969436,0.003206802,0.0039711115,0.3118373],"study_design_scores_gemma":[0.00020326712,0.005338237,0.09336844,0.0017462723,0.0013166573,0.039676867,0.0013302233,0.0031269803,0.47759542,0.00379891,0.37244028,0.000058479487],"about_ca_topic_score_codex":0.00027154293,"about_ca_topic_score_gemma":0.00040818803,"teacher_disagreement_score":0.0013174402,"about_ca_system_score_codex":0.0002307112,"about_ca_system_score_gemma":0.00031190432,"threshold_uncertainty_score":0.0044072866},"labels":[],"label_agreement":null},{"id":"W2466658396","doi":"10.1080/2162402x.2016.1204507","title":"Intratumoral expression levels of <i>PD-L1</i>, <i>GZMA</i>, and <i>HLA-A</i> along with oligoclonal T cell expansion associate with response to nivolumab in metastatic melanoma","year":2016,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Regina","keywords":"Nivolumab; TIGIT; Perforin; Melanoma; Immune checkpoint; PD-L1; Granzyme; CD8; Immune system; Immunology; Cancer research; Tumor-infiltrating lymphocytes; Cytotoxic T cell; Medicine; Tumor microenvironment; Human leukocyte antigen; T cell; Immunotherapy; Antigen; Biology","score_opus":0.011640409059253743,"score_gpt":0.24676790515993152,"score_spread":0.2351274961006778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2466658396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99753666,0.0004895627,0.0005056812,0.00004988898,0.0000071768054,0.000010670568,0.00009894215,0.000043333133,0.0012581729],"genre_scores_gemma":[0.99890757,0.000106606676,0.000292879,0.00003224886,0.000006545296,0.0000135680275,0.00012945523,0.0000059629597,0.000505104],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999087,0.000018264733,0.0000069333373,0.000019959225,0.00001545769,0.00003071152],"domain_scores_gemma":[0.99989986,0.000014690937,0.000037023467,0.000008175405,0.000010064929,0.000030217125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011272642,0.00015527422,0.00011706749,0.0002936692,0.00010490658,0.00028552176,0.000080415164,0.00020150191,0.0012914354],"category_scores_gemma":[0.00016323559,0.00010718958,0.00011716711,0.00015038403,0.00017388917,0.00015249269,0.00010291501,0.00046659357,0.00027434455],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007709395,0.00009856804,0.01969775,0.000044171273,0.000029743247,0.00008879829,0.0000298485,0.0001411218,0.9713175,0.000072114744,0.00023385264,0.00747567],"study_design_scores_gemma":[0.000103506456,0.001371226,0.4695497,0.000018962995,0.0001632736,0.0022070871,0.00022995358,0.0030324464,0.5184648,0.00046407245,0.0043760715,0.000018892884],"about_ca_topic_score_codex":0.000445467,"about_ca_topic_score_gemma":0.0005677073,"teacher_disagreement_score":0.0012914354,"about_ca_system_score_codex":0.00023094582,"about_ca_system_score_gemma":0.00010505535,"threshold_uncertainty_score":0.004320264},"labels":[],"label_agreement":null},{"id":"W2509656165","doi":"10.1080/2162402x.2016.1224044","title":"Impaired functional responses in follicular lymphoma CD8<sup>+</sup>TIM-3<sup>+</sup>T lymphocytes following TCR engagement","year":2016,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Galectins and Cancer Biology","field":"Immunology and Microbiology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Institute of Cancer Research; Institut National Du Cancer; Agence Nationale de la Recherche","keywords":"Cytotoxic T cell; Ex vivo; CD8; Immunology; Granzyme B; Biology; Immune system; Interleukin 21; Cancer research; In vivo; In vitro","score_opus":0.018991755649767426,"score_gpt":0.24509852728849207,"score_spread":0.22610677163872464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2509656165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988387,0.00045466115,0.0003292038,0.000019480094,0.0000027883766,0.000007046333,0.000086981265,0.000026780404,0.00023439141],"genre_scores_gemma":[0.9991897,0.00012478523,0.00016214611,0.000028859682,0.000004344596,0.000014073337,0.00018421565,0.00000581496,0.0002861286],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987054,0.000025220335,0.000014202887,0.000021062213,0.000020777876,0.000048233866],"domain_scores_gemma":[0.99992454,0.000013427591,0.000022659438,0.000011496744,0.000008579728,0.000019316249],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015511306,0.00029299074,0.00018980209,0.00018667804,0.00011059947,0.00026279924,0.000116761024,0.0002825985,0.0012621852],"category_scores_gemma":[0.00015192782,0.00009042065,0.0001560874,0.00009341527,0.00015870445,0.00020356318,0.0001696005,0.00035189273,0.0004283152],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003718246,0.00003763559,0.002817229,0.00004522305,0.0000065155136,0.0001620283,0.000041635805,0.000043579137,0.9938466,0.000024696361,0.000035200035,0.002567877],"study_design_scores_gemma":[0.00009800713,0.003718156,0.14036636,0.000023731232,0.00010476164,0.0070446427,0.0003365089,0.0021389942,0.8424856,0.00027125826,0.003396572,0.000015340927],"about_ca_topic_score_codex":0.00018904948,"about_ca_topic_score_gemma":0.00013670367,"teacher_disagreement_score":0.0012621852,"about_ca_system_score_codex":0.00016527885,"about_ca_system_score_gemma":0.00006895402,"threshold_uncertainty_score":0.0042224526},"labels":[],"label_agreement":null},{"id":"W2563769502","doi":"10.1080/2162402x.2016.1267094","title":"2B4-SAP signaling is required for the priming of naive CD8<sup>+</sup> T cells by antigen-expressing B cells and B lymphoma cells","year":2016,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research","keywords":"Cytotoxic T cell; CD8; Biology; T cell; B cell; Antigen-presenting cell; Interleukin 21; Priming (agriculture); CD40; Immunology; Antigen; Cancer research; Immune system; Cell biology; Antibody","score_opus":0.014742008964896802,"score_gpt":0.2354078282807221,"score_spread":0.2206658193158253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563769502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99768543,0.0003367199,0.00072291004,0.00005069861,0.000013674317,0.000014985966,0.000237836,0.000065719585,0.0008720641],"genre_scores_gemma":[0.99678767,0.00016460268,0.0007780788,0.00004131488,0.000009959925,0.000043003885,0.00073218695,0.000034318233,0.0014087972],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997414,0.000051506748,0.000023094897,0.000040968065,0.00006946011,0.00007355646],"domain_scores_gemma":[0.9997968,0.000021721075,0.0000656235,0.00001757849,0.000013367476,0.0000849036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011900191,0.00048609226,0.00024667368,0.00021322213,0.00022156189,0.00051706814,0.00028507892,0.000332525,0.002227815],"category_scores_gemma":[0.00012225256,0.00028638353,0.00021302015,0.000109935776,0.00026180712,0.0002713954,0.0003275902,0.0007925825,0.0011225867],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012037604,0.000021766427,0.00014361458,0.000013529486,0.0000015827462,0.00004493395,0.000007240949,0.000032298787,0.99930024,0.00004490979,0.000015481912,0.0002541863],"study_design_scores_gemma":[0.00005634939,0.00029997586,0.012420352,0.000009499687,0.000010085436,0.00042631995,0.000058304628,0.0017896813,0.9832929,0.00007680015,0.0015539912,0.0000058703185],"about_ca_topic_score_codex":0.0005076992,"about_ca_topic_score_gemma":0.0007979122,"teacher_disagreement_score":0.002227815,"about_ca_system_score_codex":0.00041750478,"about_ca_system_score_gemma":0.00025856568,"threshold_uncertainty_score":0.007452786},"labels":[],"label_agreement":null},{"id":"W2565577352","doi":"10.1080/2162402x.2016.1258506","title":"The influence of gut-decontamination prophylactic antibiotics on acute graft-versus-host disease and survival following allogeneic hematopoietic stem cell transplantation","year":2016,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Centre hospitalier universitaire de Québec; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"McGill University","keywords":"Medicine; Hematopoietic stem cell transplantation; Hazard ratio; Gastroenterology; Internal medicine; Antibiotics; Gut flora; Graft-versus-host disease; Stem cell; Transplantation; Immunology; Haematopoiesis; Odds ratio; Confidence interval; Biology; Microbiology","score_opus":0.012330215459031504,"score_gpt":0.2618846061685484,"score_spread":0.2495543907095169,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565577352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995329,0.0028338952,0.00012235226,0.00016340578,0.000066990135,0.000007199419,0.000060678085,0.000009230265,0.0014071348],"genre_scores_gemma":[0.9989556,0.00032828914,0.00006345437,0.00007606627,0.00003964051,0.000004496223,0.00008485271,0.0000021535209,0.00044545822],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9996313,0.00015321662,0.000022733213,0.00002674691,0.000068698195,0.00009737814],"domain_scores_gemma":[0.9989171,0.00038099845,0.00023446862,0.00007104035,0.00006316171,0.00033333417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004992856,0.00013049763,0.00027707143,0.0001391033,0.00012308187,0.0003857533,0.00012702256,0.00022104618,0.0018886934],"category_scores_gemma":[0.0012296629,0.000035621175,0.0002505264,0.00011366797,0.00019472475,0.00022964898,0.00018682281,0.0006780832,0.00018717245],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.118645504,0.009261339,0.30696273,0.00045931336,0.0011571677,0.0023113608,0.00027915704,0.0016955154,0.12155386,0.00075640203,0.0057504233,0.4311673],"study_design_scores_gemma":[0.0004896481,0.042894304,0.9212293,0.00010722941,0.0005944905,0.0023990974,0.00025830546,0.0018519525,0.021890039,0.00041044713,0.00785,0.000025243098],"about_ca_topic_score_codex":0.00029058996,"about_ca_topic_score_gemma":0.00074349984,"teacher_disagreement_score":0.0018886934,"about_ca_system_score_codex":0.00015584216,"about_ca_system_score_gemma":0.00027040904,"threshold_uncertainty_score":0.0063183308},"labels":[],"label_agreement":null},{"id":"W2566747056","doi":"10.1080/2162402x.2016.1257452","title":"Tumor-infiltrating lymphocyte composition, organization and PD-1/ PD-L1 expression are linked in breast cancer","year":2016,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":236,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Tumor-infiltrating lymphocytes; CD8; Immunohistochemistry; PD-L1; CD19; Immune system; Breast cancer; Infiltration (HVAC); Pathology; Flow cytometry; Lymphocyte; Stroma; Biology; Cancer research; Medicine; Cancer; Immunotherapy; Immunology; Internal medicine","score_opus":0.008638446302255718,"score_gpt":0.25263621476796555,"score_spread":0.24399776846570984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566747056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993174,0.0003093655,0.000109370165,0.0000063694893,9.690491e-7,0.0000031312356,0.000042792162,0.0000046385667,0.0002059744],"genre_scores_gemma":[0.9996555,0.00008313365,0.0000809944,0.00000512186,0.0000027827318,0.000003641904,0.00006272326,0.0000011841291,0.00010502276],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998996,0.000020898195,0.000011535863,0.000024242468,0.000019193656,0.000024523717],"domain_scores_gemma":[0.99982446,0.000053349693,0.00006057079,0.0000124355565,0.000020938078,0.000028263208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013723354,0.00011860337,0.00017721088,0.00076371024,0.00016997772,0.0003375526,0.00009241575,0.00017027782,0.00085756445],"category_scores_gemma":[0.0004562335,0.00016230886,0.000074889635,0.00043251005,0.00014682052,0.00017132159,0.00017650414,0.0001831101,0.00020001309],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007399806,0.00005809809,0.9430954,0.000045579494,0.000034754707,0.00022284829,0.00016056455,0.00019009378,0.043040507,0.00003377075,0.00009115564,0.012287314],"study_design_scores_gemma":[0.0000103112025,0.00012293151,0.9943591,0.00000403118,0.00002916843,0.0011715171,0.00012164111,0.00042550554,0.0033255245,0.000054420212,0.00037263698,0.0000031623902],"about_ca_topic_score_codex":0.0005156632,"about_ca_topic_score_gemma":0.00056575274,"teacher_disagreement_score":0.00085756445,"about_ca_system_score_codex":0.00014759254,"about_ca_system_score_gemma":0.00007054953,"threshold_uncertainty_score":0.0028688312},"labels":[],"label_agreement":null},{"id":"W2576512904","doi":"10.1080/2162402x.2016.1271858","title":"Acquisition of tumor cell phenotypic diversity along the EMT spectrum under hypoxic pressure: Consequences on susceptibility to cell-mediated cytotoxicity","year":2017,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut Gustave-Roussy; Institut National Du Cancer; Ligue Contre le Cancer","keywords":"Biology; Cancer research; Immune system; Immunosurveillance; Epithelial–mesenchymal transition; Phenotype; SNAI1; Mesenchymal stem cell; Wnt signaling pathway; Immunology; Cancer; Signal transduction; Cell biology; Metastasis; Genetics; Gene","score_opus":0.013818321886010797,"score_gpt":0.24372681393102957,"score_spread":0.2299084920450188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2576512904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99797744,0.00030691296,0.0011572576,0.00003211309,0.0000025039685,0.0000053929916,0.0000533809,0.000011130644,0.0004539177],"genre_scores_gemma":[0.9992582,0.00016026727,0.00019674671,0.000011613753,0.0000016431843,0.000003439045,0.00003635095,0.0000015568013,0.0003301269],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99995637,0.000010751474,0.0000027615597,0.000005992617,0.000010016259,0.00001410228],"domain_scores_gemma":[0.99995863,0.0000061140427,0.00001241895,0.0000046370656,0.000005863506,0.0000123456175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006196682,0.0000829517,0.00009662831,0.000096255484,0.00008693842,0.00016589748,0.000043006912,0.00008283289,0.00048261532],"category_scores_gemma":[0.000058030313,0.000048316884,0.000069904294,0.00005692984,0.00011536886,0.00009824844,0.00009866896,0.0001581027,0.00008293509],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006719479,0.00000770629,0.0014434711,0.0000060674265,0.0000019081303,0.0000387099,0.000011059541,0.000056388897,0.99726593,0.000074719035,0.000009407107,0.0010174317],"study_design_scores_gemma":[0.000006655666,0.00038106428,0.05842241,0.000003555441,0.000013294122,0.00083165645,0.00009927582,0.0012319838,0.9373977,0.00015111172,0.0014563975,0.0000048499473],"about_ca_topic_score_codex":0.00018718709,"about_ca_topic_score_gemma":0.00032588415,"teacher_disagreement_score":0.00048261532,"about_ca_system_score_codex":0.000087515014,"about_ca_system_score_gemma":0.00007694201,"threshold_uncertainty_score":0.001614511},"labels":[],"label_agreement":null},{"id":"W2585034864","doi":"10.1080/2162402x.2017.1285992","title":"Oncolytic measles virus encoding interleukin-12 mediates potent antitumor effects through T cell activation","year":2017,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Oncolytic virus; Measles virus; Immune system; Cancer research; CD8; T cell; Immunology; Immunotherapy; Tumor microenvironment; Virotherapy; Medicine; Biology; Measles; Vaccination","score_opus":0.023773286376553692,"score_gpt":0.31048334579199405,"score_spread":0.28671005941544037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585034864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99395967,0.0011525992,0.003801172,0.000047065998,0.0000151742,0.000023635663,0.000082810366,0.00006968466,0.00084830774],"genre_scores_gemma":[0.9967571,0.0005733151,0.0017463183,0.00001138275,0.0000059230993,0.000014953727,0.00009944544,0.0000063808593,0.0007851354],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999298,0.000014056925,0.000005128545,0.000012204997,0.00001801564,0.000020849775],"domain_scores_gemma":[0.9999621,0.000009975867,0.00000871766,0.000005635253,0.0000050581225,0.0000085856655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000082458,0.00028952115,0.00014124115,0.000118829885,0.000061966944,0.00018348884,0.0000835255,0.00015044097,0.00056662183],"category_scores_gemma":[0.000073296906,0.00006046712,0.00014790417,0.00007305191,0.00015482328,0.00011548201,0.00010748765,0.00038313412,0.00017191494],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000063252686,0.000014975181,0.000089516405,0.0000134715265,0.0000019066845,0.000014626258,0.000005980178,0.000065366316,0.99834895,0.000045674533,0.000010832401,0.0013256215],"study_design_scores_gemma":[0.000015357804,0.00031639438,0.00066832086,0.0000017878567,0.000008497115,0.00009850093,0.000006785761,0.00049208384,0.9973393,0.000023986615,0.0010277069,0.0000013612379],"about_ca_topic_score_codex":0.00024031178,"about_ca_topic_score_gemma":0.00032411775,"teacher_disagreement_score":0.00056662183,"about_ca_system_score_codex":0.00015624464,"about_ca_system_score_gemma":0.00014064605,"threshold_uncertainty_score":0.0018955469},"labels":[],"label_agreement":null},{"id":"W2587435215","doi":"10.1080/2162402x.2017.1287247","title":"The Interleukin (IL)-1R1 pathway is a critical negative regulator of PyMT-mediated mammary tumorigenesis and pulmonary metastasis","year":2017,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research","keywords":"Carcinogenesis; Cancer research; Metastasis; Cancer; Breast cancer; Medicine; Mammary tumor; Inflammation; Interleukin 6; Biology; Immunology; Oncology; Internal medicine","score_opus":0.01501972708692082,"score_gpt":0.2600620662682379,"score_spread":0.2450423391813171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587435215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9772131,0.010150748,0.0076434445,0.0006305069,0.00007928903,0.000046079338,0.0008027888,0.00033673405,0.0030973004],"genre_scores_gemma":[0.99136144,0.00315989,0.0018288573,0.00006787072,0.00002447593,0.00004199097,0.0004623857,0.000028213673,0.0030249131],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997582,0.00004370744,0.000015457988,0.000045134275,0.00007924788,0.00005817383],"domain_scores_gemma":[0.99979776,0.000016282565,0.00010751373,0.000015272355,0.000013211325,0.000049948158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019125469,0.00070918497,0.00030464667,0.00037916942,0.00020368841,0.00037789415,0.00020140012,0.00026661283,0.0015696873],"category_scores_gemma":[0.00014884515,0.00014820769,0.00026314773,0.00011998638,0.00039621544,0.00021206241,0.00029030003,0.00079952343,0.00048387307],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009404461,0.000022557644,0.00043710624,0.000039961837,0.0000028809502,0.000090038026,0.000008966721,0.000065921,0.9971704,0.00021775484,0.00007238141,0.0017780847],"study_design_scores_gemma":[0.000036826903,0.00041878555,0.020453919,0.000027083901,0.000022627419,0.001679953,0.00006767008,0.0011017517,0.9688562,0.00026610694,0.0070605027,0.000008519995],"about_ca_topic_score_codex":0.00019367502,"about_ca_topic_score_gemma":0.00028327855,"teacher_disagreement_score":0.0015696873,"about_ca_system_score_codex":0.0003140919,"about_ca_system_score_gemma":0.0002690771,"threshold_uncertainty_score":0.0052511096},"labels":[],"label_agreement":null},{"id":"W2592318296","doi":"10.1080/2162402x.2017.1299303","title":"Immune biomarkers for prognosis and prediction of responses to immune checkpoint blockade in cutaneous melanoma","year":2017,"lang":"en","type":"review","venue":"OncoImmunology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer","keywords":"Immune system; Medicine; Melanoma; Immune checkpoint; Adjuvant; Immunotherapy; Blockade; Immunology; Cancer research; Internal medicine; Receptor","score_opus":0.09316718438393705,"score_gpt":0.39413803994122476,"score_spread":0.3009708555572877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592318296","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008313057,0.99944395,0.000066223576,0.0001240442,0.000067145185,0.0000028121876,0.000011252378,0.0000029482717,0.00019836337],"genre_scores_gemma":[0.0012399878,0.9981116,0.00017956362,0.00012352965,0.00012223881,0.000007435631,0.000029678775,9.942797e-7,0.00018493489],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996736,0.000077886354,0.000062088424,0.00005409156,0.00010994268,0.000022314814],"domain_scores_gemma":[0.99926656,0.0004230337,0.00011018505,0.000015818712,0.00015600797,0.000028387869],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010934492,0.0009198998,0.0019195288,0.0029003033,0.00015784797,0.0009342943,0.0009005093,0.001100914,0.001561805],"category_scores_gemma":[0.0017683172,0.00027472904,0.0008171689,0.0017418441,0.00048577195,0.00093865243,0.0005940526,0.0017486197,0.00080896576],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010203782,0.000060556333,0.0007196837,0.012243681,0.00022061661,0.000128847,0.00003495782,0.0003407101,0.00067131885,0.0015092139,0.013821117,0.9701474],"study_design_scores_gemma":[0.00009522747,0.00035582765,0.008570914,0.026130427,0.0014283112,0.0038601768,0.0001804193,0.0007137185,0.0015667531,0.005654247,0.95134896,0.00009499689],"about_ca_topic_score_codex":0.0010753117,"about_ca_topic_score_gemma":0.001462167,"teacher_disagreement_score":0.0029003033,"about_ca_system_score_codex":0.0005842583,"about_ca_system_score_gemma":0.0007787117,"threshold_uncertainty_score":0.005782783},"labels":[],"label_agreement":null},{"id":"W2595319204","doi":"10.1080/2162402x.2017.1306618","title":"Gene expression analysis in Cutaneous T-Cell Lymphomas (CTCL) highlights disease heterogeneity and potential diagnostic and prognostic indicators","year":2017,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Université de Montréal; McGill University Health Centre; Université de Sherbrooke; Ottawa Hospital; University of Ottawa","funders":"Ottawa Hospital Research Institute","keywords":"Mycosis fungoides; Medicine; Cutaneous T-cell lymphoma; Lymphoma; Malignancy; Disease; Dermatology; Psoriasis; Gene expression profiling; Cutaneous lymphoma; Oncology; Pathology; Immunology; Gene expression; Gene; Biology","score_opus":0.010660680636948158,"score_gpt":0.28323493707237335,"score_spread":0.2725742564354252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595319204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910562,0.0032556832,0.0028349261,0.00023658418,0.000021462258,0.000020603826,0.0008488572,0.000056141336,0.0016694464],"genre_scores_gemma":[0.9971204,0.00070968893,0.0012525483,0.000056161767,0.000018563065,0.000013831403,0.0004257659,0.0000060979683,0.00039705067],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998148,0.000047746067,0.000014489334,0.000050240094,0.000039025064,0.000033730572],"domain_scores_gemma":[0.99978226,0.000071337905,0.00007142722,0.000017411905,0.000031279054,0.000026357144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022871463,0.00013924809,0.00021993283,0.0008495071,0.00014202514,0.00054346037,0.000116262185,0.00025928454,0.0008658366],"category_scores_gemma":[0.00048362912,0.00006767519,0.00013954783,0.00091015367,0.0002599214,0.00027597786,0.00013610836,0.00028503354,0.0002254445],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037602594,0.00010410373,0.2393881,0.00017490468,0.000069291316,0.0005099758,0.00016024521,0.00051814783,0.69676065,0.00048057907,0.0005303509,0.06092766],"study_design_scores_gemma":[0.000021920338,0.00048823503,0.8759152,0.000035058412,0.00014408628,0.0032724375,0.00058279536,0.0039855028,0.10894276,0.0012553121,0.005336858,0.00001977397],"about_ca_topic_score_codex":0.00050275034,"about_ca_topic_score_gemma":0.0008719795,"teacher_disagreement_score":0.0008658366,"about_ca_system_score_codex":0.00023613965,"about_ca_system_score_gemma":0.00010817038,"threshold_uncertainty_score":0.0028965473},"labels":[],"label_agreement":null},{"id":"W2609176929","doi":"10.1080/2162402x.2017.1321185","title":"Downregulation of PTP1B and TC-PTP phosphatases potentiate dendritic cell-based immunotherapy through IL-12/IFNγ signaling","year":2017,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Downregulation and upregulation; Cancer research; Cancer immunotherapy; Dendritic cell; Immunotherapy; Cell biology; Protein tyrosine phosphatase; Biology; Signal transduction; Chemistry; Immune system; Immunology","score_opus":0.012057866923661701,"score_gpt":0.25807761070688806,"score_spread":0.24601974378322636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2609176929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946765,0.0011383571,0.0021548527,0.0001290656,0.000044849225,0.00003080887,0.00013376665,0.00006029278,0.0016315824],"genre_scores_gemma":[0.99681866,0.00071374734,0.0012026724,0.000043680124,0.00001843816,0.000032166263,0.00013906068,0.000009084911,0.0010225108],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998554,0.000027093158,0.00001369831,0.000024079922,0.00003808597,0.000041591935],"domain_scores_gemma":[0.9999404,0.000010690631,0.000015966605,0.000008084007,0.0000060606967,0.00001873659],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014969773,0.00029567818,0.00025108334,0.00014052901,0.00008826117,0.00023783883,0.00012284747,0.00015920629,0.00075211225],"category_scores_gemma":[0.00007498975,0.00007895073,0.00013566119,0.000102066,0.00020932071,0.00014991658,0.00016437798,0.00075778924,0.00019205968],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027385005,0.00007993902,0.00022453902,0.00003289795,0.000004883804,0.000033782875,0.000010499496,0.00012006416,0.996407,0.00013322389,0.00005065069,0.0026286482],"study_design_scores_gemma":[0.00006309825,0.00045276497,0.0020343186,0.0000051953043,0.000028893139,0.00014640327,0.000011514334,0.00090282416,0.99396425,0.00005216432,0.002336472,0.0000019950319],"about_ca_topic_score_codex":0.00017258785,"about_ca_topic_score_gemma":0.0003188906,"teacher_disagreement_score":0.00075211225,"about_ca_system_score_codex":0.00015431216,"about_ca_system_score_gemma":0.0002242427,"threshold_uncertainty_score":0.0025160909},"labels":[],"label_agreement":null},{"id":"W2609196580","doi":"10.1080/2162402x.2017.1321184","title":"Mapping the human T cell repertoire to recurrent driver mutations in MYD88 and EZH2 in lymphoma","year":2017,"lang":"en","type":"article","venue":"OncoImmunology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Canada's Michael Smith Genome Sciences Centre; University of Victoria; Simon Fraser University; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Lymphoma; CD8; Human leukocyte antigen; Immunology; Cytotoxic T cell; Antigen; Immune system; T cell; Biology; Cancer research; Medicine; Genetics","score_opus":0.0506683785153188,"score_gpt":0.34524345492769154,"score_spread":0.29457507641237274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2609196580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99940944,0.000035647237,0.0001595485,0.0000073796846,0.0000013076674,0.0000042426327,0.00003350246,0.0000039373144,0.00034502876],"genre_scores_gemma":[0.99958676,0.000024811705,0.000092266615,0.000012721461,0.0000014820147,0.0000045228276,0.00008216903,0.000003233207,0.00019210017],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999013,0.000019446476,0.000009349529,0.000027473741,0.000014421215,0.00002811086],"domain_scores_gemma":[0.9999087,0.000032900483,0.0000091671345,0.00001568344,0.000008783989,0.000024714138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000119427525,0.00010267582,0.00009635347,0.0003172903,0.0001831693,0.00021196256,0.000120883524,0.00020393134,0.0015056789],"category_scores_gemma":[0.00022777906,0.000101838115,0.000105073676,0.0001831927,0.00017527917,0.00008891908,0.00019989468,0.00019037066,0.00021314956],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008230452,0.000090130554,0.05799864,0.000024418416,0.000027127084,0.001910747,0.00049080653,0.00024719653,0.9298116,0.00018312923,0.00013382467,0.008259251],"study_design_scores_gemma":[0.00014928359,0.0019496748,0.7030956,0.000023306317,0.00016256527,0.028823778,0.0013345545,0.0038462484,0.255319,0.0005177263,0.0047562663,0.000021889748],"about_ca_topic_score_codex":0.0005368868,"about_ca_topic_score_gemma":0.0006447911,"teacher_disagreement_score":0.0015056789,"about_ca_system_score_codex":0.00013164408,"about_ca_system_score_gemma":0.0000498553,"threshold_uncertainty_score":0.00503695},"labels":[],"label_agreement":null},{"id":"W2614729080","doi":"10.1080/2162402x.2017.1331195","title":"Targeting IL-5Rα with antibody-conjugates reveals a strategy for imaging and therapy for invasive bladder cancer","year":2017,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cégep de Sherbrooke; Fédération des Maisons D'Hébergement pour Femmes; Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"Cancer Research Society","keywords":"Immunoconjugate; Medicine; Bladder cancer; Vinblastine; Internalization; Cancer research; In vivo; Cancer; Antibody; Monoclonal antibody; Internal medicine; Immunology; Chemotherapy; Biology; Receptor","score_opus":0.0328047252033114,"score_gpt":0.3537519918207152,"score_spread":0.3209472666174038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2614729080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8685486,0.035659038,0.08129104,0.0016850559,0.00025531682,0.00026455565,0.00020637557,0.00031886678,0.0117712],"genre_scores_gemma":[0.9720138,0.006203519,0.01787355,0.00029554564,0.000044242453,0.000035957128,0.0001261377,0.000018794311,0.0033885073],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990296,0.000026990925,0.0000036352328,0.000013662287,0.000027361824,0.0000254146],"domain_scores_gemma":[0.9999639,0.00000827928,0.000010425864,0.0000037960692,0.0000049956093,0.000008679896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021158314,0.00033966688,0.00019420538,0.00018219142,0.00012481239,0.00035288814,0.0002232575,0.0004913276,0.0009569474],"category_scores_gemma":[0.00011577386,0.00013305082,0.00022069702,0.00011202143,0.00017116126,0.00029741778,0.00019785757,0.00048200245,0.0003465867],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009852256,0.000043610686,0.00028418953,0.00007424621,0.00001375762,0.00016025561,0.000026139962,0.00029680194,0.9876605,0.0006087547,0.00026141846,0.010471722],"study_design_scores_gemma":[0.000027991497,0.00062082696,0.0010842057,0.000012813705,0.000034303226,0.0008581992,0.00001917347,0.002235605,0.9844856,0.0001169238,0.010497368,0.0000069705193],"about_ca_topic_score_codex":0.00029904186,"about_ca_topic_score_gemma":0.00068391935,"teacher_disagreement_score":0.0009569474,"about_ca_system_score_codex":0.00030584304,"about_ca_system_score_gemma":0.00017489253,"threshold_uncertainty_score":0.0032013059},"labels":[],"label_agreement":null},{"id":"W2615614831","doi":"10.1080/2162402x.2017.1328336","title":"CEACAM1 as a Multi-Purpose Target for Cancer Immunotherapy","year":2017,"lang":"en","type":"review","venue":"OncoImmunology","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McGill University Health Centre","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Immunotherapy; Cancer immunotherapy; Context (archaeology); Cancer; Immune system; Immune checkpoint; Medicine; Disease; Cancer research; Immunology; Biology; Pathology; Internal medicine","score_opus":0.27580715846247555,"score_gpt":0.5474359294592606,"score_spread":0.271628770996785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2615614831","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004808596,0.9948913,0.0005184302,0.00045088955,0.00030796384,0.000008881602,0.000027144857,0.000017206994,0.0032972498],"genre_scores_gemma":[0.0031290129,0.99347234,0.0005242322,0.00031100545,0.00021756576,0.000012581194,0.000048140144,0.000003305298,0.0022818763],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99989986,0.000015039595,0.000008327146,0.000016188691,0.000046047848,0.000014506191],"domain_scores_gemma":[0.999928,0.000026492567,0.000009115631,0.000002922391,0.000023722116,0.000009795289],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027413614,0.00051779166,0.0006069688,0.001166574,0.00021688314,0.0007364868,0.0004657429,0.000753032,0.0031460077],"category_scores_gemma":[0.0002402064,0.00017029878,0.00033803485,0.0008810335,0.00029245627,0.000870183,0.00050614285,0.0014350571,0.0015048949],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006362867,0.00008632505,0.00023307718,0.012849927,0.00007009709,0.00032358486,0.0000937856,0.0006069221,0.01896738,0.016213493,0.038270343,0.9122215],"study_design_scores_gemma":[0.0000053699914,0.000050337767,0.00028367472,0.00062824955,0.000031615808,0.00084679254,0.000022020216,0.00011332481,0.0023102514,0.0015250612,0.9941743,0.000008961238],"about_ca_topic_score_codex":0.00043963606,"about_ca_topic_score_gemma":0.0009368606,"teacher_disagreement_score":0.0031460077,"about_ca_system_score_codex":0.00053240434,"about_ca_system_score_gemma":0.00059356133,"threshold_uncertainty_score":0.010524511},"labels":[],"label_agreement":null},{"id":"W2751411673","doi":"10.1080/2162402x.2017.1371895","title":"A library-based screening method identifies neoantigen-reactive T cells in peripheral blood prior to relapse of ovarian cancer","year":2017,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; University of Victoria; Canada's Michael Smith Genome Sciences Centre; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Ovarian cancer; Peripheral blood; Cancer; Oncology; Peripheral; Immunology; Cancer research; Internal medicine","score_opus":0.023411737154730772,"score_gpt":0.329068476526905,"score_spread":0.30565673937217425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2751411673","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9707762,0.0010102139,0.023331866,0.00013752475,0.0000463925,0.00022784635,0.0011744604,0.0006478457,0.0026477375],"genre_scores_gemma":[0.9804277,0.00039286877,0.013465493,0.00021363041,0.000051572348,0.00026431886,0.0019226895,0.00004246192,0.0032193537],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99964404,0.000077704586,0.000014997524,0.000088128785,0.000076644326,0.00009842462],"domain_scores_gemma":[0.9997265,0.00010838749,0.000041853025,0.000034788925,0.000035913927,0.000052623924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030344632,0.00037418745,0.00046145628,0.0010924023,0.00032473385,0.0005610772,0.00032156316,0.0005003473,0.0020464298],"category_scores_gemma":[0.00068053877,0.00024463693,0.00028372533,0.00064903166,0.00019788982,0.00018483002,0.00038671133,0.00051119894,0.0010020579],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005374813,0.00031311682,0.006698999,0.00006627927,0.000028574708,0.00011548139,0.000059908096,0.00042249533,0.96999645,0.00007308256,0.00030080893,0.02138729],"study_design_scores_gemma":[0.00015615343,0.004904055,0.09343794,0.000030930903,0.00021634878,0.0023135818,0.00016273976,0.013938865,0.87981117,0.00033932464,0.004628406,0.00006038698],"about_ca_topic_score_codex":0.0003681189,"about_ca_topic_score_gemma":0.00095442514,"teacher_disagreement_score":0.0020464298,"about_ca_system_score_codex":0.00019616881,"about_ca_system_score_gemma":0.00027561132,"threshold_uncertainty_score":0.0068460107},"labels":[],"label_agreement":null},{"id":"W2754718069","doi":"10.1080/2162402x.2017.1377873","title":"Interleukin-21 combined with PD-1 or CTLA-4 blockade enhances antitumor immunity in mouse tumor models","year":2017,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Saskatchewan","keywords":"Blockade; CD8; Monoclonal antibody; Cytotoxic T cell; CTLA-4; Cancer research; Immunotherapy; Medicine; T cell; Immune system; Blocking antibody; Cancer immunotherapy; Immunology; Immune checkpoint; Antibody; Receptor; Biology; In vitro; Internal medicine","score_opus":0.02885851850022436,"score_gpt":0.29853256680669993,"score_spread":0.26967404830647557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754718069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98714066,0.0024898956,0.006479749,0.00035715138,0.00014788381,0.00022387081,0.00060204393,0.00041630378,0.0021424312],"genre_scores_gemma":[0.9847445,0.0023244952,0.0069108135,0.00012450518,0.000081265935,0.00037188624,0.0007704505,0.00006313245,0.004608951],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993254,0.00016252129,0.00006411754,0.000121250225,0.00016715689,0.00015961786],"domain_scores_gemma":[0.999666,0.00006317055,0.00008778621,0.000048713686,0.000024037734,0.00011019618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065194425,0.001405199,0.00082790834,0.0012324401,0.0003014932,0.00054094096,0.0005228235,0.0006721161,0.0014092696],"category_scores_gemma":[0.0001425059,0.0003477938,0.00070651906,0.0004348796,0.00055577257,0.0005316467,0.00032912352,0.0026565897,0.00045213182],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060757657,0.0006786023,0.00015763936,0.00008463616,0.000019453826,0.000058327012,0.000029376477,0.0002684942,0.99615246,0.00015081813,0.00010171965,0.0016909494],"study_design_scores_gemma":[0.00015550919,0.0042626406,0.0008854349,0.000011600116,0.00004724249,0.00017040913,0.000012177819,0.0014953155,0.991462,0.000070502705,0.0014204588,0.000006615884],"about_ca_topic_score_codex":0.0005496431,"about_ca_topic_score_gemma":0.000957746,"teacher_disagreement_score":0.0014092696,"about_ca_system_score_codex":0.00049124844,"about_ca_system_score_gemma":0.00043144496,"threshold_uncertainty_score":0.0047144294},"labels":[],"label_agreement":null},{"id":"W2767656371","doi":"10.1080/2162402x.2017.1398875","title":"Harnessing innate lung anti-cancer effector functions with a novel bacterial-derived immunotherapy","year":2017,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune responses and vaccinations","field":"Immunology and Microbiology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; National Institute of General Medical Sciences; U.S. Public Health Service","keywords":"Immunotherapy; Innate immune system; Macrophage polarization; Immune system; Medicine; Immunology; Cancer immunotherapy; Lung cancer; Acquired immune system; Cytotoxic T cell; Cancer research; NKG2D; Immunity; Cancer; Effector; Macrophage; Biology; Oncology; Internal medicine; In vitro","score_opus":0.01574413630226103,"score_gpt":0.2816278328218257,"score_spread":0.26588369651956467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767656371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.948024,0.011748899,0.03305324,0.00070873,0.00019884483,0.000349013,0.00020635223,0.0003808758,0.0053301505],"genre_scores_gemma":[0.9846713,0.0035449294,0.008773261,0.0001693973,0.000046484634,0.00010233396,0.00015858092,0.000012337351,0.002521306],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998704,0.000027682214,0.000007505337,0.000023175657,0.000034655575,0.000036479658],"domain_scores_gemma":[0.99996555,0.0000052379896,0.000010338276,0.0000063540842,0.0000040624273,0.0000084786225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018190917,0.00033253102,0.00028111058,0.00019871384,0.00009364922,0.00040797467,0.0002304509,0.00031712488,0.00089849567],"category_scores_gemma":[0.00007879421,0.00009528753,0.000223312,0.00010496712,0.00027115695,0.00031679883,0.00035008028,0.00072349934,0.00031260154],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022151419,0.00036749296,0.00023702261,0.00013886415,0.000009133936,0.00008686948,0.000021511998,0.0004925167,0.9735344,0.00074159296,0.00017579438,0.02397323],"study_design_scores_gemma":[0.00029410963,0.008163624,0.0033879038,0.000037803464,0.00005301478,0.0015750603,0.0000490085,0.0040702834,0.96355283,0.00059615244,0.018202756,0.000017455464],"about_ca_topic_score_codex":0.00015650156,"about_ca_topic_score_gemma":0.00041746517,"teacher_disagreement_score":0.00089849567,"about_ca_system_score_codex":0.00023990979,"about_ca_system_score_gemma":0.00027435474,"threshold_uncertainty_score":0.0030058026},"labels":[],"label_agreement":null},{"id":"W2773596288","doi":"10.1080/2162402x.2017.1407897","title":"Oncolytic viruses sensitize human tumor cells for NY-ESO-1 tumor antigen recognition by CD4+ effector T cells.","year":2017,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Medical Research Council; Agence Nationale de la Recherche; Pancreatic Cancer UK","keywords":"Oncolytic virus; Cytotoxic T cell; Antigen; Cancer research; clone (Java method); Immune system; Immunotherapy; Biology; Virology; Melanoma; Vesicular stomatitis virus; Cancer immunotherapy; Immunology; Virus","score_opus":0.029007622710388085,"score_gpt":0.32380924515295617,"score_spread":0.2948016224425681,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2773596288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951786,0.0004819988,0.0031029722,0.00003017615,0.000020303216,0.000031311032,0.000094435876,0.00003972948,0.0010205287],"genre_scores_gemma":[0.99504495,0.00035892928,0.0023036674,0.000018735998,0.000007711533,0.000029410716,0.00019823469,0.000019781231,0.0020185187],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998791,0.000027679182,0.000008766331,0.00002279217,0.000028453911,0.000033055436],"domain_scores_gemma":[0.99990726,0.000040474864,0.00001533881,0.000018886753,0.000006392277,0.000011531178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012178204,0.0003543416,0.00021931426,0.000103803526,0.00006976518,0.00031721318,0.00012231762,0.00023784132,0.0013591405],"category_scores_gemma":[0.00013456443,0.00010753788,0.0002087678,0.00008892908,0.00021108321,0.00023485484,0.00016898001,0.0006678941,0.00028670125],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058371108,0.000022506816,0.000102649276,0.0000137130655,0.0000026482444,0.000013026703,0.000014940218,0.000058059322,0.99911183,0.00008339996,0.000012823899,0.00050603336],"study_design_scores_gemma":[0.00000819665,0.00024192728,0.00070990546,0.0000018660793,0.0000052252844,0.00009267384,0.000010349864,0.0005809861,0.9974222,0.000028580707,0.0008966019,0.000001453982],"about_ca_topic_score_codex":0.00045147433,"about_ca_topic_score_gemma":0.00039452934,"teacher_disagreement_score":0.0013591405,"about_ca_system_score_codex":0.00019769237,"about_ca_system_score_gemma":0.00018131814,"threshold_uncertainty_score":0.0045467615},"labels":[],"label_agreement":null},{"id":"W2774491730","doi":"10.1080/2162402x.2017.1412909","title":"Glioblastoma stem cell-derived exosomes induce M2 macrophages and PD-L1 expression on human monocytes","year":2017,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":365,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"National Center for Research Resources; National Institute of Neurological Disorders and Stroke; National Cancer Institute; National Institutes of Health; Cancer Prevention and Research Institute of Texas","keywords":"Microvesicles; Biology; Immune system; STAT protein; Cancer research; STAT3; Cell biology; CD14; Exosome; Tumor microenvironment; Phosphorylation; Immunology; microRNA","score_opus":0.01947856742363775,"score_gpt":0.2902528038109905,"score_spread":0.27077423638735276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2774491730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99762976,0.000537686,0.000540391,0.000056582096,0.00001714492,0.000030028867,0.00019624221,0.000022845714,0.0009692772],"genre_scores_gemma":[0.99762017,0.00030534682,0.0003956389,0.00006310804,0.00000794277,0.000031300864,0.0003122426,0.0000044842213,0.0012598074],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998815,0.000025484149,0.000010388531,0.000012124385,0.000021832053,0.000048744078],"domain_scores_gemma":[0.99995565,0.0000066494326,0.000008332863,0.000006413611,0.000009977449,0.000012913958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012336187,0.00017172523,0.00014709504,0.00021623768,0.00010479121,0.00026989492,0.000036813293,0.00012902828,0.00095421425],"category_scores_gemma":[0.00010348055,0.000078022815,0.00016500738,0.000102030965,0.000098117554,0.00008788734,0.00026920773,0.00024237283,0.00037958968],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004973889,0.00007472466,0.0017915361,0.00005224622,0.000009221364,0.0001878298,0.00008079492,0.00006540326,0.9917998,0.00020664393,0.00026166847,0.004972737],"study_design_scores_gemma":[0.00012750353,0.0009948687,0.037795372,0.000031805284,0.000036375255,0.0005106546,0.0002619448,0.0011842857,0.9503114,0.00019270128,0.008544914,0.000008144695],"about_ca_topic_score_codex":0.0003620754,"about_ca_topic_score_gemma":0.0005669957,"teacher_disagreement_score":0.00095421425,"about_ca_system_score_codex":0.00018633109,"about_ca_system_score_gemma":0.00018281562,"threshold_uncertainty_score":0.0031921268},"labels":[],"label_agreement":null},{"id":"W2788829911","doi":"10.1080/2162402x.2017.1423171","title":"Oncolytic influenza virus infection restores immunocompetence of lung tumor-associated alveolar macrophages","year":2018,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"Deutsche Krebshilfe; Deutsche Forschungsgemeinschaft","keywords":"Oncolytic virus; Tumor microenvironment; Immunocompetence; Immune system; Cancer research; Lung cancer; Influenza A virus; Biology; Immunology; Virus; Medicine; Pathology","score_opus":0.01505696059833981,"score_gpt":0.3186987107642977,"score_spread":0.30364175016595785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2788829911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975101,0.00046852618,0.0010940625,0.00003725439,0.000017407527,0.000013801896,0.000099593766,0.000057381953,0.0007018837],"genre_scores_gemma":[0.99753606,0.00026020556,0.0007492783,0.000020585196,0.000004890551,0.000018688652,0.00014736045,0.000014376185,0.001248615],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989724,0.00001937535,0.00000924069,0.00001810931,0.000020024123,0.000035966645],"domain_scores_gemma":[0.99991083,0.000013811912,0.000025106207,0.000016843425,0.000007618255,0.000025774829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012870105,0.0003046162,0.00017634383,0.00018351841,0.00011390929,0.00023002438,0.00014478284,0.00020006383,0.00057670707],"category_scores_gemma":[0.00008335746,0.000107356434,0.00015211335,0.00006548362,0.00020838458,0.00016180851,0.00015615989,0.00055474316,0.00024984113],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008253328,0.000035573747,0.000083047984,0.0000084738185,0.0000014365465,0.000022023583,0.000012395581,0.000025828991,0.9990559,0.00005504528,0.000010999316,0.0006066877],"study_design_scores_gemma":[0.000024484967,0.00068220124,0.0028179353,0.0000042385204,0.000008757184,0.0001893345,0.000032100368,0.00064858573,0.994292,0.00005467309,0.0012425479,0.0000030655185],"about_ca_topic_score_codex":0.00025613388,"about_ca_topic_score_gemma":0.00029495684,"teacher_disagreement_score":0.00057670707,"about_ca_system_score_codex":0.00013675113,"about_ca_system_score_gemma":0.00017086024,"threshold_uncertainty_score":0.0019292831},"labels":[],"label_agreement":null},{"id":"W2791879337","doi":"10.1080/2162402x.2017.1423173","title":"Increased immune infiltration and chemokine receptor expression in head and neck epithelial tumors after neoadjuvant immunotherapy with the IRX-2 regimen","year":2018,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Chemokine; Immune system; CD8; Cancer research; Immunotherapy; Tumor microenvironment; Medicine; Dendritic cell; CD68; Immunohistochemistry; Immunology; Biology","score_opus":0.007076286795418588,"score_gpt":0.24744590405908215,"score_spread":0.24036961726366357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791879337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993849,0.00017853615,0.00007323287,0.000010668869,0.0000028270715,0.000016546106,0.000056487803,0.0000059301183,0.00027080963],"genre_scores_gemma":[0.9990759,0.0000956026,0.000150404,0.000031302145,0.0000041786343,0.00005056439,0.00023997638,0.0000018570995,0.0003501179],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998683,0.000031627344,0.00000825909,0.000022177617,0.00003636475,0.000033351047],"domain_scores_gemma":[0.9999001,0.00002584532,0.00003147381,0.000011153855,0.000010697177,0.000020732943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021956554,0.00013678007,0.00031601754,0.00020783275,0.00014706783,0.00028877187,0.000071867806,0.00016525725,0.00063947076],"category_scores_gemma":[0.00022268076,0.00012511779,0.00016412379,0.00015892192,0.00020845454,0.00016955863,0.000109452216,0.00033897202,0.00011114257],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008916079,0.00096528983,0.078592986,0.00012309289,0.00007558608,0.00053272693,0.00030355313,0.0007650263,0.88802826,0.000057807352,0.00033519982,0.021304416],"study_design_scores_gemma":[0.00039219987,0.024598124,0.77767986,0.000019187048,0.00017097544,0.0020485546,0.00043756777,0.0024842664,0.18982102,0.00007943979,0.0022457875,0.000023014294],"about_ca_topic_score_codex":0.00043877464,"about_ca_topic_score_gemma":0.0008472117,"teacher_disagreement_score":0.00063947076,"about_ca_system_score_codex":0.00028733636,"about_ca_system_score_gemma":0.0002202073,"threshold_uncertainty_score":0.0021392107},"labels":[],"label_agreement":null},{"id":"W2792540082","doi":"10.1080/2162402x.2018.1442169","title":"Heating it up: Oncolytic viruses make tumors ‘hot’ and suitable for checkpoint blockade immunotherapies","year":2018,"lang":"en","type":"editorial","venue":"OncoImmunology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":124,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"Labex Immuno-Oncology; European Research Area Network on Cardiovascular Diseases; Ligue Contre le Cancer; Fondation pour la Recherche Médicale; Institut National Du Cancer; Institut National de la Santé et de la Recherche Médicale; Agence Nationale de la Recherche; Government of Canada; Canadian Institutes of Health Research; Association pour la Recherche sur le Cancer; Seerave Foundation; Institut Universitaire de France; Beatrice Hunter Cancer Research Institute; Fondation Leducq; European Commission","keywords":"Oncolytic virus; Blockade; Immune checkpoint; Tumor microenvironment; Medicine; Immunotherapy; Adjuvant; Cancer research; Immune system; Immunology; Receptor; Internal medicine","score_opus":0.02087913009251936,"score_gpt":0.32904397637263394,"score_spread":0.3081648462801146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792540082","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015177585,0.008568853,0.00026167504,0.039336856,0.95040166,0.000016607708,0.000029826071,0.0000639521,0.0011687791],"genre_scores_gemma":[0.0012457276,0.009385042,0.00020319766,0.03844708,0.9394607,0.000021782856,0.000025248322,0.000043950153,0.011167238],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973665,0.00043874283,0.00040882968,0.00032937093,0.0012686744,0.00018783643],"domain_scores_gemma":[0.9930269,0.0033150662,0.00043040686,0.00019572802,0.0022433342,0.00078843045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055518094,0.002967869,0.0016834299,0.0013854932,0.0017555518,0.004146458,0.0020570494,0.009550542,0.0047276574],"category_scores_gemma":[0.010695383,0.0008773542,0.0014751337,0.0005439034,0.0021064968,0.004221088,0.0012242682,0.021653853,0.0039790277],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010240275,0.000034966604,0.000055910907,0.00033515625,0.000025929301,0.00028003164,0.000038446466,0.0000450248,0.00056303845,0.000951112,0.9845123,0.013055597],"study_design_scores_gemma":[0.000075861324,0.000057015794,0.00023716742,0.00021733278,0.00004358831,0.00038841742,0.00004832836,0.00014839605,0.00062208687,0.0011477945,0.9969932,0.000020713973],"about_ca_topic_score_codex":0.0005617314,"about_ca_topic_score_gemma":0.0014165511,"teacher_disagreement_score":0.009550542,"about_ca_system_score_codex":0.0019656192,"about_ca_system_score_gemma":0.0013963911,"threshold_uncertainty_score":0.029361129},"labels":[],"label_agreement":null},{"id":"W2793301215","doi":"10.1080/2162402x.2018.1445459","title":"Transforming the prostatic tumor microenvironment with oncolytic virotherapy","year":2018,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; McMaster University; Centre Hospitalier de l’Université de Montréal; Children's Hospital of Eastern Ontario; Ottawa Hospital; McMaster University Medical Centre","funders":"Canadian Institutes of Health Research; Terry Fox Foundation; Prostate Cancer Canada","keywords":"Oncolytic virus; Virotherapy; Tumor microenvironment; Cancer research; Medicine; Tumor cells","score_opus":0.009857343026171481,"score_gpt":0.2680147467404387,"score_spread":0.2581574037142672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793301215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97429127,0.0033240784,0.016587142,0.00027291334,0.00008143084,0.00011734588,0.00016987383,0.000244312,0.0049116835],"genre_scores_gemma":[0.99282587,0.0015381167,0.0035170205,0.00003943215,0.000012638129,0.00003054625,0.00008419929,0.000015698899,0.0019364221],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999926,0.000013600837,0.000002484,0.000011235087,0.000019702873,0.000026973377],"domain_scores_gemma":[0.99997866,0.0000038348117,0.0000061591227,0.000003654683,0.0000019873617,0.000005624597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000101500445,0.00021020956,0.00014308008,0.00016936472,0.0001062271,0.00044219298,0.00012219777,0.00020818917,0.0006875648],"category_scores_gemma":[0.000062674146,0.000110402114,0.0001682557,0.0001171327,0.00020272682,0.00017815336,0.0003166732,0.0005395231,0.00022077553],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009243816,0.00006115491,0.00014008422,0.00004162118,0.000003833458,0.00007462698,0.000038491355,0.00069148163,0.9928847,0.00082184264,0.00008617104,0.0050635105],"study_design_scores_gemma":[0.00003178671,0.0009398266,0.001376927,0.000011923926,0.000018428904,0.0005597319,0.000064567685,0.0041544517,0.9811561,0.0004060531,0.011271301,0.00000883925],"about_ca_topic_score_codex":0.00036790507,"about_ca_topic_score_gemma":0.0006282916,"teacher_disagreement_score":0.0006875648,"about_ca_system_score_codex":0.00017625086,"about_ca_system_score_gemma":0.00020830292,"threshold_uncertainty_score":0.0023001432},"labels":[],"label_agreement":null},{"id":"W2795354240","doi":"10.1080/2162402x.2018.1434468","title":"The intestinal microbiota determines the clinical efficacy of immune checkpoint blockers targeting PD-1/PD-L1","year":2018,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Blockade; PD-L1; Immunotherapy; Immune checkpoint; Immune system; Medicine; Cancer immunotherapy; Gut flora; Clinical efficacy; Immunology; Cancer research; Internal medicine; Receptor","score_opus":0.027641767298129286,"score_gpt":0.34032556835621924,"score_spread":0.31268380105808996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2795354240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872472,0.009861226,0.00046583285,0.000435012,0.00005311606,0.000025249778,0.00023029081,0.00001636885,0.0016658166],"genre_scores_gemma":[0.9960277,0.002644954,0.00043141772,0.00016546962,0.00004828372,0.000012902929,0.0002229712,0.0000069406155,0.00043936278],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99968374,0.00009564634,0.00003108468,0.000044124747,0.00006846973,0.000076935474],"domain_scores_gemma":[0.999567,0.00008816537,0.00018281465,0.0000198285,0.00005591277,0.00008630472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028734404,0.00020409258,0.0004256721,0.00040240693,0.00025532025,0.00069300516,0.000083627354,0.0003331911,0.0016171965],"category_scores_gemma":[0.0011738501,0.00014513047,0.00023113083,0.00032947294,0.0002041031,0.00039306,0.00030777682,0.00047845297,0.00036001246],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007604351,0.0005162018,0.69352776,0.00030300074,0.00032188577,0.0005215624,0.00016374902,0.00034993744,0.18054794,0.00017525603,0.0012112577,0.11475704],"study_design_scores_gemma":[0.000074516975,0.0022345788,0.96902496,0.00010949118,0.00032560853,0.0016404353,0.00042448615,0.0012237735,0.019143077,0.00035880992,0.005420941,0.00001923404],"about_ca_topic_score_codex":0.00037748532,"about_ca_topic_score_gemma":0.0006361882,"teacher_disagreement_score":0.0016171965,"about_ca_system_score_codex":0.0001805511,"about_ca_system_score_gemma":0.00022491204,"threshold_uncertainty_score":0.005410075},"labels":[],"label_agreement":null},{"id":"W2799338998","doi":"10.1080/2162402x.2018.1467856","title":"Gene expression profiling and immune cell-type deconvolution highlight robust disease progression and survival markers in multiple cohorts of CTCL patients","year":2018,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; Université Laval; Université de Montréal; McGill University Health Centre","funders":"Fonds de Recherche du Québec - Santé; Canadian Dermatology Foundation","keywords":"Mycosis fungoides; CD52; Disease; Immune system; Oncology; Medicine; Biology; T cell; Immunology; Internal medicine; Alemtuzumab; Lymphoma; Antibody","score_opus":0.017731974657137706,"score_gpt":0.2857776371904261,"score_spread":0.2680456625332884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2799338998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952809,0.0008205125,0.001454387,0.00014767935,0.00001877468,0.000021266587,0.001119819,0.00007112503,0.0010655816],"genre_scores_gemma":[0.99727494,0.00015537337,0.00066752045,0.000116154406,0.000020565762,0.000027198892,0.0010768502,0.000022974338,0.0006383955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99963844,0.000047233934,0.00002421435,0.00011778122,0.00010049269,0.00007190633],"domain_scores_gemma":[0.99968195,0.00006511807,0.00009595928,0.00004539094,0.00006396431,0.000047624133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040580545,0.00018342357,0.0004165598,0.0007485439,0.0002925444,0.0010122457,0.00019948534,0.00039482227,0.0016478694],"category_scores_gemma":[0.0009767509,0.000106940475,0.00024838847,0.0006256737,0.00023814607,0.00030845392,0.0003290125,0.0005410407,0.0004356154],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019768833,0.00017876174,0.6303583,0.00010704015,0.00017879378,0.00037065294,0.00040703776,0.00074047846,0.31501916,0.00025334652,0.0015490772,0.0488605],"study_design_scores_gemma":[0.000043421547,0.00041843907,0.9600953,0.000023346245,0.00014496548,0.0011585637,0.000395403,0.002749819,0.030665452,0.00043596717,0.0038499108,0.000019368272],"about_ca_topic_score_codex":0.0011092447,"about_ca_topic_score_gemma":0.0019959263,"teacher_disagreement_score":0.0016478694,"about_ca_system_score_codex":0.00033286723,"about_ca_system_score_gemma":0.00018302997,"threshold_uncertainty_score":0.005512655},"labels":[],"label_agreement":null},{"id":"W2886222140","doi":"10.1080/2162402x.2018.1486950","title":"EBV infection determines the immune hallmarks of plasmablastic lymphoma","year":2018,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer; Institut Universitaire de France; Ligue Contre le Cancer; Agence Nationale de la Recherche","keywords":"Plasmablastic lymphoma; Immune checkpoint; Immune system; Lymphoma; Immunology; Medicine; Tumor microenvironment; Epstein–Barr virus; Cytotoxic T cell; Immunotherapy; Cancer research; Virus; Biology","score_opus":0.00991615788039044,"score_gpt":0.2606953859145428,"score_spread":0.2507792280341523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886222140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99619365,0.00150344,0.0011664894,0.000038001534,0.000004603659,0.0000150817095,0.00025122453,0.000026527978,0.00080104393],"genre_scores_gemma":[0.9977525,0.0006404026,0.000914115,0.00003104896,0.000010877062,0.000011696615,0.00038154545,0.0000066729312,0.0002512625],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99989486,0.0000184921,0.000007879533,0.000031230622,0.000025461508,0.00002197747],"domain_scores_gemma":[0.999918,0.000014519991,0.0000367798,0.000006506933,0.00000936057,0.000014680251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000081070626,0.00012482893,0.0001533568,0.00049249607,0.00017766938,0.00035485596,0.00008591008,0.00020441372,0.00083575345],"category_scores_gemma":[0.00025639898,0.00010661466,0.000102678074,0.00039964032,0.00017097138,0.00020352825,0.00019878014,0.00025101274,0.00026966754],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000475633,0.000043853626,0.096865594,0.00010932631,0.000028242564,0.0005198693,0.00014229376,0.00017323831,0.8814889,0.00020893042,0.00015465416,0.019789556],"study_design_scores_gemma":[0.000020946742,0.0003306638,0.9002277,0.00003824555,0.0000668389,0.0038455138,0.00046130762,0.0015542934,0.08728853,0.0009945694,0.005156381,0.000015006926],"about_ca_topic_score_codex":0.00019913925,"about_ca_topic_score_gemma":0.00034881852,"teacher_disagreement_score":0.00083575345,"about_ca_system_score_codex":0.00011532663,"about_ca_system_score_gemma":0.00010327551,"threshold_uncertainty_score":0.002795875},"labels":[],"label_agreement":null},{"id":"W2886229095","doi":"10.1080/2162402x.2018.1498439","title":"Treatment-naïve HPV+ head and neck cancers display a T-cell-inflamed phenotype distinct from their HPV- counterparts that has implications for immunotherapy","year":2018,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"Canadian Institutes of Health Research","keywords":"TIGIT; Immune system; Immunotherapy; Immune checkpoint; Medicine; Head and neck squamous-cell carcinoma; Cancer research; Antigen; Immunology; HPV infection; T cell; Head and neck cancer; Cancer; Oncology; Internal medicine; Cervical cancer","score_opus":0.03692625881733523,"score_gpt":0.3077519065233821,"score_spread":0.27082564770604683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886229095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932916,0.0030184323,0.0008059726,0.000053764747,0.000015197356,0.000053791413,0.0005025168,0.000023132397,0.0022355665],"genre_scores_gemma":[0.9970005,0.0009065593,0.0004935296,0.000063115294,0.00000988266,0.0000658987,0.0006459253,0.0000057569346,0.0008087333],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999816,0.000041406267,0.000019325686,0.000035306653,0.0000460881,0.000041856416],"domain_scores_gemma":[0.99989223,0.000025418207,0.000033961394,0.000015414129,0.000017673061,0.000015329864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022862958,0.00010882497,0.00020910011,0.00021200033,0.00017070488,0.0003859751,0.00008426415,0.00014406933,0.0017593028],"category_scores_gemma":[0.00023953631,0.00007049526,0.00019568141,0.00023408871,0.0001528626,0.00022682418,0.00015067527,0.00025425505,0.00032073582],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014145814,0.00043785575,0.28194624,0.00092708913,0.00015087509,0.00044236373,0.00040340086,0.00068957964,0.6181471,0.0007948137,0.0010122036,0.093633965],"study_design_scores_gemma":[0.00004769413,0.0021133143,0.8808872,0.000073608586,0.00015065812,0.0028296565,0.00060415186,0.0010649895,0.09745667,0.00079977716,0.013958169,0.000014106322],"about_ca_topic_score_codex":0.0003723348,"about_ca_topic_score_gemma":0.0009824604,"teacher_disagreement_score":0.0017593028,"about_ca_system_score_codex":0.00021708175,"about_ca_system_score_gemma":0.00018297396,"threshold_uncertainty_score":0.005885422},"labels":[],"label_agreement":null},{"id":"W2886634548","doi":"10.1080/2162402x.2018.1475875","title":"A point mutation in the <i>Ncr1</i> signal peptide impairs the development of innate lymphoid cell subsets","year":2018,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Medical Research Council; Centre National de la Recherche Scientifique; Institut National de la Santé et de la Recherche Médicale; Agence Nationale de la Recherche; Australian Government; National Health and Medical Research Council; CSL Limited; European Commission; Aix-Marseille Université","keywords":"Biology; Innate lymphoid cell; Mutant; Cell biology; Congenic; Immune system; Mutation; Point mutation; Innate immune system; Molecular biology; Immunology; Gene; Genetics","score_opus":0.010883113491059698,"score_gpt":0.23343832670887685,"score_spread":0.22255521321781715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886634548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888269,0.00059373584,0.003228869,0.00030383852,0.00024482285,0.000072980794,0.0016029476,0.00029536735,0.0048306603],"genre_scores_gemma":[0.9918876,0.00027214427,0.002602881,0.00013544595,0.00003191987,0.00005466367,0.0010915208,0.00010105202,0.003822734],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995977,0.0000685714,0.00006922266,0.0000853739,0.00009506424,0.00008396706],"domain_scores_gemma":[0.99958783,0.000081637045,0.00013624696,0.00007885866,0.000023715855,0.00009182323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022675475,0.00055773737,0.00030059315,0.0003264009,0.00028649904,0.0003444223,0.00057394063,0.0007335246,0.004816438],"category_scores_gemma":[0.00018771346,0.00017024261,0.00044709592,0.00020292813,0.00073097134,0.00025631808,0.00020953438,0.0010138139,0.0014616338],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016996234,0.000057641173,0.0000794024,0.000020277204,0.0000065752956,0.00011726255,0.000008830696,0.000087835724,0.9983734,0.00020381871,0.00011720888,0.00075782416],"study_design_scores_gemma":[0.000034268374,0.00021990476,0.0017079168,0.00000789889,0.000017781302,0.0006899048,0.000022070366,0.0006829449,0.99366355,0.00005478714,0.0028881233,0.000010893453],"about_ca_topic_score_codex":0.0018222566,"about_ca_topic_score_gemma":0.002641448,"teacher_disagreement_score":0.004816438,"about_ca_system_score_codex":0.0006161098,"about_ca_system_score_gemma":0.0004507775,"threshold_uncertainty_score":0.016112626},"labels":[],"label_agreement":null},{"id":"W2887082004","doi":"10.1080/2162402x.2018.1478647","title":"Brain tumor-initiating cells export tenascin-C associated with exosomes to suppress T cell activity","year":2018,"lang":"en","type":"editorial","venue":"OncoImmunology","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canada Research Chairs; Deutsche Forschungsgemeinschaft; Alberta Innovates - Health Solutions; Government of Canada; Alberta Cancer Foundation; University of Calgary","keywords":"Microvesicles; Tenascin C; Exosome; Immune system; Biology; Cancer research; T cell; Cell biology; Stem cell; Immunology; Extracellular matrix; microRNA; Gene","score_opus":0.006009878546964434,"score_gpt":0.2450397641880581,"score_spread":0.23902988564109365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887082004","genre_codex":"empirical","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99353796,0.0018616047,0.003376402,0.00007489767,0.000028620243,0.00003302263,0.0001740553,0.000057764828,0.0008555569],"genre_scores_gemma":[0.9960296,0.0010604716,0.0014235027,0.000034248376,0.00000954261,0.000019001469,0.00021611212,0.000011176675,0.0011963979],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.999941,0.000009914342,0.000005367732,0.0000103918455,0.000013665178,0.0000196693],"domain_scores_gemma":[0.9999577,0.000005319044,0.00001331217,0.000003979595,0.000007641736,0.000012010955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008735702,0.00028205934,0.00014904769,0.00020404141,0.00014005906,0.00022829477,0.00008405365,0.00013867342,0.00045467206],"category_scores_gemma":[0.00009621832,0.00004712598,0.00015889281,0.00013623417,0.00013412311,0.0001453917,0.00022362328,0.00026018123,0.00015832054],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006796381,0.000014719189,0.0004291878,0.000029608396,0.000004385707,0.00009288213,0.000012949428,0.000045854667,0.99717784,0.00009469799,0.000044821838,0.0019850952],"study_design_scores_gemma":[0.000018516894,0.00027101842,0.012071746,0.000009746502,0.0000207991,0.00079527695,0.000064675696,0.0013550196,0.98134196,0.00015992679,0.003886577,0.0000048215193],"about_ca_topic_score_codex":0.00034390666,"about_ca_topic_score_gemma":0.0005716575,"teacher_disagreement_score":0.00045467206,"about_ca_system_score_codex":0.00014874541,"about_ca_system_score_gemma":0.00021027349,"threshold_uncertainty_score":0.0015209913},"labels":[],"label_agreement":null},{"id":"W2888080031","doi":"10.1080/2162402x.2018.1502128","title":"TIM-3 expression in breast cancer","year":2018,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Galectins and Cancer Biology","field":"Immunology and Microbiology","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Centre for Advancing Health Outcomes; University of British Columbia","funders":"Fonds de Recherche du Québec - Santé; Canadian Cancer Society","keywords":"Breast cancer; Immune checkpoint; Medicine; Cancer; Tissue microarray; Estrogen receptor; Tumor-infiltrating lymphocytes; Oncology; Internal medicine; Triple-negative breast cancer; Cancer research; Immunotherapy; Pathology","score_opus":0.009024998491655035,"score_gpt":0.26445706968536276,"score_spread":0.2554320711937077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888080031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955266,0.002140802,0.00026305832,0.000044834163,0.000009003618,0.000012656058,0.00050423644,0.000020265601,0.0014785866],"genre_scores_gemma":[0.99782604,0.0006431083,0.00038281974,0.000039866183,0.000014290571,0.000018773713,0.00059287,0.00000299359,0.00047915147],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999912,0.000016298069,0.000009089323,0.000016366757,0.000018373406,0.00002794043],"domain_scores_gemma":[0.9999174,0.000012620762,0.000032595985,0.000006915172,0.000015773127,0.000014790992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002071836,0.0000910852,0.00009286497,0.00082624814,0.00014241053,0.00029156095,0.00009710345,0.0002126206,0.0010806441],"category_scores_gemma":[0.0002897752,0.00006290714,0.00013588594,0.0007396985,0.00011712232,0.00014877094,0.00019073204,0.0001441485,0.0003957864],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030013034,0.00010638399,0.6829777,0.00028570276,0.0000790039,0.0009620419,0.00035574546,0.00034118767,0.2562692,0.0002665314,0.001474841,0.053880375],"study_design_scores_gemma":[0.000021047546,0.00028461622,0.96553636,0.000025072526,0.00006733584,0.0029309974,0.0003320872,0.0009977844,0.023393748,0.00024285642,0.0061563384,0.000011813045],"about_ca_topic_score_codex":0.00072743214,"about_ca_topic_score_gemma":0.00072566856,"teacher_disagreement_score":0.0010806441,"about_ca_system_score_codex":0.00029576305,"about_ca_system_score_gemma":0.00010656027,"threshold_uncertainty_score":0.0036150813},"labels":[],"label_agreement":null},{"id":"W2888879984","doi":"10.1080/2162402x.2018.1503032","title":"Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors","year":2018,"lang":"en","type":"review","venue":"OncoImmunology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; Izaak Walton Killam Health Centre; Dalhousie University; McMaster University","funders":"Labex Immuno-Oncology; Weill Cornell Medical College; Institut National Du Cancer; Institut Universitaire de France; Ligue Contre le Cancer; Fondation pour la Recherche Médicale; Agence Nationale de la Recherche; E-Rare; Association pour la Recherche sur le Cancer; Seerave Foundation; Fondation Leducq; European Commission","keywords":"Oncolytic virus; Virotherapy; Medicine; Immunotherapy; Clinical trial; Herpes simplex virus; Food and drug administration; Melanoma; Cancer; Cancer immunotherapy; Cancer research; Immune system; Virus; Immunology; Virology; Internal medicine; Pharmacology","score_opus":0.05353625150915936,"score_gpt":0.3856434468778843,"score_spread":0.33210719536872496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888879984","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008393472,0.97921365,0.0005115756,0.0023949265,0.0040360373,0.00018169415,0.00050345995,0.00007172008,0.0122475885],"genre_scores_gemma":[0.004086031,0.96915483,0.0008871671,0.0053364746,0.0024596138,0.0002670848,0.0013008924,0.000033738914,0.016474213],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998186,0.000041137002,0.00002412181,0.000025168474,0.000066567714,0.000024442721],"domain_scores_gemma":[0.9996414,0.0001322052,0.00006188295,0.000009234987,0.00009102661,0.000064221065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078951154,0.0005765312,0.00086052547,0.0008407848,0.00020091851,0.0010671436,0.00075851823,0.0013393079,0.011718219],"category_scores_gemma":[0.00086760183,0.000117399286,0.0005811958,0.0006448615,0.00020040902,0.0010660113,0.00053947297,0.002162506,0.004182325],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053276704,0.00014999235,0.0001315912,0.014542418,0.00011854005,0.0001291637,0.00004403476,0.00016286968,0.003370904,0.004048734,0.14845692,0.82831216],"study_design_scores_gemma":[0.0002485539,0.00028461264,0.00032753655,0.0034493979,0.0001266606,0.0004245357,0.00001814422,0.00006315946,0.00089404377,0.0011111258,0.99304307,0.000009207301],"about_ca_topic_score_codex":0.00032211604,"about_ca_topic_score_gemma":0.0009004037,"teacher_disagreement_score":0.011718219,"about_ca_system_score_codex":0.00041180177,"about_ca_system_score_gemma":0.0009479324,"threshold_uncertainty_score":0.03920132},"labels":[],"label_agreement":null},{"id":"W2889975327","doi":"10.1080/2162402x.2018.1504728","title":"Somatic mutation-associated T follicular helper cell elevation in lung adenocarcinoma","year":2018,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Occupational Cancer Research Centre","funders":"Canadian Institutes of Health Research; Government of Canada","keywords":"Germinal center; Biology; Immune system; B cell; Lung cancer; Adenocarcinoma; Immunology; Immunohistochemistry; Cancer research; Follicular phase; Affinity maturation; Antigen; Follicular dendritic cells; Cancer; T cell; Pathology; Antibody; Medicine; Antigen-presenting cell","score_opus":0.010534164007506785,"score_gpt":0.26721513923945933,"score_spread":0.25668097523195255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889975327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99909914,0.00022600792,0.0001958218,0.000008761406,0.0000030211431,0.000008173651,0.000037718815,0.000017481892,0.00040382936],"genre_scores_gemma":[0.99973005,0.00005272388,0.00009559615,0.0000028984282,0.0000030761323,0.0000020731977,0.000033165976,0.0000015022227,0.00007889726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998159,0.000027925063,0.000021010526,0.000041591644,0.000052567135,0.00004112708],"domain_scores_gemma":[0.9995734,0.00007577242,0.00012823897,0.00003846472,0.00006057424,0.000123548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002511681,0.00015167032,0.00024755223,0.0010046656,0.00027622716,0.00032637757,0.00016616566,0.00032864316,0.0013262673],"category_scores_gemma":[0.00054015033,0.0001433543,0.00016468814,0.00043997774,0.00033333246,0.00017358635,0.00020328815,0.00025328482,0.0002060858],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013129233,0.00010505284,0.5554056,0.00009286703,0.00006403362,0.010679261,0.0002372965,0.00016702806,0.42185265,0.00013753708,0.00015853961,0.009787125],"study_design_scores_gemma":[0.000017879198,0.0005424854,0.93975073,0.0000057482484,0.000058171525,0.02493078,0.00020026245,0.00085449015,0.03281221,0.00012766365,0.0006909358,0.000008559982],"about_ca_topic_score_codex":0.00080008624,"about_ca_topic_score_gemma":0.00083663384,"teacher_disagreement_score":0.0013262673,"about_ca_system_score_codex":0.00026057742,"about_ca_system_score_gemma":0.00014848367,"threshold_uncertainty_score":0.004436791},"labels":[],"label_agreement":null},{"id":"W2892170876","doi":"10.1080/2162402x.2018.1509820","title":"Assessment of PD-L1 expression across breast cancer molecular subtypes, in relation to mutation rate, <i>BRCA1</i>-like status, tumor-infiltrating immune cells and survival","year":2018,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Lunenfeld-Tanenbaum Research Institute; University of Toronto; University Health Network","funders":"National Cancer Institute; National Institutes of Health; European Commission","keywords":"Tumor-infiltrating lymphocytes; Tissue microarray; Breast cancer; PD-L1; FOXP3; Cancer research; Immune system; Medicine; CD8; Estrogen receptor; Multiplex; Cancer; Immunohistochemistry; Oncology; Pathology; Biology; Internal medicine; Immunology; Immunotherapy; Bioinformatics","score_opus":0.0096826423141296,"score_gpt":0.31319507012572595,"score_spread":0.3035124278115964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892170876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99952304,0.00013693998,0.000118846925,0.0000058547444,4.141613e-7,0.0000031213037,0.00006391732,0.0000040208497,0.00014392182],"genre_scores_gemma":[0.9995765,0.000036931066,0.0001227658,0.000006939599,0.0000011343319,0.000006431474,0.00009729336,0.0000014849803,0.00015042527],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999864,0.000030658644,0.00001198459,0.00004209156,0.000026805923,0.000024431547],"domain_scores_gemma":[0.9997017,0.00010954742,0.0000885,0.000021929134,0.000038024806,0.000040307088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004129038,0.00010465729,0.00018295232,0.00048201895,0.00011061825,0.00027978653,0.00010734496,0.00015494188,0.00069114787],"category_scores_gemma":[0.0005727404,0.000110682086,0.00010399553,0.00023511473,0.00012446285,0.00017865162,0.0001367797,0.0001731336,0.00012428449],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013659874,0.000045788787,0.9047836,0.000033328164,0.000047619025,0.0000869877,0.00012293957,0.00030159505,0.083600484,0.00002692395,0.000087456916,0.0094973305],"study_design_scores_gemma":[0.000010894543,0.00040571572,0.9824102,0.000003057594,0.000036332433,0.0005401238,0.000143032,0.0011114985,0.014962331,0.00003471404,0.00033776046,0.000004335096],"about_ca_topic_score_codex":0.0004872808,"about_ca_topic_score_gemma":0.00049191614,"teacher_disagreement_score":0.00069114787,"about_ca_system_score_codex":0.0002061312,"about_ca_system_score_gemma":0.000057523474,"threshold_uncertainty_score":0.0023121238},"labels":[],"label_agreement":null},{"id":"W2892263168","doi":"10.1080/2162402x.2018.1512943","title":"Identification of PD-L2, B7-H3 and CTLA-4 immune checkpoint proteins in genetic subtypes of meningioma","year":2018,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotchkiss Brain Institute; Institute of Cancer Research; University of Calgary","funders":"Government of Canada; Health Research Board","keywords":"Immunotherapy; Immune checkpoint; Cancer research; Meningioma; Medicine; Immune system; CTLA-4; Mutation; PD-L1; Gene; Immunology; Biology; T cell; Pathology; Genetics","score_opus":0.012780361939719164,"score_gpt":0.26367748173064137,"score_spread":0.2508971197909222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892263168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986738,0.00053549005,0.00017343667,0.000040631796,0.0000034118868,0.000004406312,0.00008170813,0.0000064719566,0.00048055043],"genre_scores_gemma":[0.9993575,0.00016679075,0.00016593069,0.00001232137,0.0000050256754,0.000003110162,0.000113558344,0.000001843712,0.00017395723],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998938,0.000016410284,0.000011180439,0.000020553487,0.000029440527,0.000028583736],"domain_scores_gemma":[0.9998734,0.000027411841,0.000039746956,0.000008320108,0.000021858355,0.00002930533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001819515,0.00014400836,0.00014702058,0.0009636419,0.00017922423,0.00038714125,0.000100102276,0.0002235666,0.00066037977],"category_scores_gemma":[0.00042303884,0.000101123376,0.00016417544,0.0002828818,0.0001863851,0.00016696549,0.00018684543,0.00024119577,0.00014934757],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017046403,0.00008887608,0.7098576,0.00006777306,0.00009331033,0.0018156316,0.00021701364,0.0002934213,0.2617315,0.00019690393,0.0003082842,0.023624964],"study_design_scores_gemma":[0.000029645935,0.00029529948,0.94215053,0.000018380091,0.000069076596,0.005647239,0.00047289595,0.0015018156,0.04763836,0.0004366608,0.0017309398,0.000008973687],"about_ca_topic_score_codex":0.0009265676,"about_ca_topic_score_gemma":0.0014684022,"teacher_disagreement_score":0.0009636419,"about_ca_system_score_codex":0.000273658,"about_ca_system_score_gemma":0.0001457676,"threshold_uncertainty_score":0.0022092462},"labels":[],"label_agreement":null},{"id":"W2892370845","doi":"10.1080/2162402x.2018.1512329","title":"Preclinical evaluation of a MAGE-A3 vaccination utilizing the oncolytic Maraba virus currently in first-in-human trials","year":2018,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Guelph; University of Toronto; University Health Network; Toronto General Hospital; Children's Hospital of Eastern Ontario; McMaster University","funders":"Ontario Institute for Cancer Research; Terry Fox Foundation","keywords":"Oncolytic virus; Immunogenicity; Immunotherapy; Vaccination; Immunology; Immune system; Virology; CD8; Medicine; Antibody; Biology","score_opus":0.1424572244090407,"score_gpt":0.4622458880018727,"score_spread":0.319788663592832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892370845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97992927,0.002967148,0.006875624,0.0004947082,0.00024955207,0.0023240156,0.0022371921,0.0003224003,0.0046001757],"genre_scores_gemma":[0.9883029,0.0021391998,0.002816512,0.00015482811,0.0000556826,0.0009949674,0.0018748484,0.000040725674,0.0036203293],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997321,0.000083741375,0.000011725802,0.00003792709,0.000049545564,0.000084934625],"domain_scores_gemma":[0.9997781,0.000030701474,0.000039456754,0.000027879038,0.0000383077,0.000085603664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009125111,0.0006761157,0.00052160025,0.0003553798,0.00034392357,0.0006390205,0.0005289425,0.0006452334,0.0025009152],"category_scores_gemma":[0.00041269505,0.00023843505,0.0004250438,0.00026202737,0.0004854699,0.00049217837,0.00022590927,0.0017472925,0.0005571046],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02125175,0.024747584,0.0013778493,0.0005620006,0.00022206164,0.00025667055,0.00028017518,0.0035278727,0.89356416,0.0009765436,0.003446005,0.04978729],"study_design_scores_gemma":[0.00630726,0.46170172,0.005421308,0.000074090596,0.0003350254,0.00060095196,0.00015370459,0.003694339,0.5004709,0.00068606593,0.020524753,0.000029817033],"about_ca_topic_score_codex":0.0012049065,"about_ca_topic_score_gemma":0.001800164,"teacher_disagreement_score":0.0025009152,"about_ca_system_score_codex":0.0005073647,"about_ca_system_score_gemma":0.00090770837,"threshold_uncertainty_score":0.008366406},"labels":[],"label_agreement":null},{"id":"W2894424410","doi":"10.1080/2162402x.2018.1502905","title":"Adoptive cell therapy with tumor-infiltrating lymphocytes in patients with metastatic ovarian cancer: a pilot study","year":2018,"lang":"en","type":"article","venue":"OncoImmunology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Anticancer Fund; Kræftens Bekæmpelse","keywords":"Medicine; Tumor-infiltrating lymphocytes; Tolerability; Ovarian cancer; Melanoma; Oncology; Immunotherapy; Internal medicine; Cancer; Immune system; Aldesleukin; Progressive disease; T cell; Chemotherapy; Immunology; Cancer research; Adverse effect","score_opus":0.03149604510729136,"score_gpt":0.3048349407159007,"score_spread":0.27333889560860936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2894424410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99854857,0.00041394657,0.0002423213,0.00004394143,0.000013575057,0.00023893059,0.000040807652,0.0000119654915,0.00044588288],"genre_scores_gemma":[0.9983552,0.00041959586,0.00035819307,0.00007442559,0.0000611016,0.00027824726,0.0001540451,0.0000035117334,0.00029575315],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997875,0.00009005361,0.000012668513,0.000032432934,0.000028222572,0.00004914243],"domain_scores_gemma":[0.9997156,0.00007617876,0.000038404247,0.000046642832,0.00002246666,0.00010062148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006861198,0.00051482016,0.00063331675,0.00018141256,0.00029295165,0.00032349137,0.0002522868,0.0003800622,0.0012209358],"category_scores_gemma":[0.0006406371,0.00013246066,0.0005329052,0.000183834,0.00039019022,0.00022309324,0.00029867433,0.0007520399,0.00027529223],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13217308,0.120951936,0.08260926,0.001204304,0.00079386786,0.005520438,0.0019975528,0.0042371354,0.37366036,0.0005270098,0.0019168992,0.2744082],"study_design_scores_gemma":[0.022871053,0.8890985,0.058995694,0.000039956918,0.00030623545,0.0025452625,0.00016402065,0.001539748,0.019164301,0.00009349109,0.005165738,0.00001607144],"about_ca_topic_score_codex":0.00048264008,"about_ca_topic_score_gemma":0.0004138742,"teacher_disagreement_score":0.0012209358,"about_ca_system_score_codex":0.00023434486,"about_ca_system_score_gemma":0.00045835483,"threshold_uncertainty_score":0.004084468},"labels":[],"label_agreement":null},{"id":"W2897635618","doi":"10.1080/2162402x.2018.1527497","title":"IL-33 increases ST2<sup>+</sup>Tregs and promotes metastatic tumour growth in the lungs in an amphiregulin-dependent manner","year":2018,"lang":"en","type":"article","venue":"OncoImmunology","topic":"IL-33, ST2, and ILC Pathways","field":"Immunology and Microbiology","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; University of British Columbia","funders":"BC Cancer Agency; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Amphiregulin; Cancer research; Epidermal growth factor receptor; Medicine; Epidermal growth factor; Immunology; Immunotherapy; In vivo; Receptor; Biology; Internal medicine; Immune system","score_opus":0.01616851224553476,"score_gpt":0.24731054568069682,"score_spread":0.23114203343516207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897635618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99549246,0.0009412704,0.0014364326,0.00014972397,0.000035773217,0.000037257054,0.00024141937,0.00010484214,0.0015607206],"genre_scores_gemma":[0.9955889,0.00046144717,0.001166364,0.000095346906,0.000021286745,0.00004805316,0.0002899093,0.000022521031,0.0023062986],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999801,0.00004554821,0.000015715481,0.000027426748,0.00005467954,0.000055644956],"domain_scores_gemma":[0.9998838,0.000016606533,0.000030801915,0.000009417096,0.000011399307,0.000048029367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016493014,0.0003761549,0.00025850232,0.00022536844,0.00008728965,0.000226896,0.000084649044,0.0002257721,0.0014776391],"category_scores_gemma":[0.000093334515,0.00014369411,0.00021930045,0.0000958012,0.0001943925,0.00016955749,0.00015084863,0.000987582,0.00043299497],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021490213,0.000051345607,0.00017455597,0.000026329242,0.0000031328486,0.000048234546,0.000008179188,0.00006633933,0.9983563,0.000034176257,0.00006375753,0.0009527507],"study_design_scores_gemma":[0.000085503016,0.0015376795,0.013227251,0.000010987103,0.000028271668,0.000539024,0.00007222378,0.00301084,0.9783796,0.000082694874,0.003018322,0.000007686001],"about_ca_topic_score_codex":0.0003385604,"about_ca_topic_score_gemma":0.000697315,"teacher_disagreement_score":0.0014776391,"about_ca_system_score_codex":0.00017905801,"about_ca_system_score_gemma":0.00015854443,"threshold_uncertainty_score":0.0049431324},"labels":[],"label_agreement":null},{"id":"W2901910720","doi":"10.1080/2162402x.2018.1539613","title":"Blockade of TGF-β signaling with novel synthetic antibodies limits immune exclusion and improves chemotherapy response in metastatic ovarian cancer models","year":2018,"lang":"en","type":"article","venue":"OncoImmunology","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Queen's University","funders":"Canadian Cancer Society","keywords":"Cancer research; Ovarian cancer; Antibody; Medicine; Immune system; Immune checkpoint; Tumor microenvironment; Metastasis; Cancer; Chemotherapy; Immunotherapy; Transforming growth factor; Blockade; Immunology; Receptor; Internal medicine","score_opus":0.015940038833988014,"score_gpt":0.2739481539280792,"score_spread":0.25800811509409116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901910720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917482,0.0016606705,0.0046774787,0.000104501916,0.00003703058,0.0000605617,0.00031328085,0.000114965376,0.0012833457],"genre_scores_gemma":[0.9922351,0.0017481365,0.0033178702,0.000079844736,0.000010671539,0.00007512775,0.00069590495,0.00001684837,0.0018205267],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992204,0.000009591695,0.0000055500504,0.000011566107,0.000027233793,0.000023960345],"domain_scores_gemma":[0.9999567,0.000006811061,0.000011819511,0.0000036233107,0.0000070496867,0.000014047038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012559605,0.00034590848,0.00027122468,0.00018979865,0.000080473845,0.00016424918,0.0001952291,0.00017664219,0.00063082157],"category_scores_gemma":[0.00007901392,0.00008679777,0.00017459311,0.00010997615,0.00010907057,0.00011934522,0.000103772254,0.0005772455,0.00010763904],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012993414,0.00010976951,0.000102237624,0.00003967502,0.0000052018136,0.000020053449,0.000008883317,0.00023118818,0.9974976,0.00007689927,0.00007159451,0.0017067628],"study_design_scores_gemma":[0.000055722223,0.0015417073,0.0012167799,0.00000604737,0.000023102924,0.00013251639,0.00001062043,0.0014422402,0.99304456,0.00003996726,0.002483197,0.000003473156],"about_ca_topic_score_codex":0.00042294833,"about_ca_topic_score_gemma":0.0008176908,"teacher_disagreement_score":0.00063082157,"about_ca_system_score_codex":0.0001979572,"about_ca_system_score_gemma":0.00017701786,"threshold_uncertainty_score":0.0021103024},"labels":[],"label_agreement":null},{"id":"W2905858794","doi":"10.1080/2162402x.2018.1556080","title":"Neoantigen characteristics in the context of the complete predicted MHC class I self-immunopeptidome","year":2018,"lang":"en","type":"article","venue":"OncoImmunology","topic":"vaccines and immunoinformatics approaches","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Canada's Michael Smith Genome Sciences Centre; Genome British Columbia; University of British Columbia","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Major histocompatibility complex; Human leukocyte antigen; MHC class I; Biology; Context (archaeology); Population; Immunogenicity; Immune system; Computational biology; Immunology; Genetics; Molecular biology; Medicine; Antigen","score_opus":0.012336727366703533,"score_gpt":0.2237010912901301,"score_spread":0.21136436392342658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905858794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99865746,0.00014892443,0.0006055271,0.0000084827025,0.000002296965,0.000002854348,0.00029176485,0.00000897054,0.00027364737],"genre_scores_gemma":[0.9982917,0.00007788431,0.0008387238,0.000009088268,0.0000026980279,0.00000429195,0.00046493785,0.000004910179,0.00030577564],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99996114,0.000005601219,0.0000029536118,0.000013085011,0.000010277126,0.000006889361],"domain_scores_gemma":[0.99979335,0.000068434216,0.00006357321,0.000015334635,0.00002637325,0.000033086722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009892135,0.00018799343,0.00014536161,0.00029774065,0.00006513162,0.00019670805,0.00007585179,0.00017486919,0.0015142427],"category_scores_gemma":[0.00032332024,0.00007911088,0.00013303192,0.00022270283,0.0000802233,0.00012483964,0.000106543506,0.00019054629,0.0003478674],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009837532,0.000046539088,0.12370215,0.00011783089,0.00006382303,0.0011398098,0.00012611605,0.0024129322,0.8605391,0.0003073036,0.0001861274,0.0103745395],"study_design_scores_gemma":[0.000021095557,0.00070050225,0.82885283,0.000023315672,0.00010040563,0.007407558,0.00017188006,0.014056739,0.14394626,0.0009581171,0.0037366445,0.000024601328],"about_ca_topic_score_codex":0.00021919509,"about_ca_topic_score_gemma":0.00020861957,"teacher_disagreement_score":0.0015142427,"about_ca_system_score_codex":0.00006903844,"about_ca_system_score_gemma":0.00004207806,"threshold_uncertainty_score":0.0050656796},"labels":[],"label_agreement":null},{"id":"W2918152867","doi":"10.1080/2162402x.2019.1568812","title":"Antibiotics are associated with decreased progression-free survival of advanced melanoma patients treated with immune checkpoint inhibitors","year":2019,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":207,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Centre Hospitalier de l’Université de Montréal; Jewish General Hospital","funders":"","keywords":"Medicine; Melanoma; Immune checkpoint; Antibiotics; Immune system; Oncology; Immunotherapy; Cancer research; Immunology; Internal medicine; Biology; Microbiology","score_opus":0.007036063694775429,"score_gpt":0.23986660714244068,"score_spread":0.23283054344766524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2918152867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980938,0.001110277,0.000087015345,0.000078528414,0.000010027547,0.000006723745,0.000114163406,0.0000046471177,0.0004948679],"genre_scores_gemma":[0.9995228,0.00014579546,0.000051467356,0.000030990588,0.000012055055,0.0000051555603,0.00009500582,0.0000016316064,0.00013511034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99963593,0.00010601411,0.00003860693,0.000067795416,0.00007933149,0.00007221079],"domain_scores_gemma":[0.9977939,0.00039452067,0.0013557039,0.00006175274,0.000120813784,0.0002732267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043226522,0.00020657585,0.0004403785,0.00029724458,0.00032351268,0.0004870967,0.00017727984,0.00039297048,0.0019090825],"category_scores_gemma":[0.0017328267,0.00014544245,0.0004809691,0.00044836407,0.00019060024,0.00029201357,0.0002859789,0.00088537246,0.00016262317],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021139074,0.00014896647,0.98820007,0.00003805877,0.00017384549,0.00021049292,0.000048207567,0.00013404024,0.0018841249,0.00001823045,0.00015115933,0.00687891],"study_design_scores_gemma":[0.000031576525,0.00061520084,0.9978515,0.00000854129,0.00013397318,0.00048737458,0.000048543072,0.0002476066,0.00016130734,0.00002643173,0.0003844967,0.0000034621687],"about_ca_topic_score_codex":0.00058719056,"about_ca_topic_score_gemma":0.0010145912,"teacher_disagreement_score":0.0019090825,"about_ca_system_score_codex":0.00027116886,"about_ca_system_score_gemma":0.00027744207,"threshold_uncertainty_score":0.0063865185},"labels":[],"label_agreement":null},{"id":"W2923466071","doi":"10.1080/2162402x.2019.1581545","title":"WISP1 is associated to advanced disease, EMT and an inflamed tumor microenvironment in multiple solid tumors","year":2019,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Connective Tissue Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute; Fonds de Recherche du Québec - Santé; National Institute of Dental and Craniofacial Research; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Cancer research; Tumor microenvironment; Prostate cancer; Immunotherapy; Medicine; Immune checkpoint; Immune system; Cancer; Oncology; Internal medicine; Immunology","score_opus":0.009426189915984528,"score_gpt":0.2801354855204264,"score_spread":0.27070929560444185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2923466071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99259126,0.0016632216,0.001188474,0.00007578505,0.000009330432,0.0000137883535,0.003925897,0.00008514779,0.00044703332],"genre_scores_gemma":[0.9915587,0.00066483807,0.0012671491,0.00005206731,0.0000110613755,0.000028544522,0.005947944,0.000025618543,0.00044406625],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999754,0.000022751643,0.000027452437,0.00008638388,0.00007732014,0.000032059543],"domain_scores_gemma":[0.99931717,0.00008568047,0.00039147458,0.0000526484,0.000066351335,0.0000867399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030394233,0.00026335908,0.0003169629,0.00066086964,0.00026823158,0.00045196677,0.00014703727,0.0002224853,0.0017305837],"category_scores_gemma":[0.00039286484,0.00013993851,0.00035901304,0.00091432093,0.00021878166,0.00018600057,0.00035889927,0.0004929667,0.00030262582],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022669828,0.00009507243,0.45418024,0.00077931216,0.00048547226,0.00091468426,0.00016696923,0.0017919453,0.5161522,0.0002705687,0.0015417812,0.021354813],"study_design_scores_gemma":[0.00003024099,0.0002460045,0.91005534,0.000054099157,0.00032875928,0.0032682861,0.00017052049,0.003997087,0.07588777,0.000428931,0.0055122254,0.000020690075],"about_ca_topic_score_codex":0.00046274182,"about_ca_topic_score_gemma":0.00091794296,"teacher_disagreement_score":0.0017305837,"about_ca_system_score_codex":0.00023322411,"about_ca_system_score_gemma":0.00023910849,"threshold_uncertainty_score":0.005789399},"labels":[],"label_agreement":null},{"id":"W2927753063","doi":"10.1080/2162402x.2019.1596006","title":"Oncolytic viruses: how “lytic” must they be for therapeutic efficacy?","year":2019,"lang":"en","type":"review","venue":"OncoImmunology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":144,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Oncolytic virus; Lytic cycle; Virotherapy; Immune system; Virus; Mode of action; Viral replication; Virology; Biology; Cancer research; Immunology","score_opus":0.13032094193272278,"score_gpt":0.4091072281490994,"score_spread":0.2787862862163766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2927753063","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013889364,0.9952094,0.00030704692,0.0024802538,0.0005337943,0.0000033497845,0.000010683977,0.0000069626267,0.0013095683],"genre_scores_gemma":[0.002366242,0.9938643,0.0003687659,0.0016300816,0.00069400965,0.00001175058,0.000019821135,0.000004228688,0.0010408675],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99961686,0.00010046801,0.000052248524,0.0000684162,0.00012394742,0.00003806541],"domain_scores_gemma":[0.99948174,0.00032437727,0.000037342765,0.000020393805,0.00010181784,0.000034355704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013406945,0.0005870767,0.0013267777,0.0010743436,0.00038530066,0.002442096,0.000951352,0.0025352754,0.0021237766],"category_scores_gemma":[0.0015510692,0.0002517692,0.0003352568,0.00087095355,0.002108352,0.00465382,0.0007876089,0.0038271311,0.0018636715],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012603571,0.00007143239,0.00025456803,0.012304314,0.000058872036,0.00026578346,0.00021646384,0.0004568966,0.007259768,0.09208856,0.04537846,0.8415189],"study_design_scores_gemma":[0.000014080551,0.00007092517,0.00023627479,0.0019785652,0.000028649803,0.0009841038,0.00011124987,0.00009106929,0.0010882725,0.014355468,0.9810244,0.000017081462],"about_ca_topic_score_codex":0.0007000126,"about_ca_topic_score_gemma":0.00072765327,"teacher_disagreement_score":0.0025352754,"about_ca_system_score_codex":0.0012071772,"about_ca_system_score_gemma":0.0013555604,"threshold_uncertainty_score":0.008758664},"labels":[],"label_agreement":null},{"id":"W2939235761","doi":"10.1080/2162402x.2019.1599636","title":"Daratumumab in combination with urelumab to potentiate anti-myeloma activity in lymphocyte-deficient mice reconstituted with human NK cells","year":2019,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"H2020 European Institute of Innovation and Technology; Instituto de Salud Carlos III; Worldwide Cancer Research","keywords":"Daratumumab; Antibody-dependent cell-mediated cytotoxicity; CD137; Cancer research; CD38; Medicine; Monoclonal antibody; Immunology; CD8; Multiple myeloma; Immunotherapy; Antibody; Immune system; Biology; Cell biology; CD34","score_opus":0.013188750396068554,"score_gpt":0.27480009527139615,"score_spread":0.2616113448753276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2939235761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991955,0.0029198246,0.0019173849,0.000285691,0.00025014818,0.00016833056,0.00083635986,0.00025960317,0.0014077125],"genre_scores_gemma":[0.99133,0.0018070538,0.0022098327,0.00013006736,0.000059433827,0.00016202264,0.0009406108,0.000034057695,0.0033268754],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996617,0.0000731209,0.00002912884,0.000057784724,0.000067772395,0.00011057036],"domain_scores_gemma":[0.999861,0.00001740848,0.000037286893,0.000020206866,0.000012296345,0.000051762243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003020139,0.0006480187,0.00091831037,0.0004373638,0.00017829103,0.00049165834,0.00048273077,0.000533977,0.0014123505],"category_scores_gemma":[0.00012537708,0.000240472,0.000580306,0.00025210282,0.00032632344,0.0005074225,0.00022516889,0.0018824491,0.00043558862],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029137451,0.0013586425,0.00020001475,0.00010613215,0.000035803256,0.00010270683,0.000036101897,0.00046665446,0.9886325,0.0002206283,0.00027329443,0.0056538694],"study_design_scores_gemma":[0.0005074914,0.008216133,0.0013211973,0.000012585208,0.00007557055,0.00019091844,0.00001853125,0.0014241475,0.9850461,0.000060879953,0.0031148857,0.000011523972],"about_ca_topic_score_codex":0.00071665813,"about_ca_topic_score_gemma":0.0013936044,"teacher_disagreement_score":0.0014123505,"about_ca_system_score_codex":0.00042285118,"about_ca_system_score_gemma":0.00039317115,"threshold_uncertainty_score":0.0047248006},"labels":[],"label_agreement":null},{"id":"W2941829696","doi":"10.1080/2162402x.2019.1601481","title":"Adenosine A2a receptor promotes lymphangiogenesis and lymph node metastasis","year":2019,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Institute of Cancer Research; Canadian Institutes of Health Research","keywords":"Lymphangiogenesis; Medicine; Cancer research; Adenosine; Adenosine receptor; Receptor; Lymph node metastasis; Metastasis; Lymph node; Internal medicine; Oncology; Cancer; Agonist","score_opus":0.007330780881216674,"score_gpt":0.225946369172674,"score_spread":0.21861558829145733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941829696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99246335,0.0030165785,0.0016852085,0.00014139281,0.000045811248,0.000027679209,0.00028501998,0.0001063348,0.002228597],"genre_scores_gemma":[0.996327,0.0007311004,0.0005659973,0.000032876185,0.0000107687165,0.000030815056,0.00017216198,0.000006662216,0.0021225852],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999064,0.000018820354,0.0000070961028,0.000018052418,0.00001684986,0.00003277364],"domain_scores_gemma":[0.9999553,0.0000052080895,0.000009155679,0.000004527167,0.000004123287,0.00002155932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000115458766,0.00022746068,0.00019673938,0.0001897469,0.00010172825,0.00023196603,0.00007268855,0.00019971104,0.0012987598],"category_scores_gemma":[0.00006625926,0.00010157258,0.0002512675,0.0000982475,0.00010847178,0.00013926828,0.000121684294,0.00047072722,0.00029657286],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000240108,0.000049676455,0.00021813806,0.00003626807,0.000005220871,0.000067847424,0.000009304929,0.000040606465,0.99821484,0.000111546164,0.00008828506,0.0009181376],"study_design_scores_gemma":[0.00013151146,0.0015344005,0.024755457,0.000011763473,0.000056291377,0.00065873866,0.00008037204,0.0026608962,0.96383935,0.0001839285,0.006077177,0.000010094683],"about_ca_topic_score_codex":0.0007747071,"about_ca_topic_score_gemma":0.0010717226,"teacher_disagreement_score":0.0012987598,"about_ca_system_score_codex":0.0002017255,"about_ca_system_score_gemma":0.00017386513,"threshold_uncertainty_score":0.0043447614},"labels":[],"label_agreement":null},{"id":"W2942706196","doi":"10.1080/2162402x.2019.1608106","title":"Exposure to the antimicrobial peptide LL-37 produces dendritic cells optimized for immunotherapy","year":2019,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"McMaster University; University of Edinburgh; Manchester Collaborative Centre for Inflammation Research; University of Glasgow; Medical Research Council; Royal Society","keywords":"Immunotherapy; Dendritic cell; Ex vivo; CD8; Cancer research; T cell; Immunology; Antigen presentation; Immune system; Cross-presentation; Cytotoxic T cell; Antigen-presenting cell; Medicine; Biology; In vivo; In vitro","score_opus":0.00952301899529523,"score_gpt":0.24144026733552867,"score_spread":0.23191724834023345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942706196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98370636,0.0012568033,0.010781919,0.00019239618,0.000099376244,0.00006633087,0.00048581228,0.00014327206,0.0032678132],"genre_scores_gemma":[0.9916004,0.00052773766,0.004820731,0.0000631103,0.000010786576,0.000022160308,0.00028326942,0.000041740182,0.0026301716],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998697,0.000014911934,0.00000856139,0.000021735961,0.000039524468,0.00004552611],"domain_scores_gemma":[0.99993813,0.000008304918,0.000013040374,0.0000093225935,0.000008125937,0.00002319339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000113615635,0.00023481007,0.00016096015,0.0001605625,0.0001145301,0.00035637763,0.000117333475,0.00023769896,0.0011139198],"category_scores_gemma":[0.00009087906,0.00010756475,0.00016756916,0.0001276777,0.00021567637,0.00014116737,0.00019220386,0.00055279024,0.0004908214],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027160917,0.0000088556635,0.00006595871,0.0000060782068,0.0000011210884,0.000011360069,0.000004762452,0.00008839231,0.99911875,0.000072444585,0.000026795653,0.0005683622],"study_design_scores_gemma":[0.0000057485245,0.000052554864,0.00031808642,0.0000013863247,0.00000440057,0.000045723158,0.000006141172,0.00026406706,0.9970186,0.0000444238,0.0022373253,0.0000016269754],"about_ca_topic_score_codex":0.00062257337,"about_ca_topic_score_gemma":0.0010699781,"teacher_disagreement_score":0.0011139198,"about_ca_system_score_codex":0.00043269026,"about_ca_system_score_gemma":0.00032073527,"threshold_uncertainty_score":0.0037264228},"labels":[],"label_agreement":null},{"id":"W2943603503","doi":"10.1080/2162402x.2019.1607673","title":"Daratumumab- <sup>225</sup> Actinium conjugate demonstrates greatly enhanced antitumor activity against experimental multiple myeloma tumors","year":2019,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"Actinium Pharmaceuticals","keywords":"Daratumumab; Antibody-dependent cell-mediated cytotoxicity; Medicine; Monoclonal antibody; Cancer research; Antibody; Multiple myeloma; Cytotoxicity; Radioimmunotherapy; CD38; Bortezomib; Immunology; Pharmacology; In vitro; Chemistry; Biology; Biochemistry","score_opus":0.0184873553415234,"score_gpt":0.3007236379285656,"score_spread":0.2822362825870422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943603503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933247,0.0014553554,0.0021409136,0.00006204043,0.000021053349,0.000039886832,0.00026701138,0.00011968841,0.0025693143],"genre_scores_gemma":[0.9937576,0.00061989244,0.0031844012,0.000026846385,0.000009438646,0.000026408501,0.00038915413,0.000021998147,0.0019642997],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998739,0.00002634511,0.00000872768,0.000021994661,0.000035433575,0.000033612396],"domain_scores_gemma":[0.999954,0.000009834333,0.000012824577,0.000007665342,0.000006416256,0.000009243312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012294592,0.00032420055,0.00027251084,0.00016605525,0.00009256198,0.00017203842,0.00016507348,0.00019850135,0.0007409994],"category_scores_gemma":[0.000051780782,0.00012302754,0.00020141434,0.00014571355,0.00013501119,0.000103230406,0.000083530285,0.00044300134,0.00025025214],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017691111,0.000054272637,0.000078275596,0.000021195418,0.00000571307,0.000020592459,0.000005618916,0.00015263437,0.99816966,0.00006092686,0.000034730445,0.0012193552],"study_design_scores_gemma":[0.000013851785,0.0006317161,0.00076491426,8.963993e-7,0.000009125537,0.0000914585,0.0000024985425,0.00042051414,0.9972698,0.000006955729,0.0007870348,0.0000011761334],"about_ca_topic_score_codex":0.00069232297,"about_ca_topic_score_gemma":0.0007432002,"teacher_disagreement_score":0.0007409994,"about_ca_system_score_codex":0.00026702724,"about_ca_system_score_gemma":0.0001329102,"threshold_uncertainty_score":0.0024788976},"labels":[],"label_agreement":null},{"id":"W2948320538","doi":"10.1080/2162402x.2019.1615817","title":"Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a randomized multicenter Phase IIb trial (TRAVERSE)","year":2019,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Hospital; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Sorafenib; Medicine; Oncolytic virus; Clinical endpoint; Hepatocellular carcinoma; Immunotherapy; Internal medicine; Randomized controlled trial; Oncology; Clinical trial; Gastroenterology; Surgery; Cancer","score_opus":0.005686685340311424,"score_gpt":0.2535832565696906,"score_spread":0.2478965712293792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2948320538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99354327,0.00310073,0.00035190283,0.0004454932,0.00017628036,0.0010852693,0.00038969776,0.000060400092,0.00084709196],"genre_scores_gemma":[0.9925114,0.0018848173,0.00082504714,0.00062787294,0.00022099346,0.0015030736,0.0010339728,0.00001628299,0.0013765639],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9997658,0.00013256771,0.000012886424,0.000029635485,0.000014802523,0.000044301923],"domain_scores_gemma":[0.99972993,0.000052797586,0.00006350149,0.000022413478,0.000019890562,0.00011141597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012891399,0.00093538803,0.001440316,0.00018153455,0.00020806988,0.00068378256,0.0003146614,0.0007097979,0.0019933386],"category_scores_gemma":[0.00072479673,0.00030065535,0.0011336419,0.0002137265,0.00040294073,0.00040273182,0.00020073737,0.0013961212,0.00031866904],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9236231,0.008159196,0.0026308408,0.00060107734,0.0012555539,0.000098939374,0.00011324281,0.000991071,0.0132774785,0.00020720623,0.0021541673,0.046888165],"study_design_scores_gemma":[0.8204141,0.1684804,0.005860093,0.000045028177,0.00060872966,0.0001088102,0.00003906024,0.0009992071,0.001433434,0.00016884899,0.0018247964,0.000017443266],"about_ca_topic_score_codex":0.00063496,"about_ca_topic_score_gemma":0.0011360693,"teacher_disagreement_score":0.0019933386,"about_ca_system_score_codex":0.0005418636,"about_ca_system_score_gemma":0.00069260277,"threshold_uncertainty_score":0.0068176985},"labels":[],"label_agreement":null},{"id":"W2954718550","doi":"10.1080/2162402x.2019.1629780","title":"Expression of MHC class I, HLA-A and HLA-B identifies immune-activated breast tumors with favorable outcome","year":2019,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Instituto de Salud Carlos III; Universidad de Castilla-La Mancha; Secretaría de Estado de Investigación, Desarrollo e Innovación; CRIS Cancer Foundation; Fundación Científica Asociación Española Contra el Cáncer","keywords":"Immune system; Major histocompatibility complex; Human leukocyte antigen; Breast cancer; MHC class I; Immunology; Medicine; CD8; Antigen; Proportional hazards model; Oncology; Biology; Cancer; Cancer research; Internal medicine","score_opus":0.008402083847731799,"score_gpt":0.23174046359173806,"score_spread":0.22333837974400625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954718550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99332047,0.00016760321,0.0010368606,0.000029106885,0.0000035541882,0.000025156973,0.004721195,0.00007897838,0.00061705837],"genre_scores_gemma":[0.9903869,0.00007636682,0.0012582478,0.000022492542,0.0000046317023,0.000064370746,0.007656872,0.000033432007,0.0004966401],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99980634,0.000037039463,0.0000188319,0.00007096411,0.000027554413,0.000039299015],"domain_scores_gemma":[0.9995016,0.000103702696,0.00016533631,0.0001232293,0.00004382359,0.000062214756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053307007,0.00022760581,0.00034281352,0.0008712482,0.00021275402,0.0005271271,0.00023601021,0.00022064422,0.003098119],"category_scores_gemma":[0.0010349577,0.0001244294,0.00035049405,0.00072883803,0.00019177789,0.00014238717,0.00043912846,0.00030117374,0.000569426],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010754456,0.000051959592,0.97163343,0.00008965474,0.0001539528,0.00023949097,0.00010574979,0.0007272184,0.012814843,0.0001232841,0.0016767684,0.011308299],"study_design_scores_gemma":[0.000029598625,0.000115128634,0.9928952,0.000014419248,0.00009927085,0.00069561583,0.00007041264,0.0013653133,0.0022312,0.0001810801,0.0022969702,0.0000058620285],"about_ca_topic_score_codex":0.0009722294,"about_ca_topic_score_gemma":0.0020814103,"teacher_disagreement_score":0.003098119,"about_ca_system_score_codex":0.00016934244,"about_ca_system_score_gemma":0.00019879948,"threshold_uncertainty_score":0.010364294},"labels":[],"label_agreement":null},{"id":"W2958209428","doi":"10.1080/2162402x.2019.1641387","title":"Staphylococcal alpha-toxin tilts the balance between malignant and non-malignant CD4 <sup>+</sup> T cells in cutaneous T-cell lymphoma","year":2019,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Bispebjerg Hospital; LEO Fondet; H. Lundbeck A/S; Lundbeckfonden; Kom op tegen Kanker; Novo Nordisk UK Research Foundation; Novo Nordisk; Gentofte Hospital; Novo Nordisk Fonden; Kræftens Bekæmpelse","keywords":"Medicine; Cutaneous T-cell lymphoma; Cancer research; Lymphoma; Staphylococcus aureus; Immunology; T cell; Mycosis fungoides; Biology; Immune system; Bacteria","score_opus":0.009747334211357015,"score_gpt":0.25661911363197265,"score_spread":0.24687177942061564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2958209428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998963,0.0003877489,0.000282528,0.000021666561,0.0000033231406,0.0000031301938,0.000018744,0.000010172264,0.0003096684],"genre_scores_gemma":[0.99949324,0.000095861324,0.00018536228,0.000013574934,0.0000030714202,0.0000021558228,0.00002778919,0.0000022730235,0.00017662023],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990344,0.00002921535,0.000010729467,0.000013945117,0.000020411637,0.000022333463],"domain_scores_gemma":[0.99991107,0.000024945783,0.000026460153,0.000009460355,0.000010489408,0.000017508451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000074938,0.0001439275,0.0001474831,0.00017173162,0.00008920852,0.00029640298,0.00006924244,0.00017696082,0.0011874241],"category_scores_gemma":[0.00019379029,0.000059765036,0.0000867152,0.00009269563,0.00013388161,0.00014754498,0.00015036897,0.00024190603,0.00021381395],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000227085,0.000019229392,0.008803463,0.000022039647,0.0000052026044,0.00046706438,0.00004470443,0.00005578443,0.98659444,0.00005946461,0.000040969215,0.003660474],"study_design_scores_gemma":[0.000054537657,0.0014284098,0.1488097,0.00001748631,0.00004881396,0.011376499,0.0003643195,0.0027030613,0.8309287,0.00037927684,0.0038805662,0.0000085451375],"about_ca_topic_score_codex":0.00016462691,"about_ca_topic_score_gemma":0.00021458758,"teacher_disagreement_score":0.0011874241,"about_ca_system_score_codex":0.00017037673,"about_ca_system_score_gemma":0.000044739616,"threshold_uncertainty_score":0.003972292},"labels":[],"label_agreement":null},{"id":"W2969967850","doi":"10.1080/2162402x.2019.1655363","title":"Pre-surgical oncolytic virotherapy improves breast cancer outcomes","year":2019,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Oncolytic virus; Medicine; Breast cancer; Virotherapy; Cancer; Immunotherapy; Oncology; Cancer research; Immune system; Internal medicine; Immunology","score_opus":0.008930607414630457,"score_gpt":0.3139806672860841,"score_spread":0.3050500598714536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969967850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828248,0.008513388,0.0015652896,0.00044504707,0.0002916963,0.00012849587,0.0006143796,0.0003648293,0.0052520167],"genre_scores_gemma":[0.99298215,0.0024711667,0.0006532472,0.00014724668,0.00005160437,0.00006952138,0.00082169205,0.000024643932,0.0027786298],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99989355,0.00001329812,0.0000063647794,0.000017070763,0.000034555687,0.00003522833],"domain_scores_gemma":[0.9998518,0.000030267991,0.000037453694,0.000024326953,0.0000132533805,0.00004294812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001661891,0.00023833413,0.00046468276,0.00019966307,0.00010186385,0.00032850125,0.00016635527,0.0002290081,0.0031980388],"category_scores_gemma":[0.0002794855,0.00007432928,0.00023947329,0.00010473346,0.00013686802,0.00020542681,0.0001720099,0.001028302,0.00071865],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010520919,0.007033089,0.0048906873,0.0006548318,0.00010957697,0.00013721832,0.00008977971,0.0010546843,0.70417315,0.00043764542,0.003256237,0.26764223],"study_design_scores_gemma":[0.0011921646,0.09184119,0.156464,0.00025485884,0.0005360302,0.0023399086,0.0003307243,0.0038897356,0.6905346,0.001226694,0.051334254,0.00005586527],"about_ca_topic_score_codex":0.00027251034,"about_ca_topic_score_gemma":0.00065588416,"teacher_disagreement_score":0.0031980388,"about_ca_system_score_codex":0.00020241506,"about_ca_system_score_gemma":0.00027350828,"threshold_uncertainty_score":0.010698497},"labels":[],"label_agreement":null},{"id":"W2971391427","doi":"10.1080/2162402x.2019.1659092","title":"Aberrant upregulation of PDK1 in ovarian cancer cells impairs CD8<sup>+</sup> T cell function and survival through elevation of PD-L1","year":2019,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Hong Kong; University of Ottawa","keywords":"Ovarian cancer; Cancer research; Downregulation and upregulation; CD8; Cancer cell; Gene knockdown; Cell growth; T cell; Cytotoxic T cell; Chemistry; Biology; Cancer; Apoptosis; Medicine; Internal medicine; Immune system; Immunology; In vitro; Biochemistry","score_opus":0.012666189428212179,"score_gpt":0.2560772161786536,"score_spread":0.2434110267504414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971391427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959681,0.000793654,0.0011766631,0.0001031982,0.000030352081,0.000022622145,0.0005910081,0.000089466004,0.0012248973],"genre_scores_gemma":[0.9970379,0.0003352427,0.0007150695,0.000044636574,0.0000041728426,0.00004163988,0.0005601639,0.000008697366,0.0012524781],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998754,0.000011167819,0.000017947097,0.00002522931,0.000031407188,0.000038826292],"domain_scores_gemma":[0.9999584,0.0000055024825,0.000012505899,0.000006284709,0.000004704566,0.000012598347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008393174,0.00018062153,0.00023988506,0.00012869296,0.00011580654,0.00032130082,0.0001050279,0.0001381405,0.0010011189],"category_scores_gemma":[0.00006227523,0.00009864629,0.00014904725,0.00016711664,0.00015479008,0.0001242423,0.00013093324,0.0004930292,0.00028048735],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034334682,0.000060058468,0.0007373196,0.00006714342,0.00000618552,0.000041070372,0.000019230216,0.0001827882,0.99556583,0.00012581852,0.00014981971,0.0027014164],"study_design_scores_gemma":[0.000028509774,0.0003420558,0.007583417,0.000003899904,0.000014565173,0.00019405679,0.000039283987,0.0020270697,0.98562926,0.00004943582,0.0040847897,0.000003687017],"about_ca_topic_score_codex":0.00057832676,"about_ca_topic_score_gemma":0.00068445434,"teacher_disagreement_score":0.0010011189,"about_ca_system_score_codex":0.0002836504,"about_ca_system_score_gemma":0.0002267001,"threshold_uncertainty_score":0.0033490658},"labels":[],"label_agreement":null},{"id":"W2988646927","doi":"10.1080/2162402x.2019.1684713","title":"Identification of a CD8+ T-cell response to a predicted neoantigen in malignant mesothelioma","year":2019,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Occupational and environmental lung diseases","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre","funders":"National Health and Medical Research Council","keywords":"Medicine; ELISPOT; Immunotherapy; CD8; Immune system; T cell; Immunology; Cancer research; Cancer; Cytotoxic T cell; Cancer immunotherapy; Biology; Internal medicine; Genetics","score_opus":0.00596238603849095,"score_gpt":0.24776008396352986,"score_spread":0.2417976979250389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988646927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992342,0.00024823006,0.0002598302,0.000017234559,0.000002182155,0.0000042229944,0.000061996114,0.000009478262,0.00016260643],"genre_scores_gemma":[0.9993487,0.000115364644,0.00026357718,0.000021520204,0.0000038124704,0.0000066697894,0.00011785606,0.0000023026666,0.000120216326],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999157,0.000017288372,0.000007473585,0.000022298858,0.000019582727,0.000017660468],"domain_scores_gemma":[0.9998741,0.00003098035,0.0000372978,0.000014993025,0.00001708463,0.000025559266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001345974,0.00016924317,0.0002005084,0.00030516906,0.00015168855,0.00026043114,0.00007975959,0.00023288857,0.0006955101],"category_scores_gemma":[0.00032830716,0.00013903553,0.00016752761,0.00015757323,0.00015629023,0.00012307611,0.00018991379,0.00027258674,0.00018881889],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006635327,0.000044057168,0.15496416,0.00010063899,0.000037385627,0.0009499302,0.00020326144,0.00048049117,0.83107084,0.000052332955,0.00013809241,0.011295239],"study_design_scores_gemma":[0.00002851266,0.000802551,0.8963293,0.000033090662,0.00008787645,0.0060069384,0.0005302065,0.003674637,0.089635715,0.00037593758,0.0024849167,0.000010281163],"about_ca_topic_score_codex":0.00023683433,"about_ca_topic_score_gemma":0.0003736533,"teacher_disagreement_score":0.0006955101,"about_ca_system_score_codex":0.00012665465,"about_ca_system_score_gemma":0.00006405389,"threshold_uncertainty_score":0.0023266673},"labels":[],"label_agreement":null},{"id":"W3010808413","doi":"10.1080/2162402x.2020.1736792","title":"LAG-3 and PD-1+LAG-3 inhibition promote anti-tumor immune responses in human autologous melanoma/T cell co-cultures","year":2020,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Université de Lausanne; Krebsliga Schweiz; Ludwig Institute for Cancer Research; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Cancer Research Institute","keywords":"Tumor microenvironment; Blockade; Melanoma; Cancer research; Cytotoxic T cell; Immunotherapy; Cancer immunotherapy; CD8; Immune checkpoint; T cell; Cytokine; Immunology; Antibody; Blocking antibody; Medicine; Immune system; Receptor; Biology; Internal medicine; In vitro","score_opus":0.016431249213954606,"score_gpt":0.293452555546814,"score_spread":0.2770213063328594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010808413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890661,0.0026902927,0.00436627,0.0000796526,0.00012308337,0.00014635663,0.0006674422,0.0000866421,0.0027740586],"genre_scores_gemma":[0.9888813,0.0012287813,0.004899705,0.000085244115,0.00007189153,0.00017591192,0.0011550352,0.000028326596,0.0034737946],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995592,0.00011008779,0.00006272619,0.00009690488,0.00009641053,0.00007474394],"domain_scores_gemma":[0.99967957,0.000113213704,0.000036602007,0.00006723933,0.000048041682,0.000055393808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003458671,0.0005121895,0.0006842134,0.0002830016,0.00016536714,0.00039070775,0.00032031047,0.0003256733,0.0026453766],"category_scores_gemma":[0.00020514769,0.00018765243,0.00050321326,0.00033499257,0.000104336636,0.00015394799,0.0003106499,0.0010864794,0.0013117859],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011431517,0.0005849024,0.00043004708,0.00010759186,0.000023536077,0.00020977137,0.00009804931,0.0007528324,0.99330926,0.00011998781,0.00021646243,0.0030043921],"study_design_scores_gemma":[0.00011141468,0.0029052133,0.0025809824,0.000021419768,0.0000534391,0.00037761885,0.000046199017,0.004092688,0.98691386,0.000047738366,0.0028416526,0.000007770646],"about_ca_topic_score_codex":0.00069132965,"about_ca_topic_score_gemma":0.00092156185,"teacher_disagreement_score":0.0026453766,"about_ca_system_score_codex":0.00013520248,"about_ca_system_score_gemma":0.00020078427,"threshold_uncertainty_score":0.00884968},"labels":[],"label_agreement":null},{"id":"W3010990547","doi":"10.1080/2162402x.2020.1737385","title":"Osteosarcoma and soft-tissue sarcomas with an immune infiltrate express PD-L1: relation to clinical outcome and Th1 pathway activation","year":2020,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Lunenfeld-Tanenbaum Research Institute; Public Health Ontario; University of Toronto","funders":"Memorial Sloan-Kettering Cancer Center","keywords":"Immunohistochemistry; Osteosarcoma; Sarcoma; Undifferentiated Pleomorphic Sarcoma; PD-L1; Medicine; Immune system; Soft tissue sarcoma; Leiomyosarcoma; Cancer research; Liposarcoma; Immune checkpoint; Pathology; Internal medicine; Oncology; Immunotherapy; Immunology","score_opus":0.050693231766555026,"score_gpt":0.33524057624296144,"score_spread":0.2845473444764064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010990547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992735,0.00025501766,0.00010556261,0.000008442564,0.0000018267835,0.0000057413076,0.000071145856,0.000002245487,0.00027659553],"genre_scores_gemma":[0.9994336,0.00008408563,0.00007167917,0.0000062934937,0.000004897583,0.000009368392,0.00016325769,0.0000010438919,0.00022573349],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998024,0.00003602485,0.00003079785,0.00005052685,0.000036527308,0.00004389133],"domain_scores_gemma":[0.9995553,0.000087459885,0.00018492318,0.00002887407,0.00004195067,0.00010152125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037221235,0.00017299893,0.00023250653,0.00054276484,0.00018208462,0.00031134134,0.00010293129,0.00021812286,0.0015382497],"category_scores_gemma":[0.0005173723,0.00011821079,0.00015626864,0.00033702783,0.00025208792,0.00023502173,0.00031471418,0.00023656263,0.00029185132],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019547308,0.0001378774,0.963051,0.000056265137,0.000049604063,0.0004443542,0.00014605495,0.00009635836,0.024669072,0.000047580543,0.00006670272,0.009280433],"study_design_scores_gemma":[0.000020316107,0.00072737335,0.99406946,0.0000075215935,0.000042374602,0.0017057483,0.00026468397,0.00023696653,0.0024530166,0.00008114038,0.00038743796,0.0000039891984],"about_ca_topic_score_codex":0.00015133602,"about_ca_topic_score_gemma":0.00035008747,"teacher_disagreement_score":0.0015382497,"about_ca_system_score_codex":0.00012441147,"about_ca_system_score_gemma":0.000111222624,"threshold_uncertainty_score":0.005145967},"labels":[],"label_agreement":null},{"id":"W3015467025","doi":"10.1080/2162402x.2020.1747340","title":"Tumor-associated macrophages and macrophage-related immune checkpoint expression in sarcomas","year":2020,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":178,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital; Vancouver Coastal Health Research Institute; University of British Columbia; Vancouver Coastal Health","funders":"Canadian Cancer Society Research Institute; Terry Fox Research Institute; Icahn School of Medicine at Mount Sinai","keywords":"CD163; CD68; Sarcoma; Cancer research; Macrophage; Immune system; Immune checkpoint; Undifferentiated Pleomorphic Sarcoma; Biology; Immunotherapy; Macrophage polarization; Medicine; Immunology; Soft tissue sarcoma; Pathology; Immunohistochemistry","score_opus":0.011362589904106692,"score_gpt":0.2255924015768833,"score_spread":0.2142298116727766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015467025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984493,0.00077944243,0.00043956088,0.000009591818,0.0000011890586,0.0000067685005,0.00005174558,0.0000042810707,0.00025800377],"genre_scores_gemma":[0.9989083,0.00036895735,0.00039143796,0.000010267804,0.0000022570994,0.000013076158,0.00007110283,0.0000014803012,0.00023317988],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999859,0.00004449898,0.000015513808,0.000024783882,0.000031489446,0.000024733705],"domain_scores_gemma":[0.99980396,0.000038936683,0.00007993679,0.000014893104,0.000034659883,0.00002752005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004094572,0.00011439826,0.00011145671,0.00079188833,0.00011548805,0.00020498832,0.00006234088,0.0001466413,0.0004790622],"category_scores_gemma":[0.0003129274,0.00012891329,0.00013120433,0.0003363284,0.0001981022,0.00020582325,0.00019784039,0.00016497842,0.00012594757],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086324883,0.00007984915,0.28986955,0.00015426948,0.000052396226,0.00022276456,0.0002890515,0.00048310816,0.6968169,0.00022883898,0.000054279015,0.010885733],"study_design_scores_gemma":[0.000029046045,0.0008140779,0.83199483,0.00003880668,0.00007457511,0.0017607667,0.00079247274,0.002208411,0.15957496,0.00047884244,0.002219248,0.000013973735],"about_ca_topic_score_codex":0.0003172752,"about_ca_topic_score_gemma":0.00069533754,"teacher_disagreement_score":0.00079188833,"about_ca_system_score_codex":0.00013732609,"about_ca_system_score_gemma":0.00013904547,"threshold_uncertainty_score":0.0021654367},"labels":[],"label_agreement":null},{"id":"W3015474692","doi":"10.1080/2162402x.2020.1738812","title":"An innovative plasmacytoid dendritic cell line-based cancer vaccine primes and expands antitumor T-cells in melanoma patients in a first-in-human trial","year":2020,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Purdue Pharma (Canada)","funders":"Ligue Contre le Cancer; Etablissement Français du Sang; Agence Nationale de la Recherche","keywords":"Medicine; Cancer vaccine; Melanoma; Antigen; Priming (agriculture); Tolerability; Clinical trial; Immune system; Immunology; Cancer; CD8; Cytotoxic T cell; Cancer research; Immunotherapy; Oncology; Internal medicine; In vitro; Adverse effect; Biology","score_opus":0.013018813956085427,"score_gpt":0.2663258182441964,"score_spread":0.2533070042881109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015474692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939074,0.0018827106,0.00081873225,0.00034693067,0.00018273431,0.001537405,0.00023105509,0.00007752111,0.0010156719],"genre_scores_gemma":[0.99433726,0.0013573393,0.0011674061,0.0004488957,0.00013326081,0.00089257053,0.00047563418,0.000013946481,0.0011737178],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9997446,0.000102209386,0.000015765076,0.000037623155,0.000031262727,0.000068647045],"domain_scores_gemma":[0.99978393,0.000032348522,0.000028879296,0.000023997965,0.00002089733,0.00011008535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008870596,0.00070935977,0.001102253,0.0002479862,0.00029073542,0.0007659646,0.00041183594,0.0009904423,0.0010567774],"category_scores_gemma":[0.0004165181,0.00023446667,0.0005436974,0.00019156403,0.0004421991,0.00037306602,0.00026161925,0.0018924943,0.0002732969],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3419708,0.115273535,0.008061217,0.001652157,0.00094138377,0.0009747183,0.00066576625,0.0044685905,0.2589736,0.0011738967,0.006264526,0.25957984],"study_design_scores_gemma":[0.15280622,0.79881495,0.006052626,0.00006644979,0.0003552047,0.0005523788,0.000058957834,0.0020508084,0.03255549,0.00024946575,0.0064136456,0.000023713093],"about_ca_topic_score_codex":0.00033811462,"about_ca_topic_score_gemma":0.00047404587,"teacher_disagreement_score":0.001102253,"about_ca_system_score_codex":0.0004269089,"about_ca_system_score_gemma":0.00077414216,"threshold_uncertainty_score":0.004691303},"labels":[],"label_agreement":null},{"id":"W3015879164","doi":"10.1080/2162402x.2020.1737368","title":"Overproduction of IL-2 by Cbl-b deficient CD4 <sup>+</sup> T cells provides resistance against regulatory T cells","year":2020,"lang":"en","type":"article","venue":"OncoImmunology","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Overproduction; Cancer research; Chemistry; Medicine; Biology; Immunology; Cell biology; Genetics; Gene","score_opus":0.008863508587524912,"score_gpt":0.19716984411687924,"score_spread":0.18830633552935433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015879164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890732,0.0015478457,0.0036764576,0.00023355708,0.00022842015,0.00005977085,0.00093224883,0.00046624205,0.003782178],"genre_scores_gemma":[0.9898912,0.00040417814,0.0034675614,0.00009970204,0.00006916816,0.00005698654,0.0011199142,0.00012339746,0.0047678133],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996978,0.000063149666,0.000028108305,0.00004385787,0.00007712109,0.00008997918],"domain_scores_gemma":[0.99963975,0.00005952396,0.00009602142,0.000068746296,0.000020807063,0.00011501546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022583497,0.0007874543,0.00034816636,0.00042675162,0.00017110593,0.00080088037,0.00040791905,0.00041851093,0.0026554314],"category_scores_gemma":[0.00016180032,0.00023597218,0.00029535728,0.00020251544,0.0003575851,0.00025198795,0.00021308535,0.0017180576,0.0011914417],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013377577,0.000022904154,0.00006567381,0.000012845432,0.0000021007004,0.000023138036,0.000003375236,0.000037913043,0.9992884,0.000043021497,0.000045324632,0.00032158205],"study_design_scores_gemma":[0.000045377234,0.00019217917,0.0010217554,0.0000053574304,0.000011535237,0.00018118796,0.000013038703,0.00060785335,0.9961753,0.00003335763,0.0017087725,0.000004361733],"about_ca_topic_score_codex":0.0007237897,"about_ca_topic_score_gemma":0.000917661,"teacher_disagreement_score":0.0026554314,"about_ca_system_score_codex":0.0003907223,"about_ca_system_score_gemma":0.00034398533,"threshold_uncertainty_score":0.008883238},"labels":[],"label_agreement":null},{"id":"W3016599419","doi":"10.1080/2162402x.2020.1751561","title":"<i>Staphylococcus aureus</i> alpha-toxin inhibits CD8 <sup>+</sup> T cell-mediated killing of cancer cells in cutaneous T-cell lymphoma","year":2020,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; LEO Fondet; Lundbeckfonden; Kræftens Bekæmpelse; Novo Nordisk Fonden; Novo Nordisk UK Research Foundation","keywords":"Cytotoxic T cell; CD8; Staphylococcus aureus; Cutaneous T-cell lymphoma; Immunology; Cancer research; T cell; Medicine; Cancer; Lymphoma; Immune system; Biology; Mycosis fungoides; In vitro; Internal medicine","score_opus":0.015721376673968824,"score_gpt":0.27203376169969995,"score_spread":0.2563123850257311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016599419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981092,0.00040633447,0.00030327786,0.000036405334,0.000011706634,0.0000098827495,0.000041296815,0.000017811679,0.0010641075],"genre_scores_gemma":[0.9985745,0.00016476649,0.00036618894,0.000024140161,0.000007291536,0.000008465593,0.00011448743,0.000003945696,0.00073625374],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993455,0.000017745653,0.0000062292747,0.000004995615,0.000010543573,0.0000259888],"domain_scores_gemma":[0.9999355,0.000020242549,0.000010353605,0.0000073282486,0.000007290995,0.000019262285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000066667555,0.00014606396,0.00011513938,0.00009294896,0.00006724501,0.00011305205,0.00006043859,0.00012768428,0.0010939561],"category_scores_gemma":[0.000116871306,0.000040338145,0.00010969419,0.00005122056,0.00009912853,0.000059139365,0.000069972186,0.00023413515,0.00023629212],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003715275,0.00017862393,0.0009179465,0.000029180528,0.00000556626,0.00011255575,0.000013370857,0.00009832963,0.99424136,0.000044583852,0.00009770278,0.0038892685],"study_design_scores_gemma":[0.000059540173,0.0032721825,0.01534208,0.000008963326,0.000012475311,0.0006307808,0.000027840102,0.0018150572,0.9776363,0.000044279426,0.001148303,0.000002182765],"about_ca_topic_score_codex":0.00033028336,"about_ca_topic_score_gemma":0.00044423598,"teacher_disagreement_score":0.0010939561,"about_ca_system_score_codex":0.00009508366,"about_ca_system_score_gemma":0.000080210906,"threshold_uncertainty_score":0.0036596656},"labels":[],"label_agreement":null},{"id":"W3018073147","doi":"10.1080/2162402x.2020.1746138","title":"Prognostic value of CD73 expression in resected colorectal cancer liver metastasis","year":2020,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Colorectal cancer; Metastasis; Pathological; Internal medicine; Tissue microarray; Immune system; Cancer; Chemotherapy; Oncology; Blockade; Gastroenterology; Pathology; Immunology; Receptor","score_opus":0.017236692149681442,"score_gpt":0.264417599551246,"score_spread":0.24718090740156456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3018073147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991198,0.00048756305,0.00006695386,0.000027404558,0.000003505947,0.000001933048,0.00005704491,0.0000029921337,0.00023280081],"genre_scores_gemma":[0.99976534,0.00007135616,0.000038287995,0.000004922156,0.000006155895,0.0000014140597,0.0000644466,4.6161813e-7,0.000047593774],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99991655,0.000023220067,0.000010790264,0.000015590225,0.000013778547,0.000020001567],"domain_scores_gemma":[0.99953544,0.00014265481,0.00015390161,0.000016773558,0.000036576526,0.000114645045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001717796,0.00013125325,0.0001502152,0.00047840353,0.00017718942,0.00024767785,0.000100122896,0.00022833876,0.0009088542],"category_scores_gemma":[0.0010502267,0.000078561476,0.000093454386,0.0003611565,0.00021509847,0.00015729222,0.00015288229,0.00017643599,0.00013332258],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044369305,0.000014214495,0.99274135,0.000012457648,0.000016828808,0.000255251,0.000016175434,0.000112156704,0.0028086265,0.000019797626,0.00008562127,0.003473843],"study_design_scores_gemma":[0.000011110883,0.000115766474,0.9969441,0.0000045328425,0.00003047515,0.001135692,0.00005827936,0.00055605656,0.00084530213,0.000029376895,0.000265799,0.0000034169286],"about_ca_topic_score_codex":0.0012556764,"about_ca_topic_score_gemma":0.002518005,"teacher_disagreement_score":0.0012556764,"about_ca_system_score_codex":0.00022698016,"about_ca_system_score_gemma":0.0001339544,"threshold_uncertainty_score":0.003040433},"labels":[],"label_agreement":null},{"id":"W3033817849","doi":"10.1080/2162402x.2020.1774298","title":"Trial watch : the gut microbiota as a tool to boost the clinical efficacy of anticancer immunotherapy","year":2020,"lang":"en","type":"review","venue":"OncoImmunology","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Labex Immuno-Oncology; High-end Foreign Experts Recruitment Plan of China; European Research Area Network on Cardiovascular Diseases; Institut Universitaire de France; Centre National de la Recherche Scientifique; Ligue Contre le Cancer; Fondation pour la Recherche Médicale; Institut National Du Cancer; Institut National de la Santé et de la Recherche Médicale; Agence Nationale de la Recherche; E-Rare; Cancer Research UK; Association pour la Recherche sur le Cancer; Seerave Foundation; Institut Gustave-Roussy; Fondation Leducq; European Commission","keywords":"Gut flora; Clinical trial; Medicine; Immunotherapy; Cancer; Immune checkpoint; Cancer immunotherapy; Immune system; Microbiome; Blockade; Immunology; Bioinformatics; Internal medicine; Biology; Receptor","score_opus":0.05187093223350447,"score_gpt":0.419610271864628,"score_spread":0.36773933963112354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033817849","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024852168,0.99512696,0.0003163906,0.0014418318,0.0008620046,0.0000371945,0.00006370093,0.000020745038,0.0018826053],"genre_scores_gemma":[0.0024122894,0.9918544,0.00056266075,0.0023732907,0.00081105443,0.0000849265,0.00015403125,0.000009626275,0.0017376709],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996629,0.00012745388,0.000037151593,0.000041931664,0.00009838678,0.000032179814],"domain_scores_gemma":[0.99916065,0.0005031656,0.00010199764,0.000021933243,0.00012634945,0.00008597233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015837414,0.0006072992,0.0012245598,0.0009780248,0.00019490212,0.0011937546,0.0009160204,0.0016676307,0.0050382307],"category_scores_gemma":[0.0017779176,0.00013944447,0.00062403263,0.0007795046,0.00040786673,0.0012429329,0.00068591355,0.0030312312,0.0018939711],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047974367,0.00013165527,0.00013680245,0.016406935,0.00018800833,0.00015868332,0.00004284366,0.00023784484,0.0023291365,0.008360509,0.04813118,0.9233965],"study_design_scores_gemma":[0.0003107039,0.000494151,0.0005828914,0.006034517,0.00022525946,0.00060380204,0.00003659659,0.00012808021,0.00064362906,0.00414061,0.9867822,0.000017512808],"about_ca_topic_score_codex":0.00026306344,"about_ca_topic_score_gemma":0.00072709774,"teacher_disagreement_score":0.0050382307,"about_ca_system_score_codex":0.0005310633,"about_ca_system_score_gemma":0.0010215222,"threshold_uncertainty_score":0.016854584},"labels":[],"label_agreement":null},{"id":"W3036744650","doi":"10.1080/2162402x.2020.1779991","title":"Tumor-derived exosomes: the next generation of promising cell-free vaccines in cancer immunotherapy","year":2020,"lang":"en","type":"review","venue":"OncoImmunology","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":145,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital","funders":"","keywords":"Immune system; Microvesicles; Tumor microenvironment; Immunogenicity; Immunotherapy; Cancer immunotherapy; Cancer research; Antigen; Cancer; Cancer vaccine; Medicine; Vaccination; Immunology; Biology; microRNA","score_opus":0.0745422422957121,"score_gpt":0.32984493531963005,"score_spread":0.25530269302391795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036744650","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024889567,0.9972691,0.00054518686,0.0003895474,0.0004313429,0.0000088509605,0.000026629377,0.000013302157,0.0010670922],"genre_scores_gemma":[0.001501353,0.9964611,0.00046837956,0.00028393083,0.00022336241,0.000014967346,0.000060445152,0.0000028944166,0.0009834894],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998307,0.00003131696,0.000016181059,0.000027593664,0.00006937423,0.00002474268],"domain_scores_gemma":[0.9997832,0.000102722166,0.000026299771,0.000009658081,0.000048522426,0.000029508748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007342985,0.0008765474,0.0010295514,0.0014616346,0.00019760887,0.0010641371,0.00063736737,0.0012149527,0.0030079458],"category_scores_gemma":[0.00059448474,0.0002257495,0.00039964396,0.0012534914,0.0005036583,0.0017687761,0.0008459218,0.0022016533,0.0016913805],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000115350485,0.00009554678,0.00013201422,0.009592385,0.00005977534,0.00023194817,0.00004728691,0.0006787967,0.010159313,0.015845535,0.027131518,0.9359105],"study_design_scores_gemma":[0.000020662457,0.00014808954,0.0003522173,0.001349105,0.000050891267,0.0010236984,0.000036476707,0.00019635427,0.002300766,0.0035852713,0.990918,0.000018401422],"about_ca_topic_score_codex":0.00027756667,"about_ca_topic_score_gemma":0.00056852656,"teacher_disagreement_score":0.0030079458,"about_ca_system_score_codex":0.0006397189,"about_ca_system_score_gemma":0.0006996089,"threshold_uncertainty_score":0.010062575},"labels":[],"label_agreement":null},{"id":"W3037613484","doi":"10.1080/2162402x.2020.1782574","title":"Generation of highly activated, antigen-specific tumor-infiltrating CD8 <sup>+</sup> T cells induced by a novel T cell-targeted immunotherapy","year":2020,"lang":"en","type":"article","venue":"OncoImmunology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"National Cancer Institute","keywords":"Cytotoxic T cell; CD8; Cancer research; Immunotherapy; Tumor antigen; Antigen; T cell; Immunology; Medicine; Population; Biology; Immune system; In vitro","score_opus":0.05836458485133783,"score_gpt":0.29136447492183964,"score_spread":0.23299989007050181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037613484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99181753,0.0005445411,0.006009381,0.00006441193,0.000034279983,0.00014146746,0.00016751233,0.00013562082,0.0010853242],"genre_scores_gemma":[0.991234,0.00035627105,0.0063830665,0.00006036047,0.000030818355,0.00016200771,0.00024640426,0.000015396861,0.0015116514],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998964,0.000015924314,0.000010802339,0.000021835147,0.000025087968,0.000029900604],"domain_scores_gemma":[0.99994934,0.000006524605,0.000015367965,0.000007701321,0.000005228342,0.000015810303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010673255,0.00041833168,0.00031482973,0.00018810172,0.00007729861,0.0002047594,0.00016958757,0.000251779,0.0007898475],"category_scores_gemma":[0.000053986627,0.000103081285,0.00020231608,0.000103121594,0.00014598097,0.00012902643,0.00013972065,0.0006753091,0.0002677219],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010746061,0.000075922515,0.00008093394,0.000025946807,0.0000026816633,0.000030272524,0.0000069044063,0.000109515735,0.99766785,0.000059014998,0.000032742333,0.0018005966],"study_design_scores_gemma":[0.00010571288,0.0016041838,0.0013060847,0.000005045295,0.000019288887,0.0003069684,0.000007774367,0.00200066,0.9929028,0.000051413932,0.0016861389,0.0000038491303],"about_ca_topic_score_codex":0.00009554575,"about_ca_topic_score_gemma":0.00013598356,"teacher_disagreement_score":0.0007898475,"about_ca_system_score_codex":0.0001069977,"about_ca_system_score_gemma":0.00013606487,"threshold_uncertainty_score":0.0026423335},"labels":[],"label_agreement":null},{"id":"W3041665519","doi":"10.1080/2162402x.2020.1792058","title":"Complete and long-lasting clinical responses in immune checkpoint inhibitor-resistant, metastasized melanoma treated with adoptive T cell transfer combined with DC vaccination","year":2020,"lang":"en","type":"article","venue":"OncoImmunology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Cancerföreningen i Stockholm; Medicinska Forskningsrådet; Knut och Alice Wallenbergs Stiftelse; Kommunfullmäktige, Stockholms Stad; Stiftelsen för Strategisk Forskning","keywords":"Medicine; Immunotherapy; Melanoma; Cohort; T cell; Internal medicine; Adoptive cell transfer; Vaccination; Oncology; Immune system; Immunology; Surgery; Cancer research","score_opus":0.052239993790942296,"score_gpt":0.31734485816633023,"score_spread":0.26510486437538794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3041665519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980831,0.00057056005,0.00038654543,0.00005034937,0.000012279246,0.000060493734,0.000050770843,0.000023609035,0.0007623285],"genre_scores_gemma":[0.9990784,0.00012745301,0.0002687302,0.000041878862,0.000019848198,0.00003104258,0.00011837606,0.000005199073,0.00030910075],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.9998516,0.00004381436,0.00001801691,0.000027938795,0.000019311854,0.000039284867],"domain_scores_gemma":[0.99981207,0.000064728396,0.000027857555,0.000025744526,0.000012264662,0.000057285124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040224512,0.0003158317,0.0006257956,0.00020638961,0.00019255935,0.00023059334,0.00014157515,0.00022775431,0.00056604826],"category_scores_gemma":[0.0004133218,0.00012216899,0.00027163562,0.00009904688,0.00017555348,0.00015624896,0.00012575688,0.00050653116,0.0001448556],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026872171,0.0059724306,0.13616477,0.00049377215,0.000512076,0.010315567,0.0006345417,0.0043606902,0.5900256,0.0002433991,0.0020318087,0.22237319],"study_design_scores_gemma":[0.00629827,0.2221924,0.5118693,0.000061735496,0.0008776489,0.031498898,0.00022123876,0.0110239675,0.203027,0.00023480617,0.012639656,0.00005511582],"about_ca_topic_score_codex":0.0002978241,"about_ca_topic_score_gemma":0.0006163263,"teacher_disagreement_score":0.0006257956,"about_ca_system_score_codex":0.00025939554,"about_ca_system_score_gemma":0.00014328117,"threshold_uncertainty_score":0.0021272898},"labels":[],"label_agreement":null},{"id":"W3043742068","doi":"10.1080/2162402x.2020.1794423","title":"Elucidating the gut microbiota composition and the bioactivity of immunostimulatory commensals for the optimization of immune checkpoint inhibitors","year":2020,"lang":"en","type":"review","venue":"OncoImmunology","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Agence Nationale de la Recherche","keywords":"Immune system; Commensalism; Gut flora; Immune checkpoint; Immunology; Blockade; Biology; Immunotherapy; Medicine; Bacteria; Receptor","score_opus":0.020402985294190934,"score_gpt":0.302963220960496,"score_spread":0.28256023566630506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043742068","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027889377,0.9985929,0.00021781004,0.00017912842,0.00011404221,0.000004407413,0.00001720065,0.0000060776324,0.00058947824],"genre_scores_gemma":[0.0014855965,0.9975157,0.00027062427,0.00014192962,0.00009116482,0.0000078948015,0.000033484197,0.0000018562607,0.00045182137],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998834,0.00002532502,0.000013991542,0.00001879904,0.000043383745,0.000015165675],"domain_scores_gemma":[0.99986005,0.00006203507,0.000022561659,0.000004972254,0.000035744175,0.000014658277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003875827,0.00059342274,0.0010217343,0.0012854774,0.00015693267,0.0007154138,0.00048095745,0.0007845695,0.0022127114],"category_scores_gemma":[0.00045418472,0.0001849843,0.00040713817,0.0009228952,0.0002915593,0.0006804743,0.0005325112,0.001420859,0.0011220531],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014345889,0.00010613352,0.00020033844,0.015728885,0.00011735827,0.00019594243,0.000038014852,0.00044127763,0.010181791,0.004080089,0.013481473,0.95528525],"study_design_scores_gemma":[0.000041519113,0.00027819257,0.0015212725,0.0034799352,0.00021841915,0.0012181781,0.00005750379,0.00022514931,0.0032975278,0.0025459956,0.98709005,0.000026346392],"about_ca_topic_score_codex":0.00042296812,"about_ca_topic_score_gemma":0.0009651001,"teacher_disagreement_score":0.0022127114,"about_ca_system_score_codex":0.00037906694,"about_ca_system_score_gemma":0.0005635706,"threshold_uncertainty_score":0.007402241},"labels":[],"label_agreement":null},{"id":"W3081716951","doi":"10.1080/2162402x.2020.1792038","title":"An integrated classifier improves prognostic accuracy in non-metastatic gastric cancer","year":2020,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada)","funders":"","keywords":"Medicine; Cancer; Classifier (UML); Oncology; Internal medicine; Artificial intelligence; Computer science","score_opus":0.030801698025727874,"score_gpt":0.3188286277955083,"score_spread":0.28802692976978045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081716951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91199076,0.002344114,0.08084302,0.0007738078,0.00019547132,0.00009391983,0.0009824146,0.00090281985,0.0018736251],"genre_scores_gemma":[0.9882683,0.00021081424,0.009783085,0.000094378396,0.00009561856,0.0000348989,0.0009963207,0.00002205183,0.00049450557],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9994772,0.00015546172,0.00004650354,0.00013021956,0.00011167274,0.000078993384],"domain_scores_gemma":[0.99923635,0.00035825832,0.00009887858,0.00005930416,0.00017973219,0.00006743152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016258213,0.00065967056,0.0013351014,0.0010000904,0.0002622711,0.0009437428,0.00047742884,0.0005948123,0.0008124402],"category_scores_gemma":[0.002765721,0.00017340189,0.0006936507,0.00048729987,0.00015798185,0.00048444857,0.00063975976,0.00068830623,0.00043848215],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022233925,0.00090715534,0.32087916,0.00018370754,0.0006823012,0.00057783467,0.00013349035,0.2265,0.015204338,0.00069907395,0.008490409,0.42351905],"study_design_scores_gemma":[0.00003384343,0.0001817895,0.013381264,0.000016468019,0.00009717341,0.00009877834,0.000018799932,0.9838951,0.0012521108,0.00040478652,0.00060621504,0.0000136956705],"about_ca_topic_score_codex":0.0023573874,"about_ca_topic_score_gemma":0.0021843964,"teacher_disagreement_score":0.0023573874,"about_ca_system_score_codex":0.0003302777,"about_ca_system_score_gemma":0.0006644039,"threshold_uncertainty_score":0.008598268},"labels":[],"label_agreement":null},{"id":"W3096233695","doi":"10.1080/2162402x.2020.1836766","title":"Angiotensin-converting enzyme (ACE) inhibitor prescription affects non-small-cell lung cancer (NSCLC) patients response to PD-1/PD-L1 immune checkpoint blockers","year":2020,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; ACE inhibitor; Lung cancer; Internal medicine; PD-L1; Angiotensin-converting enzyme; Concomitant; Immune system; Captopril; Nivolumab; Cancer; Oncology; Pharmacology; Immunology; Immunotherapy","score_opus":0.011486278366947988,"score_gpt":0.25254715569708575,"score_spread":0.24106087733013776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096233695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990526,0.00048074414,0.00003348152,0.000017656821,0.000004280892,0.0000041383514,0.000090171176,8.5665215e-7,0.0003160252],"genre_scores_gemma":[0.99968755,0.00010633875,0.000015309224,0.000013862953,0.000006233036,0.0000021996066,0.00009114574,7.3406665e-7,0.00007672504],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996841,0.00007175159,0.000041147003,0.000089109984,0.00005233273,0.00006166138],"domain_scores_gemma":[0.9995122,0.000119300996,0.00023229755,0.00002274102,0.000039728806,0.00007371893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023406105,0.00010645008,0.00031176876,0.00021183486,0.00021926343,0.0003896685,0.00010425318,0.00018628882,0.0010295754],"category_scores_gemma":[0.0009102468,0.00009790875,0.00041983955,0.00036966818,0.00010600601,0.00023757185,0.00013633813,0.0002863535,0.00016904753],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007009533,0.000060807597,0.99453944,0.000013510552,0.000061930565,0.00013917472,0.000031723725,0.000036659425,0.00096760987,0.000010414926,0.000054741693,0.0033830057],"study_design_scores_gemma":[0.000009478735,0.00022330077,0.99894875,0.000003528072,0.000047307745,0.0002640895,0.000049782106,0.000088649416,0.00019483214,0.0000100087045,0.00015847327,0.000001785149],"about_ca_topic_score_codex":0.00088200776,"about_ca_topic_score_gemma":0.0017771578,"teacher_disagreement_score":0.0010295754,"about_ca_system_score_codex":0.00018697945,"about_ca_system_score_gemma":0.00017981321,"threshold_uncertainty_score":0.003444314},"labels":[],"label_agreement":null},{"id":"W3107429554","doi":"10.1080/2162402x.2020.1846901","title":"Soluble forms of PD-L1 and PD-1 as prognostic and predictive markers of sunitinib efficacy in patients with metastatic clear cell renal cell carcinoma","year":2020,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"Canceropôle PACA","keywords":"Sunitinib; Renal cell carcinoma; Medicine; Bevacizumab; Internal medicine; Oncology; Immunotherapy; Cancer; Chemotherapy","score_opus":0.01270006059543189,"score_gpt":0.22113384894628305,"score_spread":0.20843378835085116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107429554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990639,0.00067715655,0.000040377603,0.000021133957,0.0000031469615,0.000003953895,0.000051282863,0.000002759882,0.00013627858],"genre_scores_gemma":[0.9997391,0.00006626506,0.00004683359,0.000010478008,0.000007287561,0.0000031329782,0.00008165796,4.905132e-7,0.00004476438],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99976426,0.000059045004,0.00003186989,0.000054087803,0.000059728078,0.000031022977],"domain_scores_gemma":[0.9994197,0.00016157023,0.00019607022,0.000026348414,0.00006119311,0.000135116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048770904,0.00018977639,0.00045588895,0.00049075397,0.00022209976,0.00052627287,0.00015292603,0.00032393733,0.000411748],"category_scores_gemma":[0.0013968686,0.00013119295,0.00028232893,0.0004148204,0.00018344248,0.00029569142,0.00016603325,0.00033073584,0.000087952394],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002565452,0.00007484814,0.986239,0.000029679208,0.00009848205,0.00022403695,0.000068580244,0.00040156965,0.00255529,0.000020738642,0.00012709,0.0075952765],"study_design_scores_gemma":[0.00006826306,0.00068142894,0.99605334,0.000007254146,0.000080445054,0.0007064011,0.000056168854,0.001467792,0.00059970637,0.000033546865,0.00023836695,0.0000073717633],"about_ca_topic_score_codex":0.0017433986,"about_ca_topic_score_gemma":0.0024202552,"teacher_disagreement_score":0.0017433986,"about_ca_system_score_codex":0.00048317248,"about_ca_system_score_gemma":0.00027548365,"threshold_uncertainty_score":0.0035056472},"labels":[],"label_agreement":null},{"id":"W3110044506","doi":"10.1080/2162402x.2020.1851539","title":"Quantitative MRI cell tracking of immune cell recruitment to tumors and draining lymph nodes in response to anti-PD-1 and a DPX-based immunotherapy","year":2020,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"National Cancer Institute; Nova Scotia Health Research Foundation","keywords":"Medicine; Immunotherapy; Immune system; Cytotoxic T cell; T cell; CTL*; Cancer research; Cancer immunotherapy; Immunology; CD8; Biology","score_opus":0.04033887026019693,"score_gpt":0.29533635892852506,"score_spread":0.2549974886683281,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110044506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97759765,0.001227963,0.019207796,0.0000699198,0.00002141545,0.00009462232,0.00023534689,0.00013721536,0.001408162],"genre_scores_gemma":[0.9605637,0.0015316728,0.032802973,0.00010924752,0.000018639495,0.0003215557,0.00036363667,0.00005593884,0.0042325603],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998487,0.0000349181,0.000007617644,0.000036367022,0.000043151827,0.000029147965],"domain_scores_gemma":[0.9998368,0.00005447959,0.000039953793,0.000011688979,0.000028005232,0.000029013445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033670216,0.0003253884,0.00023192378,0.00030618088,0.000087396,0.00023722305,0.00021624654,0.0004083653,0.0006131486],"category_scores_gemma":[0.00022440267,0.0001591257,0.00013018318,0.00018493949,0.00028313653,0.00021901146,0.00016492544,0.00051251135,0.0001704219],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007732321,0.000014166801,0.00009230913,0.0000193339,0.0000019064031,0.000008513616,0.000014870981,0.00015090745,0.99869114,0.000023298418,0.000012873555,0.0008934344],"study_design_scores_gemma":[0.000010410715,0.00045608796,0.0022636668,0.0000039097936,0.000012250501,0.000062128805,0.000019202915,0.0049601453,0.991683,0.000020038951,0.0005044085,0.000004791138],"about_ca_topic_score_codex":0.0006525947,"about_ca_topic_score_gemma":0.00063077704,"teacher_disagreement_score":0.0006525947,"about_ca_system_score_codex":0.000214823,"about_ca_system_score_gemma":0.00020693919,"threshold_uncertainty_score":0.0020511746},"labels":[],"label_agreement":null},{"id":"W3110606521","doi":"10.1080/2162402x.2020.1851950","title":"Immune-focused multi-omics analysis of prostate cancer: leukocyte Ig-Like receptors are associated with disease progression","year":2020,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Prostate Cancer Canada; University of Toronto; Université Laval; Centre hospitalier de l'Université Laval","funders":"National Cancer Institute","keywords":"Omics; Immunotherapy; Prostate cancer; Immune system; Cancer; breakpoint cluster region; Biology; Cancer immunotherapy; Disease; Computational biology; Bioinformatics; Immunology; Oncology; Gene; Medicine; Internal medicine; Genetics","score_opus":0.025554059833030923,"score_gpt":0.2902676242626001,"score_spread":0.26471356442956917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110606521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9354656,0.005268767,0.027694862,0.0010843303,0.00007084595,0.000082930295,0.028713455,0.0005005946,0.0011186572],"genre_scores_gemma":[0.9580757,0.0011630715,0.01650059,0.00042669082,0.00005841459,0.00012373211,0.02296108,0.000074412754,0.000616378],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993167,0.00016075074,0.0000570967,0.00024775954,0.00012165456,0.000096149255],"domain_scores_gemma":[0.9992285,0.00032557553,0.00019030138,0.00009186712,0.00010308351,0.00006064494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012723427,0.0006854894,0.0010355795,0.0018256144,0.00045183385,0.0011420485,0.00035177814,0.000384078,0.0011103717],"category_scores_gemma":[0.0017380873,0.00016983435,0.0017941131,0.0017869676,0.00025381567,0.0003243032,0.0008643929,0.0005893242,0.00029506147],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014901994,0.00024838882,0.6855173,0.001632301,0.0033497112,0.0005926326,0.0003432002,0.030283187,0.17689003,0.001277986,0.0052783657,0.09309674],"study_design_scores_gemma":[0.00006070384,0.00035249093,0.86182094,0.0001526224,0.0014974272,0.0007068689,0.00053838175,0.098835975,0.020663265,0.0053251935,0.009955951,0.00009021043],"about_ca_topic_score_codex":0.0027706034,"about_ca_topic_score_gemma":0.00342774,"teacher_disagreement_score":0.0027706034,"about_ca_system_score_codex":0.00047770425,"about_ca_system_score_gemma":0.00070290687,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W3113450031","doi":"10.1080/2162402x.2020.1863626","title":"Discovery of immunogenic cell death-inducing ruthenium-based photosensitizers for anticancer photodynamic therapy","year":2020,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Beatrice Hunter Cancer Research Institute; Dalhousie University","funders":"National Cancer Institute; National Institutes of Health","keywords":"Photodynamic therapy; Cytotoxicity; Melanoma; Ruthenium; Immunogenic cell death; Cancer research; Cytotoxic T cell; Programmed cell death; Immunotherapy; Photosensitizer; Medicine; Chemistry; Apoptosis; Immunology; Immune system; In vitro; Biochemistry; Photochemistry","score_opus":0.016390434016626983,"score_gpt":0.22393754889902015,"score_spread":0.20754711488239316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113450031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9317285,0.008720707,0.05186658,0.0005795683,0.00012189588,0.00022927388,0.00018330038,0.00037376644,0.0061964705],"genre_scores_gemma":[0.9783982,0.0028304728,0.016543835,0.00014491315,0.0000227581,0.000060219892,0.000083132865,0.000022996255,0.0018934445],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993396,0.000010698579,0.000003854983,0.000014277722,0.000020406145,0.000016898875],"domain_scores_gemma":[0.99995565,0.000009079253,0.000014237349,0.0000048563734,0.000007696672,0.000008522257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016337447,0.00025715423,0.00016110187,0.00017888787,0.000089077614,0.0002360093,0.00023853352,0.00038156373,0.0005168299],"category_scores_gemma":[0.00011400872,0.000111611684,0.00021794513,0.00007464978,0.00017476367,0.00021710036,0.00019914021,0.00034338934,0.00019691729],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021966513,0.000024988885,0.000044825534,0.000039583567,0.0000036138456,0.000057798155,0.000016489323,0.00029123962,0.9942762,0.0005871512,0.00008085311,0.0045553977],"study_design_scores_gemma":[0.000013337382,0.00022948335,0.00021026729,0.000004526453,0.000008197833,0.00018321884,0.0000061350997,0.0014770236,0.99454814,0.00009060014,0.0032248457,0.0000042739393],"about_ca_topic_score_codex":0.00015292778,"about_ca_topic_score_gemma":0.00027608787,"teacher_disagreement_score":0.0005168299,"about_ca_system_score_codex":0.00024584134,"about_ca_system_score_gemma":0.00011667209,"threshold_uncertainty_score":0.001783669},"labels":[],"label_agreement":null},{"id":"W3130326316","doi":"10.1080/2162402x.2021.1885778","title":"Synergistic anti-tumor efficacy of oncolytic influenza viruses and B7-H3 immune- checkpoint inhibitors against IC-resistant lung cancers","year":2021,"lang":"en","type":"article","venue":"OncoImmunology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"Deutsche Krebshilfe","keywords":"Oncolytic virus; Cancer research; Tumor microenvironment; Immune system; Medicine; Cytotoxic T cell; Immunotherapy; Immune checkpoint; Lung cancer; Cancer; Immunology; Oncolytic adenovirus; Biology; Oncology; Internal medicine","score_opus":0.026666207144907386,"score_gpt":0.32993254255462107,"score_spread":0.3032663354097137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130326316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99602544,0.0018321429,0.0006019038,0.000047801117,0.000039635244,0.000051320687,0.00012117967,0.000048015674,0.0012324314],"genre_scores_gemma":[0.9973475,0.0008737651,0.00074469,0.000036208436,0.0000160598,0.00004410996,0.00014768541,0.0000071516833,0.0007827806],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998635,0.000026686868,0.000012964334,0.00001664298,0.00002527539,0.000054872227],"domain_scores_gemma":[0.99994624,0.000009998845,0.000010677347,0.0000067801993,0.0000052025225,0.000020964184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018616683,0.0003906543,0.00045130157,0.00023264534,0.000098284516,0.00023041532,0.00022682872,0.0002782646,0.0007152734],"category_scores_gemma":[0.000065778026,0.00011833755,0.00033113244,0.00012795559,0.0001737642,0.00017792657,0.00019500866,0.0006250118,0.00015477354],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009824606,0.00038565588,0.00021166162,0.00009072815,0.00003002639,0.00005153497,0.000023740145,0.00030185375,0.99145097,0.00013961684,0.00010937841,0.006222387],"study_design_scores_gemma":[0.00016233532,0.005523715,0.003002721,0.000009421827,0.00007697844,0.00021652563,0.000029269147,0.0016574631,0.9872472,0.000040665498,0.0020270243,0.0000067918495],"about_ca_topic_score_codex":0.00047977624,"about_ca_topic_score_gemma":0.00097307126,"teacher_disagreement_score":0.0007152734,"about_ca_system_score_codex":0.00016308328,"about_ca_system_score_gemma":0.00023327571,"threshold_uncertainty_score":0.002392888},"labels":[],"label_agreement":null},{"id":"W3135795993","doi":"10.1080/2162402x.2021.1945202","title":"Distinct microbial communities colonize tonsillar squamous cell carcinoma","year":2021,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Oral Health Pathology and Treatment","field":"Dentistry","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Science Foundation","keywords":"Tonsil; Prevotella; Microbiome; Biology; Fusobacteria; Cancer; Pathology; Firmicutes; Streptococcus bovis; Medicine; Internal medicine; Bioinformatics; 16S ribosomal RNA; Genetics; Gene","score_opus":0.023789258400418227,"score_gpt":0.2845732960484921,"score_spread":0.26078403764807384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135795993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998276,0.0006381648,0.00018660654,0.000016579292,0.0000058318906,0.000015550524,0.00039040492,0.000008539857,0.00046228993],"genre_scores_gemma":[0.99860436,0.0003541823,0.00028217,0.000032541975,0.000005438082,0.000015445126,0.0004962615,0.000003840602,0.00020567789],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998448,0.00001587382,0.000015649046,0.000046375306,0.000038508348,0.000038808004],"domain_scores_gemma":[0.9998683,0.000015177338,0.000039031547,0.00001014353,0.000028817956,0.00003853585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000079050245,0.00019269838,0.00027060838,0.0006491712,0.00038388252,0.0004576164,0.00012342741,0.00018771793,0.0011710085],"category_scores_gemma":[0.00027258592,0.00012167883,0.00024359653,0.00047144727,0.0002079868,0.00022521568,0.00042064357,0.00016427237,0.00017012074],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010405374,0.000061210914,0.4245668,0.00028702195,0.00012845546,0.0012546729,0.001264953,0.00019815245,0.5526119,0.000102152684,0.00026460597,0.018219605],"study_design_scores_gemma":[0.000007659492,0.00028710495,0.9797085,0.00004446877,0.00007101604,0.002184349,0.0019109289,0.00042856345,0.013557637,0.00008416683,0.0016961406,0.000019434416],"about_ca_topic_score_codex":0.003017875,"about_ca_topic_score_gemma":0.003847967,"teacher_disagreement_score":0.003017875,"about_ca_system_score_codex":0.00017873068,"about_ca_system_score_gemma":0.00019754899,"threshold_uncertainty_score":0.006000638},"labels":[],"label_agreement":null},{"id":"W3135861526","doi":"10.1080/2162402x.2021.1893466","title":"Tumor-intrinsic determinants of immunogenic cell death modalities","year":2021,"lang":"en","type":"review","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"Agence Nationale de la Recherche","keywords":"Immunosurveillance; Immunogenic cell death; Cytotoxic T cell; Immune system; Acquired immune system; Immunology; Antigen presentation; T cell; Antigen; Antigen-presenting cell; Inflammation; Major histocompatibility complex; Secretion; Biology; Immunotherapy; Cancer research; In vitro","score_opus":0.05194550613869627,"score_gpt":0.3467005463507449,"score_spread":0.2947550402120486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135861526","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001374628,0.99769235,0.00017825197,0.00019185133,0.00017624737,0.0000043333425,0.00001812495,0.0000073934907,0.001594084],"genre_scores_gemma":[0.0010223488,0.9973615,0.00017303143,0.00017085206,0.0001613544,0.000007683236,0.000036726018,0.0000014712264,0.001064996],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998858,0.00001801811,0.000014043255,0.00002076486,0.00004862872,0.0000126887435],"domain_scores_gemma":[0.99984396,0.00006681294,0.00002634,0.000006663187,0.000041228926,0.000015004459],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032930053,0.0006899287,0.0008830345,0.0016491549,0.00017445149,0.00086916157,0.0005656551,0.0007251681,0.0029968454],"category_scores_gemma":[0.00037981468,0.0002029852,0.00031261583,0.0012229092,0.0004110677,0.0009942102,0.0005327701,0.0013999415,0.0020480286],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005397096,0.000055485085,0.00015205197,0.0101713585,0.00004733131,0.00014687642,0.00003955939,0.00029179238,0.004110434,0.0073466515,0.021376183,0.9562083],"study_design_scores_gemma":[0.0000076825545,0.00006132024,0.000572135,0.0018959966,0.0000417232,0.0010448882,0.000023061722,0.00007711288,0.001297998,0.0019139621,0.9930524,0.000011648234],"about_ca_topic_score_codex":0.00049696286,"about_ca_topic_score_gemma":0.0008322754,"teacher_disagreement_score":0.0029968454,"about_ca_system_score_codex":0.0004599335,"about_ca_system_score_gemma":0.00054270925,"threshold_uncertainty_score":0.010025382},"labels":[],"label_agreement":null},{"id":"W3157232913","doi":"10.1080/2162402x.2021.1918373","title":"A bacterium-derived, cancer-associated immunopeptidome","year":2021,"lang":"en","type":"letter","venue":"OncoImmunology","topic":"Bacteriophages and microbial interactions","field":"Environmental Science","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Context (archaeology); Immune system; Biology; Cancer; Bacteria; Medicine; Immunology; Microbiology; Genetics","score_opus":0.014046707574041015,"score_gpt":0.2408466630210687,"score_spread":0.2267999554470277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157232913","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027967491,0.019608337,0.0006360999,0.87071395,0.09479208,0.000050657673,0.00009589441,0.00007389666,0.011232362],"genre_scores_gemma":[0.026589256,0.014318908,0.00082585553,0.83383816,0.08451565,0.000090390284,0.00007465414,0.000028702738,0.03971836],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994236,0.00017719014,0.000048047797,0.000069141206,0.00019910341,0.00008299177],"domain_scores_gemma":[0.9990107,0.0006343606,0.000060393093,0.000036930232,0.000118065676,0.00013961403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010767884,0.00061575614,0.00047957277,0.00026261964,0.0012094514,0.0012740988,0.00064740964,0.012520695,0.0025294118],"category_scores_gemma":[0.003735695,0.000319736,0.0005171798,0.00014473259,0.0013232342,0.0010734592,0.00042385748,0.009478037,0.0023113713],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024003719,0.00010404881,0.00046964426,0.00014819972,0.00001767008,0.004630113,0.000056812733,0.000108112166,0.00287565,0.0060913833,0.95350456,0.031753782],"study_design_scores_gemma":[0.0001373639,0.00018111004,0.00082170224,0.00008756731,0.000019411795,0.003307231,0.00008506139,0.00035292353,0.0016099183,0.006175796,0.9871983,0.000023605246],"about_ca_topic_score_codex":0.0009350423,"about_ca_topic_score_gemma":0.0021529263,"teacher_disagreement_score":0.012520695,"about_ca_system_score_codex":0.0014511186,"about_ca_system_score_gemma":0.000820211,"threshold_uncertainty_score":0.010528684},"labels":[],"label_agreement":null},{"id":"W3160437920","doi":"10.1080/2162402x.2021.1924492","title":"The immune microenvironment and relation to outcome in patients with advanced breast cancer treated with docetaxel with or without gemcitabine","year":2021,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Centre for Advancing Health Outcomes; University of British Columbia","funders":"Canadian Institutes of Health Research; Else og Mogens Wedell Wedellsborgs Fond; Købmand M. Kristjan Kjær og Hustru Margrethe Kjær, Født la Cour-Holmes Fond; Canadian Cancer Society","keywords":"Docetaxel; Medicine; Gemcitabine; Breast cancer; Oncology; Internal medicine; Clinical endpoint; Biomarker; FOXP3; Cancer; Immune system; Clinical trial; Immunology","score_opus":0.0067823068047744425,"score_gpt":0.24567822307952522,"score_spread":0.2388959162747508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160437920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990376,0.000539023,0.000049005175,0.00003439537,0.0000089778505,0.000010243917,0.000064784625,0.0000016866852,0.000254337],"genre_scores_gemma":[0.9996081,0.00008705259,0.000029149316,0.000026901978,0.000015524996,0.000010568535,0.00011611268,6.044903e-7,0.0001060779],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99975306,0.00009354729,0.000023410455,0.0000436226,0.000035012086,0.000051334686],"domain_scores_gemma":[0.9992416,0.0002224536,0.0002631586,0.000047508092,0.000040780786,0.00018459701],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061049225,0.00014960555,0.00041634284,0.00020954537,0.00016234058,0.00034472812,0.00012698745,0.0002726655,0.00054696656],"category_scores_gemma":[0.0012771914,0.000088630324,0.00039861913,0.00029628602,0.0001818327,0.0002137259,0.00017208487,0.00045322563,0.00010133324],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.046075113,0.0006952467,0.92559373,0.000070233495,0.00036097792,0.00029711248,0.000084492814,0.0007012551,0.004250643,0.00006592857,0.00030390025,0.02150136],"study_design_scores_gemma":[0.00073018746,0.009451261,0.9869507,0.000015917654,0.0002540389,0.000400383,0.00007309465,0.0007076247,0.0006666126,0.00012224601,0.0006185825,0.000009455511],"about_ca_topic_score_codex":0.00047766647,"about_ca_topic_score_gemma":0.00085327664,"teacher_disagreement_score":0.00061049225,"about_ca_system_score_codex":0.0003643564,"about_ca_system_score_gemma":0.00023650285,"threshold_uncertainty_score":0.0032286048},"labels":[],"label_agreement":null},{"id":"W3174761433","doi":"10.1080/2162402x.2021.1943168","title":"Type 2 innate lymphoid cells: a novel actor in anti-melanoma immunity","year":2021,"lang":"en","type":"review","venue":"OncoImmunology","topic":"IL-33, ST2, and ILC Pathways","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Cancer Council NSW; National Health and Medical Research Council; University of Queensland","keywords":"Innate lymphoid cell; Melanoma; Immunology; Innate immune system; Acquired immune system; Immunity; Immune system; Immunotherapy; Medicine; Eosinophil; Cancer research; Biology","score_opus":0.051531088889887465,"score_gpt":0.30342024517145333,"score_spread":0.2518891562815659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174761433","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013610766,0.99819344,0.000119411365,0.00046563597,0.00044563037,0.0000028321288,0.000008791312,0.000005716133,0.0006224751],"genre_scores_gemma":[0.0012174726,0.99651694,0.0001754327,0.00049899734,0.00066100544,0.0000073592178,0.000026719834,0.0000016027025,0.0008944179],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998858,0.000017258695,0.000014045426,0.000021562428,0.000044023567,0.000017371363],"domain_scores_gemma":[0.99986386,0.000050296734,0.000019591424,0.0000047655126,0.000036669204,0.000024762667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000442228,0.0007426242,0.0007617485,0.0011207627,0.00020714845,0.0008965331,0.0005688442,0.0012031208,0.0016196034],"category_scores_gemma":[0.0002965607,0.00020479666,0.0002509625,0.0010087144,0.00051753706,0.0012134279,0.00058138225,0.0025830779,0.0014641121],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016480181,0.00007182458,0.0002313574,0.008641254,0.00005770249,0.00046991097,0.000052767642,0.00028810085,0.0062734373,0.008624435,0.051556326,0.92356807],"study_design_scores_gemma":[0.000025604075,0.00009790271,0.0005870257,0.0011273618,0.000043707536,0.0014401249,0.00002915395,0.0000755406,0.0008486534,0.0023707794,0.9933415,0.000012768452],"about_ca_topic_score_codex":0.00031588078,"about_ca_topic_score_gemma":0.0006916404,"teacher_disagreement_score":0.0016196034,"about_ca_system_score_codex":0.0005520057,"about_ca_system_score_gemma":0.0007631531,"threshold_uncertainty_score":0.005418122},"labels":[],"label_agreement":null},{"id":"W3186130481","doi":"10.1080/2162402x.2021.1952539","title":"Alternol triggers immunogenic cell death <i>via</i> reactive oxygen species generation","year":2021,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Immunogenic cell death; Calreticulin; Cancer research; Immune system; HMGB1; Cytokine; Prostate cancer; Immunology; Inflammation; T cell; Medicine; Cancer; Biology; Immunotherapy; Endoplasmic reticulum; Cell biology; Internal medicine","score_opus":0.030107106238168986,"score_gpt":0.26766494366361293,"score_spread":0.23755783742544395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186130481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845072,0.0040082606,0.005989091,0.0002786885,0.00016933419,0.000104281105,0.0008693951,0.00018055589,0.003893186],"genre_scores_gemma":[0.9946102,0.00153048,0.0013594065,0.0001693498,0.000029206,0.000029739977,0.0005990697,0.000009378951,0.0016632226],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992156,0.000014199087,0.0000076046244,0.000013936675,0.000019231364,0.000023523939],"domain_scores_gemma":[0.9999291,0.000011952406,0.000025132298,0.000011286832,0.000011939008,0.0000105817135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000089722365,0.00029868714,0.00023083354,0.00022971621,0.00010357463,0.00020198262,0.00015447263,0.00023709914,0.0020855633],"category_scores_gemma":[0.00008117746,0.00007103017,0.00027759073,0.00017742172,0.00017051552,0.00020607696,0.00016616897,0.00059940276,0.00027154112],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006195416,0.0001573365,0.000395819,0.0001389861,0.000017791424,0.000092167735,0.000014755461,0.00012953088,0.99383956,0.00021930112,0.00014871225,0.004226509],"study_design_scores_gemma":[0.000033081556,0.0014352272,0.0025881229,0.000008250371,0.00002453059,0.00025005502,0.00002851996,0.00047524634,0.99218905,0.00014138529,0.002821163,0.000005356131],"about_ca_topic_score_codex":0.00021823541,"about_ca_topic_score_gemma":0.00047812858,"teacher_disagreement_score":0.0020855633,"about_ca_system_score_codex":0.00019619089,"about_ca_system_score_gemma":0.00016291774,"threshold_uncertainty_score":0.0069769025},"labels":[],"label_agreement":null},{"id":"W3189341011","doi":"10.1080/2162402x.2021.1956173","title":"Association of <i>PIK3CA</i> mutation and PTEN loss with expression of CD274 (PD-L1) in colorectal carcinoma","year":2021,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; Uehara Memorial Foundation; Stand Up To Cancer; National Institutes of Health; American Association for Cancer Research; Yasuda Memorial Medical Foundation; George W. Stone Family Foundation; Mitsukoshi Health and Welfare Foundation; Japan Society for the Promotion of Science; Dana-Farber/Harvard Cancer Center; Gary Bennett Family Fund; Dana-Farber Cancer Institute","keywords":"PTEN; Microsatellite instability; Cancer research; Medicine; Colorectal cancer; Oncology; Cancer; Immune checkpoint; KRAS; Internal medicine; Odds ratio; Immunotherapy; Biology; PI3K/AKT/mTOR pathway; Genetics; Signal transduction; Allele","score_opus":0.00587155657809464,"score_gpt":0.23575548685067801,"score_spread":0.2298839302725834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3189341011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99945575,0.00019322195,0.00008519521,0.000021843809,0.0000029416476,0.0000030029637,0.00006820935,0.0000039504616,0.0001658535],"genre_scores_gemma":[0.99982363,0.00004019032,0.00004181783,0.000006651668,0.0000029009561,0.0000016267303,0.000047714806,9.085585e-7,0.00003473005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995478,0.00009825637,0.00007877958,0.00013359006,0.000079724865,0.00006189015],"domain_scores_gemma":[0.9981913,0.0003526221,0.00091945974,0.000180936,0.00011498207,0.0002407914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007196492,0.0002004734,0.00027982975,0.00089112,0.0003821857,0.0006150025,0.00033167965,0.00042677033,0.0011197926],"category_scores_gemma":[0.0022224276,0.00043088826,0.00048769976,0.00086871575,0.00041692512,0.0002576554,0.0003421737,0.000488354,0.00014400465],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018780219,0.000008278228,0.9983209,0.000005653531,0.00005117518,0.000102786275,0.000013057482,0.00007168395,0.00070083555,0.00001105475,0.000027202841,0.0004995153],"study_design_scores_gemma":[0.000008300932,0.000048954746,0.99857223,0.0000032151436,0.000058611055,0.0004983954,0.000039956078,0.00042738262,0.00022935453,0.000024307406,0.00008582506,0.0000034050001],"about_ca_topic_score_codex":0.0075826324,"about_ca_topic_score_gemma":0.007975177,"teacher_disagreement_score":0.0075826324,"about_ca_system_score_codex":0.0004086214,"about_ca_system_score_gemma":0.00029054118,"threshold_uncertainty_score":0.015076995},"labels":[],"label_agreement":null},{"id":"W3191190767","doi":"10.1080/2162402x.2021.1959978","title":"Germinal center hypoxia in tumor-draining lymph nodes negatively regulates tumor-induced humoral immune responses in mouse models of breast cancer","year":2021,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Germinal center; Immune system; Tumor hypoxia; Lymph; Antibody; Cancer research; Hypoxia (environmental); Lymph node; Biology; Tumor progression; Immunology; Cancer; Medicine; Pathology; Chemistry; B cell; Internal medicine; Radiation therapy","score_opus":0.02564010086865083,"score_gpt":0.2682532652089415,"score_spread":0.24261316434029068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3191190767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953939,0.0014090796,0.0015204562,0.00009416723,0.000026532529,0.00003451276,0.00025278155,0.00009596895,0.0011726032],"genre_scores_gemma":[0.9962476,0.0005096371,0.0010731393,0.000053238182,0.000011698804,0.00006285064,0.00022159194,0.000017168386,0.0018030946],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99979967,0.000044309934,0.00001191392,0.000043292537,0.000043104963,0.000057713332],"domain_scores_gemma":[0.999897,0.000009911958,0.00003645726,0.0000099707,0.0000066488137,0.000039982464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015117349,0.00034280206,0.00019840823,0.00035338488,0.00012661745,0.00022949379,0.00017885957,0.0002685814,0.0011293617],"category_scores_gemma":[0.00006244804,0.00016552409,0.00017265683,0.000115316616,0.00028910107,0.00020460384,0.00016035045,0.00068130164,0.00023675937],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002702702,0.000074631505,0.00034360526,0.0000356324,0.000004038987,0.000037072794,0.000017643708,0.00005650506,0.99812883,0.00010714741,0.00003680619,0.0008878831],"study_design_scores_gemma":[0.000062156156,0.0011590293,0.009794738,0.000013814501,0.00002870939,0.00027800087,0.000050192644,0.0012082165,0.9850036,0.00012557553,0.0022714192,0.000004613042],"about_ca_topic_score_codex":0.00030586054,"about_ca_topic_score_gemma":0.0005807486,"teacher_disagreement_score":0.0011293617,"about_ca_system_score_codex":0.0003625785,"about_ca_system_score_gemma":0.00014597402,"threshold_uncertainty_score":0.0037781},"labels":[],"label_agreement":null},{"id":"W3200729455","doi":"10.1080/2162402x.2021.1939518","title":"Phased differentiation of γδ T and T CD8 tumor-infiltrating lymphocytes revealed by single-cell transcriptomics of human cancers","year":2021,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Nautical Research Society","funders":"Centre National de la Recherche Scientifique; Institut National de la Santé et de la Recherche Médicale; Fondation ARC pour la Recherche sur le Cancer; Agence Nationale de la Recherche","keywords":"CD8; Cytotoxic T cell; Biology; Cancer research; T cell; Immune system; Transcriptome; Immunophenotyping; Immunology; Cancer immunotherapy; Tumor-infiltrating lymphocytes; Immunotherapy; Antigen; Gene expression; Gene; In vitro; Genetics","score_opus":0.012480476062551111,"score_gpt":0.22823484315430226,"score_spread":0.21575436709175114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200729455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9732231,0.0029707705,0.015461966,0.000111613765,0.000026293927,0.000029774044,0.0065737236,0.00019678476,0.0014059235],"genre_scores_gemma":[0.98124343,0.0019510834,0.010500657,0.00013557139,0.000018878412,0.00007053119,0.004635142,0.000079373065,0.0013654463],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998628,0.000010767665,0.0000068553577,0.00006739753,0.000030504265,0.000021600707],"domain_scores_gemma":[0.9999225,0.000020979287,0.0000174195,0.000011523834,0.000017380486,0.000010158193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017703863,0.00012884299,0.00022629279,0.00043945442,0.000171922,0.0005837,0.00011895267,0.00024411641,0.00056605315],"category_scores_gemma":[0.00023120006,0.000139255,0.00018143402,0.00041893806,0.00017716967,0.00019457107,0.00019803178,0.00033984194,0.00028774483],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012708607,0.00000784627,0.009373876,0.00010361241,0.000024244646,0.000062811385,0.0001509154,0.0003057088,0.9804571,0.00018374385,0.0001820186,0.00902103],"study_design_scores_gemma":[0.000015098568,0.00022821355,0.34283537,0.000086921566,0.00016173016,0.0012797379,0.0008317365,0.009527499,0.6242215,0.0016788119,0.01907895,0.00005448472],"about_ca_topic_score_codex":0.00044185336,"about_ca_topic_score_gemma":0.0011191597,"teacher_disagreement_score":0.0005837,"about_ca_system_score_codex":0.00014644861,"about_ca_system_score_gemma":0.00015252047,"threshold_uncertainty_score":0.0018936992},"labels":[],"label_agreement":null},{"id":"W3204866712","doi":"10.1080/2162402x.2021.1943234","title":"The PKN1- TRAF1 signaling axis as a potential new target for chronic lymphocytic leukemia","year":2021,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Ontario Institute for Cancer Research; York University; University of Toronto","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research","keywords":"Venetoclax; Chronic lymphocytic leukemia; Medicine; Cancer research; Kinase; Leukemia; Lymphoma; Immunology; Biology; Cell biology","score_opus":0.01566190881699383,"score_gpt":0.30334040842277543,"score_spread":0.2876784996057816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3204866712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8571643,0.12767565,0.003250203,0.0012898722,0.0001620876,0.000248474,0.0007015278,0.00029069147,0.009217211],"genre_scores_gemma":[0.9477988,0.042341735,0.003362485,0.0003576772,0.00010459147,0.000116611904,0.0010312997,0.000015128793,0.0048716613],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999548,0.000007806478,0.0000036056103,0.00000835238,0.000010299,0.000015170055],"domain_scores_gemma":[0.9999671,0.0000046308296,0.000010197182,0.0000025347956,0.0000043754926,0.0000111031895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012976068,0.00032643919,0.0003399082,0.00024016542,0.00012484263,0.00030920588,0.00024707805,0.00020574065,0.0014885758],"category_scores_gemma":[0.00005749282,0.00007702761,0.00022018839,0.00018776323,0.00015899057,0.00022742686,0.00014697503,0.0006371542,0.00037284647],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021765751,0.00062251545,0.0021288798,0.0011550327,0.0000582704,0.0007948415,0.00007495036,0.0006131685,0.85348547,0.00087791216,0.001281078,0.1367313],"study_design_scores_gemma":[0.00278022,0.02356908,0.040932976,0.0003690151,0.00048817164,0.013022238,0.00022220198,0.0036070691,0.748556,0.0011735627,0.16519435,0.00008501208],"about_ca_topic_score_codex":0.00033330833,"about_ca_topic_score_gemma":0.0015711997,"teacher_disagreement_score":0.0014885758,"about_ca_system_score_codex":0.0003910213,"about_ca_system_score_gemma":0.00028015382,"threshold_uncertainty_score":0.0049797297},"labels":[],"label_agreement":null},{"id":"W3205381631","doi":"10.1080/2162402x.2021.1984677","title":"Trial watch: intratumoral immunotherapy","year":2021,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Labex Immuno-Oncology; High-end Foreign Experts Recruitment Plan of China; Stand Up To Cancer; Weill Cornell Medical College; European Research Area Network on Cardiovascular Diseases; Institut Universitaire de France; Centre National de la Recherche Scientifique; Ligue Contre le Cancer; Fondation pour la Recherche Médicale; Institut National Du Cancer; Institut National de la Santé et de la Recherche Médicale; Association pour la Recherche sur le Cancer; Seerave Foundation; Institut Gustave-Roussy; Fondation Leducq; European Commission; Agence Nationale de la Recherche; E-Rare; Leukemia and Lymphoma Society","keywords":"Oncolytic virus; Immunotherapy; Immune system; Chemotherapy; Context (archaeology); Radiation therapy; T cell; Cancer immunotherapy; Myeloid","score_opus":0.022843804974087212,"score_gpt":0.3018789860251105,"score_spread":0.27903518105102326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3205381631","genre_codex":"other","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06583338,0.0741856,0.009117203,0.1458645,0.074736506,0.03650084,0.075219214,0.0033219436,0.5152208],"genre_scores_gemma":[0.18258308,0.026400235,0.012354285,0.16382408,0.026090952,0.038734537,0.051162053,0.001144208,0.49770656],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992248,0.0003504858,0.000053957094,0.0001527651,0.000113172246,0.00010479456],"domain_scores_gemma":[0.99837923,0.00030524188,0.0002450286,0.0001917662,0.00022288418,0.00065574807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019504534,0.00082508806,0.0012576616,0.0003342853,0.0004692676,0.00196115,0.00083238515,0.0037178898,0.11112981],"category_scores_gemma":[0.0028147723,0.00019850949,0.0010879376,0.0003692702,0.00047911223,0.0015940769,0.0006638289,0.004307166,0.023262827],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13160299,0.0017707781,0.0013372226,0.0054675518,0.0010535857,0.00016134132,0.00007063082,0.00052032265,0.0035660635,0.0064215376,0.57744926,0.27057874],"study_design_scores_gemma":[0.17230941,0.011579905,0.003624535,0.0020770023,0.0006443915,0.00023357086,0.00007172536,0.0009046684,0.0011117371,0.01105938,0.7963464,0.00003725437],"about_ca_topic_score_codex":0.0004206596,"about_ca_topic_score_gemma":0.0012035244,"teacher_disagreement_score":0.11112981,"about_ca_system_score_codex":0.0008138019,"about_ca_system_score_gemma":0.0011985748,"threshold_uncertainty_score":0.37176627},"labels":[],"label_agreement":null},{"id":"W3213274906","doi":"10.1080/2162402x.2021.1995168","title":"Manufacturing T cells in hollow fiber membrane bioreactors changes their programming and enhances their potency","year":2021,"lang":"en","type":"article","venue":"OncoImmunology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre; McMaster University; TRIUMF","funders":"Canada Research Chairs","keywords":"Cryopreservation; Bioreactor; Cell; Cell culture; Chemistry; Cell biology; Biotechnology; Biology; Biochemistry; Embryo","score_opus":0.02288096904731359,"score_gpt":0.2790658329351818,"score_spread":0.2561848638878682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213274906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9697683,0.00057432347,0.027588684,0.00017116829,0.000040779167,0.000047096917,0.00020456896,0.00019896071,0.0014061127],"genre_scores_gemma":[0.96830654,0.0003647456,0.029874068,0.000078412544,0.000012126411,0.00004680584,0.00017897123,0.00005519906,0.0010830372],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99975485,0.000049323324,0.000024536283,0.000060453294,0.00006482093,0.000045944544],"domain_scores_gemma":[0.9997807,0.000054344164,0.00007776517,0.000031132677,0.000035093053,0.000021035792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035778165,0.00026881223,0.00015893372,0.00012219975,0.00013024526,0.00038397312,0.00022889482,0.0003193759,0.0006423968],"category_scores_gemma":[0.00032988747,0.00010647547,0.00030127857,0.000094644754,0.00023300473,0.00031625445,0.00022912386,0.00049828144,0.0003622917],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024763489,0.000008619291,0.000096639946,0.000010821276,0.0000015725649,0.000015806592,0.00001044752,0.00011983324,0.9989458,0.000048239144,0.000013878438,0.0007035649],"study_design_scores_gemma":[0.0000026040334,0.00008212888,0.0003255824,0.0000019062055,0.000003068951,0.000047838737,0.000007890431,0.0005196027,0.998343,0.000021975819,0.0006416457,0.0000027932858],"about_ca_topic_score_codex":0.0004104714,"about_ca_topic_score_gemma":0.00064575387,"teacher_disagreement_score":0.0006423968,"about_ca_system_score_codex":0.00023551792,"about_ca_system_score_gemma":0.00019404008,"threshold_uncertainty_score":0.0021489859},"labels":[],"label_agreement":null},{"id":"W3215925274","doi":"10.1080/2162402x.2021.2006893","title":"Keratinocyte differentiation antigen-specific T cells in immune checkpoint inhibitor-treated NSCLC patients are associated with improved survival","year":2021,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Novartis Foundation; Sanofi; Bristol-Myers Squibb; Krebsliga Schweiz; National Science Foundation","keywords":"Epitope; Antigen; Immunology; Lung cancer; Human leukocyte antigen; Immune system; Immunotherapy; CD8; Medicine; Cancer research; Biology; Oncology","score_opus":0.012535353175104302,"score_gpt":0.22722299800351764,"score_spread":0.21468764482841335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215925274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985489,0.0005896007,0.00006510092,0.00006351897,0.000014868084,0.0000067725528,0.00007159893,0.000007102151,0.0006325984],"genre_scores_gemma":[0.99947506,0.000115858216,0.000034185527,0.00004830836,0.000011655634,0.0000047176086,0.00009490141,0.0000010840374,0.00021427333],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999207,0.000017573393,0.000007528224,0.000019122843,0.000011682102,0.000023325878],"domain_scores_gemma":[0.9998147,0.00003577669,0.00006229274,0.000009830844,0.000017442737,0.00006001802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012601857,0.00012451128,0.0002836123,0.00022655551,0.00020474142,0.0002956534,0.00011274909,0.0003206576,0.0013217133],"category_scores_gemma":[0.0003907072,0.000092289025,0.00018162926,0.0002050808,0.0001234127,0.00021722564,0.0001047121,0.00047693573,0.00016640109],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004393225,0.0003987774,0.9477832,0.000055797154,0.00013509205,0.0009574971,0.000086754924,0.0002750841,0.02298252,0.00006618131,0.0007157193,0.022150151],"study_design_scores_gemma":[0.00007630007,0.0008672618,0.9942093,0.000010435873,0.000095209245,0.0017490406,0.0000944177,0.0005698571,0.001300902,0.00007841991,0.0009438124,0.0000051090037],"about_ca_topic_score_codex":0.0005002176,"about_ca_topic_score_gemma":0.00068375777,"teacher_disagreement_score":0.0013217133,"about_ca_system_score_codex":0.00016728307,"about_ca_system_score_gemma":0.00014091156,"threshold_uncertainty_score":0.004421532},"labels":[],"label_agreement":null},{"id":"W3217061495","doi":"10.1080/2162402x.2021.2005859","title":"Radiochemotherapy-induced elevations of plasma HMGB1 levels predict therapeutic responses in cancer patients","year":2021,"lang":"en","type":"editorial","venue":"OncoImmunology","topic":"Advanced Glycation End Products research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Labex Immuno-Oncology; European Research Area Network on Cardiovascular Diseases; Horizon 2020 Framework Programme; Chancellerie des Universités de Paris; Centre de Compétences Nanosciences Ile-de-France; Canadian Rheumatology Association; Institut Universitaire de France; Labex; Ligue Contre le Cancer; Division of Arctic Sciences; Fondation pour la Recherche Médicale; Institut National Du Cancer; Institut National de la Santé et de la Recherche Médicale; Agence Nationale de la Recherche; Association pour la Recherche sur le Cancer; Seerave Foundation; Institut national de la recherche scientifique; Institut Gustave-Roussy; Fondation Leducq","keywords":"Medicine; HMGB1; Breast cancer; Context (archaeology); Internal medicine; Oncology; Head and neck cancer; Chemoradiotherapy; Cancer; Squamous cell cancer; Colorectal cancer; Inflammation; Cancer research; Biology","score_opus":0.02726564328689017,"score_gpt":0.34997913794197294,"score_spread":0.32271349465508276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217061495","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002363601,0.017451119,0.00027102698,0.048504446,0.9314644,0.000036496076,0.000092129296,0.000071514616,0.0018725292],"genre_scores_gemma":[0.0016899772,0.012328868,0.00019996417,0.020323887,0.959955,0.000042909156,0.00006804424,0.000035045658,0.005356328],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99808466,0.0004995546,0.00031971798,0.0003179947,0.0006646385,0.00011342356],"domain_scores_gemma":[0.98846483,0.0055540935,0.0004676456,0.00024578435,0.0039749458,0.0012926968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054509495,0.0025092082,0.0026185638,0.0019995635,0.0011335193,0.0035275947,0.002003301,0.007919563,0.003339823],"category_scores_gemma":[0.0148040205,0.0008745139,0.0012725245,0.0009880785,0.0012153265,0.0022035313,0.0007164836,0.013650183,0.0033360985],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002653443,0.00003170646,0.00027145343,0.00046442443,0.00005845307,0.00045883254,0.000024888393,0.00005086692,0.0001617823,0.00027639983,0.9822809,0.015654875],"study_design_scores_gemma":[0.00041521582,0.00019780305,0.0046619885,0.0015529095,0.00041933454,0.0021635862,0.000116652176,0.0009850039,0.000618009,0.0017474572,0.98705417,0.00006783411],"about_ca_topic_score_codex":0.0013197478,"about_ca_topic_score_gemma":0.002255924,"teacher_disagreement_score":0.007919563,"about_ca_system_score_codex":0.0020906914,"about_ca_system_score_gemma":0.0012523946,"threshold_uncertainty_score":0.028827727},"labels":[],"label_agreement":null},{"id":"W4200464648","doi":"10.1080/2162402x.2021.2010905","title":"CCL5 production in lung cancer cells leads to an altered immune microenvironment and promotes tumor development","year":2021,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; University of British Columbia","funders":"Canadian Institutes of Health Research; BC Cancer Foundation; Terry Fox Research Institute","keywords":"CCL5; Tumor microenvironment; Immune system; Cancer research; Chemokine; KRAS; Lung cancer; Immunotherapy; Cytokine; Immunology; Medicine; T cell; CD8; Cancer; Biology; IL-2 receptor; Oncology; Internal medicine","score_opus":0.012650492094816673,"score_gpt":0.27437048894631544,"score_spread":0.26171999685149877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200464648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977901,0.0007735021,0.0005277825,0.000068089576,0.00001010148,0.000010505481,0.00011864472,0.00003002178,0.0006712158],"genre_scores_gemma":[0.999143,0.000118431824,0.0001625733,0.000019671512,0.0000061657242,0.0000065907716,0.00021270229,0.0000017519303,0.00032901464],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984896,0.00003095568,0.000014198409,0.000016578137,0.0000356623,0.00005360805],"domain_scores_gemma":[0.99986506,0.000019427884,0.000044109944,0.000014164028,0.000016380074,0.00004087381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015316842,0.00017924403,0.00011799951,0.000279969,0.00018946108,0.00033612183,0.000078802776,0.00016417356,0.0014528193],"category_scores_gemma":[0.00016132738,0.000058446116,0.00016304658,0.00013731509,0.0001421163,0.000104881874,0.0001393064,0.00029647732,0.00019829762],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028161058,0.000054300835,0.017022662,0.00003725982,0.0000129638365,0.00031554833,0.000027560081,0.000069365306,0.9797259,0.00010499601,0.00009454874,0.0022533035],"study_design_scores_gemma":[0.00005889517,0.0010603674,0.2232267,0.000018445207,0.00007138403,0.003375524,0.00022544937,0.0015799563,0.7655469,0.00013011663,0.004696567,0.00000982518],"about_ca_topic_score_codex":0.0008424986,"about_ca_topic_score_gemma":0.0011462665,"teacher_disagreement_score":0.0014528193,"about_ca_system_score_codex":0.0003012148,"about_ca_system_score_gemma":0.00021905031,"threshold_uncertainty_score":0.0048602223},"labels":[],"label_agreement":null},{"id":"W4210679360","doi":"10.1080/2162402x.2022.2033433","title":"CD4+ T cells in classical Hodgkin lymphoma express exhaustion associated transcription factors TOX and TOX2","year":2022,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Spinal Cord Injury BC","funders":"Rijksuniversiteit Groningen; Canadian Cancer Society Research Institute; Universitair Medisch Centrum Groningen; Genome British Columbia; Genome Canada","keywords":"Immune system; Antigen; Biology; Population; T cell; Cancer research; Lymphoma; Immunology; Molecular biology; Medicine","score_opus":0.018380466357034587,"score_gpt":0.2532166011963488,"score_spread":0.23483613483931423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210679360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99718696,0.0005688891,0.0006722854,0.000024665866,0.0000049215005,0.0000072111725,0.0008153488,0.000039754952,0.00068010244],"genre_scores_gemma":[0.9959836,0.000273629,0.0006331112,0.000037709324,0.000009949632,0.000019963942,0.0015181944,0.000011772594,0.0015120348],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989784,0.000011437646,0.000005793576,0.000032390577,0.000021154181,0.000031374726],"domain_scores_gemma":[0.9998933,0.000031782463,0.00003620834,0.0000068886375,0.000011970618,0.000019863972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009641348,0.000180442,0.00014386259,0.0004163018,0.00021515958,0.00029416376,0.000055802913,0.00016771094,0.0024958395],"category_scores_gemma":[0.00018626022,0.000069823815,0.00012318743,0.0004080206,0.0001612597,0.00012660405,0.0002227538,0.0001564832,0.00033949545],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073133287,0.000033883247,0.18466088,0.00023874617,0.00006688492,0.0006174065,0.00024960708,0.00041391296,0.7894774,0.00013888194,0.000586526,0.02278452],"study_design_scores_gemma":[0.000024918274,0.0003983319,0.89572406,0.000031804524,0.00013496487,0.003297292,0.0007865073,0.00095604535,0.09241699,0.00050646276,0.0057056374,0.000016962847],"about_ca_topic_score_codex":0.00035734585,"about_ca_topic_score_gemma":0.00070325396,"teacher_disagreement_score":0.0024958395,"about_ca_system_score_codex":0.00011876238,"about_ca_system_score_gemma":0.00012472969,"threshold_uncertainty_score":0.008349359},"labels":[],"label_agreement":null},{"id":"W4211179856","doi":"10.4161/onci.22789","title":"Trial watch","year":2012,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer","keywords":"Clinical trial; Medicine; Monoclonal antibody; Cancer; Basic research; Cancer research; Antibody; Immunology; Pathology; Internal medicine; Computer science","score_opus":0.05138908683919521,"score_gpt":0.37355995844054085,"score_spread":0.32217087160134567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211179856","genre_codex":"other","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0062428284,0.043849513,0.005681626,0.12513807,0.053628877,0.0059153643,0.03137641,0.0016386341,0.72652864],"genre_scores_gemma":[0.06616665,0.02392939,0.0066105733,0.238829,0.034253247,0.0071512037,0.03476424,0.00082000805,0.5874757],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984201,0.0006443527,0.00014617757,0.00029578933,0.0003255272,0.00016809025],"domain_scores_gemma":[0.99612033,0.0008924358,0.000417234,0.0005021103,0.0007613487,0.0013064633],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002455872,0.0004395401,0.0009232958,0.00064424134,0.00063507626,0.002027944,0.0009953296,0.0036509635,0.32165557],"category_scores_gemma":[0.009865164,0.00015054672,0.0011302561,0.00053280895,0.000390321,0.0015962275,0.00083292584,0.003509657,0.10066994],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003120297,0.00016533579,0.00071605353,0.0011893391,0.00016922594,0.00013540064,0.000025796924,0.000095834584,0.0002360704,0.0051075015,0.7815961,0.20744301],"study_design_scores_gemma":[0.0021547023,0.00031144696,0.0010336211,0.0013794166,0.00010186794,0.0002459077,0.000037468795,0.00014288593,0.00016910663,0.00523414,0.9891769,0.000012378058],"about_ca_topic_score_codex":0.00079951616,"about_ca_topic_score_gemma":0.0015561203,"teacher_disagreement_score":0.32165557,"about_ca_system_score_codex":0.00095928385,"about_ca_system_score_gemma":0.0016966503,"threshold_uncertainty_score":0.967576},"labels":[],"label_agreement":null},{"id":"W4220769687","doi":"10.1080/2162402x.2022.2057399","title":"Translocation of <i>Helicobacter hepaticus</i> synergizes with myeloid-derived suppressor cells and contributes to breast carcinogenesis","year":2022,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; National Natural Science Foundation of China; National Institutes of Health; National Science Foundation","keywords":"Carcinogenesis; Adoptive cell transfer; Population; Haematopoiesis; Mesenteric lymph nodes; Suppressor; Mammary gland; Myeloid-derived Suppressor Cell","score_opus":0.005088628074043257,"score_gpt":0.19320254079558566,"score_spread":0.1881139127215424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220769687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99306524,0.002042845,0.0013917183,0.00037268203,0.000067685054,0.00005165187,0.00029451563,0.00021564614,0.0024979953],"genre_scores_gemma":[0.99647456,0.00067721173,0.00039006147,0.00009541071,0.000023325676,0.00003719326,0.00026032704,0.000014453658,0.002027497],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998173,0.0000382567,0.000011179169,0.00002545968,0.000042538974,0.00006521408],"domain_scores_gemma":[0.9998994,0.0000072654593,0.00003147178,0.0000098536875,0.0000058887504,0.0000461843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015006847,0.0003225447,0.00022103271,0.00026690555,0.00010347176,0.00018160277,0.00010294494,0.00021437695,0.0017580522],"category_scores_gemma":[0.000087931854,0.000108475004,0.00020062065,0.00009140427,0.00019674256,0.00011020658,0.0002852823,0.00035520236,0.0004001422],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032465399,0.00007750245,0.00084040395,0.00006570507,0.000005766932,0.00012111688,0.000010385341,0.000041198356,0.9957267,0.00009017448,0.00016840978,0.0025279606],"study_design_scores_gemma":[0.000121657526,0.0037720324,0.052406285,0.000036530655,0.00006356845,0.0017663647,0.00016237804,0.002331178,0.9250948,0.00030007042,0.013931302,0.000013895653],"about_ca_topic_score_codex":0.00031503628,"about_ca_topic_score_gemma":0.00037191244,"teacher_disagreement_score":0.0017580522,"about_ca_system_score_codex":0.00023989445,"about_ca_system_score_gemma":0.00015982184,"threshold_uncertainty_score":0.00588125},"labels":[],"label_agreement":null},{"id":"W4226175296","doi":"10.1080/2162402x.2022.2060907","title":"LILRB4 promotes tumor metastasis by regulating MDSCs and inhibiting miR-1 family miRNAs","year":2022,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"Japan Society for the Promotion of Science; Japan Agency for Medical Research and Development","keywords":"microRNA; Metastasis; Cancer research; Medicine; Cancer; Biology; Internal medicine; Gene; Genetics","score_opus":0.012664241322099467,"score_gpt":0.23345899998469374,"score_spread":0.22079475866259426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226175296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878572,0.0046649626,0.003854804,0.0003101893,0.00006898221,0.000044159187,0.00053934933,0.00037006152,0.0022902067],"genre_scores_gemma":[0.9934628,0.0011833839,0.0019179165,0.00008316015,0.000018601124,0.000059530917,0.0005576502,0.000027830572,0.0026891457],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989367,0.00002667363,0.000009111755,0.000018663435,0.00002370312,0.000028225892],"domain_scores_gemma":[0.9999584,0.000004090962,0.000014017727,0.0000043966534,0.000005579484,0.000013446511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000111772075,0.0003834537,0.00024942032,0.00031315754,0.00013929124,0.0002103575,0.00017043587,0.00022311536,0.0016160958],"category_scores_gemma":[0.0000796424,0.00011324713,0.00026744406,0.00011267913,0.00020469888,0.00014644372,0.0001974825,0.00061762525,0.00049408776],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019355598,0.000042391075,0.00021350288,0.000049856375,0.00000684953,0.0000381921,0.00000694121,0.00006478214,0.9976532,0.000083066894,0.000097374985,0.0015503354],"study_design_scores_gemma":[0.00008964764,0.00071214035,0.006213333,0.000008831474,0.000032688193,0.00027095806,0.000039571427,0.0018030378,0.98454463,0.00013212534,0.0061461013,0.000006877565],"about_ca_topic_score_codex":0.00030795793,"about_ca_topic_score_gemma":0.00037393675,"teacher_disagreement_score":0.0016160958,"about_ca_system_score_codex":0.00021078497,"about_ca_system_score_gemma":0.0002079414,"threshold_uncertainty_score":0.0054063797},"labels":[],"label_agreement":null},{"id":"W4229368328","doi":"10.1080/2162402x.2022.2066050","title":"OX40 and 4-1BB delineate distinct immune profiles in sarcoma","year":2022,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Ottawa Mental Health Centre; Institute of Cancer Research","funders":"Cancer Research UK; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Rosetrees Trust; Royal Marsden NHS Foundation Trust","keywords":"Sarcoma; Immunotherapy; Medicine; Immune system; Radiation therapy; Cancer research; Immunology; Oncology; Biology; Internal medicine; Pathology","score_opus":0.010716853905956865,"score_gpt":0.2391249743004987,"score_spread":0.22840812039454184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229368328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99886656,0.00029970665,0.00043279407,0.000006426544,0.0000015550013,0.000004331944,0.000041251085,0.0000056631684,0.00034176264],"genre_scores_gemma":[0.9991492,0.00009453927,0.00033589877,0.000010939447,0.000003656192,0.0000053858857,0.00007664022,0.0000026010239,0.00032105038],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998752,0.00002663658,0.000011589271,0.000028834871,0.000022077385,0.000035712485],"domain_scores_gemma":[0.9998621,0.000035601566,0.000040742147,0.0000136566605,0.000020614396,0.000027319664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022924447,0.000117059906,0.00018006319,0.00076986535,0.000120735385,0.00029246046,0.000052667947,0.00019093856,0.0011485541],"category_scores_gemma":[0.00028140636,0.000095244286,0.000092420596,0.00024612815,0.0002134994,0.00019465272,0.00023351403,0.00016721913,0.000236098],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082220876,0.00003988744,0.11415177,0.000068797366,0.000026936199,0.00023712139,0.00031454657,0.00024878755,0.87190604,0.00028196297,0.000054603493,0.01184743],"study_design_scores_gemma":[0.000045089357,0.00077297713,0.8979979,0.000036257796,0.000081196216,0.0048570447,0.0013383222,0.0028520692,0.08690346,0.0011808979,0.003913951,0.000020706428],"about_ca_topic_score_codex":0.00027633912,"about_ca_topic_score_gemma":0.00062586245,"teacher_disagreement_score":0.0011485541,"about_ca_system_score_codex":0.0000975043,"about_ca_system_score_gemma":0.000086818785,"threshold_uncertainty_score":0.0038422942},"labels":[],"label_agreement":null},{"id":"W4283662383","doi":"10.1080/2162402x.2022.2093426","title":"Trogocytosis and fratricide killing impede MSLN-directed CAR T cell functionality","year":2022,"lang":"en","type":"article","venue":"OncoImmunology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Cancerföreningen i Stockholm; Vetenskapsrådet; Karolinska Institutet; Cancerfonden","keywords":"Mesothelin; Chimeric antigen receptor; Cancer research; T cell; Antigen; CD28; Tumor microenvironment; Immunology; Medicine; Immune system; Tumor cells","score_opus":0.024159371536268178,"score_gpt":0.29159067560473584,"score_spread":0.26743130406846766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283662383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99234563,0.00097321626,0.0052437903,0.0000887064,0.000008204365,0.000035113637,0.00009795895,0.0000729133,0.0011346216],"genre_scores_gemma":[0.99732035,0.00030303703,0.0013596482,0.00003071662,0.000002464284,0.000022220942,0.00007438681,0.00001086579,0.000876182],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99981445,0.000043373137,0.000015087799,0.000028465913,0.000051745614,0.00004685195],"domain_scores_gemma":[0.99988616,0.000041081086,0.00003142017,0.000013791564,0.000012269642,0.000015249907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014922999,0.0002614953,0.00025480933,0.00013850677,0.00012512962,0.0003605122,0.00015479156,0.00032998438,0.0012591651],"category_scores_gemma":[0.0001424093,0.000116446805,0.00016468689,0.00009636027,0.00030188062,0.00027517468,0.00022648447,0.0006052981,0.00032673997],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004351768,0.000013845956,0.00015283962,0.000022212838,0.0000028126174,0.000033972276,0.000012091179,0.00015967962,0.99855334,0.0001537473,0.000023063141,0.0008288278],"study_design_scores_gemma":[0.000006985133,0.00013385784,0.0011827347,0.0000030315293,0.0000054202965,0.00023793385,0.000017128412,0.0013064585,0.9958587,0.00004201036,0.0012038121,0.0000019084528],"about_ca_topic_score_codex":0.0006740148,"about_ca_topic_score_gemma":0.0011111097,"teacher_disagreement_score":0.0012591651,"about_ca_system_score_codex":0.0003105513,"about_ca_system_score_gemma":0.000286354,"threshold_uncertainty_score":0.0042123795},"labels":[],"label_agreement":null},{"id":"W4284674170","doi":"10.1080/2162402x.2022.2096535","title":"<i>Helicobacter pylori</i> serology is associated with worse overall survival in patients with melanoma treated with immune checkpoint inhibitors","year":2022,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Jewish General Hospital; McGill University Health Centre; Centre Hospitalier de l’Université de Montréal","funders":"Institute of Cancer Research; Canadian Institutes of Health Research; Institut Du Cancer de Montréal; Fonds de Recherche du Québec - Santé; Fondation pour la Recherche Nuovo-Soldati","keywords":"Helicobacter pylori; Medicine; Serology; Melanoma; Pembrolizumab; Immune system; Nivolumab; Immunology; Immune checkpoint; Oncology; Cancer research; Immunotherapy; Internal medicine; Antibody","score_opus":0.008021120937645447,"score_gpt":0.21284744110005052,"score_spread":0.20482632016240507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4284674170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982905,0.00068850693,0.00004000874,0.000088093766,0.000011014835,0.0000050237727,0.00022593916,0.000004733091,0.000646045],"genre_scores_gemma":[0.99945,0.00013618596,0.000026798865,0.000047154957,0.000015790294,0.000003211164,0.00019089582,0.000001374212,0.00012849772],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998927,0.000021537977,0.000011091358,0.000026742377,0.000021883536,0.000025933148],"domain_scores_gemma":[0.99963963,0.000035213274,0.00019512928,0.00001858556,0.000034569286,0.000076942495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020225147,0.0001354487,0.00025283603,0.0003189657,0.00027896374,0.00037597617,0.00012727293,0.00025448957,0.0014945981],"category_scores_gemma":[0.0004950929,0.0001111254,0.00031554428,0.00038835272,0.00017161605,0.00019131579,0.00024393282,0.00037687368,0.00016388764],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033422117,0.000024110992,0.99615306,0.000012025062,0.000051804178,0.00008250093,0.000017436729,0.000024660603,0.00085448,0.000006979492,0.00019074684,0.0022479855],"study_design_scores_gemma":[0.0000075273347,0.000081723214,0.9992849,0.0000050661642,0.000029966335,0.00019844362,0.00004273103,0.00008290186,0.00007599816,0.000011735209,0.00017768976,0.0000012320586],"about_ca_topic_score_codex":0.0018217484,"about_ca_topic_score_gemma":0.002352896,"teacher_disagreement_score":0.0018217484,"about_ca_system_score_codex":0.0001563694,"about_ca_system_score_gemma":0.00012959214,"threshold_uncertainty_score":0.004999876},"labels":[],"label_agreement":null},{"id":"W4289223990","doi":"10.1080/2162402x.2022.2104070","title":"Targeting 3D chromosomal architecture at the RANK loci to suppress myeloma-driven osteoclastogenesis","year":2022,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Worldwide Cancer Research; Versus Arthritis; Medical Research Scotland","keywords":"Osteoclast; RANKL; Cancer research; Multiple myeloma; Immune system; Epigenetics; Regulator; Biology; Bone marrow; Cell biology; Signal transduction; Receptor; Immunology; Genetics; Gene; Activator (genetics)","score_opus":0.014935925523961703,"score_gpt":0.2768729583328667,"score_spread":0.26193703280890496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289223990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881963,0.0011363833,0.008281753,0.00011707174,0.000037394046,0.000043979846,0.00033635565,0.0001639968,0.0016868341],"genre_scores_gemma":[0.99471164,0.000505473,0.002438616,0.000033784854,0.0000055762266,0.000027609603,0.00020080028,0.000017533872,0.0020590557],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999037,0.000015023354,0.000006375767,0.000017296788,0.00003142908,0.000026251417],"domain_scores_gemma":[0.99993587,0.000011478623,0.00002689497,0.000008386799,0.0000050227995,0.000012365958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010461528,0.00022427004,0.0001447979,0.00014507485,0.00010138553,0.000226304,0.00018386554,0.00018411396,0.0013291136],"category_scores_gemma":[0.00008419934,0.00011839997,0.0001528632,0.000118831245,0.00023651795,0.00007502115,0.00019310911,0.00054071384,0.0002509259],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045704066,0.000020125644,0.000067760426,0.00001626908,0.000002243623,0.000013316609,0.000008719862,0.000178574,0.9984687,0.0001892667,0.000021661914,0.00096753385],"study_design_scores_gemma":[0.000021817721,0.00041805612,0.0014425558,0.0000043661166,0.000012905631,0.00012155482,0.0000175374,0.0012432033,0.9931439,0.00006071846,0.0035092307,0.0000042699326],"about_ca_topic_score_codex":0.00064256456,"about_ca_topic_score_gemma":0.0016960534,"teacher_disagreement_score":0.0013291136,"about_ca_system_score_codex":0.0002656504,"about_ca_system_score_gemma":0.00031870155,"threshold_uncertainty_score":0.0044463873},"labels":[],"label_agreement":null},{"id":"W4300960076","doi":"10.1080/2162402x.2022.2127284","title":"Influencing tumor-associated macrophages in malignant melanoma with monoclonal antibodies","year":2022,"lang":"en","type":"review","venue":"OncoImmunology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"Guy's and St Thomas' NHS Foundation Trust; King's Health Partners; King's College London; Cancer Research UK; Medical Research Council; Barts Charity; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Breast Cancer Now; King’s College London","keywords":"Melanoma; Monoclonal antibody; Cancer research; Tumor microenvironment; Medicine; Immunotherapy; Immune system; Immune checkpoint; Cancer immunotherapy; Immunology; Antibody","score_opus":0.028218293026081913,"score_gpt":0.2865933822820599,"score_spread":0.25837508925597796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4300960076","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002116265,0.99836296,0.00013469692,0.00016612686,0.00024102443,0.000006036185,0.0000068999257,0.0000075516596,0.0008630548],"genre_scores_gemma":[0.0014481277,0.9966444,0.00017130411,0.0003006977,0.00027497424,0.000010814668,0.00002639326,0.0000018349333,0.0011215655],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99988174,0.000020800851,0.000012988219,0.000016341028,0.00005223053,0.000015928303],"domain_scores_gemma":[0.99990773,0.000036742153,0.000014721374,0.0000030543201,0.000025922262,0.000011811349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039252927,0.0007003633,0.00072928716,0.0014120237,0.00015843697,0.0005104654,0.0005405459,0.0009821207,0.0013301382],"category_scores_gemma":[0.00030780648,0.00023994158,0.00033851972,0.00080585975,0.00030711875,0.0007472421,0.00047686917,0.0015903079,0.0013873912],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011785956,0.00012422858,0.00021689602,0.01044275,0.000063820786,0.00038538905,0.00005762891,0.00038918012,0.008026776,0.0044309516,0.032224778,0.9435198],"study_design_scores_gemma":[0.00004045554,0.00019360115,0.0008387653,0.0013994008,0.000066274195,0.002125439,0.000023817425,0.0001417753,0.002360604,0.0014062632,0.9913884,0.000015190486],"about_ca_topic_score_codex":0.000540311,"about_ca_topic_score_gemma":0.0010225533,"teacher_disagreement_score":0.0014120237,"about_ca_system_score_codex":0.00040985414,"about_ca_system_score_gemma":0.00039171637,"threshold_uncertainty_score":0.004449725},"labels":[],"label_agreement":null},{"id":"W4317721404","doi":"10.1080/2162402x.2023.2168233","title":"The inhibitory NKR-P1B receptor regulates NK cell-mediated mammary tumor immunosurveillance in mice","year":2023,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Toronto; University of Windsor","funders":"Natural Sciences and Engineering Research Council of Canada; Universities Space Research Association; Cancer Research Society; University of Windsor","keywords":"Immunosurveillance; Biology; Granzyme B; Cancer research; Mammary tumor; TIGIT; Immune system; Downregulation and upregulation; Cell biology; Immunology; Cancer; T cell; Breast cancer; Gene","score_opus":0.007104199108676819,"score_gpt":0.21263986557963016,"score_spread":0.20553566647095334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317721404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9814844,0.0035949545,0.007125111,0.000509977,0.00011994723,0.0001321772,0.0023255728,0.00071521546,0.0039926344],"genre_scores_gemma":[0.9805463,0.0020656676,0.004188266,0.00026548395,0.00004039275,0.00027890195,0.0020086514,0.00024415695,0.010362124],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99945015,0.00008818853,0.000054285076,0.00015218703,0.00012236154,0.00013272875],"domain_scores_gemma":[0.99968445,0.00002322493,0.00012133764,0.00003415068,0.000018101518,0.000118765834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028567368,0.00067365356,0.00048626724,0.00077253487,0.00032837258,0.0007883613,0.00066196674,0.0008107855,0.002841068],"category_scores_gemma":[0.00016592753,0.00054611743,0.00057270896,0.00023060256,0.00059234654,0.0005739631,0.0004835498,0.002261607,0.0017429016],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032156814,0.00009429954,0.0002061098,0.000046764802,0.000009165753,0.00009887257,0.00002368777,0.00009639512,0.9973496,0.0003330737,0.00012622608,0.0012942228],"study_design_scores_gemma":[0.00030550646,0.0011781104,0.009602404,0.000057448637,0.00006810045,0.0013214806,0.0001265732,0.0026576843,0.97439146,0.00040817237,0.0098576145,0.000025592943],"about_ca_topic_score_codex":0.0005390749,"about_ca_topic_score_gemma":0.00066160224,"teacher_disagreement_score":0.002841068,"about_ca_system_score_codex":0.0006348826,"about_ca_system_score_gemma":0.00034484646,"threshold_uncertainty_score":0.009504259},"labels":[],"label_agreement":null},{"id":"W4365515216","doi":"10.1080/2162402x.2023.2201147","title":"Neoadjuvant immune checkpoint blockade triggers persistent and systemic T <sub>reg</sub> activation which blunts therapeutic efficacy against metastatic spread of breast tumors","year":2023,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Health, British Columbia; Ministerie van Volksgezondheid, Welzijn en Sport; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; F. Hoffmann-La Roche; Oncode Institute; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Science Foundation","keywords":"Medicine; Immune checkpoint; Breast cancer; Immune system; Cancer research; Metastatic breast cancer; Metastasis; Primary tumor; Cancer; Immunotherapy; Blockade; Oncology; CD8; Internal medicine; Immunology; Receptor","score_opus":0.02013765047830695,"score_gpt":0.2661501953040062,"score_spread":0.24601254482569923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365515216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941003,0.002369741,0.0008762564,0.00021226144,0.00008218445,0.000041157622,0.00015534073,0.00013924997,0.002023513],"genre_scores_gemma":[0.99743134,0.0008277575,0.00048555937,0.00011107174,0.000029761197,0.000046233108,0.00016324666,0.000010924273,0.00089416694],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999043,0.00001363882,0.0000066362936,0.000014972444,0.000020448126,0.000039986953],"domain_scores_gemma":[0.9999217,0.000015500822,0.000022311795,0.0000102199665,0.0000040095465,0.000026219388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010978639,0.0003114993,0.00045739877,0.000115389215,0.00008390373,0.00026544178,0.00011258075,0.00020668737,0.0011122233],"category_scores_gemma":[0.00013519579,0.0001404891,0.00020024207,0.00007135917,0.00021109289,0.00016926012,0.00012660248,0.001082307,0.00032786644],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011021944,0.00039583494,0.0005478724,0.000093112016,0.000012445732,0.000095284384,0.000017556651,0.0002753256,0.9868874,0.00017446934,0.00040603502,0.009992391],"study_design_scores_gemma":[0.0003000459,0.012704285,0.015001131,0.00003181892,0.00006939268,0.0014610045,0.000065951775,0.0040160674,0.96012837,0.00028237424,0.0059239315,0.000015639827],"about_ca_topic_score_codex":0.00025522607,"about_ca_topic_score_gemma":0.00061470474,"teacher_disagreement_score":0.0011122233,"about_ca_system_score_codex":0.00026015617,"about_ca_system_score_gemma":0.000281102,"threshold_uncertainty_score":0.0037207603},"labels":[],"label_agreement":null},{"id":"W4367184214","doi":"10.1080/2162402x.2023.2204745","title":"Early response evaluation of PD-1 blockade in NSCLC patients through FDG-PET-CT and T cell profiling of tumor-draining lymph nodes","year":2023,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Bristol-Myers Squibb","keywords":"Medicine; Blockade; CD8; Lymph; Positron emission tomography; Pathological; Oncology; Imaging biomarker; Pathology; Internal medicine; Cancer research; Immune system; Nuclear medicine; Receptor; Immunology; Radiology; Magnetic resonance imaging","score_opus":0.03555770407278394,"score_gpt":0.3185617188335017,"score_spread":0.2830040147607178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367184214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984592,0.0005704663,0.00038487435,0.000029062525,0.0000060475077,0.000026386508,0.000102181315,0.000014835588,0.00040691017],"genre_scores_gemma":[0.998777,0.00013311177,0.0004303831,0.000031544412,0.000007075417,0.000031445892,0.0002276784,0.0000027322164,0.00035911158],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99987745,0.000040795534,0.000009498556,0.000028560327,0.000018709394,0.000024900402],"domain_scores_gemma":[0.99979764,0.000066967914,0.00004221137,0.0000129286145,0.000029447046,0.000050796447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032762426,0.00026039887,0.0003925618,0.00029269815,0.00010322361,0.00028187787,0.00012834111,0.00030237867,0.00066807616],"category_scores_gemma":[0.00043282742,0.00010093379,0.00017471467,0.00014294125,0.00010473845,0.0001977178,0.00009930175,0.0004012266,0.00018404305],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013217838,0.0007511653,0.7579256,0.00013120355,0.00009345885,0.00038961993,0.00015810269,0.0013196331,0.16602553,0.00006854669,0.0003371471,0.059582178],"study_design_scores_gemma":[0.00019343111,0.009497611,0.93286866,0.00002482143,0.00015366575,0.00093201175,0.000179487,0.0058226963,0.048740488,0.00015141458,0.001419893,0.000015778709],"about_ca_topic_score_codex":0.000380901,"about_ca_topic_score_gemma":0.00076959026,"teacher_disagreement_score":0.00066807616,"about_ca_system_score_codex":0.0002169338,"about_ca_system_score_gemma":0.00014387467,"threshold_uncertainty_score":0.0022349358},"labels":[],"label_agreement":null},{"id":"W4378627997","doi":"10.1080/2162402x.2023.2218782","title":"Eribulin mesylate exerts antitumor effects via CD103","year":2023,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Tsukuba; Eisai Canada; Eisai","keywords":"Cancer research; Cytotoxic T cell; Granzyme B; Tumor microenvironment; TIGIT; CD8; Chemistry; T cell; Downregulation and upregulation; Immune system; Biology; Immunology; In vitro","score_opus":0.011743955864055916,"score_gpt":0.31917743913521274,"score_spread":0.3074334832711568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378627997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921698,0.0015142948,0.0009128931,0.000114516035,0.000031902444,0.000032465803,0.00024066019,0.00012441889,0.004859047],"genre_scores_gemma":[0.99474925,0.00061290147,0.00047249877,0.00006352674,0.000010763225,0.000028367653,0.00023609014,0.000010363377,0.003816228],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999232,0.000013428993,0.000004779715,0.000012469612,0.000016457518,0.000029615003],"domain_scores_gemma":[0.9999778,0.0000032149253,0.0000051110574,0.0000029198345,0.0000024929457,0.000008435183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004400039,0.0003349236,0.00019403841,0.00017459161,0.00008379931,0.00014720336,0.00011173521,0.00017239756,0.0018694485],"category_scores_gemma":[0.000042814172,0.00008294489,0.00012311075,0.00008798696,0.00008248725,0.00012752123,0.00010654585,0.00046620567,0.00042561023],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001495755,0.000064301625,0.00014335602,0.000032255983,0.000003953452,0.000044155986,0.0000056109666,0.000071147115,0.9953858,0.00007762998,0.00008412595,0.0039380807],"study_design_scores_gemma":[0.00008506366,0.0010764672,0.0050481623,0.000007857013,0.000021455404,0.00033158492,0.00002099684,0.0007688177,0.98643214,0.000056531935,0.0061467187,0.000004310279],"about_ca_topic_score_codex":0.0002354407,"about_ca_topic_score_gemma":0.0005212668,"teacher_disagreement_score":0.0018694485,"about_ca_system_score_codex":0.00015522256,"about_ca_system_score_gemma":0.00009954779,"threshold_uncertainty_score":0.006253898},"labels":[],"label_agreement":null},{"id":"W4379365035","doi":"10.1080/2162402x.2023.2214478","title":"Trial watch: immunotherapeutic strategies on the horizon for hepatocellular carcinoma","year":2023,"lang":"en","type":"review","venue":"OncoImmunology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovation Cluster (Canada)","funders":"National Medical Research Council; Medical Research Council; Eisai","keywords":"Medicine; Oncology; Durvalumab; Internal medicine; Hepatocellular carcinoma; Liver transplantation; Bevacizumab; Tremelimumab; Brentuximab vedotin; Nivolumab; Regimen; Atezolizumab; Immunotherapy; Intensive care medicine; Cancer; Transplantation; Ipilimumab; Lymphoma; Chemotherapy","score_opus":0.2962444592995445,"score_gpt":0.36719836804497147,"score_spread":0.07095390874542695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379365035","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018091276,0.9966658,0.000119084754,0.0006798072,0.00047842157,0.00002474866,0.000075425945,0.0000144137275,0.0017614437],"genre_scores_gemma":[0.0010271041,0.9962781,0.0002165833,0.00094381714,0.0003112883,0.000031779273,0.0001447998,0.0000045803567,0.0010419631],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998116,0.000055749817,0.000028388784,0.000021904478,0.00006127049,0.000021092366],"domain_scores_gemma":[0.9996201,0.00019977712,0.000061746876,0.0000086359,0.00007646691,0.000033272663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007354249,0.00045564046,0.0010164222,0.001113016,0.00016769655,0.0007872566,0.00066848507,0.0008015327,0.0055347867],"category_scores_gemma":[0.00097345427,0.00011864386,0.00064940634,0.0010955182,0.00017899639,0.0008454105,0.00053009705,0.0017294432,0.0019237668],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017879475,0.000054614047,0.00008762477,0.01921258,0.00013863493,0.00006501879,0.000029354847,0.00017053282,0.00080459024,0.0023658813,0.042398605,0.9344937],"study_design_scores_gemma":[0.00018544975,0.00023396545,0.0006775172,0.011438541,0.00034102408,0.00041962898,0.00003358585,0.00010781153,0.0003308387,0.0018875337,0.9843305,0.000013614812],"about_ca_topic_score_codex":0.00045219297,"about_ca_topic_score_gemma":0.0014311873,"teacher_disagreement_score":0.0055347867,"about_ca_system_score_codex":0.00043242326,"about_ca_system_score_gemma":0.0008607309,"threshold_uncertainty_score":0.018515766},"labels":[],"label_agreement":null},{"id":"W4381486868","doi":"10.1080/2162402x.2023.2222560","title":"Updates on radiotherapy-immunotherapy combinations: Proceedings of 6 <sup>th</sup> annual ImmunoRad conference","year":2023,"lang":"en","type":"review","venue":"OncoImmunology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Institute of Cancer Research","funders":"National Cancer Institute; University of California, San Francisco; EMD Serono; Genentech; European Society for Medical Oncology; Eli Lilly and Company; Associazione Italiana per la Ricerca sul Cancro; Ono Pharmaceutical; Eisai; National Institute for Health and Care Research; Seagen; F-star Therapeutics; Accuray; Mersana Therapeutics; Break Through Cancer; RefleXion Medical; Regeneron Pharmaceuticals; Parker Institute for Cancer Immunotherapy; Ipsen; Varian Medical Systems; Pfizer; Prostate Cancer Foundation; Bristol-Myers Squibb; AstraZeneca; Novocure; Cancer Research UK; Boston Scientific Corporation","keywords":"Medical physics; Medicine; Radiation therapy; Immunotherapy; Cancer; Internal medicine","score_opus":0.03747778903876445,"score_gpt":0.3168971474978056,"score_spread":0.2794193584590412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381486868","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033705545,0.9737254,0.00040352473,0.0043285713,0.011808178,0.00004646125,0.00014333951,0.000062673505,0.009144903],"genre_scores_gemma":[0.001695901,0.974394,0.0008557249,0.0046869717,0.0073293606,0.00006506145,0.00040415628,0.000025271574,0.010543545],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994955,0.00010421741,0.000059794253,0.000048485523,0.00022541122,0.00006649304],"domain_scores_gemma":[0.9986773,0.00036715515,0.00015034757,0.000026442734,0.0005816442,0.00019703875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019170154,0.0008331533,0.001012151,0.0019536866,0.00035672195,0.0017554958,0.0010349306,0.00180518,0.015474411],"category_scores_gemma":[0.0019652336,0.0003016689,0.00076300866,0.0015221048,0.00034822276,0.0017074733,0.0011212891,0.0025580712,0.008735424],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016394249,0.000098828816,0.0001437523,0.0077377907,0.000056992292,0.00017499767,0.000048327696,0.00025381363,0.00226427,0.002744372,0.33479196,0.6515209],"study_design_scores_gemma":[0.000009569218,0.000058299778,0.00020413016,0.0010725298,0.00003370186,0.0002451946,0.00001450705,0.000021486987,0.0003212144,0.00029351044,0.9977196,0.0000061860746],"about_ca_topic_score_codex":0.0005598945,"about_ca_topic_score_gemma":0.0019810626,"teacher_disagreement_score":0.015474411,"about_ca_system_score_codex":0.0008479519,"about_ca_system_score_gemma":0.0013291884,"threshold_uncertainty_score":0.05176705},"labels":[],"label_agreement":null},{"id":"W4384499645","doi":"10.1080/2162402x.2023.2233403","title":"Longitudinal immune monitoring of patients with resectable esophageal adenocarcinoma treated with Neoadjuvant PD-L1 checkpoint inhibition","year":2023,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Peripheral blood mononuclear cell; CD8; Biomarker; Oncology; Immune system; Internal medicine; Neoadjuvant therapy; Flow cytometry; Gastroenterology; Cancer; Cancer research; Immunology; Breast cancer; Biology","score_opus":0.021816981490046516,"score_gpt":0.2832220520964986,"score_spread":0.2614050706064521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384499645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991836,0.00030188498,0.00011283404,0.000010307086,0.0000028422066,0.000010914615,0.00015456406,0.0000034229522,0.00021965071],"genre_scores_gemma":[0.999252,0.00007109637,0.00012009847,0.0000251252,0.0000065666004,0.000015359154,0.00036617456,8.6929583e-7,0.00014276322],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999772,0.00006120015,0.000032271564,0.00006734919,0.000033270044,0.000033939443],"domain_scores_gemma":[0.9996306,0.000060111957,0.00015256708,0.00004029,0.000042175066,0.00007427247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003781028,0.0001591087,0.00035763043,0.00023387077,0.00014400987,0.00027837444,0.000103354614,0.00016103905,0.0004486732],"category_scores_gemma":[0.00052407605,0.000107440916,0.0001669755,0.0002187241,0.00010385501,0.0001719966,0.00021525766,0.00023045442,0.00011710758],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031068227,0.00014275433,0.9699869,0.000045920548,0.00007283213,0.00020087305,0.00012160304,0.00018398285,0.010475458,0.000025788022,0.00020541181,0.015431635],"study_design_scores_gemma":[0.000041471132,0.0023038047,0.9939306,0.000008568284,0.00008198593,0.00045902783,0.0001134484,0.0003609936,0.0019805848,0.000023733925,0.00069107156,0.0000047280355],"about_ca_topic_score_codex":0.00026176046,"about_ca_topic_score_gemma":0.0004731394,"teacher_disagreement_score":0.0004486732,"about_ca_system_score_codex":0.00016174109,"about_ca_system_score_gemma":0.00013496008,"threshold_uncertainty_score":0.0019996166},"labels":[],"label_agreement":null},{"id":"W4386741883","doi":"10.1080/2162402x.2023.2253644","title":"Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients","year":2023,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"Fondazione Italiana per la Ricerca sul Cancro; Fondazione Cassa di Risparmio di Verona Vicenza Belluno e Ancona; Università Cattolica del Sacro Cuore; Associazione Italiana per la Ricerca sul Cancro; Università degli Studi di Verona; China Scholarship Council; European Commission; Cancer Research Institute","keywords":"Immune checkpoint; Blockade; Immune system; Medicine; Myeloid; Inflammation; Cancer research; Myeloid-derived Suppressor Cell; Systemic inflammation; Monocyte; Cancer; Immunology; Immunotherapy; Suppressor; Internal medicine; Receptor","score_opus":0.00811540187893353,"score_gpt":0.23181351436910871,"score_spread":0.22369811249017518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386741883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99869484,0.0008260545,0.00010617148,0.000017083972,0.0000047349495,0.000017755543,0.000027976233,0.0000069340067,0.00029851988],"genre_scores_gemma":[0.999353,0.00025827225,0.00009839662,0.000012782252,0.000005464152,0.000012424491,0.0000763059,0.0000011314154,0.00018221352],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999596,0.0000082439155,0.000004222338,0.00000803514,0.000008276553,0.000011774959],"domain_scores_gemma":[0.99996054,0.0000043276978,0.000011145297,0.0000030918516,0.000005842406,0.000015145078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000084765525,0.00015452817,0.00026207435,0.00013884595,0.00009869099,0.00013134316,0.00006612191,0.000072039205,0.0003751429],"category_scores_gemma":[0.000119016666,0.000049765433,0.00014736332,0.000066943525,0.00006926759,0.000089694644,0.00008352295,0.00021305427,0.00006455735],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012250571,0.0014526043,0.10870633,0.0002975187,0.00015988029,0.0010755712,0.00019990507,0.0013336432,0.70391667,0.00019572023,0.0008817143,0.16952984],"study_design_scores_gemma":[0.0010255106,0.039260082,0.7936638,0.0000537407,0.00039209417,0.0035450081,0.0002909316,0.0069527333,0.14800447,0.0002761225,0.006513462,0.000022017583],"about_ca_topic_score_codex":0.00028648184,"about_ca_topic_score_gemma":0.00076822704,"teacher_disagreement_score":0.0003751429,"about_ca_system_score_codex":0.00011794709,"about_ca_system_score_gemma":0.00013445309,"threshold_uncertainty_score":0.0012550354},"labels":[],"label_agreement":null},{"id":"W4386742019","doi":"10.1080/2162402x.2023.2253642","title":"Homogeneity in immune features between colorectal liver metastases better identifies patients with good prognosis compared to pathological response to preoperative chemotherapy","year":2023,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Fonds de Recherche du Québec - Santé; Institute of Cancer Research; Institut Du Cancer de Montréal; International Hepato-Pancreato-Biliary Association; Ethicon; Université de Montréal","keywords":"Medicine; Chemotherapy; Colorectal cancer; Pathological; Immune system; Grading (engineering); Oncology; Internal medicine; Pathology; Gastroenterology; Cancer; Immunology; Biology","score_opus":0.01867915437774884,"score_gpt":0.2863768383331473,"score_spread":0.26769768395539845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386742019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99978167,0.00005997044,0.000042444946,0.0000068985773,9.512172e-7,0.0000019384927,0.000023649462,0.0000016159038,0.00008077782],"genre_scores_gemma":[0.9998709,0.000010945709,0.000027594822,0.000005373204,0.000003657542,0.0000016510804,0.000059460555,7.104283e-7,0.00001968607],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997557,0.00006851647,0.00003516769,0.000059433638,0.000030123236,0.00005101267],"domain_scores_gemma":[0.9988902,0.00028613344,0.00045564715,0.00006919643,0.00006167508,0.00023721113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026472125,0.00017782005,0.00037162114,0.00081611495,0.00023359599,0.00038193926,0.000127056,0.00028788863,0.0011293896],"category_scores_gemma":[0.0014392493,0.00013710654,0.00020489277,0.0003498426,0.0002728582,0.00025142447,0.00036756013,0.00020957354,0.00022061246],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040485442,0.000014594133,0.9953993,0.0000052631603,0.00002480061,0.000094429175,0.000033674733,0.000056849614,0.0026387577,0.000006567047,0.000026206784,0.0012946115],"study_design_scores_gemma":[0.0000071037816,0.00014238774,0.9987552,0.0000017062217,0.000013520302,0.00042928316,0.000070525435,0.00021270431,0.00029452232,0.000017334421,0.000053087762,0.0000026854464],"about_ca_topic_score_codex":0.00055936875,"about_ca_topic_score_gemma":0.0008730037,"teacher_disagreement_score":0.0011293896,"about_ca_system_score_codex":0.00015953863,"about_ca_system_score_gemma":0.000093448776,"threshold_uncertainty_score":0.0037781596},"labels":[],"label_agreement":null},{"id":"W4387907317","doi":"10.1080/2162402x.2023.2261278","title":"Driver mutations in <i>GNAQ</i> and <i>GNA11</i> genes as potential targets for precision immunotherapy in uveal melanoma patients","year":2023,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Agencia Estatal de Investigación; Instituto de Salud Carlos III; Generalitat de Catalunya; Centres de Recerca de Catalunya","keywords":"GNAQ; Melanoma; Population; Cancer; Malignancy; Cancer research; Medicine; Biology; Genetics; Mutation; Gene","score_opus":0.007912358496235821,"score_gpt":0.2520083694141703,"score_spread":0.2440960109179345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387907317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97468185,0.0111970445,0.0018369141,0.0005296385,0.00006749286,0.000043868622,0.009291887,0.0001457448,0.0022055553],"genre_scores_gemma":[0.9810884,0.0024503055,0.0028323298,0.00040599177,0.000045134853,0.00003953263,0.012431117,0.00004098397,0.0006662053],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997392,0.00004374723,0.000025980677,0.00009617753,0.000052367617,0.000042596625],"domain_scores_gemma":[0.9996661,0.00012538236,0.000094006864,0.000028083996,0.000041008407,0.000045392037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004174578,0.0002206276,0.00057252607,0.0005892484,0.00020346965,0.0006323686,0.00025375592,0.00037280007,0.0017779819],"category_scores_gemma":[0.0010661697,0.00011805106,0.0007425666,0.00082166103,0.00012502859,0.00023313741,0.00031951294,0.0004043712,0.0003313873],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024202594,0.00011934437,0.8227616,0.000781731,0.00077952334,0.0011774746,0.00014292331,0.0062357257,0.03816606,0.00058891444,0.007757585,0.11906883],"study_design_scores_gemma":[0.00041673274,0.0008028836,0.88018715,0.00051494257,0.002505979,0.005753227,0.0004191453,0.024287589,0.023682132,0.003478365,0.05786861,0.00008311711],"about_ca_topic_score_codex":0.0015966729,"about_ca_topic_score_gemma":0.002906398,"teacher_disagreement_score":0.0017779819,"about_ca_system_score_codex":0.00038676994,"about_ca_system_score_gemma":0.00033978623,"threshold_uncertainty_score":0.0059479475},"labels":[],"label_agreement":null},{"id":"W4390004386","doi":"10.1080/2162402x.2023.2290787","title":"A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies","year":2023,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center; Society for Immunotherapy of Cancer; Novartis Pharmaceuticals Corporation","keywords":"Medicine; Rash; Internal medicine; Renal cell carcinoma; Oncology; Melanoma; Nausea; Response Evaluation Criteria in Solid Tumors; Clinical endpoint; Adverse effect; Cancer; Phases of clinical research; Nivolumab; Immunotherapy; Clinical trial; Cancer research","score_opus":0.026400031308302294,"score_gpt":0.3339655591300359,"score_spread":0.3075655278217336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390004386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994399,0.0011624796,0.00059863867,0.0002156415,0.000083971405,0.0021474948,0.00056107744,0.00007599711,0.00075574196],"genre_scores_gemma":[0.98993707,0.0011110483,0.0023368616,0.00055305945,0.00023174513,0.0028382894,0.0015706096,0.00003078936,0.001390516],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9993531,0.00034687412,0.000030119263,0.000116342075,0.000057825808,0.00009577141],"domain_scores_gemma":[0.99928516,0.00012293749,0.00015104604,0.00007491204,0.000047840982,0.00031802035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023082548,0.0018025014,0.0024716835,0.00052862347,0.00043742865,0.0008560047,0.000760986,0.0009865307,0.0023606578],"category_scores_gemma":[0.001027383,0.000860605,0.0013992712,0.00048479036,0.0009714096,0.0010862392,0.00034577976,0.002849185,0.0007293257],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7004327,0.1440237,0.010882091,0.0006642477,0.0014394035,0.0002940181,0.00042722715,0.0024490436,0.055634703,0.000248851,0.0027321328,0.0807718],"study_design_scores_gemma":[0.48369136,0.50150627,0.009291847,0.000013679709,0.00028577293,0.00019339986,0.000041309857,0.0009638344,0.0024134326,0.000104273364,0.0014707551,0.000024073499],"about_ca_topic_score_codex":0.0006437899,"about_ca_topic_score_gemma":0.0014832548,"teacher_disagreement_score":0.0024716835,"about_ca_system_score_codex":0.0008832722,"about_ca_system_score_gemma":0.0014593981,"threshold_uncertainty_score":0.012207329},"labels":[],"label_agreement":null},{"id":"W4396812747","doi":"10.1080/2162402x.2024.2349347","title":"Characterization of innate lymphoid cell subsets infiltrating melanoma and epithelial ovarian tumors","year":2024,"lang":"en","type":"article","venue":"OncoImmunology","topic":"IL-33, ST2, and ILC Pathways","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Alberta Cancer Foundation","keywords":"Innate lymphoid cell; Tumor microenvironment; Innate immune system; Biology; Ovarian cancer; Melanoma; Immune system; Phenotype; Cytotoxic T cell; Cancer research; Immunology; Cancer; In vitro; Gene","score_opus":0.0074328781120161155,"score_gpt":0.20576455707811206,"score_spread":0.19833167896609594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396812747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99800986,0.0004904715,0.00054275774,0.0000106833295,0.000002660265,0.00002273633,0.00018541153,0.000007989412,0.00072735624],"genre_scores_gemma":[0.9977316,0.00027071743,0.00081058964,0.000022882894,0.000010046149,0.000034621044,0.0004787419,0.0000061977767,0.0006346329],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99990857,0.000013852377,0.000009655571,0.000020525935,0.000016286482,0.00003101674],"domain_scores_gemma":[0.9999052,0.000019312118,0.000016937402,0.000010476701,0.000017807452,0.000030346117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010935498,0.00011061845,0.00011254393,0.00072621624,0.0001200839,0.00021990117,0.00006598296,0.00015257647,0.0009657214],"category_scores_gemma":[0.00016601852,0.00006410596,0.00007744492,0.00025234715,0.0000895071,0.00011699273,0.0001679803,0.00014421585,0.00021881713],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035973525,0.000024036248,0.0377866,0.00004873177,0.0000052704545,0.00021607224,0.00015201146,0.000037396097,0.9575457,0.00010649317,0.00003600452,0.0036819417],"study_design_scores_gemma":[0.000060400685,0.0007198893,0.71597207,0.000042075488,0.00004684518,0.0055068587,0.0011177971,0.0020158107,0.26527175,0.0003761484,0.008855318,0.000014973505],"about_ca_topic_score_codex":0.00037020002,"about_ca_topic_score_gemma":0.0005656573,"teacher_disagreement_score":0.0009657214,"about_ca_system_score_codex":0.00007544227,"about_ca_system_score_gemma":0.000107309046,"threshold_uncertainty_score":0.0032306314},"labels":[],"label_agreement":null},{"id":"W4400205565","doi":"10.1080/2162402x.2024.2374954","title":"<i>Faecalibacterium prausnitzii</i> strain EXL01 boosts efficacy of immune checkpoint inhibitors","year":2024,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Ligue Contre le Cancer; Agence Nationale de la Recherche; Institut National Du Cancer; European Commission; Sorbonne Université; Seerave Foundation","keywords":"Faecalibacterium prausnitzii; Immune system; Medicine; Gut flora; Immunology; Cancer research; Immune checkpoint; Adjuvant; Immunotherapy","score_opus":0.008579587314305014,"score_gpt":0.26658473935113786,"score_spread":0.25800515203683283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400205565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960651,0.00068268843,0.0007561863,0.00030318944,0.00007486752,0.000052231968,0.00089049136,0.00008356377,0.001091686],"genre_scores_gemma":[0.9922346,0.0004929559,0.0017191811,0.00025184426,0.000029565734,0.00006644605,0.0015488404,0.000029643856,0.0036269461],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982774,0.000026903475,0.000014477436,0.00003978598,0.000046646375,0.000044548204],"domain_scores_gemma":[0.99987686,0.000013759565,0.000040966348,0.000010754311,0.000017374008,0.000040197978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018832245,0.00037543394,0.00042386918,0.0001903832,0.00015971475,0.00034050105,0.00023782295,0.00032965202,0.0016533447],"category_scores_gemma":[0.00020878215,0.000082258586,0.00025609726,0.0001323218,0.00019264511,0.00017719062,0.00027322394,0.0006931089,0.00030328898],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007444929,0.00024311236,0.0008918656,0.000052042455,0.000016799308,0.000044431654,0.000014061993,0.00006671342,0.9934795,0.000036980076,0.00020402219,0.004206035],"study_design_scores_gemma":[0.0001488657,0.010255925,0.043599054,0.000035876565,0.00009476071,0.00048444775,0.000140332,0.0010460415,0.93455535,0.00010041854,0.009515487,0.000023400784],"about_ca_topic_score_codex":0.001402893,"about_ca_topic_score_gemma":0.0021138308,"teacher_disagreement_score":0.0016533447,"about_ca_system_score_codex":0.00026228133,"about_ca_system_score_gemma":0.00029204588,"threshold_uncertainty_score":0.005531013},"labels":[],"label_agreement":null},{"id":"W4400687481","doi":"10.1080/2162402x.2024.2378520","title":"Human NK cells and cancer","year":2024,"lang":"en","type":"review","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Associazione Italiana per la Ricerca sul Cancro; Ministry of Health, British Columbia; Ministero della Salute; Fondazione AIRC per la ricerca sul cancro ETS","keywords":"Cytotoxic T cell; Immune system; Biology; Cancer immunotherapy; Immunology; Cancer cell; Myeloid-derived Suppressor Cell; NK-92; Immunotherapy; Cell biology; Effector; Function (biology); Cancer; Cancer research; Suppressor; Interleukin 21; Neuroscience; T cell; Genetics; In vitro","score_opus":0.03591132773530244,"score_gpt":0.3372357243338374,"score_spread":0.301324396598535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400687481","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02062485,0.9087365,0.0011532647,0.017540177,0.0028799754,0.000037996426,0.00041160782,0.00006991205,0.048545647],"genre_scores_gemma":[0.38790154,0.54052615,0.001499197,0.010106811,0.0030786677,0.0001040011,0.0011709813,0.000028035864,0.055584628],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998124,0.000052406675,0.000014872849,0.00003807525,0.000043263084,0.000038945036],"domain_scores_gemma":[0.9998975,0.000024464915,0.000016957232,0.000012212915,0.000024517656,0.000024388646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030593286,0.00019314354,0.00029119538,0.00046858887,0.0002883677,0.0010471272,0.00025029125,0.0008921522,0.0067826556],"category_scores_gemma":[0.0004704276,0.00006601952,0.00012926682,0.00050412904,0.00067811,0.0005829353,0.00079243036,0.00081362785,0.0019214281],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013334733,0.0001635146,0.012722859,0.0018951861,0.00009608687,0.0026308377,0.000833002,0.000712517,0.022656813,0.10206142,0.1294389,0.7254555],"study_design_scores_gemma":[0.00006110587,0.00015018939,0.00451614,0.00025399082,0.000021223255,0.003801111,0.00023091528,0.00009027806,0.002510217,0.0109756915,0.9773767,0.000012494869],"about_ca_topic_score_codex":0.0013182366,"about_ca_topic_score_gemma":0.0011489349,"teacher_disagreement_score":0.0067826556,"about_ca_system_score_codex":0.0007362668,"about_ca_system_score_gemma":0.000682635,"threshold_uncertainty_score":0.022690237},"labels":[],"label_agreement":null},{"id":"W4401340322","doi":"10.1080/2162402x.2024.2384667","title":"DNA mismatch repair defect and intratumor heterogeneous deficiency differently impact immune responses in diffuse large B-cell lymphoma","year":2024,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; National Institutes of Health","keywords":"PMS2; MSH6; MSH2; Cancer research; Biology; Diffuse large B-cell lymphoma; MLH1; Immune checkpoint; Tumor microenvironment; Immunotherapy; DNA mismatch repair; Lymphoma; Immune system; Immunology; Gene; DNA repair; Genetics","score_opus":0.010397270822970772,"score_gpt":0.28179853891762097,"score_spread":0.2714012680946502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401340322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996743,0.00015010007,0.00005090297,0.0000043066257,4.6559663e-7,0.0000017380637,0.000024679755,0.0000027543692,0.00009080418],"genre_scores_gemma":[0.9998412,0.00003081694,0.000026811118,0.0000064550245,0.0000010933716,0.000001459305,0.000046038127,8.6568474e-7,0.00004526191],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999002,0.000025742476,0.000009444567,0.000027371247,0.000016516557,0.000020648984],"domain_scores_gemma":[0.99988914,0.000020659156,0.000041111074,0.000011163544,0.000009029397,0.000028890709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000145836,0.00011247977,0.00017074429,0.00037136456,0.00007185657,0.00024754376,0.000072458024,0.00013840868,0.00043608635],"category_scores_gemma":[0.00022642055,0.00009192417,0.00009697752,0.00021361996,0.00011332037,0.00012853916,0.00013558425,0.0001322581,0.0001243766],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003580845,0.0001626068,0.675974,0.000063555184,0.000104562074,0.0009121711,0.0001654686,0.0002965006,0.3014811,0.00008265114,0.00010976513,0.017066736],"study_design_scores_gemma":[0.000039120987,0.00063174486,0.9829654,0.0000037937853,0.000058974172,0.0024886553,0.00015275204,0.00074948935,0.01227148,0.00007640425,0.0005573093,0.0000048245793],"about_ca_topic_score_codex":0.00025070898,"about_ca_topic_score_gemma":0.00031006755,"teacher_disagreement_score":0.00043608635,"about_ca_system_score_codex":0.00015384321,"about_ca_system_score_gemma":0.000057580062,"threshold_uncertainty_score":0.0014588833},"labels":[],"label_agreement":null},{"id":"W4402527544","doi":"10.1080/2162402x.2024.2400429","title":"Multiprong CD38 targeting to enhance anti-PD1 immune checkpoint blockade efficacy","year":2024,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Beatrice Hunter Cancer Research Institute; Dalhousie University","funders":"Canadian Institutes of Health Research; Beatrice Hunter Cancer Research Institute; Research Nova Scotia; Cancer Research Institute","keywords":"Blockade; Immune checkpoint; Medicine; Cancer research; PD-L1; Nivolumab; CD38; Immunotherapy; Immune system; Immunology; Internal medicine; Receptor; Biology","score_opus":0.006891819566299605,"score_gpt":0.2831083397043341,"score_spread":0.2762165201380345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402527544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98947155,0.0039010062,0.0027439038,0.0003115041,0.00011413905,0.00014093553,0.00017224708,0.00013651878,0.0030082178],"genre_scores_gemma":[0.9950029,0.0009303018,0.0018976319,0.00007123411,0.000028794722,0.00007666702,0.000095764706,0.000009193784,0.0018873758],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984527,0.000017650063,0.000009770427,0.0000290008,0.000038785158,0.00005955789],"domain_scores_gemma":[0.99993813,0.000007708268,0.000013415062,0.0000067895658,0.0000057660336,0.00002820032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002047465,0.00040792875,0.00037875684,0.00033752221,0.00014957403,0.00038271415,0.00026258733,0.00028013403,0.0020898469],"category_scores_gemma":[0.00010998328,0.000095753705,0.00019331193,0.00016103413,0.000182813,0.0004232948,0.00033719157,0.0010012911,0.00029603558],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014785544,0.0014283472,0.0004957752,0.00023493587,0.000039942006,0.0001389237,0.000050401275,0.0011284228,0.9451431,0.0008121075,0.00067841704,0.048370946],"study_design_scores_gemma":[0.0007959584,0.013166528,0.005401703,0.000032088476,0.00013814821,0.00084853615,0.00007115372,0.0046225865,0.95425385,0.00063646067,0.02000979,0.000023171828],"about_ca_topic_score_codex":0.00018290819,"about_ca_topic_score_gemma":0.0008164579,"teacher_disagreement_score":0.0020898469,"about_ca_system_score_codex":0.00036472842,"about_ca_system_score_gemma":0.00027500157,"threshold_uncertainty_score":0.006991267},"labels":[],"label_agreement":null},{"id":"W4403190877","doi":"10.1080/2162402x.2024.2413719","title":"Benzodiazepines compromise the outcome of cancer immunotherapy","year":2024,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"HORIZON EUROPE European Research Council; Agence Nationale de la Recherche; HORIZON EUROPE Framework Programme; Cancéropôle Ile de France; Institut National Du Cancer; Institut Universitaire de France; Ligue Contre le Cancer; Fondation pour la Recherche Médicale; Labex Immuno-Oncology; Association pour la Recherche sur le Cancer; Seerave Foundation; European Commission","keywords":"Medicine; Cancer immunotherapy; Immunotherapy; Compromise; Cancer; Internal medicine; Political science","score_opus":0.042816880718713604,"score_gpt":0.34140930155500787,"score_spread":0.2985924208362943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403190877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945846,0.0025869003,0.00033832368,0.0001434446,0.000027653665,0.000024455809,0.00005158852,0.000020609397,0.0022223005],"genre_scores_gemma":[0.9986343,0.0005467919,0.00011826918,0.0000481206,0.0000098654555,0.000011854533,0.000041938798,0.0000020296948,0.0005867633],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999223,0.000022343556,0.000006654539,0.0000070770616,0.000015166929,0.000026447256],"domain_scores_gemma":[0.9998616,0.000029290344,0.00003611842,0.00001589572,0.00001935342,0.000037746522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015057474,0.000112918446,0.00020334127,0.00007850973,0.00009803777,0.00014705409,0.00008940406,0.00015115763,0.0011211728],"category_scores_gemma":[0.0003344281,0.000027092208,0.00006874163,0.000056927613,0.00009390014,0.00012612352,0.00013524904,0.0002979613,0.00024097279],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007135217,0.0016695145,0.021810403,0.00044977583,0.00015740837,0.0011485297,0.00022075567,0.0006655496,0.7547066,0.0012796156,0.0013991169,0.20935746],"study_design_scores_gemma":[0.0010057138,0.05907401,0.27002904,0.00015337083,0.00049868325,0.011551028,0.00063245354,0.0038047042,0.60377556,0.0026087651,0.046827648,0.000038980736],"about_ca_topic_score_codex":0.00015349184,"about_ca_topic_score_gemma":0.00028121864,"teacher_disagreement_score":0.0011211728,"about_ca_system_score_codex":0.0001346725,"about_ca_system_score_gemma":0.00015553918,"threshold_uncertainty_score":0.0037506819},"labels":[],"label_agreement":null},{"id":"W4403214873","doi":"10.1080/2162402x.2024.2412869","title":"The landscape of T-cell engagers for the treatment of follicular lymphoma","year":2024,"lang":"en","type":"review","venue":"OncoImmunology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Cancer Institute; National Institutes of Health; Fundación Española de Hematología y Hemoterapia","keywords":"Medicine; Follicular lymphoma; Lymphoma; Cancer research; Oncology; Internal medicine","score_opus":0.03959889579960756,"score_gpt":0.3349351575010171,"score_spread":0.29533626170140953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403214873","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015818757,0.99862003,0.000086510925,0.00021366066,0.00012575026,0.000006584696,0.000016265463,0.0000076690085,0.00076538004],"genre_scores_gemma":[0.00090395304,0.9981365,0.00014138511,0.00022097536,0.00008028079,0.000009280325,0.000031297543,0.0000013667205,0.00047486226],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99984956,0.000031221287,0.000019544117,0.000021469026,0.000060606348,0.000017574925],"domain_scores_gemma":[0.99982077,0.00008842052,0.000025296595,0.0000049110167,0.00004564957,0.000015043153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005122298,0.00053827977,0.0009411075,0.0013238493,0.00018084144,0.00068645104,0.00062070653,0.0007930426,0.003202068],"category_scores_gemma":[0.0005446175,0.00021325752,0.000537262,0.0009989276,0.00026447957,0.00086080964,0.00046070645,0.0017160461,0.0013663644],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010400162,0.00007982997,0.00009368098,0.01764395,0.00011131163,0.0001144188,0.000046363286,0.000351364,0.0023359929,0.0030970662,0.022036113,0.9539859],"study_design_scores_gemma":[0.000046038564,0.00019297414,0.0005003509,0.00389626,0.00014748673,0.0006836812,0.00003471774,0.000104314815,0.00057560473,0.0013267758,0.9924786,0.000013253113],"about_ca_topic_score_codex":0.00066537125,"about_ca_topic_score_gemma":0.0015088243,"teacher_disagreement_score":0.003202068,"about_ca_system_score_codex":0.0004385854,"about_ca_system_score_gemma":0.0006756912,"threshold_uncertainty_score":0.010712028},"labels":[],"label_agreement":null},{"id":"W4404473852","doi":"10.1080/2162402x.2024.2429846","title":"Systemic administration of a viral nanoparticle neoadjuvant prevents lung metastasis development through emergency myelopoiesis","year":2024,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut National de la Recherche Scientifique","funders":"Canadian Institutes of Health Research; Fondation Jean-Louis Lévesque; Health Research","keywords":"Medicine; Metastasis; Myelopoiesis; Tumor microenvironment; Cancer research; Context (archaeology); Immune system; Tumor progression; Cancer; Immunology; Primary tumor; Bone marrow; Internal medicine; Biology; Stem cell; Progenitor cell","score_opus":0.016083435193827936,"score_gpt":0.27704574483883915,"score_spread":0.2609623096450112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404473852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98309076,0.0046280473,0.008220507,0.00031933343,0.00015228264,0.00010489485,0.00016938383,0.00020823859,0.0031066546],"genre_scores_gemma":[0.9940503,0.0013887478,0.002390495,0.00007841207,0.00002184765,0.00006591684,0.00012438776,0.000012915476,0.0018669405],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999478,0.000008377482,0.0000030475148,0.000010410861,0.000012920029,0.000017444043],"domain_scores_gemma":[0.9999621,0.000008895028,0.00001001498,0.000004207199,0.0000045382512,0.000010287491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008629738,0.00017982436,0.00020474709,0.00010654432,0.00008735676,0.00017246447,0.00010329313,0.00022665405,0.0010637916],"category_scores_gemma":[0.00010306428,0.000059576967,0.00015747845,0.000042976695,0.00015237046,0.00017375425,0.00011783692,0.0005551801,0.00017401672],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021469708,0.00011271171,0.00014528878,0.00008362956,0.0000043650834,0.000053732914,0.000013914792,0.000088886874,0.99345267,0.00019639188,0.00014255055,0.005491132],"study_design_scores_gemma":[0.000050191687,0.0029142397,0.0014573985,0.000018971694,0.000021396318,0.00025757262,0.000025853202,0.0012642967,0.98838264,0.00012623664,0.0054756836,0.0000054632687],"about_ca_topic_score_codex":0.0002467767,"about_ca_topic_score_gemma":0.00049608725,"teacher_disagreement_score":0.0010637916,"about_ca_system_score_codex":0.00011494543,"about_ca_system_score_gemma":0.00027791728,"threshold_uncertainty_score":0.003558755},"labels":[],"label_agreement":null},{"id":"W4408037006","doi":"10.1080/2162402x.2025.2473163","title":"Humanized mouse models of <i>KRAS</i> -mutated colorectal and pancreatic cancers with HLA-class-I match for pre-clinical evaluation of cancer immunotherapies","year":2025,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Canadian Institutes of Health Research; Ontario Institute for Cancer Research","keywords":"KRAS; Colorectal cancer; Medicine; Pancreatic cancer; Human leukocyte antigen; Cancer; Immunotherapy; Cancer research; Immunology; Immune system; Oncology; Internal medicine; Antigen","score_opus":0.03291333261453035,"score_gpt":0.37823464790956546,"score_spread":0.3453213152950351,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408037006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9043008,0.0034923682,0.072539434,0.0008893706,0.0006055194,0.0013747269,0.0062010027,0.0015791978,0.00901758],"genre_scores_gemma":[0.91851324,0.0035125536,0.049556006,0.0004665924,0.00009205151,0.0019998646,0.0059140525,0.00042024988,0.019525342],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99934906,0.00014013042,0.00008503815,0.00017988314,0.0001337566,0.000112115544],"domain_scores_gemma":[0.9994727,0.000067004716,0.00018711733,0.00010718,0.000048427577,0.00011776394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009375656,0.00095866126,0.00046732245,0.0011342191,0.00030743194,0.0006983352,0.0005551335,0.0008549947,0.0043574185],"category_scores_gemma":[0.0002571442,0.00038807146,0.00060329033,0.0004520415,0.0005940956,0.0006768387,0.00034506156,0.0020101364,0.0011821379],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008969514,0.00065433077,0.00038416337,0.00010570051,0.000021897195,0.00013956302,0.000050939703,0.00035030034,0.99257267,0.0012095537,0.00047648294,0.003137453],"study_design_scores_gemma":[0.0002040782,0.003271588,0.0017447354,0.00003789604,0.00007045036,0.0010394473,0.00006766428,0.0017933946,0.9757179,0.00028144533,0.015754744,0.000016600738],"about_ca_topic_score_codex":0.000445267,"about_ca_topic_score_gemma":0.0008367574,"teacher_disagreement_score":0.0043574185,"about_ca_system_score_codex":0.00050951407,"about_ca_system_score_gemma":0.00057149027,"threshold_uncertainty_score":0.014577031},"labels":[],"label_agreement":null},{"id":"W4409204557","doi":"10.1080/2162402x.2025.2484880","title":"Surrogate markers of intestinal dysfunction associated with survival in advanced cancers","year":2025,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Diet and metabolism studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"H2020 European Research Council; Bristol-Myers Squibb; Samsung; Institut Gustave-Roussy; Genentech; Ipsen; Daiichi Sankyo Europe; National Cancer Institute; Servier; Nordic Pharma Group; Eisai; F. Hoffmann-La Roche; Agence Nationale de la Recherche; Seagen; Seerave Foundation; Les Laboratories Pierre Fabre; AstraZeneca; Novocure; Taiho Pharmaceutical; Regeneron Pharmaceuticals; European Commission; Sanofi; Amgen; Pfizer; Celgene; Ignyta; Eli Lilly and Company","keywords":"Medicine; Oncology; Internal medicine; Surrogate endpoint; Cancer research","score_opus":0.01095478614241044,"score_gpt":0.26912126049815727,"score_spread":0.2581664743557468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409204557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99466264,0.002522171,0.0003652263,0.00006797294,0.000020023936,0.00001409997,0.0012542418,0.0000146319235,0.0010789471],"genre_scores_gemma":[0.9984623,0.0003364242,0.0002056969,0.000029162453,0.000013444921,0.000012304288,0.000693114,0.0000023323164,0.00024536074],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99976414,0.00008578504,0.000026606383,0.000053490752,0.000032928085,0.000037065387],"domain_scores_gemma":[0.99915516,0.00012038852,0.0004308217,0.000058715726,0.0000819711,0.00015292122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043739507,0.00024727883,0.00034040323,0.00066977635,0.000254169,0.0005832132,0.00015386344,0.0002654557,0.0011331711],"category_scores_gemma":[0.001080605,0.00007935364,0.0002303257,0.0010020063,0.00017126427,0.00019748324,0.0004345694,0.00038729832,0.00016761277],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009020061,0.000038965845,0.990422,0.00006155037,0.00010076856,0.00005166435,0.000053975135,0.00010217696,0.003142809,0.00004091877,0.00016162635,0.0049215746],"study_design_scores_gemma":[0.000005394115,0.0003061378,0.9978636,0.000010577171,0.00006405612,0.00017010674,0.00008784857,0.0001777912,0.00062671857,0.00006686329,0.000617275,0.0000037058119],"about_ca_topic_score_codex":0.00073971925,"about_ca_topic_score_gemma":0.001402658,"teacher_disagreement_score":0.0011331711,"about_ca_system_score_codex":0.00021402117,"about_ca_system_score_gemma":0.00014492884,"threshold_uncertainty_score":0.0037908554},"labels":[],"label_agreement":null},{"id":"W4410599138","doi":"10.1080/2162402x.2025.2507856","title":"Updates on radiotherapy-immunotherapy combinations: Proceedings of 8th Annual ImmunoRad Conference","year":2025,"lang":"en","type":"review","venue":"OncoImmunology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Weill Cornell Medical College; Pfizer","keywords":"Immunotherapy; Medicine; Radiation therapy; Medical physics; Cancer; Internal medicine","score_opus":0.02578443872472441,"score_gpt":0.34544427869642474,"score_spread":0.31965983997170033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410599138","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003421304,0.9661195,0.00027035756,0.005173615,0.01859838,0.000047719535,0.00017466854,0.00004525481,0.009228457],"genre_scores_gemma":[0.0017083545,0.9699052,0.00067149854,0.0055071306,0.011600142,0.00006564721,0.00044999828,0.000020238544,0.010071764],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994796,0.000109109315,0.000064531116,0.00004788914,0.0002316884,0.00006708971],"domain_scores_gemma":[0.99875045,0.0003170376,0.00016135062,0.000025797266,0.0005416067,0.0002037532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019164783,0.0007729362,0.00087641925,0.0021033809,0.00036677346,0.0017824924,0.00084549794,0.0015449028,0.013425287],"category_scores_gemma":[0.0024637757,0.00026492827,0.0008473731,0.0016726116,0.00026453656,0.0015451317,0.0010529512,0.0025826797,0.0059146364],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001675243,0.00009372201,0.00013145484,0.008086339,0.00007080867,0.00019994173,0.000062576815,0.00019452034,0.0014181298,0.0029664615,0.44510403,0.5415046],"study_design_scores_gemma":[0.000012967409,0.00005054901,0.00021031198,0.001469386,0.00003953062,0.00023167899,0.0000117879235,0.00002006957,0.00017650894,0.0002721468,0.99749833,0.000006619051],"about_ca_topic_score_codex":0.000613845,"about_ca_topic_score_gemma":0.001923137,"teacher_disagreement_score":0.013425287,"about_ca_system_score_codex":0.0008447338,"about_ca_system_score_gemma":0.0015084422,"threshold_uncertainty_score":0.0449121},"labels":[],"label_agreement":null},{"id":"W4411977696","doi":"10.1080/2162402x.2025.2521396","title":"Uncovering common transcriptional features shared by mature peripheral blood PMN-MDSCs and tumor-infiltrating neutrophils in humans","year":2025,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"Associazione Italiana per la Ricerca sul Cancro; Deutsche Forschungsgemeinschaft; Ministero dell’Istruzione, dell’Università e della Ricerca; European Cooperation in Science and Technology; Ministry of Health","keywords":"Peripheral blood; Peripheral; Medicine; Immunology; Cancer research; Biology; Internal medicine","score_opus":0.006370808758004077,"score_gpt":0.23273141373820855,"score_spread":0.22636060498020447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411977696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917697,0.001641657,0.0022145552,0.00005591529,0.000011511416,0.000021847287,0.0036614009,0.000030982363,0.00059252785],"genre_scores_gemma":[0.993185,0.00062150083,0.0019599223,0.00010450829,0.000012588343,0.00003593583,0.0035707578,0.000018760245,0.0004910976],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99982387,0.000013848273,0.000010249223,0.00010410927,0.000029870762,0.00001801775],"domain_scores_gemma":[0.9999374,0.000012144597,0.000019787685,0.000009104439,0.000010112838,0.000011377046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001271035,0.00015278654,0.00026807946,0.00042767668,0.0001612351,0.00026806875,0.00011268535,0.00020892333,0.00087287306],"category_scores_gemma":[0.00027716628,0.00012284081,0.00019466867,0.00032822829,0.0001794994,0.00008851158,0.0002083099,0.00017395418,0.00017855046],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020984698,0.00007048574,0.28302464,0.00025438494,0.00021491454,0.0010310272,0.0004751406,0.00074786396,0.6754634,0.00046065252,0.0015918714,0.03456719],"study_design_scores_gemma":[0.000045285033,0.0003394024,0.9409401,0.000041572333,0.00012331239,0.0029540975,0.0003223918,0.0022446963,0.042651027,0.0006295938,0.009680913,0.000027546299],"about_ca_topic_score_codex":0.00075198006,"about_ca_topic_score_gemma":0.0009574599,"teacher_disagreement_score":0.00087287306,"about_ca_system_score_codex":0.00014557509,"about_ca_system_score_gemma":0.00015280549,"threshold_uncertainty_score":0.0029200912},"labels":[],"label_agreement":null},{"id":"W4412034547","doi":"10.1080/2162402x.2025.2528955","title":"Benzodiazepines interfere with the efficacy of pembrolizumab-based cancer immunotherapy. Results of a nationwide cohort study including over 50,000 participants with advanced lung cancer","year":2025,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"H2020 European Research Council; Labex Immuno-Oncology; Institut Gustave-Roussy; Cancéropôle Ile de France; Institut National Du Cancer; Fondation Gustave Roussy; Institut Universitaire de France; Ligue Contre le Cancer; Fondation pour la Recherche Médicale; Agence Nationale de la Recherche; Association pour la Recherche sur le Cancer; Seerave Foundation; European Commission","keywords":"Pembrolizumab; Medicine; Lung cancer; Immunotherapy; Oncology; Cancer immunotherapy; Cohort; Internal medicine; Cancer","score_opus":0.016426121830857558,"score_gpt":0.3410293854833371,"score_spread":0.32460326365247955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412034547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975738,0.0009445562,0.00014832706,0.00008772003,0.0000067416313,0.000011479565,0.00074867235,0.000006880048,0.00047177012],"genre_scores_gemma":[0.999124,0.0002009886,0.00005694296,0.000038397593,0.0000075458065,0.0000053139706,0.00042141156,0.0000020577215,0.0001434164],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989967,0.0004423305,0.00008663389,0.00017969421,0.00018729737,0.00010741468],"domain_scores_gemma":[0.9968773,0.00048164654,0.0017991228,0.000323112,0.00030419638,0.00021468368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016689848,0.00022341507,0.00023675441,0.0004337245,0.00027301093,0.0006027521,0.0003005728,0.00029794965,0.0007663534],"category_scores_gemma":[0.004017978,0.00023149852,0.00054711,0.0006082463,0.00016337994,0.0003333096,0.00029836042,0.0003709495,0.00018623802],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003066543,0.000018880562,0.9970594,0.000009653941,0.0001330887,0.000031040356,0.00003177337,0.000022766055,0.0002253184,0.000010250168,0.00009405468,0.002057148],"study_design_scores_gemma":[0.000009337923,0.00006763983,0.9994128,0.0000018408904,0.00006744466,0.00008746935,0.000025129722,0.000083365594,0.00005665447,0.000005052081,0.00018176362,0.0000015015639],"about_ca_topic_score_codex":0.0147573305,"about_ca_topic_score_gemma":0.017070958,"teacher_disagreement_score":0.0147573305,"about_ca_system_score_codex":0.00042439275,"about_ca_system_score_gemma":0.00036802262,"threshold_uncertainty_score":0.02934289},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"agree"},{"id":"W4412578767","doi":"10.1080/2162402x.2025.2534912","title":"The human STING agonist E7766 induces immunogenic tumor clearance, independent of tumor-intrinsic STING expression in the <i> KRAS <sup>G12D/+</sup> Trp53 <sup>−/−</sup> </i> murine model of sarcoma","year":2025,"lang":"en","type":"article","venue":"OncoImmunology","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; Alberta Bone and Joint Health Institute; University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Sting; Cancer research; Agonist; KRAS; Sarcoma; Medicine; Cancer; Pathology; Internal medicine; Receptor; Physics","score_opus":0.017011622663489517,"score_gpt":0.2660783263580014,"score_spread":0.24906670369451187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412578767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979752,0.00046685172,0.0005665156,0.00003812094,0.000016111384,0.00002078157,0.00018918292,0.000038072758,0.0006893104],"genre_scores_gemma":[0.9967529,0.00057016517,0.0007816662,0.000036646215,0.0000094581965,0.000032121716,0.00035700106,0.000008856763,0.001451067],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986184,0.000025175035,0.000014330465,0.000019891593,0.000038052738,0.000040741863],"domain_scores_gemma":[0.99989533,0.000014109787,0.000036220466,0.000012556664,0.0000071781287,0.00003463506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011302456,0.00039030347,0.00023797403,0.00022948964,0.000088804176,0.00019279854,0.00015111036,0.00024082235,0.0008793105],"category_scores_gemma":[0.00007658968,0.000108951965,0.0002179738,0.00014647849,0.0002215205,0.00021719458,0.0001100392,0.0007126725,0.0002090967],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005492665,0.00018608144,0.00015159075,0.00003885109,0.0000052109294,0.000027752598,0.000013922049,0.00020673535,0.99683195,0.000056454573,0.00004906959,0.001883127],"study_design_scores_gemma":[0.000045380373,0.003196854,0.0016447539,0.0000046770447,0.0000127664025,0.000097330616,0.000022237711,0.0007289278,0.99352115,0.00001735595,0.0007052161,0.0000033413094],"about_ca_topic_score_codex":0.00028999575,"about_ca_topic_score_gemma":0.0008078118,"teacher_disagreement_score":0.0008793105,"about_ca_system_score_codex":0.00015883616,"about_ca_system_score_gemma":0.00019228946,"threshold_uncertainty_score":0.0029416084},"labels":[],"label_agreement":null},{"id":"W4414508324","doi":"10.1080/2162402x.2025.2562210","title":"IL-21-reprogrammed Vδ1 T cells exert killing against solid tumors which is enhanced by CAR arming for off-the-shelf immunotherapy","year":2025,"lang":"en","type":"article","venue":"OncoImmunology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Discovery Centre","funders":"Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care","keywords":"Chimeric antigen receptor; Immunotherapy; Cancer immunotherapy; T cell; Ovarian cancer; Tumor microenvironment; Cell therapy; Antigen; Cancer","score_opus":0.01529819831688233,"score_gpt":0.32126101308457927,"score_spread":0.30596281476769693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414508324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942159,0.00087084464,0.0027899882,0.000043520726,0.000032322183,0.000027665119,0.00020736415,0.00007383284,0.0017385593],"genre_scores_gemma":[0.9957747,0.00048445226,0.0015018506,0.000031509873,0.000006418987,0.000023246666,0.00031131206,0.000012249117,0.0018543488],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987054,0.000019033512,0.000013710018,0.000024174027,0.000037571095,0.00003494468],"domain_scores_gemma":[0.9999572,0.0000067755486,0.000012552913,0.000008805754,0.000005213118,0.000009502531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008338695,0.00026979405,0.0001543229,0.00009895786,0.00007609551,0.00030540104,0.00012235506,0.00024672848,0.0012652038],"category_scores_gemma":[0.00008092866,0.000057131725,0.00015602192,0.00009648541,0.00012274655,0.00016993996,0.0001436026,0.00039342046,0.0003788316],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006573356,0.000032061165,0.00011754875,0.000024672168,0.0000018805099,0.00003127513,0.000010915755,0.00014862006,0.99750745,0.000077247474,0.000037408234,0.0019451469],"study_design_scores_gemma":[0.0000062730114,0.00021578044,0.001059976,0.0000027458439,0.000006115023,0.00016260274,0.000011480495,0.00055056554,0.9961145,0.000017590612,0.0018507679,0.0000016871301],"about_ca_topic_score_codex":0.000118026524,"about_ca_topic_score_gemma":0.00017914442,"teacher_disagreement_score":0.0012652038,"about_ca_system_score_codex":0.00010707905,"about_ca_system_score_gemma":0.00012417551,"threshold_uncertainty_score":0.004232526},"labels":[],"label_agreement":null},{"id":"W4417071864","doi":"10.1080/2162402x.2025.2590245","title":"Deubiquitinating enzyme JOSD2 modulates cGAS to facilitate immune evasion in colorectal cancer","year":2025,"lang":"en","type":"article","venue":"OncoImmunology","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"National Natural Science Foundation of China","keywords":"Deubiquitinating enzyme; Evasion (ethics); Colorectal cancer; Immune system; Microsatellite instability; Immunotherapy; Immunosuppression; Cancer","score_opus":0.020903676722866197,"score_gpt":0.28467255722174806,"score_spread":0.26376888049888186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417071864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99330115,0.0028410824,0.002320957,0.00011821179,0.000022664348,0.0000126797895,0.00031186867,0.00006559973,0.0010057819],"genre_scores_gemma":[0.99788994,0.00057583733,0.0007005785,0.00004807038,0.000004028063,0.000005510311,0.0002590349,0.000005761938,0.0005111966],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993,0.000011032651,0.000006469218,0.000017805924,0.000017357772,0.000017282271],"domain_scores_gemma":[0.9999552,0.0000061843925,0.000018179022,0.0000038204125,0.0000047514345,0.000011868775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014428476,0.0002102805,0.00019657098,0.00016743597,0.0001158579,0.00026258433,0.000104588355,0.00013995855,0.00073504413],"category_scores_gemma":[0.00010264666,0.00007451621,0.00018989116,0.00011766715,0.00017081593,0.00013152903,0.00014359494,0.00023057265,0.00016507646],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003115,0.000036124893,0.003743974,0.000095650685,0.000024711937,0.00011753426,0.000013646239,0.00042831578,0.99028647,0.00019330723,0.00012129191,0.004627443],"study_design_scores_gemma":[0.000040534014,0.00034947088,0.030246252,0.000015814268,0.000045308232,0.0008046013,0.00007044847,0.006048531,0.9546909,0.00018928168,0.007487556,0.00001134113],"about_ca_topic_score_codex":0.00019343106,"about_ca_topic_score_gemma":0.0004910336,"teacher_disagreement_score":0.00073504413,"about_ca_system_score_codex":0.00025566373,"about_ca_system_score_gemma":0.00012421481,"threshold_uncertainty_score":0.0024589896},"labels":[],"label_agreement":null},{"id":"W7117357993","doi":"10.1080/2162402x.2025.2604877","title":"IL-37/IL-1R8 axis: a novel major mechanism of control at the interface between tumor and immune cells","year":2025,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"Associazione Italiana per la Ricerca sul Cancro; Fondazione Umberto Veronesi; Ministero della Salute","keywords":"Inflammasome; Immune system; Tumor microenvironment; Regulator; Cytokine; Inflammation; Mechanism (biology); Transcription factor; Signal transduction; Innate immune system","score_opus":0.009705949025675373,"score_gpt":0.23826926724224454,"score_spread":0.22856331821656917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117357993","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.057449423,0.91354144,0.011531109,0.0022370252,0.0010415397,0.00010293588,0.0005081583,0.00027848376,0.013309871],"genre_scores_gemma":[0.3248323,0.64821464,0.0084539885,0.0014657999,0.0013731375,0.00016033658,0.00078060065,0.00005790902,0.014661299],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998671,0.000020079127,0.000010935234,0.000028432843,0.000038444952,0.000034898665],"domain_scores_gemma":[0.9999652,0.0000054175102,0.000010378914,0.000001811098,0.000008795316,0.000008390949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016543873,0.00060857367,0.0005320665,0.0004028372,0.00021039341,0.0008803114,0.00036673027,0.00038213414,0.0013494658],"category_scores_gemma":[0.00010370469,0.000101448575,0.0003297966,0.00024371917,0.00040503615,0.0005712476,0.00037264603,0.00068012864,0.0004489911],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008850589,0.00008685683,0.0023993482,0.008771966,0.00019815323,0.0045009837,0.0007004331,0.0009757779,0.7127561,0.029860605,0.010386038,0.22847874],"study_design_scores_gemma":[0.00007062741,0.00076877465,0.0103395255,0.0010052746,0.0003991543,0.010350605,0.00083591964,0.0011519761,0.21866848,0.009746545,0.7465863,0.00007690603],"about_ca_topic_score_codex":0.00038853585,"about_ca_topic_score_gemma":0.00050246,"teacher_disagreement_score":0.0013494658,"about_ca_system_score_codex":0.00053219986,"about_ca_system_score_gemma":0.0006083742,"threshold_uncertainty_score":0.004514456},"labels":[],"label_agreement":null}]}